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Chromosome segregation errors that occur in the developing germline generate 
aneuploidies which are among the leading causes of embryonic lethality, spontaneous 
abortions and chromosomal disorders, such as Down’s syndrome. Compared to other 
species, human oocytes appear to be particularly prone to suffer chromosome mis-
segregation and the risk of aneuploid pregnancies in humans increases drastically with 
maternal age. Despite its particular importance for human health, relatively little is 
known about the basis for the high incidence of aneuploidies in human oocytes and the 
maternal-age effect. The identification and analysis of molecular pathways that promote 
genetic and chromosomal stability is important for our understanding of mechanisms 
that lead to aneuploidy and how it can be prevented.  
 
Here, I examine the role of the pluripotency associated Tex19.1 gene, in preventing 
aneuploidy during mouse female germ cell development.  I demonstrate that Tex19.1-/- 
females are subfertile when mated with wild type males due to defects in chromosome 
segregation during meiosis.  In contrast to Tex19.1-/- male gem cells, synaptonemal 
complex formation appears to be completed normally in Tex19.1-/- females but high 
levels of aneuploidy are evident during the second meiotic stages of oogenesis. The 
Tex19.1-/- females transmit these aneuploidies to their offspring likely resulting in the 
observed embryonic death and subfertility.  
 
In addition to its role in the female germline, I investigated the function of Tex19.1 
during embryonic development. I found that Tex19.1-/- knockout mice are born at a sub-
Mendelian frequency and this reduction is exacerbated in diapaused embryos, suggesting 
that Tex19.1 plays a role during a stage where a pluripotent state is maintained for a 
prolonged period of time. Furthermore, I identified high levels of aneuploidy 
accumulating in pluripotent stem cells in the absence of Tex19.1. 
 
i
Previous work demonstrated that the chromosome segregation defects in Tex19.1-/- 
males correlate with retrotransposon upregulation suggesting that Tex19.1 might be part 
of a host defence system that protects cells against mutagenic endogenous retroviruses. 
During this project, I investigated the upregulation of retrotransposon expression in 
more detail and tested at which stage of the retroviral life cycle inhibition through 
Tex19.1 might occur. I was able to show that Tex19.1 interacts with the E3 ubiquitin 
ligase, Ubr2, in 293T and ES cells suggesting a role in proteolysis.  
 
The work carried out during the course of this thesis suggests that Tex19.1 functions at 
multiple points during the germ line cycle. In particular, the defects in chromosome 
segregation observed in Tex19.1-/- female mice advance our understanding of 
mechanisms that influence the occurrence of aneuploidy. Tex19.1-/- female mice could 
provide a valuable model system for human aneuploidy and shed light on how our 
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1.1 The germline cycle 
 
Reproduction is a fundamental feature of all known life. Sexual reproduction is a 
biological process by which organisms create descendants that have a combination of 
genetic material contributed from two different members of the species. Germ cells are 
the founder cells of all sexually reproducing organisms. Specifically, in mammals 
genetic information is transmitted through successive generations by being passed in a 
self-perpetuating cycle from germ cells to pluripotent cells in the early embryo and back 
again (figure1.1). Pluripotent cells are capable of giving rise to any cell type of the adult 
organism, including germ cells. Germ cells give rise to eggs in females and sperm in 
males, the cells responsible for passing genetic information from one generation to the 
next. Fertilisation of the egg by the sperm creates a totipotent zygote which is able to 
initiate repetition of the whole cycle again. When the genome is passed on to subsequent 
generations during this cycle both the germ cells, and the pluripotent cells, must retain a 
high developmental and infinite proliferative capacity, and ensure genetic and 
chromosomal stability is maintained.  
 
During my PhD I have particularly focused on the question how chromosomal stability 
is maintained through successive generations by addressing the role of the pluripotency 
associated Tex19.1 gene during the germline cycle, in particular during embryonic and 
female germline development. This chapter reviews the current knowledge of germ cells 
and early embryonic development as well as the causes and consequences for the 









                            
Figure 1.1 The mammalian germline cycle.  Fertilization of the egg (pink) by the sperm (blue) 
produces a pluripotent zygote. The pluripotent cells in the early embryo (blue) will in turn give 
rise to germ cells (blue). The germ cells will undergo meiosis to produce egg or sperm which will 
then upon fertilization give rise to the next generation. Modified from (Öllinger et al., 2010). 
 
 
1.2 Mouse embryonic development 
 
1.2.1 Early mouse pre-implantation development 
 
Embryonic development of the mouse begins with fertilisation of the egg (or oocyte) by 
the sperm, both of which are haploid cells that no longer divide, resulting in the 
formation of the zygote (one-cell embryo), a diploid totipotent cell (Seydoux and Braun, 
2006). This cell is able to produce all of the tissues necessary for fetal development by 
having the ability to differentiate into any cell of the organism as well as the 
extraembryonic tissue associated with the fetus. After fertilisation, the zygote divides 
into a number of smaller cells called blastomeres, a process which is referred to as 
cleavage.  After fertilisation, the mitotic cell cycle and embryonic developmental 
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program is resumed which is facilitated by maternally inherited RNAs and proteins 
(Latham et al., 1992; Latham and Schultz, 2001; Stitzel and Seydoux, 2007). In the 
mouse the transition from maternal to zygotic control of gene expression occurs at the 
two-cell stage and during this time the main wave of transcriptional activation and 
translation of the embryonic genes is initiated (Schultz, 2002). This process, which is 
also called zygotic genome activation, progressively frees the embryo from the need to 
use maternally stored ribonucleic acids (RNAs) (Flach et al., 1982; Nothias et al., 1995; 
Hamatani et al., 2004a). By 2.5 days post coitum (dpc) repeated cleavage has generated 
eight morphologically discrete blastomeres (shown in figure 1.2). Before the 
blastomeres divide for the fourth time surface contact between cells increases through 
increasing cell adhesion and individual blastomeres become indistinguishable (Hyafil et 
al. 1980; Shirayoshi et al. 1983; Vestweber, et al., 1987). This process is referred to as 
compaction and induces a degree of cell polarization, as the initial radially symmetric 
blastomeres become polarised in an apical–basal manner during this time (Vestweber et 
al., 1987; Fleming et al., 2001). As cleavage proceeds to the 16-cell stage that occurs 
around 3dpc, there is a restriction in the developmental potency of the blastomeres 
eventually resulting in the generation of two distinct lineages: the trophectoderm (TE) 
and the inner cell mass (ICM) (Wang and Dey, 2006).  
 
The TE will go on and form one of the four extraembryonic membranes, the chorion, 
which provides the embryonic portion of the placenta. The cells of the ICM will give 
rise to all the cells of the organism plus the other three extraembryonic membranes (yolk 
sac, amnion and allantois). The ICM cells are considered to be pluripotent because they 
have the potential to differentiate into all three germ layers of the embryo proper: 
ectoderm, mesoderm and definitive endoderm. Formation of TE and ICM facilitates 
embryonic-abembryonic (Em-Ab) polarity in the blastocyst. The Em pole refers to the 
side of the blastocyst where the ICM is located whereas the Ab pole marks the opposite 
side where the blastocoel is situated (figure 1.2).  The exact mechanisms that underlie 
lineage specification of TE and ICM, as well as formation of Em-Ab polarity, in 
cleavage-stage embryos are still not fully understood (Johnson, 2009). However, there 
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are several models for this process that have been postulated during the last decades that 
aim to explain what is known to date (Sasaki, 2010).  
 
The earliest proposed model is the mosaic model which suggested that cell lineages are 
specified by selective distribution of determinants (Dalcq, 1957; Mulnard 1992).  This 
model appears to be true in a variety of non-mammalian species where early cleavages 
play an important role in establishing Em-Ab polarity. For example in frogs and fish 
determinants such as β-catenin define formation of the dorsal axis. Removal or ectopic 
expression of dorsal determinants in frogs or fish results in ventralised or dorsalised 
embryos, respectively (Pandur et al., 2002; Schier and Talbot, 2005; White and 
Heasman, 2008). In contrast, in mice, removal of the animal or vegetal pole of the 
zygote has not shown to negatively affect embryonic development as there is no adverse 
phenotype, therefore demonstrating that critical determinants are not needed in mouse 
zygotes, and arguing against the mosaic model for embryonic patterning in mice 
(Zernicka-Goetz 1998). Alternatively, it has been proposed that the pattern of early 
cleavages influences lineage specification during mouse embryonic development. 
Several studies suggest that the plane of the first cleavage event determines that one 
blastomere of the two-cell embryo will mainly contribute to the ICM and the other 
mainly to the TE cell lineages (Gardner, 1997; Gardner, 2001; Piotrowska et al. 2001; 
Plusa et al. 2005; Zernicka-Goetz, 2005). Furthermore, the second cleavage has also 
been implicated in deciding the developmental fate of the blastomeres in that the cell 
which divides first will mainly contribute to the ICM whereas the later dividing cell will 
give rise mainly to the TE  (Piotrowska et al., 2001; Piotrowska-Nitsche and Zernicka-
Goetz, 2005a; Piotrowska-Nitsche and Zernicka-Goetz, 2005a; Bischoff et al., 2008). 
This model remains controversial as other studies were not able to identify a correlation 
between early cleavage and blastocyst organization or a specific fate for early or later 
dividing blastomeres (Alarcon and  Marikawa, 2003; Fujimori et al., 2003; Chroscicka et 
al., 2004; Alarcon and  Marikawa, 2005; Motosugi et al. 2005; Kurotaki et al. 2007). 
Furthermore, it has been shown that artificial removal of one blastomere at the 2 or 4-
cell stage does not impair embryonic development (Tarkowski, 1959). Similarly, 
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aggregation experiments of single blastomeres, isolated at the 4- or 8-cell stage, with 
host embryos have shown that those cells are still totipotent suggesting that initially 
during cleavage all blastomeres are identical in their developmental potential and that 
linage specification in the mouse occurs after the 8-cell stage (Tarkowski & Wroblewska 
1967; Rossant, 1976; Kelly, 1977).  
 
1.2.2 Lineage specification during mouse pre-implantation 
development  
 
It has long been proposed that blastomeres after the forth cleavage adopt TE or ICM 
fates depending on their position within the embryo (Tarkowski and Wroblewska, 1967). 
This model was later refined with the polarisation model (Johnson and Ziomek, 1981a; 
Johnson and Ziomek, 1981b). The polarisation model proposes that polarisation of the 8-
cell stage blastomeres is critical for later lineage determination. While cells divide from 
8- to 16-cell stage some blastomeres will acquire a position on the surface of the embryo 
whereas others will adopt an internal position where they are completely surrounded by 
neighboring blastomeres (figure 1.2) (Johnson, 2009). The outer blastomeres retain an 
apical-basal polarity whereas internal blastomeres lose apical features and become 
morphologically apolar (Johnson and Ziomek, 1983).  During the fifth cleavage event 
more external and internal cells are generated by division of the outer polarised cells. 
Symmetric division of external cells results in two polarised cells which will stay on the 
outside. In contrast, asymmetric division of polarised cells gives rise to one polarised 
daughter which will remain external and one apolar daughter which will adopt an 
internal position (Johnson and Ziomek, 1981b). External blastomeres preferentially 
differentiate into TE whereas internal cells go on to form the ICM (figure 1.2) (Johnson 
and Ziomek, 1983; Johnson and McConnell, 2004; Suwinska et al. 2008).  However, 
until blastocyst formation the fate of individual blastomeres can be changed by changing 
their position within the embryo (Hillman et al., 1972). During the fifth cleavage event 
small cavities start to form, between blastomeres, which continually expand and 
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ultimately fuse to form a single large cavity (blastocoel) (Aziz and Alexandre, 1991). 




Figure 1.2 Cell lineage formation during mouse embryonic development. Embryonic 
development of the mouse begins with fertilization of the oocyte by the sperm in the oviduct 
resulting in a totipotent zygote. The embryo then undergoes several rounds of cell division 
ultimately resulting in a ball of cells called a morula. The late morula enters the uterus and 
develops into a blastocyst. The blastocyst contains a cavity (blastocoel) with two distinct 
populations, the inner cell mass (ICM) and the trophectoderm (the progenitor of trophoblast 
cells). Around 4 dpc the blastocyst hatches from its outer shell (the zona pellucida) and 
differentiates to produce additional cell types — the epiblast and the primitive endoderm. The 
trophectoderm then attaches to the uterine wall to facilitate the process of implantation.The cell 
types in the embryos are color coded. Figure was taken from Rossant and Tam (2009).  
 
At the blastocyst stage TE cells surround the entire embryo and ICM cells accumulate as 
a single mass attached to the basal surface of the TE. Lineage specification of TE is 
initiated at the morula stage prior to blastocyst formation when TE-specific transcription 
factors like such as Cdx2 or Eomes start to become restricted to the outside blastomeres 
(Sasaki, 2010). Expression of Cdx2, which is detected for the first time at the 8- to 16-
cell stage, initially appears random (Ralston and Rossant, 2008). However, from the 
early morula stage onwards Cdx2 expression becomes gradually restricted to the outer 
cells of the embryo. In the outer blastomeres Cdx2 facilitates suppression of ICM 
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identity resulting in the restriction of Oct4 and Nanog expression, which are required to 
specify the pluripotent cells of the ICM, specifically to an ICM fate after blastocyst 
formation. Oct4 is expressed throughout early cleavage in all blastomeres as a result of a 
maternally inherited transcript (Rosner et al., 1990; Schöler et al., 1990; Yeom et al., 
1996). At the blastocyst stage Oct4 becomes restricted to the ICM and is downregulated 
in the TE cells.  
 
Nanog expression is observed for the first time at the 8-cell stage and once again with an 
apparently random distribution (Dietrich and Hiiragi, 2007). At the blastocyst stage, 
similarly to Oct4, Nanog becomes downregulated in the TE. Nanog also becomes 
downregulated (or fluctuates) in a subpopulation of the ICM (see below). In Cdx2-/-
mutant mice Oct4 and Nanog do not become downregulated in the TE cells (Ralston and 
Rossant, 2008).  Cdx2-/- embryos are able to develop into early blastocysts and form the 
cavity but the blastocoel eventually collapses as Cdx2-/- TE cells fail to undergo further 
trophoblast differentiation and loose morphological integrity (Strumpf et al. 2005). In 
accordance with the hypothesis that Cdx2 is involved in TE lineage specification is data 
from embryonic stem (ES) cells that suggest that ectopic expression of Cdx2 induces 
trophoblast differentiation (Niwa et al., 2005). Tead4, Eomes and Elf5 have also been 
implicated to govern the specification of the TE lineage (Niwa et al., 2000; Niwa et al., 
2005). The phenotype of Tead4-/- embryos is slightly more severe than Cdx2-/- embryos 
and is characterised by the absence of TE or trophoblast-specific gene expression, failure 
to form the blastocoel and differentiation of all blastomeres into ICM (Yagi et al. 2007; 
Nishioka et al. 2008). The apparent roles of Eomes and Elf5 expression are to stabilise 
the TE lineage and to be required for the differentiation of fate-specified TE into 
trophoblast cells (Russ et al., 2000; Ng et al., 2008). As described above Cdx2-/- mutant 
embryos fail to silence Oct4 and Nanog expression in the TE lineage. Similarly, Oct4 
and Nanog are required to repress Cdx2 in the pluripotent cells (Niwa et al. 2005; Chen 
et al. 2009). Failure to repress the expression of Cdx2 in the inner cell mass, due to 
mutations in Oct4, causes all cells to commit to the TE lineage (see below) (Nichols et 
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al., 1998). Taken together this data suggests that Oct4, Nanog and Cdx2 play crucial 
roles in segregating pluripotent and TE cell fates, respectively.  
 
1.2.3 Primitive endoderm and epiblast formation  
 
At approximately 4.5dpc the blastocyst is ready for implantation. At this stage the ICM 
of the blastocyst segregates into epiblast and primitive endoderm (or hypoblast). The 
epiblast will give rise to all cells of the fetus and extraembryonic mesoderm. The 
hypoblast will eventually form extraembryonic endoderm layers of the visceral and 
parietal yolk sacs. Oct4 has been shown to be absolutely required for the ability of the 
ICM to differentiate into epiblast and possibly the hypoblast (Nichols et al., 1998). At 
the late blastocyst stage, when Oct4 expression is down regulated in the TE lineage, 
Oct4 is expressed in all cells of the epiblast and also briefly in the hypoblast. After 
implantation Oct4 expression will be restricted to the pluripotent epiblast and is absent 
from extraembryonic cell lineages (Palmieri et al., 1994). After gastrulation, Oct4 
expression becomes restricted to primordial germ cells (PGCs), the precursors of the 
germ cell lineage (Schöler et al., 1990; Yeom et al., 1996). As mentioned previously 
under 1.2.2, Oct4-/- embryos fail to produce the epiblast and hypoblast and instead cells 
of the ICM differentiate along the extraembryonic trophoblast lineage (Nichols et al., 
1998). This suggests that Oct4 is absolutely required to maintain pluripotency 
(developmental potential) of the ICM cells in the blastocyst during embryonic 
development. Consistent with this, ES cells, which are ICM-derived cell lines require a 
critical amount of Oct4 expression to maintain pluripotency and expression of Oct4 is 
downregulated upon ES cell differentiation (Niwa et al., 2000). Absence of Oct4 causes 
ES cells, similarly to ICM cells, to differentiate into TE (Niwa et al., 2000). Based on 
this data and the transient expression in the hypoblast it has been hypothised that Oct4 is 
essential for the differentiation of ICM into epiblast and possibly also for hypoblast 
commitment (Nichols and Smith, 2009).  
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Similarly to Oct4, Nanog is expressed in pluripotent embryo cells, ES cells, and the 
developing germline, and its presence is associated with an undifferentiated cell state 
(Chambers et al., 2003, Mitsui et al., 2003). During embryonic development Nanog-/- 
cells initially form pluripotent cells but are unable to maintain this state and fail to form 
the epiblast (Mitsui et al., 2003). In contrast to Oct4-/- ICM cells Nanog-/- ICM cells do 
not differentiate into TE suggesting different functions for these two genes. ES cells 
derived from Nanog-/- blastocysts can be maintained on feeder cells for at least two 
months but grow slower than control ES cells, down regulate pluripotency markets like 
Oct4 and induce expression of endoderm transcription factors and markers (Mitsui et al., 
2003). When maintained on gelatin, Nanog-/- ES cells completely down regulate 
expression of pluripotency markers and differentiate into extraembryonic endoderm 
lineages (Mitsui et al., 2003). This data appears to be in disagreement with a later study 
which reported that ES cells that have undergone conditional deletion of Nanog, after ES 
cell derivation, are prone to differentiate but are able to proliferate infinitely and 
contribute to somatic chimaeras (Chambers et al., 2007). However, it has been suggested 
that Nanog functions later than Oct4 (and other pluripotency factors), which are believed 
to trigger a cascade of events necessary to induce pluripotency, and instead is required to 
lock cells into a self-sustaining pluripotent state (Yates and Chambers, 2005; Silva et al., 
2008; Nichols and Smith, 2009). Upon differentiation of the epiblast, during gastrulation 
(see below), Oct4 and Nanog expression is downregulated in all somatic lineages but 
persists in the primordial germ cells (PGCs) (Chambers et al., 2003; Mitsui et al., 2003; 
Yamaguchi et al., 2005; Nichols and Smith, 2009).  
 
Morphologically the epiblast and the hypoblast can be clearly distinguished from each 
other by 4.5dpc. The epiblast and hypoblast appear to be restricted to their 
corresponding cell fate by 4.5dpc as experiments showed that epiblast or hypoblast cells 
were able to only contribute to their own lineage when injected into other blastocysts 
(Moody, 1999). Traditionally it was believed that all cells of the ICM have equal 
potential to acquire either epiblast or hypoblast cell fate and that the position of cells on 
the surface of the ICM would be designated to differentiate into hypoblast (Gardner, 
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1983).  Recent studies showed that by 3.5dpc individual ICM cells express mutually 
exclusive epiblast (Nanog) or hypoblast specific genes (Gata6) in a random manner 
(Chazaud et al., 2006). Furthermore, injection of single ICM cells into blastocysts 
demonstrated that individual cells largely contribute to either hypoblast or epiblast cell 
lineages (Chazaud et al., 2006). Based on this data it has been postulated that by 3.5pc 
ICM cells are largely designated to either an epiblast or a hypoblast cell fate and that 
later relocation of cells segregates the two layers (Chazaud et al., 2006). Some cells in 
this experiment contributed to both lineages suggesting that by 3.5dpc ICM cells are 
possibly biased but not absolutely committed to differentiate into either hypoblast or 
epiblast. This has also been hypothesised by a later study involving lineage tracing of 
individual ICM cells expressing a marker of the late hypoblast cell lineage (Pdgfrα). 
Live imaging of embryos expressing a histone H2B-GFP fusion protein reporter under 
the control of the Pdgfrα promoter allowed lineage tracing of individual ICM cells 
(Plusa et al., 2008). This analysis showed that before formation of the blastocyst 
hypoblast and epiblast specific transcription factors are expressed in an overlapping 
manner but confirmed mutually exclusive expression by 3.5dpc and that this biases cells 
towards one or the other lineage. The authors further suggest that at least some aspects 
of hypoblast induction require positional signals, linking the two hypotheses (Plusa et 
al., 2008). Further work will be required to understand the exact relationship between 
lineage restriction and gene expression and the mechanisms involved in segregating cells 
to their respective layer.  
 
1.2.4 Early post-implantation development  
 
By whichever mechanisms epiblast and hypoblast are segregated it is clear that at 
implantation the mouse blastocyst is distinctively partitioned into TE, hypoblast and 
epiblast (figure 1.2). At approximately 4.5dpc the blastocyst is ready for implantation 
and attaches tightly to the uterine epithelium (Senner and Hemberger, 2010). The TE 
cells begin to differentiate into an inner layer of cytotrophoblast and an outer 
multinucleated cell layer, the syncytiotrophoblast which starts to invade the connective 
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tissue of the uterus (Senner and Hemberger, 2010). Furthermore, subsequent to 
implantation the polar TE, which lines the epiblast, facilitates the formation of the 
ectoplacental cone which connects the egg cylinder (an elongated structure consisting of 
the epiblast, visceral endoderm and the extra-embryonic ectoderm) to the uterine tissue. 
The TE will ultimately give rise to the trophoblast lineages that form the majority of the 
fetal part of the placenta. The hypoblast gives rise to the visceral and parietal endoderm 
(VE and ParE) which surround the epiblast and the extraembryonic ectoderm and line 
the luminal surface of the mural trophectoderm, respectively (Rossant and Tam, 2009).  
 
The majority of the VE will give rise to extra-embryonic cell lineages, a small 
proportion of VE cells, however, will also contribute to the endoderm of the embryonic 
gut (Kwon et al., 2008; Rossant and Tam, 2009). The VE is an important source of 
signals to establish anterior-posterior polarity of the mouse embryo which is required for 
formation and correct placement of the primitive streak which marks the initiation of 
gastrulation (Tam and Loebel, 2007). The primitive streak forms opposite the anterior 
visceral endoderm (AVE) which defines the anterior side of the embryo (Thomas and 
Beddington, 1996; Rivera-Perez et al., 2003; Srinivas et al., 2004; Torres-Padilla et al., 
2007). The AVE arises from visceral endoderm cells that form at the distal tip of the 
embryo (also called distal visceral endoderm (DVE)) and then migrate to a more 
proximal position close to the extra embryonic ectoderm (ExE). Signals from the ExE, 
like Bmp4, induce expression of primitive streak markers like Wnt3 and Nodal in the 
epiblast. In turn Nodal signaling from the epiblast maintains Bmp4 expression in the 
ExE (Liu et al., 1999; Ben-Haim et al., 2006). Secretion of Nodal and Wnt3 antagonists 
like Cer1, Lefty1 and Dkk1 by the AVE confers anterior identity to the underlying 
epiblast by shielding it from signals that induce primitive streak formation in the 
posterior epiblast and restrict the primitive streak to the appropriate location within the 
embryo (Yamamoto et al., 2004; Kimura-Yoshida et al., 2005; Rodriguez et al., 2005; 
Richardson et al., 2006). Indeed, in embryos that lack both antagonists, the anterior side 
of the primitive streak becomes expanded, or ectopic primitive streaks form (Perea-
Gomez et al., 2002). The primitive streak is the hallmark for the initiation of gastrulation 
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which results in the formation of the embryonic germ layers (ectoderm, mesoderm and 
definitive endoderm) (Tam and Loebel, 2007).  Epiblast cells that ingress through the 
primitive streak are incorporated into the endoderm or form a new layer of mesoderm in 
the space between the epiblast and the definitive endoderm (Tam and Loebel, 2007). 
Cells that remain in the epiblast will form the ectoderm. Lineage tracing of individual 
cells showed that epiblast cells are able to give rise to any of the three germ layers until 
ingression takes place (Lawson et al., 1991).  A diagram summarising the process of 
early post-implantation development in the mouse is shown in figure 1.3. In addition to 
the three germ layers are primordial germ cells (PGCs), which constitute the founder 
cells of the germ cell lineage, established during gastrulation around 7dpc (Tam and 
Loebel, 2007). This process, also referred to as germ cell specification, is described in 




Figure 1.3 Early post-implantation development from 4dpc to 6.5dpc. (a) Blastocyst at 
implantation (see also figure 1.2). (b) 5dpc embryo prior to formation of distal visceral endoderm 
(Pre-DVE). (c) The 5.5dpc embryo is characterised by formation of the distal visceral endoderm 
(DVE). (d) At 6dpc the anterior visceral endoderm has formed (AVE). (e) Early primitive streak 
formation at 6.5dpc. Primitive endoderm is presented in grey. In a-b ICM and epiblast in blue. In 
c-e ectoderm, mesoderm and definitive endoderm progenitors are marked in blue, orange and 
yellow respectively. Primitive streak is colored in crimson. Figure was taken from Tam and 








The above sections described stages of embryonic development that normally occur 
sequentially and without interruption. However, rodents have the ability to delay 
embryonic development by arresting the embryo at the late blastocyst stage, after 
segregation of epiblast and hypoblast but prior to implantation to counteract sub-optimal 
conditions for reproduction associated with demands on maternal nutrients (Renfree and 
Shaw, 2000). For example in mice diapause occurs to delay implantation of newly 
formed embryos in response to lactation. This might occur frequently when a mating 
pair is housed together as female mice are able to mate shortly after the female has given 
birth during the post-partum estrus. Implantation itself requires a synchronous interplay 
between embryos and the uterus as the uterus is only capable of supporting attachment 
and invasion by the blastocyst for a limited period of time. In mice, uterine receptivity to 
accept a blastocyst for implantation depends on the coordinated actions of the ovarian 
steroid hormones, progesterone and estrogen, as implantation fails in estrogen and 
progesterone mutant mice (figure 4.8) (Lyden et al., 1995; Hewitt et al., 2002).  
Preparation for implantation begins with a preovulatory increase in estrogen which 
initiates proliferation of uterine epithelial cells. By 3 dpc, progesterone levels begin to 
increase which stimulates uterine stromal cell proliferation. High levels of progesterone 
are needed for both embryo implantation and maintenance of post-implantation 
development. By 4dpc, estrogen levels increase again which appears to be critical for 
implantation to occur and stimulate, together with progesterone, the proliferation and 
differentiation of uterine stromal cells.  This rise in estrogen concentration does not take 
place when the mating has occurred during post partum estrus. This is due to the fact 
that lactation inhibits the secretion of gonadotropin, which in turn stimulates the 
production of estrogen, resulting in insufficient secretion of ovarian estrogen at 4 dpc in 
mothers that are suckling a litter (figure 4.8).  As soon as estrogen levels increase, 
implantation proceeds normally.  Diapause can be induced experimentally by 
ovariectomy of female mice at 2.5dpc, which abolishes the rise in estrus at 4 dpc, and 
simultaneous administration of progesterone to maintain the pregnancy.  Implantation 
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and normal development of experimentally arrested embryos can be achieved by pre-
treatment with progesterone followed by small dose of estrogen or by transfer to a 
hormonally primed, pseudopregnant recipient mother (Yoshinaga & Adams, 1966; 
McLaren, 1973). Diapause can also be induced by chemical ovariectomy by 
simultaneous administration of tamoxifen and depo-provera on day 2.5 of gestation 
(Hunter and Evans, 1999). Tamoxifen is a non-steroidal anti-estrogen that has been 
shown to exhibit estrogen antagonistic and agonistic actions in a species specific manner 
(Hunter and Evans, 1999). Combined administration of tamoxifen and depo-provera (the 
brand name for depot medroxyprogesterone acetate), appears to cause anti-estrogenic 
effects resulting in delayed implantation (Hunter and Evans, 1999). Similarly to embryos 
diapaused by surgical ovariectomy chemically diapaused embryos implant and develop 





Figure 1.4 Hormone levels required for embryonic development and implantation. A rise in  
leutinizing hormone (Lh) levels, a gonadotropin (orange), stimulates estrogen (blue) and 
progesterone (green) secretion by the ovary resulting in ovulation. Preparation for implantation 
begins with the preovulatory increase in estrogen which initiates proliferation of uterine epithelial 
cells. By 3 days post-coitum progesterone levels begin to increase (P4) which stimulates uterine 
stromal cell proliferation. During this time the uterine environment is considered pre-receptive 
which means that the uterus is unable to initiate implantation but also less hostile to blastocyst 
survival. By 4 dpc of pregnancy, or pseudopregnancy, estrogen levels increase again (E2) and 
stimulate together with progesterone the proliferation and differentiation of uterine stromal cells 
resulting in a uterine environment that is receptive for blastocyst implantation. By 5dpc the 
uterine environment becomes nonreceptive (refractory) to implantation. Lactationally, surgically 
and chemically-induced diapauses antagonize the second peak in estrogen levels (E2) and 
inhibit blastocyst implantation. Simultaneous administration of progesterone ensures that the 
pregnancy is maintained; figure taken from (Wang and Dey, 2006).  
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Entry of the embryo itself into diapause may involve the epiblast cells entering or 
perpetuating an ES cell-like state (Batlle-Morera et al., 2008). This is based on the 
observation that the LIF/gp130 signalling pathway, which is important for the 
maintenance of ES cells in culture, is required for diapause, but not for normal 
development at this stage. The main function of gp130 signalling in vitro is the 
suppression of ES cell differentiation (Smith, 2001). It is possible that the phenotype of 
gp130-/- embryos is caused by apoptosis of inappropriately differentiating epiblast cells 
(Nichols et al., 2001). Apart from the gp130 receptor little is known about the genes that 
the embryo requires to undergo diapause. It is known that upon diapause the blastocyst 
enters a state of proliferative and metabolic quiescence. Expression changes of many 
genes have been observed between activated and delayed blastocysts by microarray 
(Hamatani et al., 2004). However, many of those expression changes can be attributed to 
the cellular and physiological events that are expected to change with ceased 
proliferation and metabolism. Of the 229 genes that were found to be differentially 
expressed between delayed and activated blastocysts approximately 30% have not been 
functionally investigated so far. Therefore it is possible that one or several important 
regulators of diapause might be among those (Hamatani et al., 2004). Interestingly, 
expression levels of gp130 did not appear to be significantly altered between delayed 
and active blastocysts (Hamatani et al., 2004).  
 
1.3 Germ cell development 
 
1.3.1 Germ cell specification  
 
In mice, and possibly all mammals, the initiation of the germline depends on secreted 
signals from the previously segregated extraembryonic lineages (Hayashi et al., 2007). 
Inducing signals from the Exe and VE, like Bmp4, Bmp8b and Bmp2, instruct a small 
number of adjacent pluripotent proximal epiblast cells to become PGCs while the 
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majority of epiblast cells differentiate towards a somatic cell fate (Saitou, 2009). It 
appears that until this stage epiblast cells are not committed to develop into a certain cell 
fate as transplantation of epiblast cells from the distal tip of the embryo next to the Exe 
showed that those cells were capable to develop into PGCs when exposed to the 
inducing signals (Tam and Zhou, 1996). Mutations in either of those signaling genes 
cause failure of PGC specification resulting in either absence or severe reduction of 
PGCs (Lawson et al., 1999; Ying et al., 2000; Ying and Zhao, 2001). In order to analyse 
the difference between epiblast cells that will commit to a PGC and those that will 
commit to a somatic cell fate Saitou et al. (2002) investigated the transcriptional profile 
of epiblast cells at single cell resolution. They found that Bmp4 signaling induced 
expression of Fragilis, an interferon-induced transmembrane protein, in epiblast cells, 
that acquire germ cell competence (Saitou et al., 2002). The formation of lineage 
restricted PGC precursors is marked by expression of Blimp1 in six of the Fragilis 
positive cells which are in direct contact with the overlying Exe (Ohinata et al., 2005; 
Hayashi et al., 2007).  The function of Blimp1 during germ cell specification involves 
the suppression of the somatic cell fate, expressed by their non-PGC neighbours, and the 
induction of germ cell character in the Fragilis positive epiblast cells. Germ cell 
character is induced by repression of mesodermal genes like Hoxa1 and Hoxb1, both of 
which are expressed to a high level in the surrounding somatic cells and upregulation of 
pluripotency-associated genes such as Nanog and Stella (Ohinata et al., 2005). Blimp1-/- 
embryos initially form a cluster of about 20 PGCs but fail to repress somatic cell lineage 
specific gene expression and fail to migrate towards the developing genital ridges. By 
7.25dpc a cluster of 40 Stella (earliest known marker for fate-restricted PGCs) and 
alkaline phosphatase (marker of an undifferentiated state) positive founder PGCs can be 
observed at the posterior end of the primitive streak in the extraembryonic mesoderm 
(Exm) (Saitou, 2009). Around 7.5dpc PGCs initiate migration where they travel from the 
extraembryonic tissues back into the embryo, passing through the developing hindgut, 
before reaching and colonising the emerging genital ridges at 10.5 dpc (Bendel–Stenzel 
et al., 1998). During this time, the number of PGCs increases to more than 3,000 and by 
13.5 dpc, the number in the fetal gonads reaches around 22,000 (Tam and Snow, 1981). 
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1.3.2 Epigenetic remodeling during early PGC differentiation  
 
During the migratory period PGCs undergo substantial global epigenetic changes 
(Surani, 2001). This is followed by widespread epigenetic reprogramming at 11.5dpc 
which might be expected for cells that must ensure that the zygote acquires totipotency 
in order to give rise to the next generation (Sasaki and Matsui, 2008). Initially, the 
chromatin of Blimp1 expressing PGCs comprises similar genome-wide repressive 
epigentic marks, such as DNA methylation, Histone 3 lysine 9 dimethylation 
(H3K9me2) and H3K27 trimethylation (H3K27me3), like the chromatin of their 
surrounding somatic neighbors (Seki et a., 2007; Sasaki and Matsui, 2008). Migrating 
PGCs initiate global changes in DNA methylation, H3K9me2 and H3K27me3 (Seki et 
al., 2005). DNA methylation and H3K9me2, which are generally associated with long-
term rather than transient repression,  are gradually erased resulting in a global 
chromatin state that is largely free of repressive chromatin marks between 7.5 and 
8.25dpc (Seki et al., 2005). This coincides with transient inhibition of RNA polymerase 
II dependent transcription, possibly to circumvent transcriptional misregulation caused 
by the reduction in repressive epigenetic marks (Seki et al., 2007). From approximately 
8.25dpc there is an increase in global H3K27me3 levels, a less permanent repressive 
mark, that also correlates with the erasure of H3K9me2. This possibly occurs in order to 
inhibit the expression of lineage specific genes that are upregulated during early 
differentiation and to maintain an appropriate repressive chromatin state of the PGC 
genome. Since this mark is considered a less permanent repressive mark than H3K9me2 
it is possible that its role also involves keeping lineage specific silenced genes poised for 
rapid transcriptional activation and helps to maintain pluripotency. Furthermore, in 
female germ cells reactivation of the X-chromosome is also initiated during the 
migratory period of PGCs (de Napoles et al., 2007; Sugimoto et al., 2007). By 10.5dpc, 
the PGCs have migrated to the genital ridges and undergo further large-scale chromatin 
remodeling that results in genomic imprints being erased (Chong, and Whitelaw, 2004). 
Genomic imprinting itself refers to a genetic phenomenon by which certain genes are 
expressed in a parent-of-origin-specific manner. Deletion of imprints is reflected by 
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demethylation of the imprinted loci (Chong, and Whitelaw, 2004). This occurs 
simultaneously with demethylation of other regions of the PGC genome (Sasaki and 
Matsui, 2008). Once parental imprints have been reset new, gender specific imprints 
must be introduced (Sasaki and Matsui, 2008). Imprints are re-established after sex 
determination has been initiated and germ cells have differentiated  to become either 
male or female in order to give rise to sperm or oocytes, respectively (Sasaki and 
Matsui, 2008). 
 
1.3.3 Sex determination 
 
Before colonising the prospective gonadal tissues XX and XY PGCs appear to behave 
identically in most aspects. The germ cells’ decision to embark on either a male or 
female developmental pathway appears to be determined through the embryonic gonadal 
environment, rather than the chromosomal sex of the germ cells themselves (Kocer et 
al., 2009). Indeed, it has been shown that XY germ cells in female chimaeric embryos 
can develop as oocytes and XX germ cells are able to differentiate into 
prospermatogonia in male chimaeric embryos (Ford et al., 1975; Palmer and Burgoyne, 
1991). In contrast, the decision of the initially bipotential, undifferentiated gonad to 
develop along a female (ovarian) or male (testicular) pathway depends on the 
inheritance of X and Y sex chromosomes (Matzuk and Lamb, 2008; Kocer et al., 2009). 
Differentiation of the primordial gonad into either ovary or testis ultimately directs the 
sexual development of the rest of the embryo (Kocer et al., 2009). The decision whether 
gonadal somatic cells differentiate into testicular sertoli cells or ovarian granulosa cells 
is controlled by the presence or absence of the Y chromosomal testis determining factor 
Sry between 10.5dpc and 12.5dpc (Lovell-Badge and Robertson, 1990; Koopman et al., 
1991; Sekido et al., 2004).  Expression of Sry upregulates Sox9 which appears to be both 
necessary and sufficient to induce testicular development.  XY females are often 
characterised by mutations that inactivate Sry.  Ectopic expression of this gene causes 
testis formation and physical and behavioral sex reversal in XX embryos (Gubbay et al., 
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1990; Sinclair et al., 1990; Koopman et al., 1991; Cameron and Sinclair, 1997). 
Similarly expression of a Sox9 transgene in a XX mouse promotes testis development of 
XX gonads (Bishop et al., 2000; Vidal et al., 2001). Wnt/b-catenin signaling in the XX 
gonadal somatic cells ensures, at least in part, female sex determination by antagonising 
Sry/Sox9 signaling (Kim et al., 2006; Chassot et al., 2008). This is supported by the 
observation that ectopic expression of a stabilised form of beta-catenin in 11.5 dpc 
gonadal somatic cells results in ovary formation in XY mice (Maatouk et al., 2008).  
 
In the adult gonads expression of the transcription factors Foxl2 in granulosa cells and 
Dmrt1 in sertoli cells appears to be essential to maintain sex determination in mice long 
after the choice to embark along a female or male developmental pathway in the embryo 
has been made. A mutation in Foxl2 in the adult mouse can cause transdifferentiation of 
granulosa cells towards a sertoli cell fate and loss of Dmrt1 appears to upregulate Foxl2 
and causes transdifferentiation of sertoli cells into granulosa cells in adult testis 
(Uhlenhaut et al., 2009; Matson et al., 2011).  
 
As mentioned above a germ cells’ decision to develop as either male or female is guided 
by sex-determining signaling molecules secreted by the prospective testes or ovaries, 
respectively (Kocer et al., 2009). Initially, between 12.5 to 13.5dpc male and female 
embryonic gonads are colonised by post-mitotic/pre-meiotic germ cells which represent 
the transition between the end of mitosis and the start of meiosis (Hilscher et al., 1974; 
McLaren, 1984; McLaren, 2003). Work from Adams and McLaren (2002) suggests that 
germ cells in XY gonads have responded to the testicular environment and are 
committed to spermatogenesis by 12.5dpc. Germ cells in XX gonads appear to have 
responded to the ovarian environment by 13.5dpc and are fully committed along a 
female pathway (Adams and McLaren, 2002). The first sex-specific morphological 
difference between male and female germ cells becomes evident when female germ cells 




1.3.4 Meiosis in males and females 
 
Between males and females the general outline of meiosis (described under 1.4.2) is 
conserved but the details are remarkably different. One sex specific difference is in the 
timing of meiosis (figure 1.6). In both sexes PGCs continue to divide mitotically until 
about 13.5 dpc (McLaren and Southee, 1997). In a male embryo the germ cells arrest in 
the G0 stage of the cell cycle, resuming mitosis after birth (Hilscher et al., 1974; 
McLaren, 1984). Meiosis begins at 8 to 10 dpc and continues without interruption 
throughout the life of the male due to a continuous supply of diploid spermatogonia 
entering meiosis. In contrast, female meiosis begins during fetal development and all 
oocytes that the female will possess in her lifetime are produced at this stage. For this 
process germ cells stop proliferating at 13.5dpc and enter prophase of meiosis I as 
oocytes. The oocytes pass through the different stages of prophase and then arrest at 
diplotene around the time of birth. This specialized prolonged arrest state is known as 
dictyate (Speed, 1982). During the oocytes’ meiotic arrest, homologous chromosomes 
are physically held together as bivalents by crossover events and cohesion complexes 
between the deoxyribonucleic acid (DNA) molecules. Oocytes remain arrested in this 
state until sexual maturation; meiosis is not continued until hormonal stimulation shortly 
before ovulation and the second division is completed when the egg is fertilized (figure 




Figure 1.5 Meiosis in males and females. Pluripotent cells (green) are found in early mouse 
embryos. By 7.5dpc primordial germ cells (PGCs, orange) have differentiated from the 
pluripotent cells. The PGCs proliferate and migrate towards the genital ridge. They have 
colonized the developing gonads by 11.5 dpc. Around 13.5 dpc PGCs in male embryos enter 
quiescence. A few days after birth some of the male germ cells differentiate into spermatogonial 
stem cells. Those provide a continuous supply of spermatogonia that undergo meiosis and 
differentiate into mature sperm in the adult mouse. In contrast PGCs in female embryos initiate 
meiosis at around 13.5 dpc but arrest at the end of prophase I a few days after birth. Meiosis 
resumes in fully grown adults upon ovulation and the second meiotic division is only completed 




1.4 Mitosis and Meiosis 
 
Meiosis is a specialized type of cell division during which the number of chromosomes 
is reduced by half so that fertilization during sexual reproduction results in the 
generation of a diploid karyotype. The reduction of chromosome number is 
accomplished by essentially one round of DNA replication followed by two rounds of 
cell division, meiosis I and meiosis II. This process creates haploid daughters from a 
diploid parental cell in a manner that ensures each daughter cell a complete haploid 
genome (Page and Hawley, 2003). In order to understand how chromosomes are 
segregated during meiosis it is important to be familiar with the principles of 





Mitosis is a form of eukaryotic cell division which results in the production of two 
daughter cells genetically identical to the parent cells and each another. Mitosis is 
preceeded by interphase and then subdivided into prophase, prometaphase, metaphase, 
anaphase and telophase during which the genetic information of a cell is first duplicated 
and then segregated into the two daughter cells (outlined in figure 1.6) (Sullivan and 
Morgan, 2007). During interphase the cell prepares for cell division by increasing in size 
and replicating its DNA. DNA replication results in two identical copies of each 
chromosome which are then called sister chromatids. During mitosis sister chromatids 
need to be accurately segregated to ensure accurate transmission of genetic material to 
each daughter cell. A key difference between mitosis and meiosis is that sister 
chromatids remain joined after metaphase in meiosis I, whereas in mitosis they separate 
(figure 1.7).  
 
Figure 1.6 Mitotic chromosome segregation. The various stages of the cell cycle are 
depicted. During interphase, the cell undergoes growth and replication of the DNA. Upon 
replication of the spindle pole body and DNA, the cell undergoes a second round of growth and 
subsequently enters mitosis. Mitosis is divided into prophase (when the chromatin is 
condensed), prometaphase (when kinetochore microtubules start to interact with kinetochores), 
metaphase (when chromosomes become bi-oriented), anaphase (when the sister chromatids 
segregate to opposite spindle poles) and telophase (when chromosomes decondense). In most 
eukaryotes, the nuclear membrane degrades during mitosis and reforms during telophase, but 











Figure 1.7 Mitosis and Meiosis (A) Interphase which preceeds mitosis is subdivided into G1, S 
and G2 phase. During G1 synthesis of various enzymes that are required in S phase is taking 
place. During S phase diploid cells replicate chromosomes. This is followed by the G2 phase 
where microtubules and other proteins are produced that are required during the process of 
mitosis.  During mitosis (M) sister chromatids segregate so that diploid daughters are produced. 
(B) During meiosis two rounds of chromosome-segregation (meiosis I and II) follow a single 
round of DNA replication during pre-meiotic S-phase. Meiosis I results in the segregation of 
homologous chromosomes (shown in red and blue), which are held together by chiasmata, are 
segregated to opposite poles. During meiosis II sister chromatids get segregated resulting in the 
formation of haploid gametes taken from Marston and Amon (2004).  
 
 
In order for sister chromatids to be correctly segregated bi-orientation on the mitotic 
spindle needs to be achieved. Bi-orientation refers to a process where sister chromatids 
align on the mitotic spindle in a manner that allows microtubules emanating from 
opposite spindle poles to attach to the sister chromatid kinetochores in order to pull them 
apart to opposite spindle poles (see figure 1.5) (Verdaasdonk and Bloom, 2011). 
Attachment of microtubules to sister chromatid kinetochores can be erroneous probably 
because of the ‘search and capture’ nature of this process (Musacchio and Salmon, 
2007). In order to ensure fidelity of chromosome segregation formation of bi-orientation 
is monitored by the spindle-assembly checkpoint (SAC). The SAC delays anaphase if 
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chromosomes are not properly attached so that the error can be corrected and therewith 
ensures faithful chromosome segregation in mitosis (Musacchio and Salmon, 2007). The 
linkage between sister chromatids brings the two centromeres/kinetochores into close 
proximity which is important for correct microtubule attachment (Shintomi and Hirano, 
2010). Sister chromatids are held together from DNA replication until the onset of 
chromosome segregation by the cohesin complex. The cohesin complex consists of four 
core subunits: two subunits of the structural maintenance of chromosomes (SMC) 
protein family, Smc1 and Smc3; the kleisin family protein Scc1/Rad21 and Scc3/Psc3 
(Nasmyth and Haering, 2005). The cohesin proteins associate with the chromosomes 
before DNA replication and are afterwards converted into the physical linkage that holds 
the sister chromatids together through G2 phase. It has been shown that in vertebrates 
the major bulk of cohesin disassociates from the sister chromatid arms during prophase, 
before the sisters are separated (Losada et al. 1998; Waizenegger et al. 2000). 
Dissociation of the cohesin complex from the chromatid arms might involve 
phosphorylation of cohesin subunits as several residues of the cohesin subunits 
SA2/Scc3 and RAD21/Scc1 are phosphorylated in a mitosis-specific manner. 
Furthermore, expression of an only poorly phosphorylatable mutated version of 
SA2/Scc3 in HeLa cells results in inefficient dissociation of cohesin from chromatin 
during prophase I (Hauf et al., 2005).  This suggests that phosphorylation of cohesin 
subunits enables the cohesin complex to dissociate from the chromatin during prophase. 
Despite the dissociation of cohesin from the chromatid arms during prophase I sister 
chromatid cohesin is maintained until the onset of anaphase. This is facilitated by 
centromeric cohesin which escapes release from chromatin during prophase 
(Waizenegger et al. 2000). It has been suggested that centromeric cohesin is protected 
from phosphorylation by Shugoshin (Sgo) to ensure that cohesin persists at the 
centromeres until anaphase (Shintomi and Hirano, 2009). This theory is based on the 
observation that the Sgo protein is found to localise to the centromeres during prophase 
and disappears from the centromeres at the onset of anaphase. Knockdown of Sgo by 
RNA interference (RNAi) in HeLa cells causes premature separation of sister 
chromatids resulting in cell cycle arrest (McGuinness et al., 2005). At metaphase the 
26
nuclear envelope has disappeared (the fragmentation of which starts during prophase, 
and is complete in pro-metaphase), and the sister chromatids align on the cells equator. 
This is followed by the onset of anaphase, during which a specific endopeptidase, called 
separase, is activated to cleave the kleisin subunit Scc1/Rad21 (Uhlmann et al., 1999). 
This results in disassociation of the cohesin complex, thereby allowing chromatid 
separation. The chromatids then move to opposite ends of the cell towards the spindle 
poles (Sullivan and Morgan, 2007).  Anaphase is followed by telophase which results in 
reassembly of the nuclear envelope around each daughter nuclei. At the same time the 
binucelate cell is divided into two by the process of cytokinesis to form the two daughter 





Chromosome segregation during meiosis depends to some extent on the same machinery 
used during mitosis. However,  since meiotic cells reduce chromosome numbers by 
undergoing two rounds of chromosome segregation after only one round of DNA 
replication, several meiosis-specific innovations are required to generate haploid 
gametes (Handel and Schimenti, 2010; Öllinger et al., 2010). During the first round of 
chromosome segregation, meiosis I, only one of the two homologues of each duplicated 
chromosome is partitioned into each of the two daughter cells. During the second round 
of chromosome segregation, meiosis II, the duplicated chromosomes separate into their 
constituent sister chromatids which are then partitioned equally between two daughter 
cells. Prior to entering meiosis, the DNA is replicated during premeiotic S-phase that 
converts each chromosome into two sister chromatids resulting in a cell with four 
chromatids of each type of chromosome – two maternal and two paternal chromatids 
(Handel and Schimenti, 2010; Öllinger et al., 2010). Both the two maternal and paternal 
sister chromatids are referred to as homologue chromosomes. Premeiotic DNA 
replication is followed by prophase I, which is subdivided into leptotene, zygotene, 
pachytene, diplotene and diakenisis, during which homologues chromosomes pair, align 
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and undergo recombination which will result in crossover (CR) formation between the 
DNA molecules of homologous chromosomes (Jones, 2008). The CR events physically 
connect homologue chromosomes until metaphase I. The first meiotic division 
segregates homologous chromosomes rather than sister chromatids and therefore a 
physical connection between homologous chromosomes is required to allow proper bi-
orientation of homologous chromosomes on the meiotic spindle and subsequent 
segregation to opposite spindle poles (Schvarzstein et al., 2010). Connection between 
sister chromatids is maintained until metaphase II when the second meiotic division 
segregates sister chromatids to opposite spindle poles in order to generate haploid 
gametes.  
 
1.4.2.1 Sister chromatid cohesion  
 
During meiosis sister chromatids are paired and physically bound together by 
incorporation of meiosis specific cohesion proteins (Uhlmann and Nasmyth, 1998). This 
is initiated during premeiotic DNA replication when the mitotic cohesin subunit 
Scc1/Rad21 is largely replaced by the meiosis specific subunit Rec8 (Eijpe et al., 2003).  
During the leptotene stage of prophase I the remaining meiotic cohesin components, 
Smc1β, Smc3, and Stag3, associate with the meiotic chromosomes. Work in fission 
yeast and mammals showed that mutations in meiotic cohesin proteins not only results in 
premature sister chromatid separation but also defects in meiotic recombination and 
synaptonemal complex formation (Klein et al., 1999; Eijpe et al., 2000; Pelttari et al., 
2001; Eijpe et al., 2003; Revenkova et al., 2004; Xu et al., 2005). This data, together 
with further work carried out in fission yeast which showed that ectopic expression of 
Scc1/Rad21 is not able to restore meiotic recombination and synaptonemal complex 
formation in rec8Δ cells suggests that meiotic-specific cohesin is not only required to 
hold sister chromatids together, but also to generate the correct chromosomal 
architecture for the subsequent meiotic processes that are discussed below (Toth et al., 
2000; Yokobayashi et al., 2003). 
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1.4.2.2 Meiotic recombination  
 
Meiotic recombination is initiated by the formation of DNA double-strand breaks 
(DSBs) which are introduced into the genome by the meiosis-specific endonuclease 
Spo11 (Romanienko and Camerini-Otero, 2000). The DSB are then resected on either 
side of the break by 5'–3' exonucleolytic processing to create 3' overhangs of single-
strand DNA (ssDNA) which are initially bound by replication protein A (RPA) 
(Symington and Gautier, 2011). In mammals the DSB resection is dependent on a 
variety of factors including the MRN complex, CtIP, Sgs1 and Exo1 (Bernstein and 
Rothstein, 2009; Youds and Boulton, 2011). Replacement of RPA by Rad51 
recombinase and its meiosis-specific paralogue Dmc1 marks the assembly of early 
recombination foci (Li and Ma, 2006). Processing of the DNA double-strand breaks at 
these early recombination foci is crucial for homologue chromosomes to pair. Spo11-/- 
and Dmc1-/- mice are infertile as they fail to pair and synapse homologues chromosomes 
which possibly reflects the involvement of early meiotic recombination in the homology 
search (Pittman et al., 1998; Baudat et al., 2000).  Association of DSBs with Rad51 and 
Dmc1 results in the formation of nucleoprotein filaments which invade adjacent DNA 
molecules to search for homologous DNA sequences (Hunter and Kleckner, 2001). In 
order to generate exchanges between homologous chromosomes maternal filaments have 
to invade paternal chromatids and vise versa as invasion of sister chromatids would, like 
it takes place in mitotic cells, simply result in repairing the DSB (Collins and Newlon, 
1994; Schwacha and Kleckner, 1994; Paques and Haber, 1999). The mechanisms that 
biases invasion towards homologous chromosomes rather than sister chromatids during 
meiosis are currently not well understood but likely require several meiosis specific 
proteins (Schwacha and Kleckner, 1997). For example, Rec8 null mice (Rec8-/-) show 
recombination between sister chromatids instead of homologous chromosomes (Xu et 
al., 2005). This suggests that Rec8 plays a role in directly limiting synapsis to 
homologous chromosomes during mammalian meiosis or organising a meiotic 
chromosome structure which favours recombination between homologous 
chromosomes. Recombination between homologous chromosomes proceeds when the 
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invading 3’ filament of one of the homologues becomes paired with a complementary 
strand of the other homologous chromosome to create recombination intermediates 
(Petronczki et al., 2003).  Interaction between these invasion intermediates and the 
second DNA double strand break end results in the formation of a meiotic recombination 
intermediate known as a double Holliday junction that possesses regions of heteroduplex 
DNA containing complementary DNA strands from the two homologous chromosomes 
(Youds and Boulton, 2011). The double Holliday junctions are then subjected to further 
processing to be resolved as either as interhomolog crossovers (CRs) or as non-
crossovers (NCRs) (see figure 1.8) (Constantinou et al., 2001; Öllinger et al., 2010; 
Youds and Boulton, 2011). A NCR event refers to a situation where only small regions 
of single DNA strands have been exchanged between chromatids from homologous 
chromosomes whereas in the case of a CR event both DNA strands of the recombining 
chromatids have been exchanged between homologous chromosomes at the 
recombination site. CR and NCR events are marked by loss of early recombination 
markers, like Dmc1 and Rad51, from meiotic chromosomes and as the recombination 
sites mature they incorporate the recombination-associated proteins Msh4 and Msh5 
(Youds and Boulton, 2011). Data from Msh4-/- and Msh5-/- mice suggests that both 
proteins are crucial for the formation of CRs. Mice with a mutation in either protein fail 
to form CRs and are consequently sterile (Edelmann et al., 1999; Kneitz et al., 2000). As 
meiosis proceeds, the majority of recombination sites in the nucleus is resolved as NCRs 
as shown by a decrease of >200 early recombination events to around twenty-five Mlh1-
containing CRs (Moens et al., 2007). Mlh1, which participates in the late step of CR 
formation, is considered a marker for recombination that will mature as CRs. This is 
based on the fact that Mlh1 appears to exclusively associate with recombination sites 
that are designated to form CRs (Broman et al., 2002; Froenicke et al., 2002). Mature 
CR events appear as chiasmata and as they are involved in maintaining the physical 
connection between homologous, which ensures two homologues are being pulled to 
opposite poles at meiosis I. It is essential that every chromosome has at least one CR in 
order to achieve faithful chromosome segregation to take place during the first meiotic 
division (Carpenter, 1994). This is well demonstrated by the phenotype of Mlh1-/- mice 
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which show defective chiasmata formation resulting in meiotic arrest (Edelmann et al., 
1996). The mechanisms that regulate the number and distribution of chiasmata in the 
meiotic genome are still not clear. However, recent evidence suggests that the location 
of DSB formation might be influenced by chromatin structure and certain sequence 
motifs (Fukuda et al., 2008; Mets et al., 2009; Baudat et al., 2010). Figure 1.8 
summarises the processes of CR and NCR formation.  
 
 
Figure 1.8 Model for meiotic crossover or non-crossover formation. Red and blue lines 
represent single DNA strands. Generated DSBs are resected to generate ssDNA with 3′ 
overhang. Strand invasion events result in recombination intermediates. If the second end of the 
original DSB also engages with the homologue, a double Holliday junction is formed which leads 
to crossover products (left hand side). The majority of recombination intermediates are not 
resolved as crossovers but as non-crossovers.  Non-crossovers are formed when the invading 
strand associates with the opposite end of the original break, as in synthesis-dependent strand 







1.4.2.3 Meiotic chromosome synapsis 
 
In order for homologous recombination between chromosomes to initially occur, 
homologous sequences must first find each other. How exactly each chromosome 
searches for and identifies its homologous partner for recombination is not well 
understood but it is thought that the interaction of the meiotically induced DNA DSBs 
(described previously) with matching sequences on the homologous chromosome, brings 
the axis of homologous chromosomes into alignment (Page and Hawley, 2004). 
Homologue chromosomes roughly align their axes with their partner during the zygotene 
stage of meiosis and chronologically with homologous chromosome alignment are 
chromosome pairing and synapsis taking place. During homologous chromosome 
synapsis the synaptonemal complex (SC) assembles between homologous chromosomes 
which is thought to function as a scaffold to enable the repair and recombination 
processes and ultimately crossover formation between interacting chromatids as 
described above (Page and Hawley, 2004; Costa and Cooke, 2007). The SC itself is a 
meiosis-specific tripartite proteinaceous synaptonemal complex structure comprised of 
axial elements (AEs), transverse filaments (TFs) and the central element (CE) (Page and 
Hawley, 2004; Costa and Cooke, 2007). Assembly of the synaptonemal complex is 
initiated during leptotene when the axial element (AE) proteins Sycp2 and Sycp3 
assemble on the meiotic chromosomal axes (Schalk et al. 1998; Pelttari et al. 2001). This 
is followed by the assembly of TFs, mainly consisting of Sycp1, and CE proteins Syce1, 
Syce2 and Tex12 during zygotene (Costa et al., 2005; Öllinger et al., 2005; Hamer et al., 
2006). Formation of TFs and the CE facilitates close connections between the AE 
associated with one pair of homologous sisters and with the AE associated with the other 
pair. The AEs from this stage onwards are termed lateral elements (LEs) (Costa and 
Cooke, 2007). The completely assembled SC, which has formed at pachytene, physically 
links homologous chromosomes in a zipper-like manner and thus mediates synapsis 
(Öllinger et al., 2010).  
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Studies from Sycp2-/- and Syp3-/- mice have shown that assembly of the AEs during 
leptotene is required for subsequent formation of the SC during spermatogenesis. Male 
Sycp2-/- and Sycp3-/- mice show impaired meiotic chromosome synapsis as Sycp1 
filaments, which are generally considered to mark synapsis, neither assemble nor 
function properly in the absence of either protein. Immunofluorescence and electron 
microscopy showed that only short and fragmented stretches of Sycp1 are associated 
with the meiotic chromosomes (Yuan et al., 2000; Yang et al., 2006). In contrast Sycp2-/- 
and Sycp3-/- females show, based on Sycp1 localisation, more complete synapsis and are 
fertile albeit at a reduced level (Yuan et al., 2002; Yang et al., 2006). This reduction in 
fertility in Sycp3-/- females is caused, at least in part, by a failure in CR formation 
resulting in high rates of aneuploidy in mature oocytes and subsequently embryo 
lethality (Yuan et al., 2002). The phenotype of Sycp1-/- mice demonstrates that Sycp1 is 
essential for the formation of homologous chromosome synapsis. AEs assemble and 
align normally but synapsis does not take place in the absence of Sycp1 resulting in 
sterility of both sexes (de Vries et al., 2005). Furthermore, it was shown that late Mlh1 
containing recombination foci are not formed in Sycp1-/- spermatocytes resulting in 
impaired CR formation (de Vries et al., 2005). Similarly mutations in AE and TF 
components disrupt homologous chromosome synapsis. In the absence of either of the 
CE proteins short regions of synaptonemal complex assemble but are unable to extend 
along the entire chromosome axis and early recombination events do not mature into 
meiotic CRs resulting in male and female sterility (Bolcun-Filas et al., 2007, Hamer et 
al., 2008; Bolcun-Filas et al., 2009). In addition to components of the SC,  meiotic 
specific cohesin proteins facilitate the completion of synapsis between homologous 
chromosomes (Revenkova et al. 2001; Eijpe et al. 2003; Revenkova et al. 2004). For 
example Smc1β-/- mice exhibit high levels of incomplete synapsis which is thought to be 
caused by defects in the compaction of meiotic chromatin (Revenkova et al. 2004). 
Taken together it appears that the events of cohesin protein assembly, meiotic 
recombination, and homologous chromosome pairing and synapsis during meiosis are 
closely interdependent. Homologous pairing and chromosome synapsis appear to be 
initiated by meiotic recombination which in turn allows meiotic recombination sites to 
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mature. Pachtytene is followed by the diplotene stage of meiosis during which the 
synaptonemal complex disassociates (Costa and Cooke, 2007).  Connection between 
homologous chromosomes at this stage is maintained by the previously mentioned 
chiasmata and by cohesin complexes linking the sister chromatid arms (Revenkova and 
Jessberger, 2005). These homologous chromosome pairs, called bivalents, can then align 
on the meiotic spindle for reductional segregation in meiosis I. 
 
 
Figure 1.9 Overview of the processes occurring during prophase I of meiosis. During the 
leptotene (leptonema) stage of prophase I homologous chromosomes begin to align and AEs 
begin to assemble on sister chromatids of each homologous chromosome (turquoise and gold 
lines). Spo11 induces DSBs, characterised by γH2AX accumulation, which mediates 
recombination. Formation of early recombination foci is marked by binding of Dmc1 and Rad51 
to DSBs. During zygonema (zygotene) chromosomes have been aligned and synapsis is 
initiated as demonstrated by formation of the TFs (here shown by assembly of Sycp1). 
Formation of the SC is complete by pachytene (pachynema). During pachytene a small 
proportion of recombination intermediates matures into crossovers as marked by assembly of 
Mlh1 and Mlh3. When recombination is completed the SC disassembles and homologous are 
held together by chiasmata (this stage is referred to as diplonema or diplotene). Figure was 







1.4.2.4 Segregation of homologous chromosomes and sister chromatids 
during meiosis 
 
Metaphase I is preceded by diakinesis, the last stage of prophase I, which is very similar 
to pro-metaphase of mitosis, as during this time the nuclear membrane disintegrates and 
the meiotic spindle begins to form (Schvarzstein et al., 2010). The physical connection 
between homologous chromosomes achieved by chiasmata and cohesin proteins is 
essential to achieve bi-orientation of homologous chromosomes on the meiotic spindle 
midway between the poles and subsequent traction of maternal and paternal 
kinetochores toward opposite poles during metaphase I (Hauf and Watanabe, 2004). To 
ensure that homologous chromosomes, rather than sister chromatids, segregate during 
meiosis I the sister chromatids of each homologous chromosome have to behave as a 
single functional unit and attach to microtubules emanating from the same pole (Sakuno 
and Watanabe, 2009). It has been suggested that during MI, similar to mitosis, a SAC 
functions to delay anaphase until proper kinetochore-microtubule attachments are 
formed (Wassmann et al., 2003; Niault et al., 2007; Hached et al., 2011). Once correct 
bi-orientation is achieved cohesin proteins are lost from chromosome arms during the 
transition from metaphase I to anaphase I but not the centromeres as shown by 
immunostaining for Rec8, Smc3 and Smc1β on meiotic chromosomes (Revenkova et al. 
2001; Eijpe et al. 2003). Displacement of cohesin complexes from the chromosome arms 
requires separase-mediated proteolytic cleavage of the cohesin subunit Rec8 (Kudo et 
al., 2006). Dissociation of the cohesin complex from the chromosome arms is thought to 
allow the chiasmata that link the bivalent to resolve and the homologous chromosomes 
to separate during the metaphase-anaphase transition of meiosis I. The persistence of 
cohesin complexes at the centromeres ensures that the physical connection between 
sister chromatids is maintained at this stage (Schvarzstein et al., 2010).  
 
In mammals Shugoshin-like-2 (Sgol2) is responsible to protect centromeric cohesin until 
the metaphase II to anaphase II transition. It has been shown that Sgol2-/- mice are 
unable to retain centromeric cohesin during meiosis I resulting in single chromatids at 
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metaphase II which will give rise to aneuploid gametes resulting in infertility (Lee et al., 
2008; Llano et al., 2008). Meiosis II appears similar to mitotic chromosome segregation 
as it results in separation of sister chromatids. During meiosis II the connection between 
sister chromatids, mediated by centromeric cohesin, facilitates bi-orientation and the 
attachment of sister kinetochores to microtubules emanating from opposite poles of the 
spindle (Hauf and Watanabe, 2004). During the metaphase-anaphase transition of 
meiosis II Sgol2 becomes inactivated and sister chromatid separation is mediated by 
cleavage of the remaining Rec8 by separase (Kudo et al., 2006). The sister chromatids 
by convention are now called sister chromosomes. The last step of meiosis is telophase 
II, which is similar to telophase I, and is marked by de-condensing and lengthening of 
the chromosomes as well as the disappearance of the spindle and reassembly of the 
nuclear envelope around each daughter nuclei (Strachan and Read, 2004). Meiosis 
concludes with the production of four haploid spermatozoa in males and two haploid ova 
in females which completes meiosis. The meiotic processes described in this, and the 













Figure 1.10 Chromosomal behaviour during mouse meiosis Pre-meiotic germ cells contain  
one maternal and one paternal  copy of each chromosome which are also called homologous 
copies or chromosomes (orange and red threads, only two homologous chromosome axes are 
shown for clarity). Prior to entering meiosis DNA replication duplicates each chromosome. The 
duplicated chromosomes are referred to as sister chromatids and are held together by meiosis-
specific cohesion complexes (black rings). During leptotene the chromosomes are condensing 
and meiotic recombination is initiated (not shown) and the axial elements of the synaptonemal 
complex assemble along the chromosomal axes (not shown). This is followed by zygotene 
where homologous chromosomes start to pair and then synapse as the synaptonemal complex 
continues to assemble (black zipper-like structure). Synapsis is complete by pachytene and 
recombination between homologous chromosomes has generated crossover sites. During 
diplotene, the synaptonemal complex disassembles and the crossover sites mature into 
chiasmata which act as a physical connection between homologous chromosomes. Homologous 
chromosomes align on the meiotic spindle during metaphase I. This is followed by cleavage of 
cohesin subunits along the chromosome arms which allows the chiasmata to resolve and 
homologous chromosomes to segregate during anaphase I. Cleavage of centromeric cohesions 
in meiosis II then facilitated sister chromatid segregation. Each round of meiosis generates four 
genetically distinct haploid products from a diploid cell, taken from Öllinger et al. (2010). 
 
 
1.5 Spermatogenesis and oogenesis  
 
 
Taken together, germ cell development ultimately aims to create developmentally 
competent haploid oocytes in the female and haploid sperm in the male. Fusion of 
oocyte and sperm results, in a diploid zygote which will undergo all of the above 
described developmental steps and give rise to the next generation. In order to ensure 
that fertilisation can occur germ cells have to, in addition to meiosis, undergo cellular 
differentiation and develop into mature gametes. The entire process of producing a 
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Female germ cells grow and undergo meiotic maturation within ovarian follicles (Edson 
et al., 2009). As described under section 1.3 germ cells in the embryonic ovary initially 
divide mitotically and at this stage they are referred to as oogonia. Following this, the 
oogonia then differentiate into oocytes and enter meiosis. Initially oogonia are arranged 
in clusters in the ovary. Pepling and Spradling (1998) showed by using confocal 
microscopy that those clusters contained 2n germ cells as the majority of cells appear to 
divide synchronously.  Additionally, electron microscopy revealed that the oogonia were 
interconnected by intercellular bridges between 11.5 to 17.5dpc caused by incomplete 
cytokinesis (Pepling and Spradling, 1998).  This process is conserved from flies to 
mammals and it has been reported that defects in cluster and intercellular bridge 
formation causes sterility in female flies (de Cuevas et al., 1996). In mammals the 
function of intracellular bridges is less clear as Tex14-/- mutant female mice, which lack 
formation of intercellular bridges between oogonia, are fertile (Greenbaum et al., 2009). 
Between 20.5-22.5dpc oogonia clusters undergo repeated programme breakdown until 
individual oocytes remain to give rise to primordial follicles (Pepling and Spradling, 
2001). A large proportion of germ cells undergo apoptosis at this stage and only about 
30% of all clustered germ cells will actually form primordial follicles (figure 1.11) 
(Pepling and Spradling, 2001). The majority of primordial follicles are dormant until 
postpubertal activation and this group of  primordial follicles represents the finite pool of 
oocytes that a female has available during her reproductive life span (Edson et al., 2009). 
Primordial follicles have formed by the time of birth in mice and by mid-gestation in 
humans, this is characterised by individual oocytes enclosed by a single layer of 
squamous pre-granulosa cells (figure 1.11) (Edson et al., 2009).  
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The function of granulosa cells involves the nurture and protection of the oocytes which 
in turn facilities the proliferation and differentiation of granulosa cells. Cross-talk 
between oocytes and somatic cells plays an important role in ovarian follicular 
development (McGee and Hsueh, 2000; Vanderhyden, 2002; Albertini and Barrett, 
2003). For example, Dong and colleagues (1996) showed that deletion of the 
transcription factor Figα impairs formation of the pre-granulosa cell layer which results 
in germ cell depletion and female infertility. Similarly, mutation in the oocyte derived 
growth differentiation factor-9 (Gdf-9) causes defects in maturation of follicular somatic 
cells resulting in impaired oocyte growth and maturation and hence infertility (Dong et 
al., 1999). In order to generate fertilisable oocytes primordial follicles are progressively 
activated from the resting pool from the onset of puberty. Several primordial follicles 
start to grow during each menstrual (in humans) or estrus cycle (in mice). Activation is 
irreversible and activated follicles that are not selected for further development and 
ovulation will undergo atresia through apoptotic cell death (McGee and Hsueh, 2000). 
Activated primordial follicles develop into primary follicles characterised by oocyte 
growth and transformation of the granulosa cells into a cuboidal shape (figure 1.11) 
(McGee and Hsueh, 2000). The granulosa cells proliferate and become multilayered to 
form secondary follicles (figure 1.11). Once the follicle is surrounded by two layers of 
granulosa cells an additional layer of somatic cells differentiates and forms the 
outermost membrane of the follicle called theca cells (Hirshfield, 1991; Tajima et al., 
2007). Transition from the secondary to the tertiary or antral follicle stage involves 
formation of a fluid-filled cavity adjacent to the oocyte called the antrum which 
separates two functionally distinct granulosa cell populations (figure 1.11) (Edson et al., 
2009). The granulosa cell population that surrounds the oocytes and promotes its 
growth, maturation and development are called cumulus granulosa cells (Matzuk and 
Lamb, 2002). The other granulosa cell population, mural granulosa cells, line the wall of 
the follicle and are involved in production and secretion of steroids as well as ovulation 
(Matzuk and Lamb, 2002). From the secondary follicle stage onwards granulosa cells 
begin to express follicle-stimulating hormone (Fsh) receptors and regulation of 
folliculogenesis switches largely from an intraovarian to extraovarian process (Edson et 
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al., 2009). Stimulation of granulosa cells by Fsh is essential for the transition from 
secondary follicles to antral follicles as demonstrated by infertility in Fsh-receptor-/- 
females which are characterised by a block in folliculogenesis before antral follicle 
formation (Aittomaki et al., 1995). Absence of Fhs causes granulosa cell apoptosis and 
atresia of those follicles (Aittomaki et al., 1995). Furthermore, Fsh stimulates granulosa 
cell proliferation, estrogen production, and luteinizing hormone (Lh) receptor expression 
(Hawkins and Matzuk, 2008). Fsh and Lh are gonadotropins secreted by the pituitary 
gland in response to stimulation by gonadotropin-releasing hormone (GnRH) which is 
produced by the hypothalamus (Hawkins and Matzuk, 2008). In response to low levels 
of Lh, theca cells produce androgens which are converted to estrogen in the granulosa 
cells (Hawkins and Matzuk, 2008). A rise in estrogen levels stimulates further 
development of the antral follicle and at very high levels estrogen induces an Lh surge 
that will finally lead to ovulation during which the oocyte is released from the ovary into 
the oviduct in preparation for fertilization (figure 1.11) (Edson et al., 2009). If the timing 
between ovulation and seminal deposition in the females’ reproductive tract is correct 
fertilisation of the oocyte should occur successfully. Ovulation occurs in a cyclic manner 
during the adult life of female mammals until the pool of primordial follicles is 





Figure 1.11 Oocyte maturation in the mammalian ovary.  Clusters formed during mitotic 
proliferation of female germ cells will undergo programmed breakdown and individual oocytes 
will give rise to primordial follicles. Oocyte and granulosa cell (GC) growth and differentiation 
causes follicles to develop into primary, secondary and antral follicles. Ovulation releases the 
oocyte surrounded by cumulus cells (cumulus oocyte complex (COC)) from the ovary into the 




As described under 1.3 the decision of the initially indifferent embryonic gonad to 
develop into either an ovary or a testis depends on the inheritance of the X and Y 
chromosomes. Sry expression in the gonadal somatic cells induces differentiation into 
sertoli cells which in turn influences differentiation of other gonadal cell types along a 
male pathway (Palmer and Burgoyne, 1991). By 12.5dpc clusters of PGCs surrounded 
by Sertoli cells have organized into testis cord structures which are characteristic of XY 
gonads. From this point onwards PGCs are called gonocytes. The cord structures 
differentiate into seminiferous tubules in which the gonocytes grow and undergo meiotic 
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maturation to produce spermatozoa. Between 0 and 6dpp the quiescent gonocytes 
resume proliferation and migrate to the basement membrane of the seminiferous tubule 
(Huckins and Clermont, 1968; Bellve et al., 1977; de Rooij and Russell, 2000). It has 
been suggested that in rodents some of the gonocytes develop into differentiating 
spermatogonia which undergo the first round of postnatal spermatogenesis, whereas a 
second subpopulation of gonocytes will establishe a spermatogonial stem cell (SSC) 
population that then provides the basis for all subsequent rounds of spermatogenesis (de 
Rooij, 1998; de Rooij and Russell, 2000; Orwig et al., 2002; Yoshida et al. 2006). This 
theory is based on experiments which show that gonocytes, after resumption of mitotic 
proliferation, give rise to neurogenin 3 (Ngn3) positive and c-Kit negative cells, as well 
as neurogenin 3 (Ngn3) negative and c-Kit positive cells in parallel (Yoshinaga et al., 
1991; Schrans-Stassen et al., 1999; Yoshida et al. 2006). Expression of Ngn3 and 
absence of c-Kit is characteristic for undifferentiated spermatogonia which are capable 
of self-renewal and the generation of differentiating cells. Upon differentiation 
spermatogonia downregulate Ngn3 expression and start to express c-Kit (Yoshinaga et 
al., 1991; Schrans-Stassen et al., 1999; Yoshida et al. 2006). The cells that undergo the 
first wave of spermatogenesis do not pass through a Ngn3-positive, undifferentiated 
spermatogonia stage, but directly give rise to c-Kit expressing cells (Yoshinaga et al., 
1991; Schrans-Stassen et al., 1999; Yoshida et al. 2006).  
During the first wave of spermatogenesis germ cells in all tubules undergo a single 
synchronised wave of germ cell development (Bellve et al., 1977; Maratou et al., 2004). 
In contrast, to ensure a constant supply of mature sperm, in the postpupertal male germ 
cells undergo subsequent rounds of spermatogenesis within seminiferous tubules at 
different times. Spermatogonia that enter meiosis are referred to as primary 
spermatocytes (Maratou et al., 2004). Spermatocytes that undergo the second meiotic 
division are referred to as secondary spermatocytes and the resulting haploid cells are 
termed spermatids. The haploid spermatids then undergo spermiogenesis which involves 
dramatic morphological changes. In order to generate spermatozoa, spermatids extrude 
their cytoplasm, generate the sperm tail, and highly condense their DNA (O'Donnell et 
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al., 2011).  During each stage of spermatogenesis cells move progressively further 
towards the lumen of the tubule. During spermiogenesis it is not only spermatids that 
undergo changes, the supporting sertoli cells that allow spermatozoa to be disengaged 
into the lumen of the seminiferous tubule also change and this process is called 
spermiation (O'Donnell et al., 2011). The spermatozoa then travel through the 
epididymis where they are further modified to acquire motility, and become capable of 
fertilization (Gatti et al., 2004).  
Self-renewal of SSCs ensures that spermatogenesis takes place during the majority of a 
male’s lifespan. The maintenance of the stem cell state and therewith self-renewal of 
SCC is thought to be facilitated by the adherence of SSCs to the basement membrane of 
the tubule (Shinohara et al., 2000). Spermatogenesis commences with the division of 
individual SCCs (Asingle (As)) which will give rise to either two new As spermatogonia or 
a two-cell clone called type Aprogeny or Apr which is connected by an intercellular 
cytoplasmic bridge (figure 1.12). The two-cell Apr will in turn divide to form clones of 4, 
8 and 16 Aaligned cells (Aal4-16) leading to spermatogonial clones of increasing length (de 
Rooij and Mizrak, 2008). As, Apr and Aal are c-Kit negative and considered 
undifferentiated spermatogonia (Nakagawa et al., 2007). After arrest at the G0 stage of 
the cell cycle Aal16 spermatogonia transform into A1 differentiated spermatogonia which 
are c-Kit positive (Schrans-Stassen et al., 1999). Subsequent mitotic divisions result in 
the formation of A2, A3 and A4 spermatogonia (Russell et al. 1990, de Rooij & Russell 
2000).  A4 spermatogonia give rise to intermediate spermatogonia which divide 
mitotically to produce type B spermatoginia (figure 1.13A). Type B spermatogonia 
divide once more and then enter the first meiotic division as primary spermatocytes 
(Oatley and Brinster, 2008). During cell division and differentiation spermatogonia 
remain connected by intercytoplasmic bridges that allow diffusion of RNAs and other 
solutes across all cells within a clone (Kato et al., 2004). If those bridges are not formed 
spermatogonia are unable to reach meiosis as demonstrated by the observation that a 
mutation in the above described Tex14 gene causes male infertility (Greenbaum et al., 
2006). After cells that have entered and completed meiosis further maturation takes 
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place, as described above. A diagram summarising the postnatal events of 
spermatogenesis is given in figure 1.13. 
 
Figure 1.12 Cell fate decisions of spermatogonial stem cells. (A and B) In the mammalian 
testes spermatogonial stem cells (SSC) either undergo self-renewal to maintain a SSCs 
population that ensures a continuous supply of germ cells during the majority of the male’s life 
span or differentiate which will result in the production of mature spermatozoa. As, Apr and Aal  are 
considered undifferentiated spermatogonia. As self renew by forming two new single cells or 
initiate differentiation by maintaining a cytoplasmic linkage between the two daughter cells (Apr). 
The Apr spermatogonia divide and form a chain of four spermatogonia (Aal) which divide twice 
more until they develop into differentiated A1 spermatogonia. The cells undergo further cell 
divisions and after a total of 9-10 divisions spermatocytes form. Figure was taken from de Rooij 























Figure 1.13: Spermatogenesis in murine testes. (A) Division of As can give rise to 
spermatogonia that are committed to differentiation (Apr). Apr undergo a series of mitotic 
divisions to produce Aal4, Aal8 and Aal16 spermatogonia. Aal16 give rise to more mature 
spermatogonia, beginning with A1 spermatogonia and ending with type B spermatogonia. Type 
B spermatogonia enter meiosis and give rise to haploid spermatids which will undergo 
spermiogenesis to produce mature spermatozoa (Figure was taken from Oatley and Brinster, 
2008). (B) Spermatogonia are the least differentiated germ cells in the adult testis and if 
committing to differentiation and subsequently enter meiosis give rise to primary spermatocytes. 
As spermatogenesis proceeds, germ cells (blue) progressively move towards the lumen of the 
tubule while retaining contact with the Sertoli cells (pink). Spermatocytes undergoing the second 
meiotic division are referred to as secondary spermatocytes. Meiosis results in haploid round 
spermatids which will undergo severe morphological changes to mature into spermatozoa. 













Aneuploidy refers to an aberration from the normal chromosome compliment, euploidy, 
caused by gain (hyperploidy) or loss (hypoploidy) of one or more individual 
chromosomes (Jallepalli and Lengauer, 2001). Aneuploidy can result from errors in 
mitotic chromosome segregation or errors during either of the two meiotic divisions. 
Chromosome abnormalities of both pre- and post-zygotic origin have been postulated to 
be responsible for early pregnancy failures in humans (Munne et al., 1999).  
 
1.6.1 Generation of Aneuploidy 
 
1.6.1.1 Post-zygotic origin of aneuploidy 
 
Aneuploidy of post-zygotic origin is usually a result of mis-segregation of chromosomes 
in one or few blastomeres during embryo proliferation. This results in a cytological 
mosaic state of cells within the developing embryo caused by an apparently random 
allocation of chromosomes to daughter cells (Wells et al., 1999; Munne et al., 2002; 
Ambartsumyan and Clark, 2008). This is also referred to as mosaic aneuploidy. 
Presumably the earlier that chromosome mis-segragation occurs during embryo 
proliferation, the greater the number of daughter cells that will inherit the abnormal 
karyotype. It has been suggested that the oocyte plays, at least in humans, an important 
role in providing RNAs and proteins required for maintaining genetic and chromosomal 
stability in early embryos until embryonic genome activation occurs (Braude et al., 
1988). Nevertheless, little is known about the mechanisms that ensure faithful 
chromosome segregation during early embryonic development despite its particular 
importance for the survival of the embryo (Ambartsumyan and Clark, 2008). Mosaic 
aneuploidy also occurs in embryos with chromosomal abnormalities of pre-zygotic 
origin as it has been recently reported that primary aneuploid embryos progress to a 
mosaic aneuploid state during early development (Lightfoot et al., 2005). Recently van 
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Echtern-Arends and colleagues (2011) reviewed 36 studies that examined the karyotype 
of cells in human pre-implantation embryos and reported that 73% of 815 embryos were 
characterised by mosaic aneuploidy. This number is consistent with data from an earlier 
study (that was not included in the review) which found that 70% of all human pre-
implantation embryos were idientified as having mosaic aneuploidy (Sandalinas et al., 
2001). However, it is unclear if this data is representative for normal, early human 
development as the embryos in the studies described were derived by in vitro 
fertilisation (IVF).  The fact that the gametes used to produce the embryos analysed in 
the studies were derived from couples that were reproductively challenged, and therefore 
had problems with optimal gamete function might be the reason for the high rates of 
mosaic aneuploidy observed in the embryos, rather than being a general feature of early 
human development. However, it was shown by Vanneste et al (2009) that high rates of 
aneuploidy are also present in early IVF embryos derived from gametes of young, 
healthy couples with normal fertility who were undergoing IVF because of genetic risks 
for hereditary diseases, rather than fertility problems. Embryos analysed just after 
fertilisation showed low levels of aneuploidy but at the 8-cell stage only 9% of embryos 
showed a completely normal chromosomeset, the majority showed abnormalities and 
only about 50% possessed at least some euploid blastomeres meaning that 50% of those 
embryos had no chromosomally normal blastomeres at all (Vanneste et al., 2009). This 
data suggests that the extremely high incidence of aneuploidy in pre-implantation human 
embryos is either an artifact of in vitro maturation or that early human development is 
extremely prone to suffer defects in chromosome segregation.  
 
It is known that certain culture conditions can induce aneuploidy in oocytes during 
maturation in vitro, and that this might also apply for mitotic divisions of early pre-
implantation embryos (Carrell et al., 2005; Requena et al., 2009). In contrast to human 
pre-implantation embryos, only 1-2% of embryos from fetal diagnosis have been 
reported to show abnormal karyotypes (Kalousek et al., 1991; Sandalinas et al., 2001; 
Lightfoot et al., 2005). This suggests that aneuploidy levels observed in human pre-
implantation embryos represent either a consequence of in vitro culture that does not 
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occur during development of naturally conceived embryos or, given the data described 
above, do indeed resemble a feature of normal human pre-implantation development, 
that aneuploid cells or embryos, are eliminated during early development. In order to 
address this matter, early human pre-embryos conceived in vivo would need to be 
analysed and karyotyped. However, due to ethical reasons this does not represent a valid 
option and therefore it is currently not possible to clearly distinguish between the two 
possibilities. Comparison of aneuploidy in IVF and naturally conceived mouse embryos 
might provide useful information about to what extent, if at all, aneuploidy rates differ 
between in vitro and in vivo developing embryos.  
 
1.6.1.2 Pre-zygotic origin of aneuploidy 
 
In addition to aneuploidies of post-zygotic origin aneuploidies of pre-zygotic origin 
represent a major cause of the formation of aneuploid embryos as aneuploid gametes 
will transmit the abnormal karyotype to their offspring if fertilised. Aneuploidy 
transmitted to offspring through the parental germline may be caused by mis-segregation 
of chromosomes during either of the two meiotic divisions. Failure to resolve the 
physical connection or chiasmata between homologous chromosomes during the first 
meiotic division results in both homologues segregating together to the same pole which 
is referred to as “true” non-disjunction (Hassold and Hunt, 2001). Homologous 
chromosomes segregating to the same pole can also originate from premature resolution 
of chiasmata or failure to establish crossovers in the first place. This defect, referred to 
as “achiasmate” non-disjunction, might result in homologues segregating independently 
to the same pole (figure 1.14) (Hassold and Hunt, 2001). Furthermore, premature sister 
chromatid separation might result in the segregation of a whole homologue and a single 
chromatid to each spindle pole (figure 1.15) (Hassold and Hunt, 2001). Aneuploidy 
resulting from the second meiotic division is generally caused by a failure of sister 
chromatid separation (figure 1.14). However, which of these constitutes the major cause 
of aneuploidy observed in the human female germline is still subject to controversy.  
Studies from human trisomies suggest that maternal MI errors are likely an important 
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contributor to most human aneuploidies (Wolstenholme and Angell, 2000; Rosenbusch, 
2004; Pellestor et al., 2005; Hassold et al., 2007). For example, a comparison of 1070 
cases of trisomy 21 provides evidence that the majority of cases are caused by maternal 
MI errors associated with failure in recombination or distally located chiasmata (Allen et 
al., 2009). Trisomy 21 cases scored as arising at maternal MII have been associated with 
extremely proximal chiasmata suggesting that they in fact derive from recombination 
errors that affect MI segregation (Risch et al., 1986). Both maternal MI and so-called 
MII errors increase with maternal age but interestingly the recombination errors 
underlying trisomy 21 differ between age groups (Oliver et al., 2009). In women under 
30 years of age failure of recombination is the most frequent cause of trisomy 21 
whereas this particular defect is not prevalent in women between 30-34 years. In women 
older than 35 trisomy 21 caused by recombination failure is elevated again (Hassold and 
Hunt, 2009; Oliver et al., 2009). Furthermore trisomy 21 caused by distally located 
chiasmata appears to decline with increasing maternal age whereas trisomy 21 caused by 
pericentromeric exchanges in MII errors seems to increase (Oliver et al., 2009). It is not 
yet clear what these age-related recombination changes mean but different 
recombination patterns have also been linked with the fidelity of chromosome 
segregation for chromosomes other than chromosome 21 during meiosis (Hassold et al., 
2007; Hassold and Hunt, 2009). Those studies suggest that homologues chromosomes 
with no crossovers or crossovers too far (distal) or too close (proximal) to the 
centromeres are prone to non-disjunction in humans. For example, in addition to 
chromosome 21, trisomies 16 and sex chromosomes trisomies have been correlated with 
alterations in the location of cross-over formation whereas reductions in recombination 
appear to predispose chromosomes 13, 15, 16, 18, 21 and 22 as well as the sex 
chromosomes to mis-segregate (Bugge et al., 1998; Robinson et al., 1998; Thomas et al., 
2001; Lamb et al., 2005; Sherman et al., 2006; Bugge  et al., 2007; Hall et al., 2007a, 
Hall et al., 2007b). The observations from those studies suggest that sub-optimal 
recombination events occurring in the fetal oocyte contribute to human non-disjunction. 
Other groups have postulated that premature sister chromatid separation, rather than 
non-disjunction of whole bivalents at meiosis I, represents the main source of 
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chromosomal aberrations in our species (Angell, 1991; Angell et al., 1991; Pellestor et 
al., 2002). In accordance with that Vilard et al. (2006) found that among 43 abnormal 
human oocytes out of 141 oocytes 80% of cases showed premature sister chromatid 
separation. Furthermore, premature sister chromatin separation has been proposed to be 
the main underlying mechanism of age-related aneuploidy in humans (Angell et al., 
1994; Angell, 1997; Wolstenholme and Angell, 2000). Taken together those data 
suggest that there are likely multiple causes of human age-related nondisjunction and 
that some chromosomes might be more susceptible to certain defects than others. This is 
supported by a study by Garcia-Cruz et al (2010) where the authors show that among 46 
human oocytes premature sister chromatid separation events are most prevalent for 
chromosome 22, followed by chromosome 15 whereas vulnerable patterns of meiotic 
recombination appear characteristic for chromosome 16. 
 
It has been proposed that the maternal age related effect of human aneuploidy is the 
consequence of a two-hit failure process (Orr-Weaver, 1996). This model suggests that 
the first hit is caused by nondisjunction-prone chiasmata configurations in the human 
fetal oocyte and the second hit results from an age-dependent component which reduces 
the ability of the cell to partition the error prone chromosomes (Lynn et al., 2005). 
Different mechanisms for the second hit have been proposed including degeneration of 
centromeric cohesin, spindle aberrations and chromosome misalignment, depletion of 
oocyte pools and a deterioration of the SAC with increasing maternal age (LeMaire-
Adkins et al., 1997; Volarcik et al., 1998; Kline et al., 2000; Hodges et al., 2005; Cheng 










Figure 1.14 Achiasmate non-disjunction during meiosis. A normal meiosis I (MI) achieves 
the segregation of homologue chromosomes (purple and blue). Mis-segregation can occur when 
homologues fail to separate and travel together to the same pole or when homologues that have 
failed to pair and/or recombine travel independently to the same pole. Normal meiosis II 
facilitates the segregation of sister chromatids. Non-disjunction at MII is assumed to result from 
failure of the sisters to separate. 
 
                 
Figure 1.15 Premature sister chromatid separation Mis-segregation of homologue 
chromosomes (purple and blue) during MI can result from premature separation of sister 
chromatids (purple). In this case chromatids, rather than homologues, segregate from one 
another. It has been reported that in addition to mutations affecting the cohesin complex 
pericentromeric exchanges might disrupt sister chromatid cohesion, resulting in the premature 
separation of sisters at MI (Hassold and Hunt, 2001).  
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1.6.2 Consequences of aneuploidy 
 
Aneuploidy generally results in inviability. Therefore it is not surprising that in most 
organisms the likelihood of chromosome mis-segregation during meiosis is very rare. 
For example in the yeast Saccharomyces cerevisiae the frequency of aneuploidy is 
estimated to be as low as 1 in 10,000 and also only around 1 in 3,000 in the fruit fly 
Drosophila melanogaster (Sears et al., 1992; Koehler et al., 1996). In the mouse the 
incidence of meiotic errors seems to be higher, however, the overall incidence of 
aneuploidy among zygotes does not exceed 1–2% (Hasshold and Hunt, 2001).  In 
contrast an estimated 10-30% of all fertilized human oocytes are aneuploid. Aneuploidy 
is the most common chromosome abnormality of our species and the dosage imbalance 
of chromosomes is a major cause of reproductive failure (Hasshold, 2007). As 
demonstrated by many mouse models defects in meiotic chromosome behaviour during 
spermatogenesis produce aneuploid gametes leading to spermatocyte cell death that 
results in male sub- or infertility. For example several meiotic mutations affecting 
processes that take place during prophase of meiosis, such as mutations in genes that are 
involved in early recombination or synaptonemal complex formation, trigger meiotic 
arrest and subsequent death of spermatocytes during mid-pachytene, resulting in reduced 
fertility or infertility (Yuan et al., 2000; Yang et al., 2006; Bolcun-Filas et al., 2007; 
Hamer et al., 2008). In contrast, in females, germ cells respond less strictly to meiotic 
defects and oocytes tend to tolerate some states of aneuploidy (LeMaire-Adkins et al., 
1997; Hunt and Hassold, 2002; Yuan et al., 2002; Kouznetsova et al., 2007).  Females 
with mutations in certain meiotic genes are fertile but pass aneuploidies on to their 
progeny leading to high rates of dysmorphology and mortality within the first days of 
embryonic development (Eichenlaub-Ritter, 2005).  
 
Approximately 7–10% of clinically recognized pregnancies are known to be 
chromosomally abnormal (Hassold and Hunt, 2001). However, the total numbers of 
aneuploid pregnancies is likely to be underestimated because the loss or gain of some 
human chromosomes is lethal and therefore these pregnancies may not survive long 
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enough to reach clinical attention. It is believed that aneuploidies constitute the leading 
cause of miscarriage in humans (Wells and Delhanty, 2000; Pacchierotti et al., 2007). In 
cases where the aneuploidies are compatible with live birth they are responsible for 
various clinical syndromes. Aneuploidy caused by loss or gain of one chromosome are 
also referred to as monosomy or trisomy, respectively.  The only known monosomy 
which is able to survive until birth is Turner syndrome that is caused by loss of one X 
chromosome. In contrast, several trisomies survive until birth. Among those are sex 
chromosome trisomies like Klinefelter syndrome (XXY) and triple X syndrome (XXX). 
It is possible that sex chromosome aneuploidies are reasonably well tolerated, because as 
in a normal situation, all but one of the X chromosomes get inactivated and thus the X-
linked gene dosage remains one (Chow et al., 2005). Although about 15% of X-linked 
genes escape inactivation the over-expression of those appears to be compatible with life 
(Carrel et al., 2005). The Y chromosome itself comprises relatively few protein-coding 
genes, 78 in total, and increased dosage from the Y chromosome seems compatible with 
life (DesGroseilliers et al., 2002; Skaletsky et al., 2003). Whole chromosome 
aneuploidies of most autosomes are not viable and those trisomies that do survive after 
birth can have severe phenotypes like trisomies of chromosomes 13, 18 and 21 (Hassold 
and Hunt, 2001). Trisomy 13 (Patau syndrome) and trisomy 18 (Edwards syndrome) are 
hallmarked by a very short life expectancy (days and months, respectively), mental 
retardation as well as multiple developmental abnormalities. Trisomy 21 or Down’s 
syndrome, the paradigm of whole chromosome aberrations in human development, is the 
mildest of all the autosomal aneuploidies and is compatible with a relatively long life 
(Roper and Reeves, 2006). The reason for trisomy 21 being the mildest is likely due to 
the fact that chromosome 21 is the smallest autosome with the fewest genes. However, it 
too results in a range of developmental abnormalities and is the most common known 
genetic cause of mental retardation (Antonarakis et al., 2004). 
Several studies in mice showed that aneuploid mouse embryos are, despite having an 
abnormal karytope, and depending on the particular chromosome gained or lost, often 
capable of cell division, differentiation as well as implantation and initiation of the 
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gastrulation process. However, most aneuploid embryos are not able to sustain 
gastrulation and/or suffer growth and developmental retardation (Hernandez and Fisher, 
1999; Lightfoot et al., 2005). The defects arising at gastrulation might be a result from 
aneuploid cells undergoing apoptosis at this stage and this is discussed below. 
Robertsonian chromosomes are formed by joining single chromosomes at the 
centromere ends. This has no immediate effect on the phenotype of the organism but 
confers the carrier with a higher risk of chromosome mis-segregation during meiosis. By 
taking advantage of mouse strains carrying Robertsonian chromosomes it was shown 
that severity of developmental defects that occur in aneuploid embryos depends on the 
type of aneuploidy and on the particular chromosome gained or lost (Hogan et al., 1994). 
Aneuploid mouse embryos can be produced selectively for any chromosome by crossing 
mice doubly heterozygous for two different Robertsonian chromosomes involving the 
same chromosome (Hogan et al., 1994). Studies using this approach showed that mice 
suffering from autosomal trisomies or monosomies were characterised by variable 
phenotypes depending on which chromosome is affected. Autosomal trisomies of 
chromosomes 2, 7, 8 or 15 are embryonic lethal before 10 days gestation whereas 
chromosome 3, 4, 5, 9, 11 or 17 trisomies are lethal by 10-13dpc and 1, 6 and 10 by 
15dpc (Gropp et al, 1975; Gropp et al 1983; Gearhart, J. et al, 1986; Dyban and 
Baranov, 1987; Gearhart, et al, 1987; Beechey and Searle 1988; Smith and Walker, 
1992; Cacheiro et al 1994). Only very few trisomic embryos survive until birth 
(chromosomes 12, 13, 14 or 18) and only embryos with trisomy 19 have been reported 
to survive beyond birth (Gropp et al 1983; Gearhart et al, 1986; Morriss-Kay and Putz 
1986; Dyban and Baranov, 1987; Ninomiya et al, 1993; Lorke, 1994). Monosomies are 
even more detrimental than trisomies and in the case of most chromosomes results in 
embryonic lethality at the blastocyst stage or earlier (Kaufman and Sachs, 1975; Epstein 
and Travis, 1979). Observations regarding the fate of embryos from Sycp3-/- females 
suggest that aneuploid cells undergo apoptosis in the post-implantation epiblast. Sycp3-/- 
females transmit aneuploidy to about 1/3 of their offspring and it has been shown that 
those embryos exhibit morphological abnormalities by 7.5dpc and embryo structure is 
lost by 8.5dpc. This suggests that embryos with abnormal karyotype succumb early in 
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gestation during gastrulation. It has been shown that this is mediated through a p53-
independent apoptotic mechanism (Lightfoot et al., 2005). 
As mentioned above, the majority of aneuploidies are of maternal origin resulting from 
errors during the first meiotic division (Hassold and Hunt, 2001). Between 1% and 4% 
of sperm and as many as 10-30% of human oocytes have been estimated, by molecular 
cytogenetic analysis, to be aneuploid (Hasshold and Hunt, 2001; Pacchierotti et al., 
2007). In addition to the gender effects on the incidence of aneuploidy, there exists a 
striking relationship between maternal age and aneuploidy. The risk for aneuploidy 
among women in their early 20s in a clinically recognized pregnancy is 2-3% whereas 
among women which are at the end of their reproductive lifespan the risk dramatically 
increases to at least 50% (Hassold and Chiu, 1985). The basis for the effect of maternal 
age on the occurrence of aneuploidy or for the general difference in incidence of 
aneuploidy between our own and other species is still unclear. Two recent studies show 
that mammalian female aging, and the occurrence of chromosome mis-segregation, 
correlate with decreased levels of the cohesin protein Rec8 and the cohesion protector 
protein Sgo2 in mice. This suggests that age related loss of centromere cohesion in older 
females might contribute to the increased levels of aneuploidy in aging women (Chiang 
et al., 2010; Lister et al., 2010). However, given the complexity of the process of 
chromosome segregation, and in particular meiosis, it is likely that several problems 
contribute to the high frequency of female transmitted aneuploidy observed in humans. 
Meiotic mouse mutants provide valuable tools to model the gain or loss of whole 
chromosomes during meiosis in order to understand the mechanisms that underlie 
human aneuploidy (Hassold et al, 2007). Existing mouse models for aneuploidy are 







1.6.3 Existing mouse models for aneuploidy 
 
The study of human female meiosis is challenging and complicated given the long life 
cycle of the oocyte and the technical, as well as ethical difficulties, to obtain and study 
material from humans. As reliable protocols for the induction of mammalian meiosis in 
vitro currently do not exist, mice represent an important model system to advance our 
understanding about the mechanisms that may cause or contribute to chromosome mis-
segregation.  
 
The characterisation of a large number of mouse knockout models has linked mutations 
in genes involved in synapsis, recombination, sister chromatid cohesion, and other 
meiotic pathways involved with chromosome mis-segregation. These models also 
showed that female germ cells appear to respond less strictly than male germ cells to 
certain abnormalities that can arise during meiotic chromosome synapsis and 
segregation. This difference is despite the fact that both male and female germ cells 
possess meiotic checkpoint mechanisms that detect abnormal chromosome behavior 
during meiosis in order to prevent the formation of aneuploid gametes (Morelli and 
Cohen, 2005; Jones, 2008). Male and female mice that lack genes functioning during 
meiotic recombination such as Spo11, Dmc1, Msh4 and Mlh1 are typically infertile. 
Spo11, Dmc1 and Msh4 mutants show defects in paring and synapsis of homologue 
chromosomes and germ cells undergo arrest at prophase I (Pittman et al., 1998; Baudat 
et al., 2000; Kneitz et al., 2000; Romanienko and Camerini-Otero, 2000). Mutations in 
Mlh1 also cause sterility in both sexes but pairing and synapsis of homologous 
chromosomes is not disrupted. However, recombination sites are unable to mature, 
leading to the formation of achiasmate meiotic chromosomes that result in the majority 
of chromosomes being found as univalents at pro-metaphase which will trigger meiotic 
arrest and apoptosis. Similarly mutations in genes involved in chromosome synapsis 
cause defects in meiotic progression. Mice with mutations in the lateral elements Sycp2 
or Sycp3 of the synaptonemal complex are characterised by impaired chromosome 
synapsis as mentioned under 1.4 (Yuan et al., 2002; Yang et al., 2006). In males this 
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triggers apoptosis at the pachytene stage of meiosis resulting in infertility. In contrast 
Sycp2-/- and Syc3-/- females are subfertile. It has been shown that subfertility, at least in 
Sycp3-/- females, is caused by a failure in bivalent formation resulting in high rates of 
aneuploidy in the mature oocytes. It appears that differences in the phenotype of Sycp3-/- 
females which are subfertile and Mlh1-/- which are infertile, albeit both being 
characterised by formation in achiasmate meiotic chromosomes, is caused by different 
numbers of univalent chromosomes present at pro-metaphase I. Kouznetsova and 
colleagues observed that a small number of univalents, as observed in Sycp3-/- females, 
avoids detection at pro-metphase resulting in progression of meiosis, whereas in Mlh1-/- 
females the large number of chromosomes found as univalents will cause meiotic arrest 
(Edelmann et al., 1996; Kouznetsova et al., 2007). Mutations in the meiosis specific 
cohesin subunit Smc1β cause aberrant chiasmata formation in oocytes with crossovers 
frequently being located closer to the telomeres and connection between homologous 
chromosomes frequently lost by pro-metaphase I (Hodges et al., 2005). This effect 
appeared exacerbated with maternal age as in addition to loss of connection between 
homologous chromosomes, older females also show premature loss of sister chromatid 
cohesin. Similarly mutations in Rec8 cause impaired synapsis and therefore problems 
with recombination between homologous chromosomes leading to sterility in both sexes. 
These models elucidate that all stages of meiotic pro-phase are crucial and must occur 
properly for faithful chromosome segregation to take place.  
 
It has been suggested that in humans sequence divergence between chromosomes causes 
reduced meiotic recombination resulting in increased achiasmate non-disjunction (Borts 
et al., 2000).  In 1993 Hale et al. showed that F1 female progeny from C57BL/6J x Mus 
spretus crosses, two inbred mouse strains with about 1% sequence divergence, suffered 
defects in chromosome synapsis and reduced fertility. A later study by Koehler et al. 
(2006) analysed the oocytes of the F1 progeny from C57BL/6J x Mus spretus crosses in 
more detail and observed, in addition to defects in homologous chromosome synapsis, 
disturbed meiotic recombination and increased levels of achiasmate non-disjunction. 
The level of aneuploidy in 4 weeks old F1 female progeny was about 10% (1% in 
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controls) and increased to 20% (2.6% in controls) in 8-11 month old females (Koehler et 
al., 2006). The increase in aneuploidy in older females in this study might be explained 
by the centromeric loss of cohesin observed in older female mice as described by Chiang 
and colleagues (2010) and Lister and colleagues (2010).  
 
1.7 Germ cells, pluripotent stem cells and 
retrotransposons  
In the last 20 years, progress has been made towards understanding the occurrence of 
aneuploidy in humans. However, it remains largely obscure why humans show much 
higher rates of aneuploidy than other species, or why the risk of transmitting 
aneuploidies increases with maternal age in humans. In recent years a number of mouse 
mutants have been generated that have defects in silencing retrotransposons.  
Interestingly, in many of these models the de-repression of retrotransposons correlates 
with defects in meiotic progression and the occurrence of aneuploidy (Kuramochi-
Miyagawa et al., 2004; De La Fuente et al., 2006; Carmell et al., 2007; Öllinger et al., 
2008, Soper et al., 2008).  
1.7.1 Retrotransposons 
 
Transposon elements are stretches of DNA that can move and multiply within the 
genome of an organism and were first described by Barbara McClintock during the 
1940s (McClintock, 1956). Transposons must be active in the germline, or in pluripotent 
cells in early embryos that can give rise to germ cells, in order to amplify themselves in 
the host genome through evolutionary time. Genome-sequencing projects have shown 
that the mammalian genomes contain large numbers of transposon elements which have 
accumulated over millions of years by being copied into new genomic locations 
(Giordano at al., 2007). Type I transposon elements or retrotransposons, constitute the 
major class of transposon elements in mammals and comprise around 37.5% of the 
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mouse genome (Mouse genome sequencing consortium). Retrotransposons are mobile 
genetic elements that amplify and move themselves to new locations in the genome. 
Retrotransposons can be divided into two classes on the basis of either the presence or 
absence of long terminal repeats (LTRs). Non-LTR retroelements are the autonomous 
long interspersed elements (LINEs) and the non-autonomous short interspersed elements 
(SINEs).  LINE-1 encodes two proteins required to mediate retrotransposition and these 
proteins are also used by SINEs to retrotransposons as SINEs are derived from 
endogenous small cellular RNAs that lack protein-coding capacity of their own (Martin, 
1991; Wallace et al., 2008). The entire class of non-LTR retrotransposons is at least 600 
million years old (Malik et al., 1999). Over evolutionary time non-LTR retrotransposons 
have increased the diversity of the genome through a variety of mechanisms and at 
present continue to sculpt mammalian genomes by behaving as insertional mutagens. 
The LTR containing retroelements are the endogenous retroviruses (ERVs) and are 
found in the genomes of numerous eukaryotes and have similar structures to simple 
retroviruses. An exogenous retrovirus (XRVs) occasionally may infect the germline 
which can lead to an integrated provirus that is passed to the offspring and inherited in a 
mendelian fashion and which will then be called an ERV (Stoye, 2001). The common 
feature of non-LTR and LTR retrotransposons is that they reproduce through an RNA 
intermediate which is reverse-transcribed back into DNA by a reverse transcriptase to 
allow integration back into the genome (figure 1.16). Whenever a retrotransposon lands 
in the host genome it may destabilize the genome by modifying gene structure, altering 
or abolishing gene expression, by deleting large blocks of DNA or by favouring 









      
Figure 1.16 The life cycle of LTR retrotransposons The retrotransposon life cycle starts with 
transcription of the in the host genome residing, element. The region that encodes the viral 
structural and enzymatic proteins is flanked by LTRs. Transcription is followed by translation of 
the produced RNA resulting in protein expression of genes carried by the virus. The gag gene 
encodes structural proteins that form the virus-like particle (VLP) where reverse transcription will 
take place. The pol gene encodes several enzymatic functions, including a protease that cleaves 
the Pol polyprotein, a reverse transcriptase (RT) that copies the retrotransposon's RNA into 
cDNA, and an integrase (IN) that integrates the cDNA back into the genome (taken from 
Havecker et al., 2004). 
 
 
1.7.2 Mechanisms to control transposon elements in pluripotent 
stem cells and germ cells 
 
It is believed that retrotransposons and other transposable elements have shaped the 
evolution of genomes in which they reside for tens or even hundreds of millions of years 
by generating insertion mutations or altering gene expression by functioning as  
regulatory units for host genes and contributing to genetic innovation (Speek, 2001; 
Jurka et al., 2007). Furthermore, it has been suggested by Peaston et al. (2007) that 
retrotransposons might act as alternative promoters and/or as first exons for certain 
genes in oocytes and cleavage stage embryos and therefore regulate expression of those 
genes during early development. This and the generation of genetic diversity through de 
novo transposition events might, at least in part, have contributed to the evolutionary 
success of retrotransposons which is reflected by the fact that retrotransposons comprise 
a major part of mammalian genomes. However, mutations and deletions caused by 
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retrotransposons will, in many cases, be harmful and correlate negatively with the fitness 
of the host. Therefore, germ cells and pluripotent cells may need to limit the level of 
retrotransposon activity. It has been shown that in mice the developing germ cells as 
well as pluripotent cells appear to possess mechanisms to silence expression of 
retrotransposons and limit their mutagenic activity (described below) but it is unknown 
if this is the case in other species. Mutations in genes involved retrotransposon 
repression result in increased expression of retrotransposons and presumably defects 
during embryonic development and meiosis. 
 
1.7.2.1 Retrotransposon silencing in embryonic stem cells 
 
As mentioned above, retrotransposons have to reproduce in germ cells or pluripotent 
cells in the early embryo, which can give rise to germ cells, in order to manifest 
themselves in the host genome through the generations. One of the major mechanisms to 
restrict expression of retrotransposons used by somatic, pluripotent as well as germ cells 
is transcriptional repression. DNA methylation plays a role in transcriptional repression 
of retrotransposons in somatic cells and in germ and pluripotent cells. The majority of 
DNA methylation in the mammalian genome is thought to be associated with 
retrotransposon sequences and some of those are activated in the event of genome wide 
demethylation (Yoder et al., 1997). However, pluripotent cells appear to depend less on 
this mechanism as ES cells with mutations in all three catalytically active DNA 
methyltransferases (Dnmt1-/-Dnmt3a-/- Dnmt3b-/- triple knock out (Dnmt TKO) ES cells) 
show modest upregulation, around ~4-8 fold, of IAP, RLTR45, RLTR1B and MMERGLN 
elements (Reichmann et al., submitted).  This level of upregulation is small compared to 
the upregulation of IAP elements seen in differentiated somatic tissues in response to 
hypomethylation as Dnmt1-/- fibroblasts upregulate IAP expression by about 50 to 100-
fold (Jackson-Grusby et al., 2001). The is caused, at least in part, by the fact that ES 
cells rely on the transcriptional co-repressor Kap1 to repress IAP elements (Hutnick et 
al., 2010; Rowe et al., 2010; Karimi et al., 2011). Kap1 presumably acts by recruiting 
the histone H3K9 methyltransferases Eset/Setdb1 to IAP as well as MERVL, MusD and 
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MuLV retrotransposon chromatin loci. However, not all retrotransposons are targeted by 
Kap1 and/or show enrichment for the repressive histone modification H3K9 methylation 
and therefore it is likely that additional mechanisms play a role in transcriptionally 
repressing these retrotransposons in ES cells. It has also been shown that pluripotent 
cells restrict retrotransposon expression through a variety of mechanisms. For example 
the Dicer mediated siRNA pathway has been reported to regulate IAP and MuERVL-L 
endogenous retrovirus transcript abundance in mouse pre-implantation embryos as well 
as LINE1 and IAP retrotransposon expression in ES cells (Calabrese et al., 2007; 
Kanellopoulou et al., 2005; Hutnick et al., 2010). However, these changes appear to be 
rather subtle, around 2-fold, which suggests that this pathway is probably not a major 
mechanism to silence retrotransposon expression in ES cells. A recent study by Kano et 
al. (2009) suggests that LINE1 RNA produced in germ cells is passed on to the zygote 
where it can get reverse transcribed and integrated in the genome during the early 
cleavage stages. This implies that pluripotent cells might have further post-
transcriptional mechanisms in place in addition to Dicer-dependent RNAi in order to 
restrict the retrotransposition of inherited retrotransposon transcripts. It also suggests 
that germ cells are not only required to repress retrotransposon activity to protect their 
own genome but also to avoid retrotransposon RNA that is carried over by either oocyte 
or sperm into the next generation.  
 
1.7.2.2 Retrotransposon silencing in male and female germ cells 
 
As mentioned above both pluripotent cells and especially somatic cells rely on DNA 
methylation to silence certain retrotransposons. However, DNA methylation patterns in 
the developing germline are dynamic and differ between the sexes. PGCs undergo, as 
described under 1.3, widespread DNA demethylation soon after colonising the gonad 
when genetic imprints are erased. Accordingly, this provides a developmental window 
where transposon elements are not silenced by DNA methylation. PGCs show partial 
demethylation of IAP elements by 11.5dpc and over the following few days, DNA 
methylation of retrotransposons is further reduced (Hajkova et al., 2002; Lees-Murdock 
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et al., 2003). Subsequent de novo methylation sequential to the genome wide 
hypomethylation has a major impact on fertility by resetting gametic imprinted 
methylation marks, according to the sex of the individual, and by resilencing of 
transposon elements.  
 
In the male germline de novo methylation of retrotransposons starts around 14.5dpc and 
IAP elements are fully methylated at 17.5dpc, well in advance of meiosis and this is 
believed to be constantly maintained throughout the adult life of the organism (Lees-
Murdock et al., 2003). In male germ cells Dnmt3L, which acts as a co-factor for the de 
novo methyltransferases, and two of the mouse piwi-like genes, Mili and Miwi2 are 
required to establish de novo methylation of retrotransposons in mitotically quiescent 
prospermatogonia (Kuramochi-Miyagawa et al., 2008). Mili as well as Miwi2 contain a 
piwi domain that is implicated in binding and cleaving RNA molecules (piRNAs) 
(Kuramochi-Miyagawa et al., 2004; Carmell et al., 2007). It is thought that piRNAs 
directly influence de novo methylation by acting as a sequence specific guide for the 
methylation machinery. However, a more indirect relationship between piRNA/Piwi-like 
protein complexes and de novo DNA methylation cannot be excluded at present 
(Unhavaithaya et al., 2009). Consistent with the idea that piRNA/Piwi-like protein 
complexes influence de novo methylation, Dnmt3L-/-, Miwi2-/- and Mili-/- male germ cells 
show remarkably similar phenotypes. Specially, the mutants are characterised by loss of 
methylation and subsequent upregulation of IAP and LINE1 elements in neonatal testis 
which correlates with defects in chromosome synapsis resulting in germ cell apoptosis 
during pachytene and therefore infertility. Several other genes have been identified to 
function in the piRNA pathway and are also characterised by retrotransposon 
derepression and meiotic defects in the male germline (Chuma et al., 2006; Soper et al., 
2008; Ma et al., 2009; Reuter et al., 2009; Shoji et al., 2009; Frost et al., 2010; Zheng et 
al., 2010). 
 
In contrast the function of the piRNA pathway in female germ cell remains yet to be 
elucidated. Miwi2 expression is mainly restricted to the male germ line but Mili is also 
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expressed in female germ cells. Mili-/- females are fertile but show about a 3.5-fold 
increase in IAP RNA abundance in growing oocytes (Kuramochi-Miyagawa et al., 2001; 
Watanabe et al., 2008). This suggests that Mili is involved in retrotransposon silencing 
in the female germ line but that the de-repression of IAP transcripts that occurs in the 
Mili-/- oocytes is not sufficient to affect fertility. It will be interesting to determine how 
exactly Mili silences retrotransposons in the female germline. De novo methylation of 
retrotransposons takes also place in the female germline but later than in male germ cells 
during oocyte growth after the oocytes have progressed through the early meiotic 
prophase. Furthermore, in females de novo methylation of retrotransposons appears not 
to be Dnmt3L dependent. Still, DNA methylation has been proposed to be required for 
silencing retrotransposons and progression through meiosis in the female germline (De 
La Fuente et al., 2006). This is based on data from Lsh-/- female embryos which show 
reduced DNA methylation at IAP retrotransposons in meiotic oocytes and that these 
oocytes fail to progress through early meiotic prophase due to severe impairment of 
homologous chromosome synapsis (De La Fuente et al., 2006).  The meiotic phenotype 
of Lsh-/- males has not been determined as Lsh-/- mice die perinatally or a few days after 
birth before prospermatogonia enter meiosis (Geiman et al., 2001; Sun et al., 2004). 
Similar to pluripotent cells, female germ cells use siRNA mechanisms to constrain 
expression of transposable elements. Mouse oocytes with a tissue-restricted lack of the 
Dicer mediated siRNA pathway are not able to progress through meiosis I. Specifically, 
oocytes that lack Dicer show impaired spindle formation with misaligned chromosomes 
and upregulation of SINE elements and the RLRT10, MT and MTA endogenous 
retroviruses (Watanabe et al., 2008; Murchison et al., 2007). However, since Dicer also 
seems to be involved in the regulation and turnover of maternal transcripts it is not 
possible to clearly associate the retrotransposon upregulation with the observed 
phenotype (Murchison et al., 2007). 
 
Given the huge number of different retrotransposon families in the mouse genome, it is 
likely that germ cells and pluripotent cells use multiple mechanisms to silence 
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retrotransposons, and that different retrotransposon families have varying susceptibilities 
to different silencing mechanisms.  
 
1.8 Tex19.1  
 
In addition to the mechanisms described above our group found a role for Tex19.1 in the 
suppression of endogenous retroviruses. Tex19.1 is a mammalian-specific gene of 
unknown biochemical function that is expressed in germ cells and pluripotent stem cells.  
It was originally isolated as a ‘Testis-expressed’ gene in a screen to identify genes 
expressed in spermatogonia but not somatic cells and was also found to be a putative 
target of the germline specific RNA-binding protein Dazl by Howard Cooke’s group 
(Page et al., 2001; Reynolds et al., 2005; Childs, 2006; Kuntz et al., 2008; Öllinger et al., 
2008). Tex19.1 is well conserved among mammals but does not share sequence 
similarities with any known protein domains which makes speculations about its 
function difficult (Kuntz et al., 2008).  Humans have a single TEX19 gene with a 
premature stop codon in place of a conserved tryptophan residue that truncates the 
protein to 164 amino acids in length if used (Childs, 2006). The codon is conserved in 
macaque and chimpanzee and in all three species the subsequent 111 residues are 
conserved after the premature stop codon (Childs, 2006). In humans there is an 
additional premature stop codon, thirty-two residues after the first one (Childs, 2006). 
The conservation of the first stop codon in human, chimp and macaque indicates that the 
primate lineage has coped with a single, substantially-truncated gene for at least 23.3 
million years since the last common ancestor (Kumar et al., 2005). Why the open 
reading frame downstream of the stop codon has failed to degenerate over such a long 
time is open to speculation. It is not clear at this point if the mRNA is translated into 
protein and if the truncated version would be functional. It is possible that the mRNA is 
a substrate for mRNA editing or other events that might facilitate a read through the stop 
codon/s resulting in a full length version of the protein. This would be in accordance 
with the fact that the amino acid sequence downstream of the stop codon has been 
conserved, suggesting it is still under selective pressure. However, the NCBI expressed 
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sequence tags database (ESTdb) does not provide evidence for this mechanism. In 
contrast to the primate lineage there are two Tex19 genes in the mouse that have been 
generated in rodents by a duplication event that gave rise to Tex19.1 and Tex19.2. 
Tex19.1 is a cytoplasmic protein of 354 amino acids in length. It is expressed in the pre-
implantation embryo as well as pluripotent cells like embryonic stem cells (ES) and 
embryonic germ cells (EG) and its expression is switched off upon ES cell 
differentiation and in the somatic cells of adult mice (Childs, 2006; Kuntz et al., 2008). 
In adult mice, Tex19.1 expression is restricted to the gonads (Childs, 2006; Kuntz et al., 
2008). This expression pattern suggests that Tex19.1 could have a role in pluripotency or 
germline function. In order to analyze the potential role of Tex19.1 in germ cell and 
pluripotent cell function, Tex19.1-/- knockout mice have been generated in the lab and the 
role of Tex19.1 in the male germline has been characterized (Öllinger et al., 2008) 
 
1.8.1 Retrotransposon upregulation and fertility defects in Tex19.1-/- males 
 
In the male gonad Tex19.1 is expressed in the cytoplasm of spermatogonia and early 
spermatocytes but not in further differentiated late pachytene spermatocytes (Öllinger et 
al., 2008). Deletion of Tex19.1 results in impaired spermatogenesis (Öllinger et al., 
2008). Tex19.1-/- knockout spermatocytes initiate meiotic recombination and assemble 
the AEs of the SC but synapsis of homologues chromosomes is impaired in about half of 
these cells (Öllinger et al., 2008). In addition, two thirds of metaphase I spermatocytes 
exhibit univalent chromosomes in Tex19.1-/- animals compared to around 6% in controls 
(Öllinger et al., 2008). Univalent chromosomes refer to a state where the homologues 
chromosomes, that should be paired up as bivalents at metaphase I, have prematurely 
separated. 
 
Currently, it is not clear whether the univalents in the Tex19.1-/- spermatozytes might 
have arisen from the asynapsed chromosomes observed during pachytene or, more 
likely, were generated from normal synapsed pachytene cells. The latter would suggest a 
role for Tex19.1 after pachytene in establishing or maintaining the bivalent. However, 
66
similar to the other mouse mutants discussed above the asynapsis observed in the 
Tex19.1-/- males correlate with an increase in abundance of retrotransposon transcripts. 
Tex19.1-/- knockout males show upregulation of RNA from the MMERVK10C 
endogenous retrovirus in the testes and this transcript accumulates specifically in meiotic 
spermatocytes but not in mitotic spermatogonia in the absence of Tex19.1 (Öllinger et 
al., 2008). This retrotransposon upregulation occurring specifically in meiotic cells 
differs from previously described mutants since Dnmt3L, Miwi and Mili-/- males show 
de-repression also in the mitotically dividing spermatogonia. Tex19.1-/- do not upregulate 
transcripts of IAP or LINE1 retrotransposons and hence element specificity as well as 
the timing of retrotransposon de-repression differ between Tex19.1-/- mice and    
Dnmt3L-/-, Miwi2-/- and Mili-/- mice. There is also no detectable change in the DNA 
methylation status of MMERVK10C retrotransposons in Tex19.1-/- knockout testes which 
suggests that Tex19.1 does not appear to be involved in the Dnmt3L/Mili/Miwi2-
dependent mechanism that methylates and silences retrotransposons in quiescent 
prospermatogonia (Öllinger et al., 2008). Tex19.1 may play a role in post-transcriptional 
silencing of retrotransposons during spermatogenesis, although further work is needed to 





















1.9 Thesis outline 
 
The general aims for the research project presented here were threefold: 
 
1) To obtain a better idea about the extent of retrotransposon de-repression in 
Tex19.1-/- male germ cells and the mechanism by which Tex19.1 might promote 
retrotransposon silencing in the male germline (chapter 3).  
 
2) To analyse other aspects of the Tex19.1-/- knockout phenotypes in more detail.  
In chapter 4 I analyse the function of Tex19.1 during embryonic development. 
 
3) To characterise the phenotype of Tex19.1-/- females. This was the main focus of 


























Most chemicals used throughout this project were of analytical grade and supplied by 
the manufacturer stated. Cell culture chemicals were cell culture grade and chemicals 
used for oocyte culture were of embryo grade.  
 
2.1 Microbiological techniques 
 
 
2.1.1 Growth of bacterial strains 
 
For the preparation of plasmid DNA, competent DH5-α Escherichia coli (E. coli) 
(Invitrogen) transformed with the desired plasmid, were grown on either L-agar plates 
(10g/L NaCl, 10g/L Bacto-tryptone, 5g/L Yeast extract, 15g/L Difco Agar), inverted and 
incubated at 37°C overnight or in liquid culture (shaking at 200rpm) in Luria-Bertani 
(LB) medium (10g/L NaCl, 10g/L Bacto-tryptone, 5g/L Yeast extract). Both contained 
the appropriate antibiotic (Ampicillin at 50μg/L or Kanamycin at 50μg/L) to select for 
transformants carrying the desired plasmid. Growth of bacterial strains was carried out 
as described (Sambrook and Russel, 2001).  
 
2.1.2 Bacterial transformations 
 
For bacterial transformations 50μL aliquots of chemically competent DH5-α E. coli 
(library or subcloning efficiency) or One Shot TOP10 competent cells (Invitrogen) were 
incubated on ice with 10-100ng plasmid DNA for 30min. Cells were then heat shocked 
at 42°C for 30 seconds and returned onto ice for two minutes. 250μL of SOC medium 
(Invitrogen) was added to each transformation and the cultures incubated at 37°C for 60 
minutes with shaking (200rpm) to allow recovery and expression of resistance genes. 
20-100µL of the transformation mixtures was plated onto L-agar plates containing the 
appropriate antibiotic to select for the desired plasmid (Ampicillin at 50μg/μL or 
Kanamycin at 50μg/μL). Plates were incubated overnight inverted at 37°C to allow 
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growth and colony formation. In summary bacterial transformations were carried out 
according to the instructions provided by the manufacturer (Invitrogen). 
 
2.2 Preparation and manipulation of DNA 
 
2.2.1 Plasmid DNA isolation 
 
For plasmid DNA isolation single bacterial colonies were picked from agar plates and 
used to inoculate 5mL cultures of LB medium containing the appropriate antibiotic for 
selection. Those were then grown in a 37°C shaking incubator. For mini-preparation of 
plasmid DNA, cultures were grown for 12-16 hours, cells pelleted by centrifugation at 
4000g for five minutes and DNA isolated using QIAGEN spin miniprep columns 
(QIAGEN). For maxi-preparation of plasmid DNA, 5mL cultures were grown for eight 
hours and used to inoculate 100mL LB medium containing the appropriate antibiotic in a 
1L conical flask. Cultures were grown with shaking overnight at 37°C and plasmid DNA 
was isolated by using QIAGEN maxiprep colums. Both isolation procedures were 
carried out following the instructions of the manufacturer.  
 
2.2.2 Phenol/Chloroform extraction of nucleic acids 
 
In principle nucleic acids were purified by phenol/chloroform extraction as described by 
Sambrook and Russel (2001). In brief, an equal volume of 25:24:1 
phenol:chloroform:isoamyl alcohol (50% buffered phenol, 48% chloroform (v/v). 2% 3-
methyl-1-butanol (v/v) pH >7.8) (Sigma) was added to the DNA/RNA preparation and 
vortexed for one minute before centrifugation at 10,000g in a benchtop microcentrifuge 
for ten minutes. The top aqueous layer was removed to a fresh tube, and the process 
repeated if a substantial interface was visible between the two layers after the first 
centrifugation. If not, an equal volume of chloroform was added to the nucleic acid 
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preparation, and the centrifugation step repeated. The aqueous layer was then subjected 
to ethanol precipitation to isolate DNA/RNA. 
 
2.2.3 Ethanol precipitation of nucleic acids 
 
Similarly to section 2.2.2, ethanol precipitation of nucleic acids was carried out 
according to the protocols provided by Sambrook and Russel (2001). For ethanol 
precipitations of nucleic acids 0.1 volumes of 3M sodium acetate pH 5.2 and 2 volumes 
of 100% ice-cold ethanol were added to DNA/RNA samples, mixed and incubated at –
20°C over night. Samples were microcentrifuged at 10,000g in a benchtop 
microcentrifuge at 4°C for 15 minutes. The supernatant was discarded and the pellets 
washed with 70% ethanol and the centrifugation repeated. The supernatants were 
removed and pellets allowed to air dry at room temperature before resuspension in an 
appropriate volume of dH2O or Tris-EDTA (TE) (10 mM Tris-Cl, pH 7.5. 1 mM EDTA) 
buffer. 
 
2.2.4 Agarose gel electrophoresis 
 
1-3% horizontal agarose (HiPure Low EEO Agarose, Biogene UK) gels (w/v) were 
prepared with 1x Tris/Borate/EDTA (TBE) buffer to resolve DNA samples. Ethidum 
Bromide (EtBr) was added to molten agarose to a final concentration of 0.5μg/mL 
before pouring to allow visualisation of DNA under ultraviolet light. 6x  loading buffer 
(15% Ficoll 400 (Amersham Biosciences), 0.25% Orange G) was added to all DNA 
samples before loading. 500ng of 1kb ladder DNA size marker (Invitrogen) was loaded 
into a well on each gel to enable sizing and quantification of DNA fragments. Stained 
DNA was photographed using the Biorad Universal Hood II System (Biorad) and a 
thermal printer (Mitsubishi). Agarose gel electrophoresis was previously described by 




2.2.5 Gel purification of DNA fragments 
 
PCR products or linearised plasmid DNA were separated from unwanted DNA 
fragments by agarose gel electrophoresis and isolated by gel purification in order to 
obtain clean products for cloning or other downstream applications. The appropriate 
band was excised from the gel using a clean razor blade under illumination from 
ultraviolet light. QIAQuick Gel Extraction Kit columns were used to isolate DNA 
fragments following the instructions provided by the manufacturer.  
 
2.2.6 Analysis of nucleic acid quality and quantity 
 
Quantification of DNA was measured either by comparison of the unknown quantity of 
DNA with a known quantity on an agarose gel or by measuring its absorbance at 260nm 
(A260) using a spectrophotometer by following the instructions provided by the 
manufacturer (Nandrop ND-1000, Nanodrop Technologies Inc). 
 
2.2.7 Polymerase chain reaction (PCR) 
 
PCR primers were designed by selecting a sequence between 17 and 25 nucleotides in 
length. Primers for use in RT-PCR reactions were, when possible, designed to span 
introns to prevent amplification of contaminating genomic DNA. Primer pairs were 
designed using the Primer 3 program (http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi) to reduce the chances of self-complementarity and 
therefore excess primer-dimer formation in the PCR reactions. Primer sequences are 
given in table 2.1. PCRs contained 0.5 units (U) Platinum Taq or Taq polymerase 
(Invitrogen), 0.5mM dNTPs (Invitrogen) and 1mM each primer (Sigma). 10x PCR 
buffer and 50mM Magnesium Chloride (MgCl2) were supplied with the respective 
polymerase and used at a concentration of 1x and 2.5mM respectively. PCRs were 
conducted in a DNA Engine Tetrad PCR machine (MJ Reseach) in 0.1mL or 0.5mL 
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tubes. Typical PCR conditions used were 95°C for 5 min followed by 25 cycles of 95°C 
for 30 sec, 55 ± 10 ºC for 30 sec, 72°C for 1min.  Reactions were then incubated for 
72°C for 10 min. PCR has been described by (Sambrook and Russel, 2001).  
 
2.2.8 Bisulfite conversion and sequencing of DNA 
 
500ng genomic DNA was bisulphite treated using EZ Methylation Gold (Zymo 
research) and eluted in a final volume of 10μL according to manufacturer’s instructions.  
Bisulphite primers were designed to amplify regions of interest (Table 2.1) and PCR 
amplification was performed in two rounds as follows:  The first reaction was performed 
in a total volume of 50μL and contained 1x PCR buffer (Invitrogen), 2mM MgCl2, 
dNTPs (0.5mM each), 150μM each primer, 1.5 U platinum Taq polymerase (Invitrogen) 
and 1μL bisulphite treated DNA.  Reactions were incubated in a DNA Engine Tetrad 
PCR machine (MJ Reseach) at 95°C for 5 min followed by 25 cycles of 95°C for 30 sec, 
48ºC for 30 sec, 72°C for 1min.  Reactions were then incubated for 72°C for 10 min. 
The PCR product was purified using a QIAGEN PCR purification column according to 
the instructions provided by the manufacture. 5μL of purified PCR product were used 
for the second amplification step. The second reaction was performed as described 
above but in a total volume of 100μL. Reactions were incubated in a thermocycler at 
95°C for 5 min followed by 25 cycles of 95°C for 30 sec, 52ºC for 30 sec, 72°C for 
1min.  Reactions were then incubated for 72°C for 10 min. A negative control using 1μL 
water as template was performed for each set of reactions.  The products were resolved 
on a 1.5% agarose gel. PCR resulted in one 450bp (full length) and one 350bp product. 
The desired product (full length band) was isolated performing gel extraction as 
described previously. Purified PCR products were ligated into pGEM Teasy vector 
(Promega) according to manufacturers instructions at 4°C overnight and transformed 
into DH5-α E. coli; Library Efficiency (Invitrogen).  Transformants were selected by 
plating bacteria on agar supplemented with ampicillin and X-gal.  Up to 50 white 
colonies per transformation were cultured in 1mL LB supplemented with ampicillin and 
plasmid DNA was isolated and sequenced using SP6 sequencing primer (performed by 
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technical services, MRC HGU).  Each sequence was imported into BioEdit program and 
aligned to a reference sequence for the region using ClustalW.  The methylation status of 
each CpG dinucleotides from each bacterial clone was assessed by C to T conversion 
using QUMA online program (Kumaki et al., 2008). 
 
Gene Purpose of primer Primer Sequences 
Tex19.1 



















Table 2.1: PCR primer sequences. 
 
2.3 Preparation and manipulation of RNA 
 
2.3.1 RNA isolation and purification 
 
RNA was isolated from cultured cells, embryoid bodies or tissues using TRIzol 
according to the instructions provided by the manufacturer (Invitrogen). Cultured cells 
were washed in ice-cold PBS and lysed in an appropriate amount of TRIzol. Cells were 
homogenized by passing the solution several times through a pipette followed by 
vortexing. Homogenized samples were incubated at room temperature to allow the 
dissociation of nucleoprotein complexes, before addition of 0.2mL chloroform per 
0.75mL of TRIzol used, mixed and centrifuged at full speed in a benchtop 
microcentrifuge. The aqueous phase was collected, mixed with 0.5 volumes of isopropyl 
alcohol, per 0.75mL of TRIzol used, and incubated at -20°C over night and then 
centrifuged to precipitate the RNA. Pellets were washed with 70% ethanol prepared with 
RNase-free water (MilliQ). Air-dried RNA pellets were resuspended in 20 μl RNase-free 
dH2O. The RNA was then treated with DNAse I by using the DNA-free kit from 
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Ambion in order to digest any possible genomic DNA contamination. This was carried 
out as recommended by the manufacturer. RNA was stored at –70°C. 
 
2.3.2 cDNA synthesis 
 
DNAse I treated RNA was used to produce cDNA with First Strand cDNA Kit 
(Invitrogen) according to the manufacturer’s instructions. Before addition to the cDNA 
reaction mixture, RNA was heated to 65°C for ten minutes then placed on ice to remove 
secondary structure. To ensure maximum coverage of transcripts, random primers were 
used to generate random-primed cDNA. To check genomic DNA contamination was not 
occurring, reactions were set up with and without SuperScript III Reverse Transcriptase. 
20μL cDNA reactions were prepared containing either 1μg of the corresponding total 
RNA, 250ng of random primers, 1μL 10 mM dNTP mix, 4μL 5x first strand buffer, 1μL 
0.1M DTT, 1μl RNAse Inhibitor, 1μL SuperScript III Reverse Transcriptase, dH2O up 
to 20μL. The reactions were incubated in a DNA Engine Tetrad PCR machine (MJ 
Reseach)  at 25°C for 5min, 50°C for 60min and 70°C for 15min. cDNA preparations 




To detect presence/absence of transcripts, PCRs were carried out using cDNAs as 
template. 1µL cDNA, or dH2O as no template control, or 1µL of cDNA reactions set up 
without SuperScript II (Invitrogen) as no RT controls, were used as template in standard 
20µL PCR reactions (2µL 10X PCR buffer, 0.6µl 50mM MgCl2, 0.3µl 10mM forward 
primer, 0.3µL 10mM reverse primer, 0.4µL 10mM dNTP mixture, 1U Taq polymerase. 
Primer sequences are given in Table 2.2. All reactions were subjected to thermal cycling 
in a DNA Engine Tetrad PCR machine (MJ Reseach) using the following conditions: 
94°C for 2min, 25-35 cycles of (94C for 30sec, 48-55°C for 30sec, 72°C for 1min), 
72°C for 5 minutes. 20µL of RT-PCR reaction products were resolved and photographed 
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on 2% agarose in 1x TBE gels as detailed above. PCR has been described by (Sambrook 
and Russel, 2001).  
 
2.3.4 Quantitative-PCR  
 
In order to detect and quantify the presence/absence of RNA transcripts quantitative RT-
PCR (qPCR) was carried out using cDNAs as template. For each reaction cDNAs were 
diluted 1 in 50. For each reaction 5µL of a primer mix containing the required forward 
and reverse primers at a concentration of 1.2 pmol/µL were used. Controls reactions 
were also set up with dH2O as no template control and dilutions of cDNA reactions set 
up without SuperScript II (Invitrogen) were used as no RT controls.  qPCR was 
performed using SYBR Green PCR System (Stratagene) and a CFX96 Real-Time PCR 
Detection System (Bio-Rad). The conditions used for PCR were the following: 94°C for 
15min, 45 cycles of (94°C for 15sec, 55°C for 30sec. 72°C for 30sec), melt curve from 
65°C to 95°C with 0.5°C increment for 5min. Primers were validated to work under the 
used conditions at 90-100% efficiency. Primer sequences are given in Table 2.2. Three 
technical replicates were performed for each biological sample and the relative changes 
in gene expression determined using the 2-∆∆Ct method (Livak and Schmittgen, 2001). 
The transcript of the housekeeping gene ß-actin was used to normalise cDNAs and the 
expression levels relative to wild type ES cells or littermate controls are shown. A two-
tailed t-test was used to determine statistical significance of qRT-PCR gene expression 
changes.  
 
2.3.5 Illumina Beadarray Gene Expression Profiling of Tex19.1-/- 
testes 
 
RNA was isolated from 16 dpp testes using TRIzol (Invitrogen) as described above. 
RNA was treated with DNAseI (Roche) for 2h at 37°C to remove genomic DNA 
contamination. cRNA samples were prepared using Illumina TotalPrep RNA 
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Amplification Kit (Ambion). Hybridisation to Illumina WG-6 arrays according to the 














































































































































































Table 2.2: RT-and qRT-PCR primer sequences. 
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2.4 Protein isolation and analysis 
 
2.4.1 Total cell protein extracts from mammalian cells 
 
Cells grown in monolayers were rinsed with phosphate buffered saline (PBS) and lysed 
in 20μL of PBS and 20μL of 2x SDS LaemmLi protein loading buffer (125mM Tris (pH 
6.5), 4% SDS (w/v), 10% 2 β-mercaptoethanol (v/v), 20% glycerol (v/v), 0.1% 
bromophenol blue (w/v), 100mM DTT) per cm2 of culture area, and scraped from the 
surface of the flasks. The cell lysates were passed several times through a 21-guage 
syringe and then boiled for 5 minutes. Samples were stored at –20°C until required. 
 
2.4.2 Total cell protein extracts from mammalian tissues 
 
Tissues were homogenized in 100μL of 2x Laemmli SDS protein loading buffer (see 
above) per 100mg of tissues with help of an electric pestle. Samples were then boiled for 
5 minutes and stored at –20°C until required. 
 
2.4.3 Resolution of proteins by SDS-PAGE 
 
20µg of protein of each sample was resolved on polyacrylamide gels ((10% acrylamide 
(v/v), 0.39M Tris-HCl (pH8.8), 0.1% SDS (w/v), 0.1% ammonium persulphate (w/v), 
0.04% TEMED (N,N,N’,N-tetramethylethylene diamine) (v/v) in dH2O) and stacking 
gels (4% acrylamide (v/v), 0.13M Tris-HCl (pH6.8), 0.1% SDS (w/v), 0.1% ammonium 
persulphate (w/v), 1% TEMED (v/v) in dH2O)) using 30% acrylamide (29:1 
acrylamide:bis-acrylamide (v/v) (Severn biotech). Gels were run in electrophoresis tanks 
(Hoefer) in Tris-gylcine running buffer ((25mM Tris base, 250mM glycine (pH8.3), 
0.1% SDS (w/v)) at 40V/cm for around 1.5h. Pre-stained protein standards (Invitrogen) 
were loaded alongside samples to aid sizing of proteins. Preparation of SDS-gels for 
protein separation has been described by Sambrook and Russel (2001). Alternatively 
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20μg of protein of each sample was resolved on pre-cast Bis-Tris gels according to the 
instructions provided by the manufacturer (Invitrogen).  
 
2.4.4 Western blotting 
 
Western blotting was performed using standard procedure. After SDS-PAGE the 
stacking gel was removed and protein samples were transferred onto PVDF membrane 
(GE Healthcare) by wet western blotting using a GENIE blotter. Gels were transferred 
onto membranes within a sandwich of two pieces of Whatman paper above and below 
the gel and membrane. Gel, membrane and filter paper were soaked in pre-chilled 
transfer buffer (0.48M Tris, 39M Glycine, pH 9.2, 4°C) and placed between two 
electrodes. After 1.5h of transfer the stacks were disassembled and the membrane 
washed briefly in water. Membranes were rinsed in Ponceau’s stain (Sigma) to visualise 
proteins on the membrane and allow assessment of the quality of the transfer. 
Membranes were then washed in PBS and blocked in blocking solution (5% (w/v) non-
fat skimmed milk powder in PBST (PBS, 0.1% Tween-20)) for 20 minutes. Primary 
antibodies were diluted in blocking solution, and incubated with membranes overnight at 
4°C with constant rotation. Three 5min washes in PBST preceded the incubation of the 
membrane with the secondary antibody in blocking solution for one hour at room 
temperature with constant rotation. Membranes were washed a further three times in 
PBST and detected using SuperSignal West Pico Chemiluminescent Substrate (Thermo 
Scientific). Signals were exposed onto X-ray film (Kodak). Antibodies and dilutions 
used are given in table 2.3.  If re-blotting was required membranes were stripped with a 
mild stripping buffer (0.1M glycine, pH2.1) twice for 15 minutes, blocked in blocking 
solution and incubated with primary and secondary antibodies as described above. 






Antibody  Source Species and concentration 
used 
Tex19.1 Ian Adams’ Group, Human 
Genetics Unit, UK 
Polyclonal anti-rabbit 
1:100 




IAPE Marie Dewannieux, Institute 




LINE1 ORF1 Sandy Martin”s Group, 
University of Colorado, USA 
Polyclonal anti-rabbit 
1:2000 
Pabp1 Nikki Gray”s Group, Human 




β-actin Abcam Monoclonal anti-mouse 
1:5000 
Gapdh Abcam Polyclonal anti-rabbit 
1:1000 
Ubr2 Abacm Monoclonal anti-mouse 
1:1000 
GFP Roche Monoclonal anti-mouse 
1:2000 
Oct4 BD Transduction Laboratories Monoclonal anti-mouse 
1:2000 




2.5.1 Immunohistochemistry (IHC) 
 
IHC was basically performed as described (Öllinger et al., 2008). In brief, embryos were 
recovered from CD1 wild type matings, fixed at room temperature and fixed for 3 hours 
in 4% paraformaldehyde (PFA) in PBS. Afterwards the tissues were washed in PBS and 
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then dehydrated through ethanol, followed by xylene. The tissues were embedded in 
paraffin wax at 58°C. 6μm-thick sections were dewaxed in xylene and rehydrated. For 
antigen retrieval the slides were boiled for 15 minutes in 0.01 M sodium citrate, pH 6.0 
in a microwave and then allowed to cool down to room temperature. The sections were 
blocked in PBS-BSA-azide containing 10% goat serum and 0.1% tween for 1 hour at 
room temperature. The slides were then incubated with 50μL rabbit anti-Tex19.1 (Ian 
Adams Group) primary antibody diluted in the blocking solution at 1:100 or 1:300. Anti-
rabbit IgG (Sigma) served as negative control. Slides were washed in PBST. Bound 
antibody was detected using the DAKOvision ABC diaminobenzidine (DAB) kit as 
described by the manufacturer (DakoCytomation). Slides were counterstained 
haematoxylin as described by Puchtler et al., 1986.  
 
2.5.2 Immunoflouresence (IF) 
 
IF was basically performed as described (Öllinger et al., 2008). In brief, testes were 
collected from 16dpp Tex19.1+/- and Tex19.1-/-, 3 each. Tissues were fixed over night at 
4°C in 4% PFA. Afterwards tissues were processed as described under 2.5.1. After 
antigen retrieval slides were blocked in PBS-BSA-azide containing 10% goat serum and 
0.1% tween for 1 hour at room temperature. The slides were then incubated with 50μL 
rabbit anti-LINE1 ORF1 primary antibody alone or in combination with mouse anti-
SYCP3 (Abcam) diluted in the blocking solution at 1:300 overnight at 4°C. Anti-rabbit 
IgG (Sigma) served as negative control. Slides were washed in PBST (PBS plus 0.01% 
Tween) incubated with green anti-mouse and red anti-rabbit Alexafluor secondary 
antibodies (diluted 1/500 in blocking solution, Invitrogen) for 1hr at room temperature, 






2.6 Sucrose gradient analysis 
 
To separate protein complexes cell lysates were centrifuged through a sucrose density 
gradient which was then fractionated, and the RNA or proteins in each fraction subjected 
to qPCR or western blotting.  
 
2.6.1 Polysome gradient preparation  
 
Polysome gradients were prepared as described by Gillian-Daniel et al. (1998). In brief, 
18dpp testes were homogenized in 200μL of lysis buffer (20mM Hepes, 150mM KCl, 
5mM DTT, 5mM MgCl2, 100U/mL RNAsein, EDTA free mini complete protease 
inhibitor (Roche), 10nM calyculin A, ± 150μg/mL cycloheximide, ±20mM EDTA, ± 
300μg/mL RNAse A) with help of an electric pestle.  ES cells from 2 confluent 75cm2 
dishes were homogenized in 300μL of lysis buffer by pipetting up and down several 
times. After homogenization 0.5% of NP40 was added and the samples were then 
incubated on ice for 10 minutes. After lysing the cells nuclei and membranous debris 
were removed by centrifugation (12,000g, 5 minutes at 4°C). The supernatant was 
layered onto a 11mL linear sucrose gradient (10-50% sucrose w/v). For preparation of 
the gradient sucrose was dissolved in gradient buffer (20mM Hepes, 250mM KCl, 
10mM MgCl2, 1 μg/μL Heparin, 5mM DTT). Gradients were prepared either by freezing 
gradient method (layering of 1.67mL 50%, 42%, 34%, 26%, 18%, 10% on top of each 
other by freezing each individual concentration before applying the next one followed 
by defrosting over night at 4°C which facilitates formation of a linear gradient) or by 
using a gradient master (BioComp). Using the gradient master gradients were poured by 
mixing equal volumes of 10% and 50% sucrose solutions.  Gradients were centrifuged in 
a SW41Ti rotor (Beckman) for 120 minutes at 38,000rpm at 4°C. After centrifugation 
1mL fractions were collected and used for RNA or protein extraction. Fractions were 
collected with either a BiComp gradient station or a Pharmacia superfrac fraction 
collector. Absorbance of RNA at 254nm was recorded by using an econo UV monitor 
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(Bio-Rad) or inline UV monitor (Pharmacia) to assign location of polysomal, 80s, 40s 
and mRNP peaks to the fractions collected.  
 
2.6.2 Size gradient preparation 
 
Size gradient preparation was basically performed as described (Eskeland et al., 2004).  
To analyse at which molecular weight Tex19.1 migrates within a sucrose gradient, in 
order to examine if it might function in a complex, cytoplasmic ES cell cytoplasmic 
extract was loaded on 10-30% (w/v) sucrose gradients. Sucrose gradients were prepared 
in BC100 buffer (25 mM HEPES/KOH (pH7.3), 100 mM NaCl, 1 mM MgCl2, 0.5 mM 
EGTA, 0.1 mM EDTA, 10% glycerol (v/v), 1 mM DTT, and 0.2 mM PMSF) as 
described by Eskeland et al., 2004. ES cell extract was kindly provided by Ragnhild 
Eskeland.  The gradient was prepared using a gradient master 105/106 (BioComp) set at 
2.40 min/81.5 deg/15 rpm. Centrifugation was performed using a SW41 rotor 
(Beckman) at 41 000 rpm for 28 h at 4°C. 0.5 mL fractions were collected using the 
BioComp gradient station and analyzed by 10% SDS-PAGE. 
 
2.6.3 RNA isolation from sucrose gradients 
 
In order to isolate RNA from sucrose gradients, fractions were digested with 20μg/μL 
proteinase K in presence of 1% SDS and 10mM EDTA for 30 minutes at 37°C. RNAs 
were recovered by extractions with a 3 times volume of Trizol LS reagent according to 
the instructions provided by the manufacturer (Invitrogen). Isolated RNA was stored at –
70°C until required. cDNA was synthesis was performed as described above.  
 
2.6.4 Extraction of protein from sucrose gradient fractions 
 
Proteins were isolated from sucrose gradient fractions by methanol precipitation. 600μL 
of methanol were added to 150μL of sucrose, followed by vortexing. Then 150μL were 
85
added, samples were vortexed again followed by 450μl and a third vortex step. Samples 
were centrifuged immediately for 5min in a benchtop microcentrifuge. The upper 
aqueous layer was removed and discarded. Proteins were precipitated by addition of 
650μL of methanol and centrifugation. Supernatant was removed, the protein pellet air-
dried and then resuspended in Laemmli protein loading buffer and boiled for 5min. 
Isolated protein samples were stored at –20°C until required. 
 
2.7 Mammalian cell culture 
 
2.7.1 Freezing and thawing cells stored in liquid nitrogen 
 
All cell suspensions were frozen in 1mL aliquots of 10% dimethyl sulfoxide (DMSO) 
(v/v), 20% fetal calf serum (FCS), and standard media (DMEM or GMEM) in screw-top 
cyrotubes (Nunc). To retrieve cells from liquid nitrogen, cells were thawed in a 37°C 
water bath as quickly as possible and then spun down in culture medium to remove the 
DMSO, before seeding into 25cm2 culture flasks. Flasks for ES cell culture were pre-
coated with sterile 0.1% gelatine in PBS for 15 minutes which was aspirated before 
addition of media and cells. Cell culture techniques have been described by Hogan et al., 
(1994).  
 
2.7.2 Routine cell culture and harvesting 
 
Feeder independent ES cells were cultured in E14 media (GMEM, 10% FCS, 1% non 
essential amino acids (NEAA), 1% sodium pyruvate, 1% penicillin/streptomycin (P/S), 
1% L-glutamine (L-glut), 0.001% ß-mercaptoethanol (ß-ME), 1mL LIF conditioned 
media per 500mL GMEM, in a gelatinised culture flasks at 37°C until required 
confluence. Feeder dependent ES cells were cultured on fibroblast feeder layer. ES cells 
wild type, heterozygote and deficient for Tex19.1 were cultured at 37°C in ES cell media 
(DMEM, 15% FCS, 1% P/S, 1% L-glut, 1% NEAA, 1% sodium pyruvate, 1μL LIF, 5μL 
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ß-ME). Primary embryonic fibroblasts or 3T3s were cultured in STO media (DMEM, 
10% FCS, 10% P/S, 10% L-glut). To pass either of the cell lines above cells were 
washed once with PBS and then trypsinised for 2 minutes at 37°C. The reaction was 
stopped by adding 10x the amount of media containing FCS to the cells. Cells were spun 
at 1000rpm for 4 minutes, resuspended in fresh media, counted and either reseeded at a 
concentration of 2x105/mL or frozen. To freeze the cells 8x106cells/mL were 
resuspended in 500mL of media to which then 500mL of freezing media were added 
(DMSO, FCS, culture media). Cells were placed in polystyrene boxes at -70°C and after 
they were frozen stored at -150°C in liquid nitrogen. ES cell culture techniques have 
been described by Hogan et al., (1994).  
 
2.7.3 Development of feeder cells for ES cell culture 
 
Development of the feeder cells was performed as follows: Primary embryonic 
fibroblast cells were cultured until 80-90% of confluence in STO media (DMEM, 10% 
FCS, 10% P/S, 10% L-glut and then incubated with mitomycin C (MITC) (10µg/mL of 
MITC final concentration) at 37°C for 2.5 hours. After this time period cells were 
washed 3x with PBS, trypsinised and seeded at a density of 2x105 cells/mL into 
gelatinised flasks. Cells were allowed to settle for at least 4 hours before used as feeders 
for ES cell culture.  Generation of feeder cells for ES cell culture has been described by 
Hogan et al., (1994).  
 
2.7.4 Cell counting 
 
For cell counting, a drop of the resuspended cell suspension was placed on a 
haemocytometer with a weighted coverslip on top to generate an airtight seal. The total 
volume defined by the counting grid was 1x10-4 mL, and cell concentrations per mL 




2.7.5 Embryoid body formation 
 
ES cells were differentiated into embryoid bodies (EBs) by using hanging drop culture 
method. Ninety-six small hanging drops of ES cell media lacking LIF containing 600 
cells per 20µL drop were cultured for two days suspended from the lids of bacterial petri 
dishes. The EBs that formed were transferred to bacterial culture dishes of 10 cm 
diameter and cultured in suspension in 10mL of ES media lacking LIF for a further five 
days. A half media change was performed every second day. At day 7 the EBs were 
transferred to a 10cm diameter tissue culture dish, onto which they attach, and form 
outgrowths in which extensive differentiation occurs. At day 10 beating structures were 
typically seen in the differentiated cultures indicating that cardiomyocytes had 
differentiated (Boheler et al., 2002). Samples of the embryoid bodies were taken at 0, 2, 
4, 7 and 10 days of culture, RNA extracted and RT-PCR performed as described above 
to proof down regulation of Tex19.1 upon differentiation 
 
2.7.6 Generation of primary embryonic fibroblasts 
 
Mouse embryonic fibroblasts were collected from embryos 12.5dpc of age, either from 
embryos obtained Tex19.1+/- matings in order to generate Tex19.1-/- and control 
fibroblasts or CD1 matings in order to generate feeder cells for ES cell culture. Placental 
and maternal tissues as well as head and all innards and blood vessels were removed 
from freshly harvested embryos. Carcasses were washed 3x in PBS containing 10% P/S. 
Three embryos per 75cm2 culture dish were minced to make a slurry which was 
trypsinised in 1mL of trypsin for 10min. Trypsin activity was quenched by adding 1mL 
STO media and samples were pipetted up and down to break up tissues. Cells are 
allowed to grow up to confluency and splitted twice before being used in experiments, as 
feeders or frozen down as stocks. Derivation of feeder cells for ES cell culture has been 




2.7.7 Drug treatment of fibroblasts 
 
Fibroblasts, either 3T3s or PEFs were seeded into T25 flasks at a concentration of 
0.5x105 cells per mL. The day after seeding, cells were treated with 1μM 5-aza-2'-
deoxycytidine (Sigma), 1M of TSA (Sigma) or a combination of TSA and 5-aza-2'-
deoxycytidine. The drug treatment was repeated every day for 3 days before the cells 
were harvested for RNA or protein expression analysis.  
 
2.7.8 Transfection of cells 
  
Cells were grown to 80% confluency and transfected with plasmid DNA using 
Lipofectamine (Invitrogen) diluted in OPTIMEN (Invitrogen) by following the 
instructions provided by the manufacturer. Slight amendments were made for 
transfection of ES cells which were transfected in ES media without serum to enhance 
transfection efficiency. Plasmids used for examination of N-end rule activity have been 
described by Dantuma et al., 2000. Tex19.1 expressing plasmid was previously 
generated in the lab by Chao-Chun Hun by cloning the Tex19.1 open reading frame into 
a pEXPR-IBA105 vector (IBA BioTagNology).  
 
2.7.9 Luciferase assay 
 
Following transient transfection, as described under 2.7.9, activities of firefly (Fluc) and 
Renilla (Rluc) luciferase were determined from ES cell lysates. Luciferase activity was 
measured using a Dual-Luciferase Reporter Assay System according to the instructions 
provided by the manufacturer (Promega), 40μL of cell lysates per assay and a Lumat LB 
9507 luminometer (Berthold Technologies). Relative luciferase activity was obtained by 
dividing the firefly luciferase activity by the Renilla luciferase activity, then normalizing 
to the ratio calculated for the negative control, pRF with no insert, whose value was set 
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to 1. Plasmids were a kind gift of Sandy Martin from the University of Colorado. 
Generation and functional analysis of plasmids has been described by Li et al. (2006).  
 
2.8 In vitro assays for protein/RNA interactions 
 
2.8.1 mRNA capture assay 
 
16dpp testes were homogenized in 100μl of lyses buffer per 100mg of tissues (20mM 
Hepes, 150mM KCl, 5mM DTT, 5mM MgCl2, 100U/mL RNAsein, EDTA free mini 
complete protease inhibitor (Roche)) with help of an electric pestle. After lysis 
membranous debris was removed by centrifugation (12,000g, 5 minutes at 4°C). Those 
samples were then subjected to RNP capture with oligo(dT)-cellulose. Briefly, 10 mg of 
oligo(dT)-cellulose (Ambion) were blocked in 1 mL of binding buffer (20mM Hepes, 
150mM KCl, 5mM DTT, 5mM MgCl2) containing 5% BSA for 1 h at 4°C.  Half of each 
sample was mixed with 0.5 mL of binding buffer and 25μL of blocked matrix. The other 
half was retained as input controls. For competition assays, 200 μg of (A)25 (Sigma 
Oligos) was added 30 min before the addition of extracts. After being incubated for 1 
hour min at 4°C on a rotating wheel, beads were spun down and washed three times with 
binding buffer; bound proteins were eluted by boiling in 40μL of 2× LaemmLi buffer. 
Ten percent of input and all of bound protein were western blotted for Tex19.1 and 
Pabp1 (see table 2.3). 
 
2.9 Mouse husbandry 
 
2.9.1 Animal care 
 
The mice analysed in this study carry a targeted deletions of the Tex19.1 gene in which 
the entire Tex19.1 open reading frame has been replaced with a neomycin cassette 
(Öllinger et al, 2008). Mice analysed here have been backcrossed 3x and maintained in a 
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C57BL/6 inbred background. C57BL/6 mice were obtained from Charles River. All 
animal work was conducted under a UK Home Office project licence with approval 
from an institutional ethics committee. Animal breeding and female copulation plug 
checking was conducted twice a day by standard methods. Females found plugged were 
scored as positive for insemination and marked as 0.5dpc. For superovulation females 
were stimulated with 5 IU pregnant mares' serum (PMS) and 5 IU human chorionic 
gonadotrophin (HCG) by intraperitoneal injection, 48 h apart, in order to induce 
superovulation. Mice were sacrificed by cervical dislocation.  
 
2.9.2 Genotyping PCR 
 
DNA was isolated from ear clips (taken from mice 12 dpp or older), embryo tail tips or 
whole embryos (up to 10.5dpc) by using DNAreleasy according to the instructions 
provided by the manufacturer (Anachem Ltd). Genotyping PCR was performed as 
described under 2.2.7. Sequences of genotyping primers are given in table 2.1. The wild 
type allele gives a band of 205bp and the knockout allele a band of 310bp. 
 
2.9.3 Breeding analysis  
 
Breeding data were obtained by genotyping pups born from Tex19.1+/- crosses. Analysis 
was done on pups born as first litters, pups born as subsequent litters from crosses where 
the male had been separated from the female after a plug was found and on pups born as 
subsequent litters from matings were the mating pair was constantly housed together in 






2.9.4 Chemically induced delay of embryo implantation and 
analysis of developmental potential  
 
Embryonic diapause was induced in pregnant female mice at 2.5dpc by subcutaneous 
administration of tamoxifen (0.5μg per g of mouse in 100μL sesame oil) and 
intraperitoneal administration of depo-provera (0.05mg per g of mouse in 100μL PBS) 
as described by Hunter and Evans (1999). Diapause commences 2 days later, just before 
the normal time for implantation (4.5 dpc.). The ability of delayed blastocysts to resume 
development was investigated by flushing embryos from the uterus after two days of 
diapause and transferring them to pseudopregnant recipients at 2.5 dpc (this step was 
performed by Emma Murdoch). Pups born were analysed by genotyping as described 
above.  
 
2.9.5 Lactation induced delay of embryo implantation and 
analysis of developmental potential  
 
Tex19.1+/- mating pairs were set up and in order to ensure that the female conceived 
another litter during postpartum estrus only, the male separated from the female one day 
after the day the female had given birth.  Lactation induced signaling resulted in 
embryonic diapause and its effects on development embryos was analysed by isolating 
the litters at the designated stages.  
 
2.9.6 Female fertility data 
 
Fertility data were obtained by mating Tex19.1-/- homozygote and Tex19.1+/- 
heterozygote females with C57BL/6 wild type males. On the day a plug was found 
mating pairs were separated and the females were allowed to carry the pregnancy to 
term. Fertility of females was assessed by the number of pups born from those matings. 
 
92
2.10 Chromosome spreads 
 
2.10.1 Chromosome metaphase spreads and counts of ES cells  
 
Metaphase spreads were performed as described previously (Boyle et al., 2001). In order 
to enrich cell populations for cells with metaphase I chromosomes ES cells were 
cultured in presence of 0.1ug/mL colcemid (KaryoMAX) for 2 hours. Afterwards cells 
were harvested as described under 2.6.2 and washed 1x with PBS. Cells were incubated 
for 10min in presence of 0.25% KCl and 0.25% sodium citrate. Cells were then 
centrifuged at 900rpm for 5 minutes. Afterwards hypotonic solution was removed. 
Slowly 5mL of fixative (3:1 methanol/acetic acid; prepared fresh) was added drop wise 
to the cells. Fixative was removed by centrifugation and fresh fixative added. This 
procedure was repeated 3 times. Cells were dropped onto superfrosted glass slides from 
10-20cm high. Slides were allowed to air dry. Chromosomes were then visualised by 
DAPI staining and analysed by microscopy. Remaining cells were stored at -20°C in 
fixative for extended times.  
 
2.10.2 Pachytene spreads 
 
Preparation and analysis of pachytene spreads from oocytes were performed as 
described previously (Bolcun-Filas et al., 2009). Ovaries were dissected from embryos 
and put into RPMI media (Invitrogen). The ovary was placed on a slide with one drop of 
RPMI and pricked with scalpels to release the oocytes. Sucrose (1.125g/ 25mL of H2O) 
was added and oocytes were incubated for 1h, then treated with 0.05% Triton-X-100 for 
10 mins and fixed in 2% PFA for 1h. Slides were washed in distilled H2O and then 
blocked in PBS + 5% goat serum with 0.15% BSA and 0.1% Tween-20 for 1h at room 
temperature. Slides were incubated with the primary antibodies, mouse anti-Sycp3 
(Abcam) and rabbit anti-Sycp1 (Abcam), diluted in blocking solution 1 in 200 and 1 in 
250, respectively, overnight at 4°C. Slides were washed in PBST (PBS plus 0.01% 
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Tween) incubated with Alexa488 anti-mouse and Alexa594 anti-rabbit Alexa Fluor 
secondary antibodies (diluted 1/500 in blocking solution, Invitrogen) for 1hr at room 
temperature, washed in PBST and then mounted with mounting media plus DAPI 
(250ng/mL).  
 
2.10.3 Metaphase I spreads 
 
Females that were not in estrus were given an intraperitoneal injection of 5IU PMS 
between 3 and 3.30 pm. Ovaries were collected in KSOM media 42 hours later. Ovaries 
were then placed in 100μl prewarmed equilibrated media (alpha-MEM without 
nucleosides, containing 0.3mg/mL BSA, penicillin, streptomycin) and pierced 
repeatedly  with a 25G needle to release oocytes. Oocytes were then transferred into a 
fresh drop of media, pipetted up and down to remove cumulus cells and washed 3x in 
fresh drops of media. GV-stage oocytes were selected and cultured at 37°C for 2 h. 
Oocytes that had undergone GV breakdown were selected and cultured for further 3 
hours at 37°C. Chromosome spreads were performed as described by Yuan et al. (2002). 
After 5h of culture chromosome spreads were performed by incubating the oocytes in 
1% sodium citrate for 15-20 minutes. Single oocytes were transferred to a superforst 
glass slide and fixed with 3:1 methanol:acetic acid fix.  Slides were allowed to air dry 
and chromosomes stained with 0.05μg/mL DAPI in PBS for 10 minutes at room 
temperature. Slides were then mounted with Vectashield hard set mounting media, 
coversliped and analysed.  
 
2.10.4 Metaphase II spreads 
 
Metaphase II oocytes were harvested from super ovulated females 18 hours post HCG 
administration by dissecting out the oviduct and releasing zygotes from the ampulla into 
37°C  warm KSOM media. Oocytes were treated with 0.5mg/mL hyaluronidase for five 
minutes to remove cumulus cells and then washed 3x in FHM. Chromosomes were 
spread as described above and after fixation stained by DNA FISH using a major 
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satellites probe in order to facilitate chromosome counting. FISH was carried out as 
described previously (Boyle et al., 2001). For DNA FISH the slides were washed briefly 
in 2  SSC and incubated with 100μg/mL RNaseA for 1 h at 37°C. The slides were 
dehydrated using 70, 90, 100% ethanol and air dried. Slides were denatured in 70% 
formamide/2  SSC at 70°C for 75s, transferred to ice-cold 70% ethanol, and then into 90 
and 100% ethanol and air dried. Fifteen microlitres of 100ng biotin-labelled major 
satellite paint were denatured at 70°C, re-annealed at 37°C for 15 min and hybridized on 
the slide under a sealed coverslip overnight at 37°C. ). Probes were kindly provided by 
Shelagh Boyle. The slides were washed 4  3 min in 2  SSC at 45°C, 4  3 min in 0.1  
SSC at 60°C and then 4  SSC 0.1% Tween-20 at room temperature. Biotinylated probes 
were detected using FITC-conjugated avidin, followed by biotinylated anti-avidin and a 
final layer of FITC-conjugated avidin (Vectashield). Slides were mounted with 
Vectashield hard set mounting media, containing DAPI, coversliped and analysed. 
 
2.10.5 Anaphase II spreads 
 
Metaphase II oocytes were harvested from super ovulated females 16 hours post HCG 
administration by dissecting out the oviduct and releasing zygotes from the ampulla into 
KSOM media. Oocytes were treated with hyaluronidase to remove cumulus cells and 
then washed 3 times in FHM media. Oocytes were then cultured in FHM media 
containing 5% P/S, 5mM SrCl2 (Sigma) and 2mM EGTA (Sigma) for 2h as described 
by Kishigami and Wakayama (2007). Chromosome spreading and analysis was 
performed as described under 2.10.3. 
 
2.10.6 Zygote chromosome spreads 
 
Zygotes were harvested from naturally mated plugged females at 0.5dpc by dissecting 
out the oviduct and releasing zygotes from the ampulla into KSOM. Zygotes were 
treated with hyaluronidase as described under 2.10.4 to remove cumulus cells and then 
washed 3 times in FHM. Zygotes were then incubated in KSOM with 0.1μg/mL 
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2.11.1 Brightfield microscopy 
Brightfield images were taken using a Coolsnap HQ CCD camera (Photometrics Ltd, 
Tucson, AZ) Zeiss Axioplan II fluorescence microscope with Plan-neofluar objectives 
(Carl Zeiss, Welwyn Garden City, UK). Colour additive filters (Andover Corporation, 
Salem, NH) installed in a motorised filter wheel (Ludl Electronic Products, Hawthorne, 
NY) were used sequentially to collect red, green and blue images, which were then 
superimposed to form a colour image. Image capture and analysis were performed using 
in-house scripts written for IPLab Spectrum (Scanalytics Corp, Fairfax, VA). 
2.11.2 Fluorescence microscopy 
 
Fluorescence images were taken using a Hamamatsu Orca AG CCD camera 
(Hamamatsu Photonics (UK) Ltd, Welwyn Garden City, UK) Zeiss Axioplan II 
fluorescence microscope with Plan-neofluar objectives, a 100W Hg source (Carl Zeiss, 
Welwyn Garden City, UK) and Chroma #83000 triple band pass filter set (Chroma 
Technology Corp., Rockingham, VT) with the excitation filters installed in a motorised 
filter wheel (Prior Scientific Instruments, Cambridge, UK). Image capture and analysis 







2.12 Statistical analysis 
 
Chi-square test was used to test for statistical significant difference in distribution of 
categorical data when there were more than two categories of data. Two-tailed Fisher’s 
exact test was used to analyse significance in cases were sample sizes were small (n < 5) 
and/or the number of categories was two. Mann-Whitney-U test, a non-parametric test, 
was used to analyse for significant difference between variables where a normal 
distribution could not be assumed. Unpaired two-tailed Student’s t-test was used to 
analyse significance of differences in continuous data between groups. Statistical 
significance was considered as p < 0.05. Statistical analyses were performed using Excel 












Chapter 3:  Investigation of the role of the 

















The first aim of this thesis was to gain a better understanding of the mechanism by 
which Tex19.1 promotes retrotransposon silencing. As described in chapter 1, Tex19.1-/- 
meiotic spermatocytes show de-repression of a specific retrotransposon called 
MMERVK10C, the upregulation of which was identified by microarray (Öllinger et al., 
2008). The rational for performing a microarray in this study was that Tex19.1 might 
influence the expression of genes known to be required for meiotic chromosome 
synapsis. However, the microarray showed no indication of expression changes in genes 
that are known to be required for spermatogenesis, but instead revealed upregulation of 
five probes in the Tex19.1-/- tissue, all of which were not annotated with gene symbols 
(Öllinger et al., 2008). The corresponding probe sequences gave multiple BLAST hits 
scattered throughout the mouse genome, which suggested they might recognize 
repetitive elements. Aligning these probe sequences against the Repeatmasker database 
of repetitive elements revealed that these probes were 100% identical to the ERVK LTR 
retrotransposon MMERVK10C. This observation was validated by qRT-PCR, Northern 
blotting and in situ hybridization (Öllinger et al., 2008).  
 
Öllinger et al. (2008) did not observe an upregulation of LINE1, SINE or IAP elements 
in Tex19.1-/- testes. Carrying on from this work, one of the aims of this chapter was to 
clearly establish if other retrotransposons are upregulated in the absence of Tex19.1 in 
testes, or if the de-repression is indeed specific to MMERVK10C. Furthermore, we 
wanted to understand how loss of Tex19.1 could affect MMERVK10C expression. In 
contrast to the frequently studied and well characterised IAP or LINE retrotransposons 
little was known, at the beginning of the project, about how expression of MMERVK10C 
is generally controlled in somatic, germ or pluripotent cells. As described under 1.7.2 
employ several different cell types DNA methylation and/or H3K9 methylation to 
control retrotransposon transcription. In order to obtain a better overview of the 
transcriptional regulation of MMERVK10C, and hence a better understanding of why 
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MMERVK10C might be up-regulated in Tex19.1-/- testes, we analysed the RNA 
expression levels of MMERVK10C in different DNA methylation and/or H3K9 
methylation cell line mutants. 
 
However, mis-expression of MMERVK10C RNA could not only be caused by failure of 
transcriptional repression but by failure to inhibit any stage of the retroviral life cycle. 
For example increased retroviral protein stability might result in increased 
retrotransposition events which would introduce more copies of the element into the 
genome which would in turn result in higher levels of RNA transcripts produced. It is 
also possible that an increase in translation might cause increased stability of 
MMERVK10C transcript resulting in the upregulation of MMERVK10C RNA observed 
in Tex19.1-/- mutants as decay and translation are two competing fates for cytoplasmic 
mRNAs (Shyu et al., 2008). Translation of an mRNA itself occurs in large protein 
structures which are called the polysomes (Ruan et al., 1997). Sucrose gradients can be 
used to gain an indication of the state of an mRNA molecule in the cytoplasm (Ruan et 
al., 1997). Actively translated mRNAs loaded with ribosomes are found in the heavier 
compartment of a sucrose gradient. As can be seen from figure 3.13 polysomes are 
readily separated according to the number of associated ribosomes (Esposito et al., 
2010). The 40S and 60S peaks represent mRNAs bound by either the small or large 
ribosomal subunits, respectively (figure 3.1). Joining of the 40S and the 60S subunits 
forms the 80S ribosome, mRNAs attached with one ribosome are also referred to as 
monosomes, and translation is initiated when the assembled ribosome identifies and 
commits to a translational start codon (Jackson et al., 2010). mRNAs that are not 
translated form messenger ribo-nucleo-protein (mRNP) particles which can be 
distinguished on a sucrose gradient from the translated transcripts as they sediment 
slower than mRNAs associated with ribosomal subunits or whole ribosomes (figure 3.1) 
(Ruan et al., 1997). Translational regulators of mRNAs might be expected to be found in 
the polysome compartment of a sucrose gradient where they might stall translating 
ribosomes on mRNAs or induce premature termination of translation. Very potent 
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translational repressors might prevent access of the ribosomal subunits to mRNAs in the 
first place and therewith sequester them away from the translational machinery. 
 
                            Eukaryotic polysome profile 
 
Figure 3.1 Representative trace of a eukaryotic polysome profile. Peaks containing mRNPs, 
small and large ribosomal subunits (40S and 60S, respectively and polysomes are indicated.  
Figure was taken and modified from Esposito et al. (2010). 
 
Ian Adams utilised sucrose gradients to asses the state of MMERVK10C mRNA in the 
cytoplasm of Tex19.1-/- and Tex19.1+/- male germ cells. He found that MMERVK10C 
mRNA migrates in the heavier fractions of a sucrose polysome gradient, the 
compartment where mRNAs are more efficiently translated, in Tex19.1-/- testis compared 
to Tex19.1+/+ controls (figure 3.2). This result raised the possibilities that Tex19.1 might 
either promote the degradation of actively translated MMERVK10C mRNA or be acting 







Figure 3.2 Northern blot for MMERVK10C transcript from 16dpp Tex19.1-/- and control 
testes sucrose gradient fractions (Ian Adams). 
 
In this chapter I carry on from those initial observations by determining the localisation 
of Tex19.1 protein on a sucrose polysome gradient as well as further characterising the 
localisation of retrotransposon mRNA in Tex19.1-/- and control testes. 
 
Another indication for a possible mechanism by which Tex19.1 may repress 
retrotransposons came from a recently published paper by Jeremy Wang’s group (Yang 
et al., 2010). The data they present suggest that Tex19.1 acts on the protein rather than 
on the mRNA level as they identified Ubr2 as a binding partner of Tex19.1 in wild type 
testes (Yang et al., 2010). This finding was of great interest as Ubr2-/- mice to some 
extent phenocopy Tex19.1-/- mice. Ubr2-/- mice exhibit, like Tex19.1-/- mice, defects in 
the progression through meiotic prophase in male germ cells and show a reduction in the 
numbers of Ubr2-/- females born (Kwon et al., 2003; An et al., 2010). Ubr2 itself is a 
ubiquitously expressed E3 ubiquitin ligase implicated in the N-end rule pathway of 
protein degradation. The N-end rule pathway states that the nature of the N-terminal 
amino acid of a protein, also called N-degron, defines the half-life of the protein (Tasaki 
and Kwon, 2007). Amino acids are classified as stabilizing or destabilizing residues 
depending on whether they increase or decrease the likelihood of a protein being 
degraded (figure 3.3). E3 ubiquitin ligases that function in the N-end rule pathway, like 
Ubr2, recognize destabilizing residues and label substrates for proteolysis by covalently 
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linking an internal Lys residue of the substrate with an ubiquitin moiety. Ubiquitin plays 
an essential role as a secondary signal for proteolysis in eukaryotes by targeting proteins 
for degradation by the 26S proteasome (figure 3.4) (Bedford et al., 2010). The selectivity 
of ubiquitylation according to the N-end rule pathway represents the crucial step in 
substrate selection and is mainly determined by the E3 enzymes (N-recogins) 
(Varshavsky, 1997). Based on the physical interaction between Tex19.1 and Ubr2, found 
by immuno-precipitation from testes extracts, as well as on the phenotypic similarities 
between Ubr2-/- and Tex19.1-/- mice, we reasoned that both proteins might function as a 
complex in the same pathway. In order to understand if Tex19.1 might affect 
retrotransposon protein stability in this chapter I examined if Tex19.1 might promote N-





















                      
 
Figure 3.3 The N-end rule code and generation of N-degrons. In eukaryotes the basic 
residues Arg, Lys and His and the hydrophobic residues Leu, Phe, Trp, Tyr and Ile function 
independently as destabilizing residues. Met, Pro, Ala, Ser, Thr, Gly and Val are stabilizing 
residues. Endoproteolytic cleavage of proteins results in protein fragments with novel N-termini 




Figure 3.4 The N-end rule pathway of protein degradation. In eukaryotes destabilizing residues (Ds), 
also called N-degrons, of the protein substrate (green) are recognized by E3 ligases (blue) which contain 
specific binding sites for the destabilizing residue (Ds). The E3 ligase causes in combination with an E2 
ubiquitin-conjugating enzyme (E2) the attachment of ubiquitin (Ub) to a lysine (K) on the target protein. This 
is followed by attachment of a second ubiquitin to the first, of a third to the second and so on. The multi-
ubiquitylated protein substrate is recognized by the proteasome and targeted for proteolysis. Modified from 






3.2.1 Retrotransposon mRNA expression in Tex19.1-/- testes 
 
 
3.2.1.1 Analysis of retrotransposon RNA expression in Tex19.1-/- testes 
 
The analysis of individual upregulated probes in the previously performed microarray in 
Tex19.1-/- testes lead to the identification of MMERVK10C as being upregulated in the 
absence of Tex19.1 in mice on a mixed genetic background (129/Ola x CD1) (Öllinger et 
al., 2008). During this project we wanted to take this finding further and examine how 
widespread retrotransposon de-repression in Tex19.1-/- mutants might be. In order to do 
so I performed gene expression profiling of mutant and control mice, in which the 
Tex19.1 mutation was backcrossed onto an inbred C57BL/6 genetic background, in 
order to minimise genetic variation between the animals, using the repeat-annotated 
Illumina Mouse WG-6 v2.0 Beadchip probes. Prepubertal mice at the age of 16dpp were 
used as the defects in progression through meiosis, which perturb the normal cellular 
composition of the testis, are first becoming apparent at this stage and are therefore 
unlikely to have a major influence on the results (Öllinger et al., 2008). In order to 
monitor repetitive element expression on a genome-wide scale Illumina Mouse WG-6 
v2.0 Beadchip probes were repeat annotated and the obtained gene expression profiles 
analysed by Ian Adams as described (Reichmann et al., submitted). Ian Adams identified 
that 2.6% of probes on the array (494 out of 19,089) mapped to repeats and could be 
classified into 172 different repetitive elements (including LTR retrotransposons, LINE, 
SINE and DNA transposons) which in general, similar to other probes on the array, 
showed no significant changes in expression levels between Tex19.1-/- and control 
animals (Reichmann, et al., submitted). However, ten probes (0.05%) on the array were 
significantly upregulated by at least 2-fold in Tex19.1-/- testes and six of these probes 
belonged to the LTR retrotransposon class all of which were identified to map to 
MMERVK10C. In order to verify our results obtained from the repeat-annotated Illumina 
105
Beadarray data I performed qRT-PCR on 16dpp Tex19.1-/- and control testes. I was able 
to confirm an approximately 2.2-fold upregulation of MMERVK10C transcript by qPCR 
in Tex19.1-/- testes compared to controls (figure 3.4A) (two-tailed t-test, p<0.05). I 
analysed the expression of MMERVK10C RNA in Tex19.1-/- testes in more detail by 
performing qRT-PCR for MMERVK10C gag, pol and env transcripts, which encode the 
three major proteins within the retroviral genome, by using primers specific for either 
sequence. I found that both MMERVK10C env and pol transcripts were significantly 
upregulated in Tex19.1-/- mice (two-tailed t-test, p<0.05) (figure 3.4B). In contrast, 
MMERVK10C gag expression appeared not to be different between mutant and control 
testes (two-tailed t-test, p>0.1) (figure 3.5B). This is consistent with the microarray data 
which suggested that MMERVK10C env probes were upregulated to a larger extent than 
the probe complementary to the gag region of MMERVK10C (Reichmann et al., 
submitted). The pol sequence is not covered by probes on the array. I also performed 
qPCR for a variety of other retrotransposons that were represented by probes on the 
microarray but did not appear to be upregulated in Tex19.1-/- testes. I was able to 
confirm that LINE1 as well as one representative member of each the ERV1 (RLTR4), 
ERVK (IAP) and ERVL (MERVL2a) LTR retrotransposon families do not change in 
expression in the absence of Tex19.1 (figure 3.4.A). Similarly, IAPEY3 and 
MMERVK9E, two retrotransposons closely related to MMERVK10C, show no change in 
expression in Tex19.1 mutants (figure 3.4.A). Taken together, systematic annotation and 
analysis of repeat-annotated Illumina Mouse WG-6 v2.0 microarrays and subsequent 
qPCR confirm the MMERVK10C upregulation in Tex19.1-/- C57BL/6 testes, identified 
previously on a mixed (129/Ola x CD1) genetic background, and extend the range and 
variety of repetitive elements expression analysed in Tex19.1-/- mutants. Intriguingly, 
among the 172 expressed elements represented in this microarray dataset, MMERVK10C 
constitutes the only repetitive element whose expression changes by more than 2-fold in 
the absence of Tex19.1. Furthermore, the upregulation of MMERVK10C appears to be 
fairly specific as even closely related retrotransposons are not upregulated in Tex19.1-/- 
testes compared to controls. This raises the question why specifically MMERVK10C is 
de-repressed in Tex19.1-/- males and if inhibition is lost at the DNA, RNA or protein 
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level when Tex19.1 is absent as mis-expression of MMERVK10C RNA could be caused 
by failure to suppress any stage of the retroviral life cycle. 
 
A 
qPCR analysis retrotransposon expression in Tex19.1-
/- and control testes 
 
B 
qPCR analysis for MMERVK10C expression in      
Tex19.1-/- and control testes 
 
Figure 3.4 qRT-PCR showing relative expression of repetitive elements in Tex19.1-/- 
knockout and control 16dpp testes. (A and B) Expression levels for each repetitive element 
(mean ± standard error for three animals) were normalized to β-actin and expressed relative to 
littermate controls. Sdmg1 is a single-copy control gene expressed in sertoli cells, which should 
not be affected in Tex19.1-/- mice, to verify normalization between animals. Asterisks indicate 
statistically significant differences (two-tailed t-test, p<0.05).  
 
 
3.2.2 Transcriptional regulation of MMERVK10C  
 
3.2.2.1 Transcriptional regulation of MMERVK10C by DNA methylation 
 
As described in chapter 1, it is well established that DNA methylation plays a pivotal 
role in transcriptional silencing of certain retrotransposons. For example the well 
characterised IAP elements, which belong to the same LTR retrotransposon family 
(ERVK) as MMERVK10C, have been previously reported to be repressed by DNA 
methylation in somatic cells and germ cells (Jackson-Grusby et al., 2001; Bourc'his and 
Bestor, 2004). However, MMERVK10C is less well studied and at the beginning of the 
project no information was available concerning how expression of this relatively 
obscure element is regulated. Previous work in our laboratory could not detect any 
notable changes in DNA methylation status of MMERVK10C in Tex19.1-/- testes 
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(Öllinger et al., 2008). It can not be excluded though, given the presence of large 
numbers of MMERVK10C copies in the mouse genome that defects in DNA methylation 
status might have been missed in this analysis or that only specific copies might be 
affected. Therefore we took a more general approach in order to identify how 
MMERVK10C transcription can be silenced.  
 
To understand if DNA methylation might contribute to MMERVK10C repression I 
analysed expression of this element in mouse embryonic fibroblasts (MEFs) which are 
hypomorphic for Dnmt1 (I will refer to those as Dnmt1-/-) and represent a model for 
genome wide hypomethylation (Lande-Diner et al., 2007). Null mutations in Dnmt1 
normally result in apoptosis in somatic cells - the cells used here were double mutants 
for Dnmt1 and p53 with the controls being only mutant for p53 (Lande-Diner et al., 
2007). For this experiment, Tex19.1 and IAP serve as positive controls as RNA 
upregulation of those two genes in response to hypomethylation, has previously been 
reported (Walsh and Bestor, 1999; Gaudet et al., 2004, Hackett et al., submitted). 
Tex19.1 mRNA expression is elevated by ~ 450-fold and IAP transcript by ~ 50-fold in 
p53-/- Dnmt1-/- MEFs. In contrast, LINE1 (downregulated by ~1.6-fold), MusD (~1.4-
fold change) and MMERVK10C (~1.3-fold change) respond less strongly to mutations in 
Dnmt1-/- in fibroblasts. Statistical significance of those changes could not be assessed as 
we only had one p53-/- Dnmt1-/- and one control line available for those experiments. In 
order to circumvent this caveat I performed the same analysis on experimentally 
hypomethylated fibroblasts (figure 3.6). However, the data presented in figure 3.5A 
suggest that other and/or additional mechanisms may contribute to the transcriptional 
silencing of those elements in somatic cells (figure 3.5A). To test if DNA methylation 
levels were decreased in Dnmt1-/- MEFs I performed bisulfite sequencing of the 
MMERVK10C LTR/5’UTR region which revealed a ~ 50% reduction in DNA 
methylation in p53-/- Dnmt1-/- knockout compared to p53-/- control MEFs (figure 3.5B). It 
is worth noticing that the element is heavily methylated in the first place (figure 3.5B). 
The extent of de-methylation of MMERVK10C is lower compared to i.e. the Tex19.1 
promoter which shows around 80% reduction in p53-/- Dnmt1-/- knockout compared to 
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p53-/- control fibroblasts (J. Reddington, personal communication). The lower reduction 
in methylation levels at MMERVK10C loci compared to the Tex19.1 locus could be 
explained by active targeting by de novo methyltransferases (Jones and Liang, 2009). 
Alternatively, the sensitivity to the hypomorphic allele of Dnmt1 might differ between 
genomic loci. The primers used for bisulfite sequencing and qPCR analysis of 
MMERVK10C were designed to pick up a large proportion of the elements in the mouse 
genome. Given the large number of copies in the mouse genome it can not be excluded 
that a subset of MMERVK10C elements, which are not recognised by the qPCR primers 
used, might be upregulated in hypomethylated cells. However, the data I present suggest 
that the majority of MMERVK10C elements are not upregulated upon loss of 
methylation in fibroblasts.  
 
Given the result that MMERVK10C RNA appears not to be upregulated in 
hypomethylated fibroblasts I hypothised based on 
- the observation that MMERVK10C is upregulated in a germ cell context when 
Tex19.1 is absent  and 
- the fact that Tex19.1 is mis-expressed in hypomethylated fibroblasts  
that Tex19.1 might be one of the factors contributing to MMERVK10C silencing in the 
event of global hypomethylation. To address this I experimentally hypomethylated 
Tex19.1-/- and Tex19.1+/+ primary MEFs (pMEFs) and performed qPCR for expression 
of MMERVK10C. The reasoning behind this experimental design was that if Tex19.1 
should be involved in MMERVK10C silencing in hypomethylated somatic cells  
Tex19.1-/- pMEFs would be expected to show a larger upregulation of MMERVK10C 
transcript than Tex19.1+/+ pMEFs when experimentally hypomethylated. I induced 
hypomethylation during culture by treating the cells with 5’-deoxy-2’-azacytidine (Aza). 
Aza is an analogue of cytosine and has DNA demethylating effects but also shows 
cytotoxicity at a certain dose (Patel et al., 2010).  It becomes incorporated into DNA 
during S-phase and covalently links Dnmts to DNA. This creates genome-wide Dnmt 
protein–DNA cross-links which results in a reduction in the soluble Dnmt1 protein pool 
(Patel et al., 2010). Furthermore, Aza causes proteasomal degradation of non-chromatin 
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bound Dnmt1 through a mechanism which depends on DNA synthesis and targeting of 
DNA incorporated Aza residues by Dnmt1 itself (Patel et al., 2010). Both effects lead to 
replication-dependent global hypomethylation.  
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           qPCR for Tex19.1 and retrotransposon expression in p53-/- and p53-/- Dnmt1-/- MEFs  
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Figure 3.5 RNA expression of repetitive elements and Tex19.1 and methylation status of 
MMERVK10C in hypomethylated fibroblasts. (A) Expression levels for each repetitive 
element and Tex19.1 (mean ± standard error for 3 technical replicates) were normalized to β-
actin and expressed relative to p53-/- controls. (B) Bisulfite sequencing showing the methylation 
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status of MMERVK10C LTR/5’UTR in p53-/- Dnmt1-/- and p53-/- control fibroblasts. Bp are shown 
relative to LTR start site (LTR = 1bp to 434bp; 5’UTR = 435bp to 903bp). 
 
 
   
First I treated NIH3T3 mouse embryonic fibroblasts with Aza in order to strengthen the 
observations regarding gene expression made in p53-/- Dnmt1-/- fibroblasts and to analyse 
if Tex19.1 RNA would get translated into protein in somatic cells. Figure 3.6A shows 
that treatment of NIH3T3 fibroblasts results in a ~ 4000-fold increase of Tex19.1 and ~ 
100-fold increase of IAP expression compared to controls (two-tailed t-test, p<0.005) 
(figure 3.6A). As these are genes are known to be silenced by DNA methylation the 
conditions used here seem sufficient to induce Aza dependent hypomethylation in 
NIH3T3 fibroblasts (Jackson-Grusby et al., 2001; Hackett et al., submitted). 
Importantly, this RNA expression translates into Tex19.1 protein expression (figure 
3.6B). Treatment of NIH3T3 cells with Aza did not significantly affect RNA levels of 
LINE1 but resulted in a ~ 5.5 fold increase of MMERVK10C (figure 3.6C) (two-tailed t-
test, p>0.05 and p<0.01, respectively). This was surprising given the fact that no 
significant upregulation of MMERVK10C could be observed in p53-/- Dnmt1-/- MEFs 
compared to controls while hypomethylation was observed (figures 3.5A and B and 
3.6B). I performed bisulfite sequencing which showed no de-methylation of 
MMERVK10C loci in Aza treated NIH3T3 cells compared to controls (possible 
explanations for this are discussed under 3.3) (figure 3.6D). Expression of the 
methylation dependent genes Tex19.1 and IAP suggests that hypomethylation has taken 
place to some extent but bisulfite sequencing of those loci would be required to confirm 
this observation. As can be seen from figure 3.6E treatment of Tex19.1+/+ and Tex19.1-/- 
pMEFs with Aza resulted in induction of Tex19.1 RNA in the wild type and not the 
mutant cell lines and IAP RNA expression in wild type and mutant pMEFs as expected 
(two-tailed t-test, p<0.001 and p<0.005, respectively). However, the levels of de-
repression were lower than observed for Aza treated NIH3T3s (figures 3.6A and 3.6E). 
This is likely explained by the slower replication rate in pMEFs compared to NIH3T3s. 
An active cell cycle is important for this experiment as cells have to replicate in order to 
loose methylation. Furthermore, in slowly replicating cells it takes longer for the 
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cytosine analogue to become incorporated into the DNA resulting in less de-methylation 
over a given period of time (3 days of culture in this experiment). Similarly to Aza 
treated NIH3T3 cells, Aza treated Tex19.1+/+ and Tex19.1-/- pMEFs showed no 
significant change in LINE1 RNA levels (two-tailed t-test, p>0.05). However, 
MMERVK10C transcript levels are significantly elevated in Aza treated cells when 
compared to untreated controls (two-tailed t-test, p<0.05) (figure 3.6E). Importantly no 
difference in MMERVK10C RNA expression between Tex19.1+/+ and Tex19.1-/- pMEFs 
in response to Aza could be observed (two-tailed t-test, p>0.1) (figure 3.6E). In 
conclusion the here presented data suggests that upregulation of Tex19.1 in 
hypomethylated fibroblasts does not influence MMERVK10C RNA abundance and 
therefore upregulation of Tex19.1 in p53-/-Dnmt1-/- cells probably does not suppress 
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qPCR for Tex19.1 and retrotransposon expression in Tex19.1+/+ and Tex19.1-/- pMEFs treated with Aza and 




Figure 3.6 Tex19.1 and retrotransposon expression in Aza treated NIH3T3s, Tex19.1+/+ and 
Tex19.1-/- PEFs. (A) RNA expression levels for IAP and Tex19.1 in Aza treated NIH3T3 cells 
compared to untreated controls (mean ± standard error for 2 biological replicates). (B) Tex19.1 
protein expression in untreated and Aza treated NIH3T3 cells. Expression in testes and p53-/-  
Dnmt1-/- served as positive controls. (C) RNA expression levels for LINE1 and MMERVK10C in 
Aza treated NIH3T3 cells compared to untreated controls (mean ± standard error 2 biological 
replicates. (D) Bisulfite sequencing showing the methylation status of MMERVK10C genomic 
loci in Aza treated NIH3T3 and control fibroblasts. Bp are shown relative to LTR start site (LTR = 
1bp to 434bp; 5’UTR = 435bp to 903bp). (E) Tex19.1, IAP, LINE1 and MMERVK10C RNA 
expression in Aza treated Tex19.1+/+ and Tex19.1-/- pMEFs and untreated controls (mean ± 
standard error 2 biological replicates). (A, B, C and E) RNA expression levels were normalised 
to β-actin and expressed to relative controls. Asterisks indicate statistically significant differences 




3.2.2.2 Transcriptional regulation of MMERVK10C by histone modifications 
 
Given the observation that upregulation of MMERVK10C RNA was observed in Aza 
treated NIH3T3 cells but not in p53-/- Dnmt1-/- fibroblasts I questioned if this might 
result from changes in histone modifications rather than DNA methylation. It has been 
previously reported that treatment with Aza can result in a decrease of global histone 3 
lysine 9 di-methylation levels (H3K9me2) (Wozniak et al., 2007). It is possible that Aza 
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treatment of cells results in decrease of further histone modifications but this has not 
been reported so far. H3K9me2 and histone 3 lysine 9 tri-methylation (H3K9me3) 
represent, together with DNA methylation and histone deacetylation, the best-
characterised covalent modification associated with a repressed chromatin state 
(Wozniak et al., 2007; Krishnan et al., 2011). Therefore, and because repeats belonging 
to the ERVK subfamily have been reported to appear within chromatin regions enriched 
for H3K9me3, we tested if MMERVK10C shows upregulation in cells with defects in 
establishing the H3K9 methylation mark (Day et al., 2010). Kap1 is a protein required to 
recruit a histone methyltransferase as well as a histone deacetylase complex to target loci 
(Sripathy et al., 2006). Kap1-/- ES cells show reduction in H3K9me3 and activation of 
several retrotransposons including IAP (24-fold) and MMERVK10 (30-fold) (Rowe et 
al., 2010). To test if MMERVK10C might also be regulated by Kap1 mediated H3K9 
me3 in somatic cells we performed qRT-PCR on Kap1-/- and Kap1+/+ pMEFs for 
MMERVK10C and IAP. qPCR of Kap1-/- and Kap1+/+ ES cells, which showed a ~14-
fold and ~ 4-fold increase in MMERVK10C and IAP RNA levels, served as positive 
control (figure 3.7A). Conditional Kap1-/- and Kap1+/+ pMEF and ES cell RNA was a 
kind gift from Didier Trono’s laboratory. The upregulation of IAP elements in the ES 
cell sample analysed in this experiment appears to be lower compared to the published 
data (Rowe et al., 2010). Kap1-/- ES cells show defects in maintaining pluripotency and 
it is possible that in this particular experiment a large population of Kap1-/- cells has 
differentiated. The approximately 70% reduction in Tex19.1 expression in Kap1-/- cells 
suggests that this is indeed the case (figure 3.7A). However, expression analysis of 
further pluripotency markers would be required to confirm this hypothesis. In contrast, 
MMERVK10C expression appears not to respond as strongly to differentiation 
suggesting that other or additional mechanisms achieve IAP silencing compared to 
MMERVK10C. Kap1-/- pMEFs show a slight increase in IAP expression (~1.8-fold) and 
possibly MMERVK10C expression (~1.2-fold) (figure 3.7B). Similar to the analysis 
performed with p53-/-Dnmt1-/- and control MEFs statistical testing for significant 
changes of gene expression could not be performed for Kap-/- and control ES cells and 
pMEFs as we only had RNA for one of each cell type available. However, the low 
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magnitude of the changes observed in Kap1-/- pMEFs compared to controls suggests that 
other or additional mechanisms silence those retrotransposons in somatic cells. In the 
case of IAP elements this likely involves DNA methylation and for MMERVK10C, 
H3K9me3 methylation might still be an important factor but is possibly facilitated in 
Kap1 independent ways. 
 
In addition to H3K9 di- and tri-methylation, histone hypoacetylation is associated with 
gene repression (de Ruijter et al., 2003). Histone deacetylation is achieved by histone 
deacetylases (HDACs) which remove acetyl groups from lysine residues and is 
associated with the formation of condensed and transcriptionally silenced chromatin (de 
Ruijter et al., 2003). In order to examine if histone deacetylation might contribute to 
silencing of MMERVK10C in somatic cells we treated NIH3T3 cells with Trichostatin A 
(TSA) (an HDAC class I and II inhibitor) and Aza and TSA in combination (Yoshida et 
al., 1990; Patel et al., 2010). Treatment of NIH3T3 cells with TSA lead to an ~ 5.6-fold 
increase in Tex19.1 expression (two-tailed t-test, p<0.05), ~ 1.2-fold increase in IAP 
expression (two-tailed t-test, p>0.05) , ~ 1.3-fold increase in LINE1 expression (two-
tailed t-test, p>0.05) and a ~ 1.1-fold increase in MMERVK10C expression (two-tailed t-
test, p>0.05). This suggests that deacetylation, mediated by HDACs that can be inhibited 
by TSA, is not a major contributor to MMERVK10C transcriptional repression in 
somatic cells (figure 3.7C). Upregulation of VL30 after TSA treatment by ~ 3.8-fold 
(two-tailed t-test, p<0.05) and ~ 31-fold after Aza and TSA treatment (two-tailed t-test, 
p<0.01) suggests that inhibition of HDACs was achieved during this experiment as one 
particular VL30 locus has been previously reported to show mis-expression after TSA 
treatment of mouse fibroblasts (Brunmeir et al., 2010). The ~ 31-fold increase of VL30 
transcript resulting from TSA and Aza treatment compared to the ~ 3.8-fold and ~ 9-fold 
increase resulting from TSA or Aza treatment alone suggest that for this retrotransposon 
DNA methylation and histone modifications act synergistically to inhibit expression. For 
Tex19.1 and the retrotransposons tested, including MMERVK10C, expression in cells 
treated with Aza and TSA in combination was lower compared to cells treated with Aza 
alone (figure 3.7C). This suggests that for those genes the two drugs likely do not act 
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synergistically. Taken together the data presented here show that Kap1 is not a major 
mediator of transcriptional silencing of IAP and MMERVK10C elements in somatic cells 
despite being of particular importance for regulating their expression in ES cells. 
Furthermore, silencing of IAP and MMERVK10C in somatic cells does not depend on 
class I and II HDACs.  
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Figure 3.7 Retrotransposon expression in TSA and Aza treated NIH3T3 fibroblasts. (A) 
RNA expression levels for Tex19.1, IAP and MMERVK10C in Kap1-/- and control ES cells (mean 
± standard error for 3 technical replicates). (B) RNA expression levels for MMERVK10C and IAP 
in Kap1-/- and control PEFs. (C) RNA expression levels for Tex19.1 and IAP in Aza, TSA and 
Aza & TSA treated NIH3T3 cells compared to untreated controls (mean ± standard error for 3 
technical replicates). (D) RNA expression levels for LINE1, MMERVK10C and VL30 in Aza, TSA 
and Aza & TSA treated NIH3T3 cells compared to untreated controls (mean ± standard error 2 
biological replicates. (A, B, C and D) RNA expression levels were normalised to β-actin and 
expressed relative to controls. Asterisks indicate statistically significant differences in expression 
between untreated and treated NIH3T3 cells (two-tailed t-test, p<0.05).  
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3.2.3 Post-transcriptional regulation of retrotransposons 
 
Mis-expression of MMERVK10C RNA could be caused by failure to inhibit any stage of 
the retroviral life cycle. Based on Ian Adams’ previous observation, that MMERVK10C 
shifts into the heavier compartment of a polysome sucrose gradient, where more actively 
translated mRNAs are found, it seemed possible that Tex19.1 might inhibit 
MMERVK10C expression at the level of translation (figure 3.1).  
 
3.2.3.1 Retrotransposon protein expression in Tex19.1-/- testes 
 
At the beginning of the project there were no antibodies available against MMERVK10C. 
We reasoned that it seems rather unlikely that Tex19.1 should have evolved to solely 
repress one specific retrotransposon. Therefore, I tested other retrotransposons, for 
which there are established antibodies, for protein up-regulation in Tex19.1-/- testes 
compared to controls. First we tested the expression of IAP and IAPE elements. The 
retroviral families of the two elements are related but IAPEs contain in addition to gag 
and pol proteins, for assembly of intracellular viruslike particles, also a reading frame 
for the retroviral env gene (Reuss, 1992). As mentioned before IAPE elements (like 
IAPEY3) are closely related to MMERVK10C (Reichmann et al., submitted). However, 
as can be seen from figure 3.8A-D, IAP and IAPE do not show a change in the absence 
of Tex19.1 at the protein or RNA level in 16dpp testes, suggesting that they are not 
targets for Tex19.1 in male germ cells. In contrast, LINE1 ORF1 protein (ORF1p) seems 
to be upregulated by about 3-fold in Tex19.1-/- 16dpp testes by western blot, as evaluated 
through densitometry scans, which does not appear to result from an increase of LINE1 
mRNA (figure 3.8E and F). This is in accordance with comparison of the protein levels 
of LINE1 ORF1p between Tex19.1-/- and controls by immuno-fluorescence (IF) studies 
which showed that overall fluorescence levels significantly increase by about ~ 2-fold 
(two-tailed t-test, p<0.05) but the sub-cellular localisation of LINE1 expression does not 
change between Tex19.1+/- and Tex19.1-/- testes (figure 3.9). In Tex19.1-/- mutants and 
controls, LINE ORF1p is mainly observed to be present in meiotic spermatocytes at 16 
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dpp. Taken together those data suggest that Tex19.1 might affect the translation of 
LINE1 mRNA or the protein stability of LINE1 ORF1p in male germ cells.  
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Figure 3.8 Retrotransposon protein expression in 16dpp testes (A) IAPE protein expression 
in 16 dpp Tex19.1+/- and -/- testes by western blot. (B) RNA expression levels for IAPE in 16dpp 
Tex19.1+/- and -/- testes corresponding to animals shown in A. (C) IAP protein expression in 
16dpp Tex19.1+/+, Tex19.1+/- and -/- testes by western blot. (D) RNA expression levels for IAP in 
16dpp Tex19.1+/+, Tex19.1+/- and Tex19-/- testes corresponding to animals shown in C. (E) LINE1 
protein expression in 16dpp Tex19.1+/+, Tex19.1+/- and Tex19.1-/- testes by western blot. (F) RNA 
expression levels for LINE1 in 16dpp Tex19.1+/+, Tex19.1+/- and Tex19.1-/- testes corresponding 
to animals shown in E. (B,D and F)  graphs shown represent mean ± standard error for 3 
technical replicates and RNA expression levels were normalised to β-actin and expressed 
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Figure 3.9 LINE1 protein expression in 16dpp Tex19.1-/- testes (A) a) IF for anti-LINE1 (red) 
staining in Tex19.1+/- testes. b) IF for anti-LINE1 (red) staining in Tex19.1-/- testes. c) IF for IgG 
(red) in Tex19.1-/- testes. d) IF for LINE1 (red) and Sycp3 (red) staining in Tex19.1+/- testes. (B) 
Fluorescence levels for LINE1 staining in Tex19.1+/- and Tex19.1-/- testes (mean ± standard error 
for three animals) was normalised to IgG and expressed relative to littermate controls. Asterisks 








3.2.3.2 Retrotransposon protein expression in Tex19.1-/- ES cells 
 
In order to test if translational regulation of retrotransposons might be affected in 
Tex19.1-/- mutant ES cells we performed western blots for IAP, IAPE and LINE1 protein 
expression in Tex19.1-/- ES cells. IAP protein expression appears relatively uniform 
between the ES cells lines used (figure 3.10A). In contrast IAP RNA expression in 
Tex19.1-/- and control ES cells seems more variable than in testes but does not segregate 
with protein abundance or genotype (figure 3.10B). This is also largely the case for 
IAPE RNA and protein expression for the cell lines studied, however, one Tex19.1-/- cell 
line behaves as outlier and shows an about 25-fold upregulation of IAPE RNA compared 
to controls (figure 3.10D). This increase in RNA is not reflected by an increase in 
protein (figure 3.12C). LINE1 RNA expression appears to be variable between all cell 
lines analysed and the same is true for LINE1 protein expression in male and female ES 
cells (figure 3.10E and F). In contrast to the data presented in figure 3.9E, which 
demonstrated upregulation of LINE1 ORF1p in Tex19.1-/- testes compared to controls, 
LINE1 ORFp appears to be highly variable between different ES cell lines. The 
discrepancy between the two data sets could be caused by the fact that ES cells might 
generally show high variation of LINE ORF1p expression levels between cell lines 
which would make it difficult to pick up small changes in protein abundance. 
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Figure 3.10 Retrotransposon protein expression in Tex19.1-/- and control ES cells (A) IAP 
protein expression in Tex19.1-/- and control ES cells by western blot. (B) RNA expression levels 
for IAP in Tex19.1-/- and control ES cells corresponding to cell lines shown in A. (C) IAPE protein 
expression in Tex19.1-/- and control ES cells by western blot. (D) RNA expression levels for 
IAPE in Tex19.1-/- and control ES cells corresponding to cell lines shown in C. (E) LINE1 protein 
expression in Tex19.1-/- and control ES cells lines by western blot. (F) RNA expression levels for 
LINE1 in Tex19.1-/- and control ES cells lines shown in E. (B,D and F)  Graphs represent mean ± 
standard error for 3 technical replicates.  
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In order to directly test if Tex19.1 might regulate LINE1 translation in ES cells I 
transfected Tex19.1-/- and control ES cells with reporter plasmids containing LINE1 
sequence. The plasmids were kindly provided by Sandy Martin from the University of 
Colorado. Sandy Martin’s laboratory has previously reported that sequences upstream of 
ORF1 and ORF2 are involved in translational regulation of LINE1 elements (Li et al., 
2006). LINE1 RNA is dicistronic when its two ORFs are translated and it has been 
suggested that mechanisms, alternative to the standard cap-dependent recognition 
system which is followed by ribosome scanning to the first AUG, are needed for 
efficient translation of both proteins (Li et al., 2006). One of the mechanisms that allow 
translation of the RNAs in a cap-independent manner is via an internal ribosomal entry 
side (IRES). IRESes are found in a wide variety of viral and cellular RNAs and 
functionally defined by their ability to promote independent translation of the second 
cistron in a dicistronic RNA. Using this definition, it was found that the sequences 
upstream of ORF1 and ORF2 in mouse LINE1 RNA are IRESes (Li et al., 2006). In 
order to test if Tex19.1 might regulate LINE1 translation via its 5’UTR, in particular via 
the IRES, we transfected Tex19.1-/- and control ES cells with reporter plasmids 
containing LINE1 sequence. The vector backbone of the constructs used here was pRF, a 
dicistronic reporter vector that contains renilla luciferase (rluc) cloned downstream of a 
composite SV40/T7 promoter as the first cistron, and of firefly luciferase (fluc) as the 
second cistron. A highly structured element, between the two reporter genes but 
upstream of the cloning site for the LINE1 sequences, serves as a barrier to expression 
of fluc by read-through translation (figure 3.11A). Fluc expression is therefore indicative 
of IRES activity. The cells were transfected with the empty vector (pRF) and a vector 
containing parts of the LINE1 3’UTR (pRF3) which both served as negative controls 
(figure 3.11B). The known CrPV intergenic IRES served as a positive control 
(pRFCrPV) (figure 3.11B). As expected Tex19.1-/- and control ES cells showed an 
increase pRFCrPV fluc expression by ~2.6 to 8-fold compared to the negative controls 
(figure 3.11C). For pRFD and pRFA, which contain 400 nt upstream of the first LINE1 
AUG and a LINE1 fragment extending 201 nt upstream of the ORF2 AUG respectively, 
it was found that those sequences promote translation over empty vector and negative 
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control but no difference between Tex19.1-/- and control ES cells could be observed 
(figure 3.11B and C). It is worth mentioning that three active families of LINE1 
elements (Tf-, Gf-, and A-type) can be distinguished in the mouse genome based on 
different repeated 200 bp monomer units within their 5’ UTRs (Ostertag and Kazazian, 
2001). The element tested in this experiment belongs to the Tf-type and it can not be 
excluded that Tex19.1 might target Gf- and/or A-type LINE1s in ES cells and male germ 
cells but not Tf-type LINE1s (Li et al., 2006). However, it is also possible that LINE1 is 







      Sequence dependent fluc expression in Tex19.1-/- and control ES cells 
 
Figure 3.11 LINE1 5’UTR dependent fluc expression in Tex19.1-/- and control ES cells. (A) 
Diagram of the pRF dicistronic reporter vector containing firefly (Fluc) and Renilla (Rluc) 
luciferase genes. The dicistronic mRNA can be transcribed by an SV40 promoter/enhancer 
sequence in vivo or by a T7 promoter in vitro. ΔEMCV between the two reporter genes upstream 
of the cloning site for the LINE1 sequences serves as a barrier to expression of fluc by read-
through translation. (B) Diagram of a LINE1 element. LINE1 sequences cloned into pRF 
dicistronic reporter reporter are indicated pRFA, pRFD and pRF3. (C) Relative luciferase 
activities (to pRF ± standard error) of the 400nt (pRFD) or 201nt (pRFA) upstream of ORF1 and 
ORF2, pRF3 (LINE1 3’UTR) and pRFCrPV in Tex19.1-/- and control ES cells. Diagrams 
presented in A and B were taken and modified from Li et al., (2006).  
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3.2.3.3 Does Tex19.1 act as a translational regulator of retrotransposons? 
 
LINE1 RNA and LINE1 ORF1p appeared variable in Tex19.1-/- and control ES cells. 
Together with the luciferase assay those data suggest that Tex19.1 is not a translational 
regulator of LINE1 in ES cells. However, the increase of LINE1 protein in Tex19.1-/- 
testes, the cytoplasmic localization of the Tex19.1 protein as well the northern blot 
analysis, prepared by Ian Adams, shown in figure 3.1, suggest that Tex19.1 might act as 
a translational regulator of LINE1 and MMERVK10C in male germ cells. In order to test 
if Tex19.1 might inhibit translation by direct binding of target mRNAs in testes I used 
oligo (dT) cellulose in order to isolate polyadenylated mRNAs from 16 dpp wild type 
testes extract. Proteins associated with mRNAs were eluted from the beads by boiling in 
Laemmli buffer and then analyzed by western blot. Figure 3.12 shows that Pabp1, which 
served as a positive control, can be captured by binding polyadenylated RNAs to the 
oligo (dT) cellulose. This seems to be specific to polyadenylated RNAs as blocking of 
the oligo dT beads with poly A does largely abolish Pabp1 binding to the beads. In 
contrast Tex19.1 protein is clearly detectable in the input but can not be found in the 
sample eluted from the oligo (dT) cellulose. This suggests that Tex19.1 is not associated 














         Native pulldown for proteins physically associated with 
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Figure 3.12 Tex19.1 is not associated with polyadenlyated mRNAs in mouse testes. 
Western blot for 16 dpp testes extract. Extract was subjected to binding by oligo(dT) cellulose 
and proteins bound to mRNA were eluted from the beads. Competition with poly A chains served 
as control. Samples were blotted for Pabp1 and Tex19.1.  
 
 
In order to analyse if the Tex19.1 protein is associated with polysomes and therefore 
possibly the translational machinery I performed sucrose gradients of 16 dpp wild type 
testes and ES cells extract. In order to do so cells or tissues were lysed in the presence of 
cycloheximide, which acts to block peptidyl transfer and prevent ribosome run off, or 
RNAse which causes disaggregation of the ribosomes (Fenwick, 1968). Lysates were 
then centrifuged through 10-50% sucrose gradients and absorbance at 254 nm was used 
to establish the position of polysomes, monosomes (80S ribosomes), ribosomal subunits 
and mRNPs. Fractions from the gradient were methanol precipitated and western blotted 
for Tex19.1, Pabp1 and β-actin. Pabp1, which served as a positive control, was detected 
throughout the gradient, including the polysomal fractions in the presence of 
cycloheximide treatment and relocalised to lighter fractions upon RNAse treatment in 
ES cells and testes as expected (figure 3.13A, B, C and D) (Sachs and Davis, 1989; Gray 
et al., 2000). β-actin, which is not RNA associated, can be found in the mRNP and 
monosome fractions but is not detectable in the heavier compartment of the sucrose 
gradient and its localisation does not change upon RNAse treatment (figure 3.13A, B, C 
and D).  Figure 3.13A and C show that Tex19.1 protein is predominately found in the 
mRNP fractions of a sucrose polysome gradient in wild type 16 dpp testes and wild type 
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ES cells. This localization does not seem to be RNA dependent as Tex19.1 protein does 
not shift into lighter fractions if samples are treated with RNAse before being analysed 
on the sucrose gradient (figure 3.13B and D). The slight shift in Tex19.1 protein seen in 
figure 3.13B likely is not caused by the RNAse treatment but by small difference in the 
gradient itself and/or efficiency of protein precipitation prior to western blot analysis. 
This is based on the observation that comparison of Tex19.1 protein localisation on a 
sucrose gradient from several animals did not result in a consistent shift of Tex19.1 
protein in response to RNAse treatment (not shown). Similarly, treatment of ES cell 
extract with EDTA (EDTA chelates Mg2+ ions which causes protein complexes to 
dissociate) and with EDTA and RNAse in combination showed no consistent shift of 
Tex19.1 protein into lighter fractions of a 10-50% sucrose polysome gradient. However, 
Pabp1, which served as control, did shift upon treatment with EDTA or EDTA and 
RNAse into the lighter fractions of the sucrose gradient in ES cells. It is possible that, 
since Tex19.1 protein does migrate in the lighter fractions of the polysome gradient to 
start with, the system is not sensitive enough to see a possible shift upon RNAse and/or 
EDTA treatment. Based on the data presented here it is reasonable to conclude that 
Tex19.1 does not localise with the actively translated part of the sucrose gradient and 
hence it is plausible that Tex19.1 might directly or indirectly prevent access of 
ribosomes or other components of the translational machinery to mRNAs, i.e. 
MMERVK10C. This could explain the shift of MMERVK10C mRNA into the more 
actively translated part of the sucrose gradient seen in Tex19.1-/- testes (figure 3.1). In 
order to verify the data shown in figure 3.1, as well as to analyze if the increase of 
LINE1 protein might be the result from an increase in translation in the absence of 
Tex19.1, we performed polysome gradients from Tex19.1-/- and control 18dpp testes. 
The difference in the polysome profiles between figure 3.13 and 3.14 results from the 
fact that different gradient stations and therewith different detection and fraction 
collection systems were used for the two experiments. To analyse the abundance of 
RNAs in different compartments of the sucrose gradient the fractions classified as 
mRNPs and 40S peaks, 60S and 80S as well as polysomes were pooled and RNA 
precipitated with Trizol LS reagent (figure 3.14A). For simplicity pooled mRNP and 
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40S fractions are referred to as mRNPs, 60S and 80S as monosomes and the remaining 
fractions as polysomes. I performed qRT-PCR for LINE1 and MMERVK10C RNA. As 
can be seen from figure 3.14B and C MMERVK10C expression was between ~2.5 to 4-
fold upregulated in Tex19.1-/- testes input fractions whereas LINE1 expression appeared 
similar between Tex19.1-/- and control animals. This is consistent with the data presented 
in figures 3.4 and 3.8. The majority of the over-expressed MMERVK10C RNA was 
found to be localized to the mRNP fractions and no shift of MMERVK10C transcript into 
the monosome or polysome compartment could be observed in the absence of Tex19.1 
using this assay. Similarly, LINE1 transcript was not enriched in the monosome or 
polysome compartment in Tex19.1-/- mutants compared to controls. In summary, I have 
shown here that Tex19.1 appears not to be associated with polyadenylated RNAs under 
the native pull down conditions used. Moreover, Tex19.1 does not localise to polysomes 
in wild type testes and ES cells, the localisation of Tex19.1 on a sucrose gradient profile 
does not change upon RNAse or EDTA treatment. In addition LINE1 and MMERVK10C 
transcripts do not shift into the heavier compartment of the sucrose gradient in Tex19.1-/- 
mutant testes. In conclusion the here presented experiments, together with the luciferase 
experiment presented in figure 3.11, suggest that Tex19.1 is not a translational regulator 
of LINE1 or MMERVK10C.  These observations and the discrepancy between the data 
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Figure 3.13 Sucrose gradient on 16dpp wild type testes and wild type ES cells. (A and B) 
16dpp testes extract was treated with cyclohexamide (A) or cyclohexamide and RNAse (B) and 
individual fractions blotted for Pabp1, Tex19.1 and β-actin. (C and D) Wild type ES cells extract 
was treated with cyclohexamide (C) or cyclohexamide and RNAse (D) and individual fractions 
blotted for Pabp1, Tex19.1 and β-Actin. (E and F) ES cells extract was treated with EDTA (E) or 
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Figure 3.14 qRT-PCR on sucrose gradient fractions from 18dpp Tex19.1+/- and Tex19.1-/- 
testes. (A) Sucrose gradient profile for 18dpp testes showing fractions pooled for each category. 
(B) Transcript levels for MMERVK10C (mean ± standard error for technical replicates) in 
Tex19.1-/- testes were normalized to β-actin and expressed relative to one of the littermate 
controls. (C) Transcript levels for LINE1 (mean ± standard error for technical replicates) in 







3.2.4 What are the interaction partners of Tex19.1? 
 
The data presented in the previous section show that Tex19.1 does not move into lighter 
fractions of a polysome gradient upon RNAse treatment and does not strongly associate 
with polyadenylated mRNAs in testes extract. In order to gain a better understanding 
how Tex19.1 functions during embryonic and germline development and 
retrotransposons repression we examined with which proteins Tex19.1 might interact. In 
order to investigate if Tex19.1 protein is part of a complex we performed a sucrose size 
gradient. Figure 3.15A shows that the majority of Tex19.1 protein in cytoplasmic ES 
cell extract migrates at a size of 150 – 443 kDa within the sucrose gradient. No Tex19.1 
protein migrating within the sucrose at 44kDa, the predicted molecular weight of 
Tex19.1, could be observed by western blot. This suggests that Tex19.1 might migrate at 
a different size than its predicted molecular weight due its native confirmation or 
because the majority of detectable Tex19.1 protein is part of a complex. Ian Adams was 
able to show by mass-spectrometry of GFP pull-downs from 293 cells stably transfected 
with GFP-tagged Tex19.1 that Tex19.1 interacts with the E3 ubiquitin ligase UBR2. 
This is in accordance with a recent study which identified an interaction between 
Tex19.1 and UBR2/Ubr2 in HeLa and male germ cells (Yang et al., 2010).  During the 
course of this thesis I was able to confirm by western blot that Tex19.1 also interacts 
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Figure 3.15 Tex19.1 interacts with Ubr2 in 293 cells and ES cells. (A) 293T cells and 293T 
cells stably expressing Tex19.1-GFP were subjected to GFP-TRAP immuno-precipitation. 
Pellets were analyzed by western blot with the indicated antibodies. (B) ES cells, ES cells stably 
expressing GFP and ES cells stably expressing Tex19.1-GFP were subjected to GFP-TRAP 




This prompted me to examine if Tex19.1 and Ubr2 might function together in the same 
pathway and if this interaction could, at least in part, explain the Tex19.1-/- phenotypes. 
To address if Tex19.1 influences Ubr2 function and acts as a component of the N-end 
rule pathway of protein degradation, we used a reporter system that uses green 
fluorescent protein (GFP)-based substrates for the quantification of 
ubiquitin/proteasome-dependent proteolysis in living cells (Dantuma et al., 2000). The 
expression plasmids used for this reporter system use N-end rule and ubiquitin fusion 
degradation (UFD) signals to convert the stable jellyfish GFP into a substrate for 
ubiquitin–proteasome-dependent proteolysis (Dantuma et al., 2000). In this study I used 
four Ub-GFP plasmids, one negative and one positive control and two N-end rule 
substrates (figure 3.16A). The negative control Ub-M-GFP does not contain a 
degradation signal upon ubiquitin cleavage and is therefore expected to be as stable as 
unmodified GFP. The UFD substrate Ub-G76V-GFP or Ub-G-GFP, which served as 
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positive control, contains a mutated uncleavable ubiquitin moiety and should therefore 
be constantly targeted for degradation. The two plasmids that serve as N-end rule 
substrates contain arginine (Ub-R-GFP) and leucine (Ub-L-GFP) as destabilizing amino 
acids with Ub-R-GFP being more efficiently targeted than Ub-L-GFP. Firstly, we tested 
if all 4 GFP plasmids would show the expected expression pattern when transfected into 
HeLa cells. Cells were transfected with the GFP plasmids in combination with a far-red 
expression plasmid, which served as a control for transfection efficiency, and FACS 
analysed 48h post-transfection. Figure 3.16B shows that transfection of the four 
plasmids into HeLa cells gave the expected result with Ub-M-GFP being the most stable 
plasmid of the four, Ub-R-GFP and Ub-L-GFP being less stable and Ub-G-GFP being 
the least stable. We then transfected those plasmids into two Tex19.1-/- ES cell lines and 
two control lines and observed no Tex19.1 dependent difference between the GFP 
expression levels of either plasmid (figure 3.16C). However, when we transfected the 
plasmids into HeLa cells with an empty vector and a vector expressing Tex19.1 protein 
we observed a statistically significant reduction in the amount of Ub-GFP-L expression 
in cells transfected with Tex19.1 compared to the empty vector control suggesting an 
increase in N-end rule pathway activity (two-tailed t-test, p<0.05). Possibly reasons for 
the discrepancy between loss of function experiment in the ES cells and the gain of 
function experiment in the HeLa cells are discussed in 3.3. Taken together the data 
presented here suggest that Tex19.1 interacts with Ubr2 in ES cells and that Tex19.1 
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Figure 3.16 Tex19.1 dependent Ub-X-GFP expression monitored by fluorescence 
intensity. (A) Diagram of the Ub-X-GFP plasmids. The amino acid in bold represents the N-
degron (R and L), the UFD signal (UbG76V-GFP will be referred to as Ub-G-GFP) or the residue 
referring stability (M). The lysine residues in position 3 and 17 are potential ubiquitination sites, 
taken from Dantuma et al., (2000). (B-E) Flow-cytometric analysis of transiently transfected 
HeLa (B and D) or Tex19.1-/- and control ES cells (C) expressing the Ub-X-GFP plasmids. GFP 
expression levels were normalised to far-red expression levels and Ub-M-GFP. Asterisks 
indicates statistically significant change (two-tailed t-test, p<0.05). (D)  HeLa cells were 
transfected with Ub-X-GFP   plasmids     in    combination with empty and Tex19.1 expression 
vector. (B and C) or mean ± standard error for three biological replicates (D and E).  
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3.3 Discussion  
 
In this chapter I hoped to better understand the role of Tex19.1 in retrotransposon 
suppression. Firstly, I verified the repertoire of repetitive elements upregulated in the 
absence of Tex19.1 in the testes which were identified using a novel, repeat-annotation 
method of microarray data (this was performed by Ian Adams). Next, I set out to learn 
more about how the relatively obscure MMERVK10C retrotransposon is transcriptionally 
regulated. I also tested the hypothesis that Tex19.1 affects translational efficiency of 
retrotransposons. I finished the chapter by investigating the interaction of Tex19.1 with 
Ubr2 and I provide preliminary evidence that Tex19.1 modulates N-end rule pathway 
degradation of target proteins.  
 
3.3.1 Retrotransposon RNA upregulation in Tex19.1-/- males  
 
The extent of retrotransposon de-repression in Tex19.1-/- testes was investigated by 
taking advantage of repeat-annotated Illumina Mouse WG-6 v2.0 Beadchip probes. 
Using this method we found that MMERVK10C, but not related retrotransposons, are 
upregulated in Tex19.1-/- testes in inbred C57BL/6 mice at 16dpp which we were able to 
confirm by qRT-PCR (figure 3.4). The up-regulation of MMERVK10C is consistent with 
the previously reported over-expression of this element in Tex19.1-/- animals on a mixed 
(129/Ola x CD1) genetic background (Öllinger et al., 2008). Interestingly Mary Taggart, 
in Ian Adams’ laboratory, was able to show that the upregulation of MMERVK10C RNA 
is caused by mis-expression of multiple genomic copies suggesting that de-repression 
does not occur at a single locus. It is not clear why we see RNA upregulation of 
MMERVK10C but not i.e. IAPs, LINEs or SINEs in Tex19.1-/- mutants. One of the 
questions to answer is where this specificity is coming from, and if mouse mutants in i.e. 
Dnmt3L, Miwi2 and Mili, all of which also have defects in meiotic progression 
correlating with defects in retrotransposon repression, show MMERVK10C upregulation 
or if the de-repression of this particular element is restricted to Tex19.1-/- germ cells. In 
137
those mutants data about MMERVK10C have not been published and instead only the 
better characterized IAP and LINE1 elements were examined (Bourc'his and Bestor, 
2004; Kuramochi-Miyagawa et al., 2004; Carmell et al., 2007). Michael Ling from 
Hamish Scott’s laboratory analysed MMERVK10C expression in 8dpp Dnmt3L-/- and 
control testes and showed that there is no significant difference in expression between 
mutants and controls (Michael Ling, personal communication). This suggests that 
upregulation of MMERVK10C is not a general result of defects in meiotic chromosome 
synapsis and that Dnmt3L is dispensable for MMERVK10C silencing in male germ cells. 
On the contrary, Tex19.1 silences MMERVK10C RNA expression in the testes but 
appears not to be required for silencing of IAP, LINE1 or even elements closely related 
to MMERVK10C. This and the microarray findings presented here suggest that different 
retrotransposons and even closely related elements differ in sensitivity to regulatory 
mechanisms in developing germ cells and that Tex19.1 specifically promotes silencing 
of  MMERVK10C expression during spermatogenesis. However, the basis for this 
specificity is still unclear. 
 
3.3.2 Transcriptional regulation of MMERVK10C by DNA 
methylation 
 
As summarized under 1.7.2.2 in the majority of mouse mutants that upregulate 
retrotransposons and show defects in the progression of meiosis in the male germ line, 
retrotransposon de-repression is thought to be ultimately mediated by defects in DNA 
methylation which leads to a loss of transcriptional suppression (Bourc'his and Bestor, 
2004; Kuramochi-Miyagawa et al., 2004; De La Fuente et al., 2006; Carmell et al., 
2007). Analysis of MMERVK10C expression in p53-/- Dnmt1-/- fibroblast showed no 
upregulation despite being 50% demethylated compared to controls. This suggests that 
MMERVK10C behaves different from the well characterised IAP elements in somatic 
cells as IAPs are strongly upregulated in hypomethylated fibroblasts (figure 3.5). 
Interestingly, LINE1 RNA also showed no significant change in abundance in those cells 
(figure 3.5). In ES cells silencing of LINE1 transcription does not seem to be dependent 
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on DNA methylation as ES cells null for Dnmt1 and the de novo methyltransferases do 
not exhibit a significantly change in  LINE1 expression levels (Reichmann et al., in 
submission). However, in Dnmt3L mutant testes, where de novo methylation of 
retrotransposons is impaired, LINE1 shows upregulation at the RNA level by northern 
blot (Bourc'his and Bestor, 2004). Similarly, Miwi2 and Mili mutant germ cells 
upregulate LINE1 RNA which is also correlating with loss of DNA methylation at the 
promoter (Kuramochi-Miyagawa et al., 2008). MeCP2-/- mutant neurons, which are null 
for a protein which is thought to be involved in DNA methylation recognition, also show 
elevation of LINE1 transcription (Muotri et al., 2010). Furthermore, a study performed 
by Jackson-Grusby et al., (2001) reports an about 3-fold upregulation of LINE1 RNA in 
Dnmt1-/- mutant fibroblasts suggesting that the LINE1 promoter is able to drive 
expression in fibroblasts. The discrepancy in the LINE1 expression levels presented in 
this thesis and the study by Jackson-Grusby et al., (2001) could result from differences 
in the cell lines used for the analysis. The fibroblasts used by Jackson-Grusby et al., 
(2001) are conditionally null for Dnmt1-/- whereas the Dnmt1-/- MEFs used in this study 
have been suggested to be severe hypomorphs rather than Dnmt1 null (Li et al., 1992). 
In either cell line DNA methylation levels of LINE1 have not been assessed. It is 
possible that the hypomorphic Dnmt1 mutant MEFs are able to maintain DNA 
methylation of LINE1 to some extent and therewith transcriptional repression.  
 
The reason for MMERVK10C not showing an increase in transcription in p53-/- Dnmt1-/- 
MEFs could be that other or additional mechanisms facilitate silencing of this element in 
fibroblasts or that MMERVK10C requires specific transcription factors which might be 
present germ cells but not in somatic cells. However, data obtained by Michael Ling 
show no statistically significant increase of MMERVK10C transcript in Dnmt3L-/- testes 
(see 3.3.1). In comparison IAP elements are upregulated about 6-fold by affymetrix 
microarray in Dnmt3L-/- testes suggesting that MMERVK10C behaves different from IAP 
in Dnmt3L mutant testes (Hata et al., 2006).  To clearly test if DNA methylation is 
required for transcriptional repression of MMERVK10C in this tissue bisulfite 
sequencing of the MMERVK10C locus and comparison with DNA methylation of IAP 
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and LINE1 promoter regions, which are mis-expressed in the absence of Dnmt3L, would 
be required. In contrast to Dnmt3L+/- and Dnmt3L -/- testes and p53-/- Dnmt1-/- fibroblasts, 
NIH3T3 fibroblasts showed mis-expression of MMERVK10C by qRT-PCR analysis 
upon Aza treatment compared to untreated controls (figure 3.6).Why MMERVK10C loci 
show demethylation in p53-/- Dnmt1-/- fibroblasts but not Aza treated NIH3T3 cells is 
unclear as in both cases IAP and Tex19.1 transcripts, which have been reported to show 
severe upregulation in response to demethylation at their promoters, are strongly mis-
expressed (figure 3.6) (Walsh and Bestor, 1999; Gaudet et al., 2004, Hackett et al., 
submitted). It is possible that only a subset of cells has undergone DNA demethylation 
upon Aza treatment at the time of harvesting. The expression changes observed by 
qPCR could result from this subset of cells. The discrepancy between the expression 
analysis and bisulfite sequencing might be caused by bisulfite sequencing not being 
sensitive enough to detected DNA demethylation in only a subset of cells. Another 
explanation might be that MMERVK10C might be very efficiently targeted by Dnmt1 or 
the de novo methyltransferases and hence Aza treatment over a limited period of time 
might not be sufficient to induce demethylation at MMERVK10C loci. Bisulfite 
sequencing of the Tex19.1 and IAP promoters should be performed and compared to the 
methylation status of the MMERVK10C promoter in Aza treated cells. No or little 
demethylation of Tex19.1 and IAP loci would suggest that the expression changes 
observed in figure 3.6 result from a subset of cells in the population and that this subset 
of cells is not sufficient to show DNA demethylation by bisulfite sequencing of the 
whole cell population. Alternatively, analysis of the DNA methylation status might not 
correspond to the same copies that are examined on the RNA level due to the large 
number of copies in the mouse genome. Taken together the data I presented here show 
that MMERVK10C behaves different from IAP elements, which also belong to the 
ERVK family, in fibroblasts in response to DNA demethylation. When I tested if 
Tex19.1 expression might modulate the levels of MMERVK10C transcript in p53-/-
Dnmt1-/- cells I found that MMERVK10C was not differentially expressed between 
Tex19.1-/- and control Aza treated pMEFs (figure 3.6). This suggests that the lack of 
MMERVK10C mis-expression in p53-/-Dnmt1-/- cells is not mediated by the upregulation 
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of Tex19.1. In conclusion MMERVK10C does not rely as heavily on DNA methylation 
for transcriptional silencing in somatic cells and possibly, based on the Dnmt3L data 
from Michael Ling, in germ cells as IAP elements. As mentioned above Ian Adams did 
not observe hypomethylation of MMERVK10C LTR/5’UTR in Tex19.1-/- testes. This and 
the here presented data suggest that MMERVK10C mis-expression during 
spermatogenesis in the absence of Tex19.1 is caused by other mechanisms than 
transcriptional upregulation through hypomethylation of this element.  
 
 
3.3.3 Transcriptional regulation of MMERVK10C by histone 
modifications 
 
As mentioned above Aza treatment of NIH3T3 fibroblasts induced expression of 
MMERVK10C transcript which was surprising given the fact that MMERVK10C did not 
appear to be upregulated p53-/- Dnmt1-/- fibroblasts. One explanation could be that Aza 
facilitates, in addition to DNA demethylation, changes in histone modifications. It is 
known that treatment with Aza results in a decrease of the repressive histone mark 
H3K9me2 and it is possible that Aza treatment affects further histone modifications like 
H3K9me3 (Wozniak et al., 2007). This would be in accordance with the observations 
made in figures 3.5 and 3.6 which showed upregulation of MMERVK10C RNA in Aza 
treated fibroblasts but not p53-/- Dnmt1-/- MEFs. It is known from computational methods 
for analysis of repetitive elements from short-read sequencing data that retrotransposons 
belonging to the ERVK family, like MMERVK10C and IAPs, generally appear within 
clusters  in the genome enriched for H3K9me3 (Day et al., 2010). In accordance with 
this it has been previously demonstrated that loss of H3K9me3 strongly correlates with 
induction of MMERVK10C expression in ES cells null for the methyltransferase Setdb1 
(Karimi et al., 2011). In contrast, Dnmt TKO ES cell lines only show a slight induction 
of MMERVK10C transcript and simultaneous knockdown of Setdb1 and Dnmt1 in ES 
cells by RNA interference did not increase the level of MMERVK10C expression over 
that observed upon loss of Setdb1 alone. In contrast to MMERVK10C young IAP 
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elements show an accumulative effect of de-repression upon loss of H3K9me3 and DNA 
methylation in pluripotent cells (Rowe el al., 2010; Karimi et al., 2011). This strengthens 
the hypothesis that MMERVK10C is repressed in a different way from IAP elements. It 
appears that H3K9me3 is one of the major repressors of MMERVK10C activity in ES 
cells. In ES cells, Setdb1 is recruited to target loci via Kap1, and as mentioned before 
mutations in Kap1 result in global loss of H3K9me3 and retrotransposon mis-expression, 
including MMERVK10C, in ES cells (Rowe et al., 2010). H3K9me3 is also a major 
contributor to silencing of IAP elements in ES cells and early embryos (Rowe et al., 
2010, Karimi et al., 2011). Upregulation of IAP RNA in Dnmt TKO ES cells is a modest 
~4-8 fold compared to the mis-expression observed in hypomethylated somatic cells 
(Hutnick et al., 2010). Taken together, those data suggest that in contrast to IAPs, where 
silencing by H3K9me3 in ES cells is replaced by DNA methylation as the major 
repressor in somatic cells, MMERVK10C repression does not appear to undergo the 
same switch upon ES cell differentiation. It is unclear if H3K9me3 or other mechanisms 
facilitate silencing of MMERVK10C in somatic cells. In addition to DNA methylation 
and H3K9me3, histone deacetylation has been implicated in transcriptional silencing of 
certain retrotransposons in human EC cells and mouse somatic cells (Brunmeir et al., 
2010; Garcia-Perez et al., 2010). However, histone deacetylation, at least in cases where 
it depends on HDACs that can be inhibited by TSA, can be excluded to be a major 
contributor to MMERVK10C transcriptional silencing in fibroblasts (figure 3.7). As 
H3K9me3 seems to be a major determinant of MMERVK10C transcriptional repression 
in pluripotent cells, we tested if MMERVK10C might be also upregulated in Kap1-/- 
pMEFs.  Figure 3.7 shows that this is not the case. This suggests that mechanisms other 
that H3K9me3 silence MMERVK10C in somatic cells or that histone methyltransferases 
are recruited to MMERVK10C loci in a Kap1 independent manner in somatic cells.  
Reagents like somatic cell lines with mutations in genes known to facilitate H3K9me3 in 
differentiated cells or small molecule inhibitors of histone methyltransferases would 
help to understand if H3K9me3 is required to silence MMERVK10C in somatic cells. It 
would be interesting to perform chromatin-immuno-precipitation (ChIP), which can be 
used to investigate the interaction between proteins and DNA, on Tex19.1+/+ and 
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Tex19.1-/- testes for H3K9me3 at the MMERVK10C locus in order to establish if this 
mark is impaired in the mutants. However, microarray data from Tex19.1-/- and 
Tex19.1+/+  testes showed that only 0.05% (10 probes) out of 19,089 probes were 
significantly upregulated by at least 2-fold in Tex19.1-/- testes and that six of these 
probes belonged to MMERVK10C (Reichmann et al., submitted). Based on those data it 
seems unlikely that a global loss of this repressive histone mark has occurred in  
Tex19.1-/- mutants. Similarly, it also seems implausible that Tex19.1 should affect 
H3K9me3 solely at the MMERVK10C locus. Taken together, despite H3K9me3 being a 
possible repressor of MMERVK10C transcription, it appears likely that Tex19.1 
promotes silencing of this element by mechanisms other than H3K9me3.  
 
3.3.4 Post-transcriptional regulation of retrotransposons by 
Tex19.1 
 
Instead of affecting MMERVK10C transcription, Tex19.1 could also influence any of the 
other stages of the retrotransposon life cycle. Since Tex19.1 is a cytoplasmic protein any 
direct effects on MMERVK10C and other retrotransposons might be post-transcriptional 
and acting on the RNA or protein rather than the DNA level. Western blot analysis for 
IAP, IAPE and LINE1 protein levels showed that LINE1 ORF1p but not IAP or IAPE 
protein levels are elevated in 16dpp Tex19.1-/- testes compared to controls (figure 3.8). 
This is not caused by an increase in LINE1 RNA (figure 3.8). The 3-fold upregulation 
identified by western blot is similar to the upregulation identified by IF studies on 
sections from Tex19.1-/- and control testes were an about 2-fold upregulation could be 
observed (figure 3.9). IF analysis showed that LINE1 ORF1p can be found in the 
pachytene spermatocytes which is the cell type where defects in meiotic progression are 
observed for the first time in Tex19.1-/- mutants. Taken together those data suggest a loss 
of translational repression or an increase of LINE1 ORF1 protein stability in Tex19.1-/- 
male germ cells. Western blot and qPCR analysis for IAP, IAPE and LINE1 protein and 
RNA expression in ES cells showed that RNA expression appears to be variable 
between cell lines for all three retrotransposons and no Tex19.1 dependent change of 
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IAP and IAPE protein between knockout and control cell lines could be observed (figure 
3.10). As mentioned under 3.2.3.2 this discrepancy between the testes and ES cell data 
sets could be caused by the fact that ES cells might generally show high variation of 
LINE ORF1p expression levels between cell lines which would make it difficult to pick 
up small changes in protein abundance. In order to examine if LINE1 is a target for 
translational repression by Tex19.1 I transfected reporter plasmids for 5’UTR mediated 
translation of LINE1 RNA into Tex19.1-/- and Tex19.1 +/+ ES cells. This showed no 
difference between mutant and control cell lines (figure 3.11). This suggests that 
Tex19.1 does either not regulate the translation of LINE1 via its 5’UTR or that Tex19.1 
is generally not a translational repressor of LINE1 in ES cells. However, given the large 
amount of diverse LINE1 elements, in particular three active subclasses, in the mouse 
genome it is also possible that Tex19.1 acts on some but not other subclasses and that 
the sequence of the LINE1spa element, belonging to the Tf-type of LINE1s, used in this 
study is not a target for Tex19.1. Overall further work is required to establish if Tex19.1 
might have similar roles in testes and embryonic stem cells. In both, wild type testes and 
ES cells, Tex19.1 does not associate with polysomes (figure 3.14). Furthermore the data 
presented in figure 3.12 suggest that Tex19.1 is not associated with polyadenylated 
mRNA in wild type testes and neither LINE1 nor MMERVK10C RNA shift into the 
more translated part of the sucrose gradient in Tex19.1-/- compared to control testes 
under the conditions used during this project (figure 3.15). Taken together the here 
presented data suggest that Tex19.1 is not a translational regulator of LINE1 or 
MMERVK10C. The discrepancy between the result presented in figure 3.15 compared to 
the shift of MMERVK10C into the more translated part of the sucrose gradient in the 
absence of Tex19.1 observed by Ian Adams (figure 3.1) might be based on the fact that  
the qPCR primers amplify a different subset of MMERVK10C transcripts compared to 
the northern blot probe. Another possible explanation might be that, as can be seen from 
figure 3.1, MMEVRK10C in the northern blot analysis can predominantly be found in 
fraction 7, however, the polysomes localise to fractions 5 to 10. If MMERVK10C RNA 
would be shifting in response to translation a more even distribution might be expected. 
The fact that MMERVK10C is found in the heavier compartment of the sucrose gradient 
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by northern blot could be caused by an increase of viral particle formation in the absence 
of Tex19.1 as viral particles are relatively large protein assemblies (Hammarstedt et al., 
2000). For the qPCR analysis individual mRNP, monosome and polysome fractions 
were pooled together based on the recorded profile. If an increase in viral particles 
should be responsible for the shift, which possibly results in an enrichment of 
retrotransposon RNA predominantly in a certain fraction of the heavier part of the 
sucrose gradient, in Tex19.1 mutants, pooling of fractions might dilute this effect. 
However, the fact that MMERVK10C gag, pol and env transcripts are all upregulated to 
different extents as shown in figure 3.4 represents a possible caveat with this theory.  In 
order to test if either of the two theories might be true individual fractions of the 
gradients should simultaneously be analysed by qPCR and northern blot and then 
compared. 
 
3.3.5 Tex19.1 interacts with Ubr2 and may modulate N-end rule 
mediated protein turn over  
 
In order to understand by which mechanism Tex19.1 might represses retrotransposon 
expression we wanted to examine if Tex19.1 functions in a complex and with which 
proteins it might interact. Figure 3.16A shows that the majority of Tex19.1 is likely 
bound in a complex as it migrates at larger sizes than its predicted molecular weight on a 
sucrose size gradient. Interestingly, we were able to confirm Ubr2 being a binding 
partner for Tex19.1 in ES cells (figure 3.16B). Interaction between Tex19.1 and Ubr2 in 
male germ cells and Tex19.1 and UBR2 in HeLa cells has been previously reported 
(Yang et al., 2010). Figure 3.17 shows that Tex19.1 enhances Ubr2 activity in a gain of 
function experiment but not a loss of function experiment. In addition to Ubr2 there are 
believed to be at least 3 other E3 proteins that recognize N-degrons (Tasaki et al., 2005). 
Therefore one possible explanation of the discrepancy between the loss of function 
experiment in the ES cells and the gain of function experiment in the HeLa cells could 
be that other Ubr proteins in the Tex19.1-/-  ES cell  lines target N-end rule GFP 
substrates efficiently enough that no difference between wild type and controls can be 
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observed. In conclusion the data I present here demonstrate that the interaction between 
Tex19.1 and Ubr2 is conserved in ES cells which suggests that Tex19.1 might fulfil 
similar roles in germ cells and pluripotent cells. Based on the data presented in figure 
3.17D I speculate that Tex19.1 might promote Ubr2 function. However, further work 
will be required to establish if this indeed the case and importantly which proteins 
represent possible targets for the Tex19.1 and Ubr2 complex.  
 
 3.3.6 Functional role of the Tex19.1 protein in retrotransposon 
repression  
 
It was previously known that MMERVK10C transcript is upregulated in Tex19.1-/- testes 
but it was not clear if retrotransposon upregulation might be more widespread (Öllinger 
et al., 2008). Here I have advanced our understanding of this and shown that 
retrotransposon mis-expression in Tex19.1-/- testes is fairly restricted to MMERVK10C. 
Furthermore, I have provided evidence that DNA methylation appears to play a minor 
role in silencing MMERVK10C at the DNA level. How relevant this might be for the 
RNA up-regulation of MMERVK10C observed in Tex19.1-/- male germ cells remains to 
be seen as I was able to provide evidence that Tex19.1 might not act at the DNA, RNA 
or translational level but at the level of protein stability. LINE1 ORF1p appears to be 
upregulated in Tex19.1-/- testes and based on the interaction between Tex19.1 and Ubr2 
it is possible that in the absence of Tex19.1 LINE ORF1p is stabilised due to a loss of N-
end rule mediated proteolysis. However, it is currently not clear if LINE ORF1p 
represents indeed a substrate for Ubr2. It is possible that cleavage of a few amino acids 
from the LINE1 ORF1p N-terminus creates N-degrons and makes LINE1 ORF1p a 
target for Ubr2. Alternatively Tex19.1 might act as a scaffold/adaptor to help Ubr2 
ubiquitinate LINE1 ORF1p. Currently this is merely speculation and further analysis of 
retrotransposon proteins, including MMERVK10C, will be required to understand the 











Chapter 4: Characterisation of the role of 














Tex19.1 expression has been reported to be restricted to germ cells, pluripotent cells and 
the placenta (Childs, 2006; Kuntz et al., 2008; Öllinger et al., 2008). In the germline 
Tex19.1 RNA expression has been reported in migrating PGCs isolated from the hind-
gut region of 9.5dpc embryos by qRT-PCR (Hackett et al., submitted). The same study 
demonstrated Tex19.1 expression at 10.5dpc and 13.5dpc in the gonads of both sexes. 
This is in accordance with data where RNA expression of Tex19.1 from 13.5dpc through 
to adulthood in the gonads of both sexes has been reported by RT-PCR (Childs, 2006; 
Kuntz at al., 2008). During embryonic development Tex19.1 RNA has been shown to be 
expressed at the 1, 2, 8 and 16 cell and blastocyst stage (Kuntz et al., 2008). RT-PCR 
showed that Tex19.1 is also expressed in embryonic germ cells (EG) and ES cells and 
upon in vitro differentiation Tex19.1 becomes down-regulated in ES cells (Childs, 2006; 
Kuntz et al., 2008). Furthermore, Tex19.1 protein expression has been demonstrated in 
fetal germ cells at 14.5dpc, and in male germ cells in the adult gonads as well as in ES 
cells (Öllinger et al., 2008). This expression pattern is similar to Oct4, as described in 
chapter 1.  
 
In order to analyze the physiological function of Tex19.1, Rupert Öllinger generated 
knockout mice. Generation and analysis of mice that have disruption in one or more 
genes is a powerful reverse genetic approach for studying the role of genes whose 
function has not been determined. In the case of the Tex19.1 gene, mutants were 
generated by replacing the Tex19.1 open reading frame with a neomycin selection 
cassette by homologous recombination in E14 embryonic stem cells (figure 4.1) 




Figure 4.1: Schematic representation of the Tex19.1 locus. In order to generate Tex19.1 
knockout mice the Tex19.1 gene in the wild type allele is replaced with a neomycin cassette. SP 
indicates the location used for the Southern blot probe and BamHI sites and mark the length of 
restriction fragments for each allele. Taken from Öllinger et al., (2008). 
 
By crossing animals heterozygous for the knockout allele Rupert Öllinger identified a 
reduction in the number of Tex19.1-/- animals born on a mixed genetic background 
(129/Ola x CD1). The second aim of my thesis was to characterise the embryonic 
lethality of Tex19.1-/- mice in more detail.  
 
During this project I repeated the breeding analysis with mice where the Tex19.1 
mutation had been back crossed three times into a C57BL/6 background. The reasons for 
this were two-fold. The 129/Ola x CD1 background used in the original study could not 
be easily maintained since genetic and therewith phenotypic variability would increase 
in subsequent generations due to the hybrid background.  Secondly, the backcross into a 
C57BL/6 background reduced genetic variation between animals. In order to understand 
at which stages of embryonic development absence of Tex19.1 might affect viability, I 
characterised the expression pattern of Tex19.1 in the embryo in more detail. As 
mentioned above Tex19.1 is expressed in the pluripotent cells of the early pre-
implantation embryo. In order to investigate if Tex19.1-/- knockouts die due to defects in 
those cells and in order to establish an in vitro model for the characterization of Tex19.1 
function we analyzed Tex19.1-/- knockout ES cells.  Mouse ES cells are, as mentioned 
before, derived from the ICM of the blastocyst and can therefore be considered as a 
model for the pluripotent cells of the pre-implantation embryo. Ian Adams and Rupert 
Öllinger previously derived ES cells from Tex19.1+/- heterozygous crosses. They found 
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that among 20 generated ES cell lines there was no significant deviation from the 
expected Mendelian ratio (4 Tex19.1-/- ES cells, 6 Tex19+/+ and 10 Tex19.1+/-). In order 
to examine if the reduction of Tex19.1-/- homozygotes is caused by problems in the 
pluripotent cells of the pre-implantation embryo I characterized if Tex19.1-/- ES cells can 
differentiate and if they show upregulation of retrotransposons. Furthermore, I analysed 
the karyotype of Tex19.1-/- ES and control cell lines in order to understand if an increase 













4.2.1 Tex19.1-/- homozygotes are born at a reduced frequency  
 
Analysis of heterozygous crosses in a C57BL/6 background showed a 32% reduction of 
Tex19.1-/- homozygotes born. I found that of 785 pups born from heterozygous crosses, 
213 were Tex19.1+/+, 442 Tex19.1+/- and 130 Tex19.1-/-. This is a significant deviation 
from the expected 1:2:1 ratio (χ2-test p < 0.0005) and suggests that Tex19.1 plays a role 
during embryonic development (summarized in table 4.1).  
 
Genotype Number (and %) of pups     
observed 
Number (and %) of pups 
expected 
Tex19.1+/+ 213 (27) 193 (25) 
Tex19.1+/- 442 (56) 386 (50) 
Tex19.1-/- 130 (17) 193 (25) 
Table 4.1: Observed and expected distribution of Tex19.1-/- pups. 
 
 
4.2.2 Reduction of Tex19.1-/- homozygotes is exacerbated in 
subsequent litters and shows strong male/female sex bias 
 
Interestingly, further analysis of the breeding data revealed that the reduction of  
Tex19.1-/- pups is exacerbated in subsequent litters compared to first litters. Table 4.2 
shows that pups born from first litters, meaning pups born from female mice that have 
not given birth before, show a 25% reduction of Tex19.1-/- animals (χ2-test p<0.05). In 
contrast pups born as subsequent litters, which refers to pups born from female mice that 
have at least given birth once before, and importantly from matings where the mating 
pair has been constantly kept together, the reduction of Tex19.1-/- mutants is 
approximately 74% and (p<0.0005) (table 4.3).   
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Furthermore, the reduction of homozygote Tex19.1-/- animals in subsequent litters is 
associated with a strong male/female sex bias with females showing an 88% reduction 
and males a 44% reduction from the expected Mendelian ratio (χ2-test p<0.0005 and 
p<0.05, respectively). This contrasts with pups born from first litters, whereby there is a 
27% reduction in homozygote females and a 23% reduction in Tex19.1-/- males. This 
effect was also apparent on the mixed genetic background as observed by Rupert 
Öllinger (data not shown). Taken together, this data suggests that absence of Tex19.1 
affects embryonic development of both sexes and that this effect is exacerbated in pups 
born as subsequent litters. Furthermore, the increase in embryonic lethality of Tex19.1-/- 
pups in subsequent litters affects females even stronger than males.  
 
 
Genotype Total number 
(and %) of pups 
observed 
Number (and %) 
of females 
observed 
Number (and %) 
of males 
observed 
Number (and %) 
of males or 
females 
expected  
Tex19.1+/+ 111 (25) 52   (12) 59   (13) 55.5  (12.5) 
Tex19.1+/- 250 (56) 120 (27) 130 (29) 111   (25) 
Tex19.1-/- 83   (19) 40   (9) 43   (10)    55.5  (12.5) 
Table 4.2: Observed and expected distribution of Tex19.1-/- pups in first litter. 
 
 
Genotype Total number 
(and %) of pups 
observed 
Number (and %) 
of females 
observed 
Number (and %) 
of males 
observed 
Number (and %) 
of males or 
females 
expected  
Tex19.1+/+ 60   (30) 25 (13) 35 (17) 25.25 (12.5) 
Tex19.1+/- 125 (62) 73 (36) 52 (26) 50.5   (25) 
Tex19.1-/- 17   (8) 3   (1) 14 (7) 25.25 (12.5) 




Female mice are receptive to mate shortly after the female has given birth during the 
post-partum estrus. If a mating pair is consonantly kept together, as described above for 
pups born as subsequent litters, mating will usually occur during the post-partum estrus 
(Gilbert, 1984).  This means that the female will conceive another pregnancy while 
suckling a litter. Therefore the data presented in table 4.2 and 4.3 implied to us that the 
exacerbated reduction of Tex19.1-/- pups born from subsequent litters is caused by 
lactating mothers. I wanted to confirm that viability of Tex19.1-/- embryos was indeed 
compromised by lactation of the mother and not caused by some other defect that might 
occur in subsequent pregnancies in Tex19.1+/- females. In order to do so, I analysed pups 
born from subsequent litters where the mating pair had been separated as soon as the 
female was plugged. This procedure ensured that the female would not be suckling a 
litter when becoming pregnant again. The numbers of homozygote pups born from 
subsequent litters of non-lactating females were similar to those born from first litters   
(χ 2-test p>0.2) (tables 4.2, 4.3 and 4.4). This contrasts significantly with the number of 
pups born from lactating mothers and therefore suggests exacerbated lethality of 
Tex19.1-/- embryos occurs indeed in response to lactation (χ 2-test p< 0.0005) (tables 4.2, 
4.3 and 4.4).  
 
 
Genotype Total number 
(and %) of pups 
observed 
Number (and %) 
of females 
observed 
Number (and %) 
of males 
observed 




Tex19.1+/+ 46 (30) 23 (15)  23 (15) 19.25 (12.5) 
Tex19.1+/- 76 (49) 34 (22) 42 (27) 38.5   (25) 
Tex19.1-/- 32 (21) 11 (7) 21 (14) 19.25 (12.5) 





As described in chapter 1, in lactating mothers, embryos in the next litter usually enter a 
developmental delay at the blastocyst stage, known as diapause in order to prevent two 
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litters being born too close to each other (Renfree and Shaw, 2000). In order to test if 
Tex19.1 might be required during embryonic diapause, we chemically induced 
developmental arrest with tamoxifen and depo-provera as described previously (Hunter 
and Evans, 1999). In each case 15 females were superovulated, mated and at 2.5dpc 
injected with tamoxifen and depo-provera to induce diapause.  At 6.5 dpc the arrested 
blastocysts were isolated and transferred to the uterus of 2.5 dpc pseudopregnant 
recipient females (the isolation of blastocysts and embryonic transfers were carried out 
by Emma Murdoch). In the two experiments, only 63 and 70 blastocysts were isolated 
and transferred and from those, 23 and 25 pups were born and genotyped, respectively.  
Surprisingly, independent of genotype, I noticed a 54% reduction in the number of 
females born from chemically diapaused blastocysts (χ2-test p<0.0005). Since the major 
reduction of Tex19.1-/- pups occurs in females, this experiment is not appropriate to 
address the question of whether or not Tex19.1 plays a role during embryonic diapause. 
This experiment would need to be repeated at least twice and therefore the number of 
mice required to obtain a sufficient number of chemically arrested male and female pups 
born appears unreasonable. Accordingly, we did not pursue this experiment further. 
Instead, we analysed lactation-induced diapaused embryos in more detail.  
 
 
Genotype Total number 
(and %) of pups 
observed 
Number (and %) 
of females 
observed 
Number (and %) 
of males 
observed 




Tex19.1+/+ 11 (23) 2 (4) 9  (19) 6  (12.5) 
Tex19.1+/- 30 (62.5) 8 (16) 22 (46) 12 (25) 
Tex19.1-/- 7  (14.5) 1 (2) 6  (13) 6  (12.5) 




To investigate at which stages mutation in Tex19.1 affects viability of embryos in 
lactating mothers, diapaused embryos were isolated at the equivalent of 13.5 dpc from 
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nursing females, genotyped and sexed by PCR. All embryos isolated had undergone 
diapause which varied between 3 to 5 days from litter to litter. However, difficulties 
arose through the fact that it appeared that C57BL/6 females may have problems to 
maintain embryonic diapause in general as 40% of investigated females were not 
pregnant at the desired stage but showed degenerated implantation sites. However, it is 
not clear if this is indeed true for C57BL/6 females as there have not been any studies 
that have examined the ability of different mouse strains to maintain diapause to date. 
No deformed or developmentally retarded embryos were observed among the isolated 
embryos, however, as table 4.6 shows, the reduction of a large amount of Tex19.1-/-  
female embryos has occurred by 8.5-10.5 dpc (χ2-test p<0.05). During the process of 
isolating the embryos from the deciduas for genotyping, 13 bloody and/or empty 
deciduas were noticed. This suggests that a large proportion of Tex19.1-/- embryos has 
died before 10.5dpc. In order to test if Tex19.1-/- embryos suffered lethality during 
embryonic diapause or after implantation, lactation-induced diapaused blastocysts were 
isolated at the equivalent of 5.5dpc and genotyped. All isolated and genotyped 
blastocysts looked morphological normal with epiblast, hypoblast and trophectoderm 
being clearly distinguishable by brightfield microscopy (not shown). Gene expression 
differences between Tex19.1-/-, Tex19.1+/- and Tex19.1+/+ blastocysts were not 
investigated in this study. Table 4.7 shows that distribution of Tex19.1+/+, Tex19.1+/- and 
Tex19.1-/- embryos among lactation-induced diapaused blastocysts is not different from 
the distribution observed in pups born as first litters (χ2-test p>0.5) but significantly 
different from pups born as subsequent litters (χ2-test p<0.05). This suggests that the 
reduction we observe in Tex19.1 homozygote embryos does not occur at the blastocyst 








Genotype Total number 
(and %) of 
embryos 
observed 
Number (and %) 
of females 
observed 
Number (and %) 
of males 
observed 
Number (and %) 
of males or 
females 
expected  
Tex19.1+/+ 27 (28) 14 (14) 13 (13.5) 10.875 (12.5) 
Tex19.1+/- 54 (56) 28 (29) 26 (27) 21.75   (25) 
Tex19.1-/- 16 (16) 4   (4) 12 (12.5) 10.875 (12.5) 
Table 4.6 Observed and expected distribution of embryos isolated from lactating females 
at 13.5dpc. Developmental stage of embryos appeared to vary from litter to litter. It appears that 




Genotype Total number (and %)of 
embryos observed 
Number (and %) of embryos 
expected 
Tex19.1+/+ 5   (17) 7.25 (25) 
Tex19.1+/- 18 (62) 14.5 (50) 
Tex19.1-/- 6   (21) 7.25 (25) 
Table 4.7 Observed and expected distribution of lactation induced diapaused blastocysts.  
 
 
4.2.3 Tex19.1 expression is associated with a pluripotent cell 
state in embryonic cell lineages and is also present in 
extraembryonic tissues during development 
 
In order to understand why viability of embryos is affected when Tex19.1 is absent we 
examined the expression pattern of Tex19.1 in more detail. It has been previously 
reported that Tex19.1 RNA becomes down regulated upon ES cell differentiation 
(Childs, 2006; Kuntz et al., 2008). To see if Tex19.1 RNA expression is indeed 
associated with pluripotency in embryonic stem cells we differentiated E14 ES cells in 
hanging droplet culture (figure 4.2). RT-PCR showed that Tex19.1 RNA expression 
becomes down regulated upon differentiation and is not detectable by day 7 of 
differentiation. The down-regulation of Tex19.1 coincides with down-regulation of the 
pluripotency markers Oct4 and Nanog and up-regulation of markers for the 3 germ 
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layers (Gata4 endoderm, Msx3 ectoderm, Nkx2.5 mesoderm). This suggests that Tex19.1 
is expressed in pluripotent cells and becomes down-regulated upon differentiation. As 
mentioned before, it has been shown that Tex19.1 is expressed in the pluripotent cells of 
the pre-implantation embryo (Kuntz et al., 2008). However, the expression of Tex19.1 in 
the post-implantation embryo has not been reported but there are pluripotent cells 
present also at early stages of this process. In order to see if Tex19.1 is expressed after 
implantation I performed immunohistochemistry (IHC) on sections of early post-
implantation embryos. Figure 4.3 shows that anti-Tex19.1 staining can be observed in 
the early post-implantation embryo. At 6.5dpc anti-Tex19.1 staining is present in the 
ectoplacental cone, extraembryonic ectoderm and the epiblast. In 7.5 dpc embryos 
Tex19.1 staining is present in extraembryonic tissues but is downregulated in epiblast-
derived tissues in the embryo with some faint staining present in embryonic mesoderm 
and extraembryonic mesoderm. One day later, Tex19.1 is not detectable in the 
embryonic tissues at 8.5 dpc. Tex19.1 staining is also not present in the hindgut 
endoderm where primordial germ cells are located at this stage. At 9.5dpc Tex19.1 
staining is mainly detected in the placenta. Concerning the observed reduction of 
Tex19.1-/- homozygotes born from heterozygous crosses, the expression data presented 
here, together with the published data, suggest that the phenotype could result from 
problems in the pluripotent cells of the pre-implantation embryo, problems in the 





Figure 4.2: Tex19.1 expression is downregulated upon ESC differentiation. ESCs were 
differentiated by hanging droplet culture in the absence of LIF. Loss of pluripotency is reflected 
by loss of Oct4 and Nanog expression. Tex19.1 expression is not detectable by day 7 of 
differentiation, which is in accordance with the loss of pluripotency. Expression of Gata4, Msx3 
and Nks2.5 marks differentiation into the three germ layers (d0 is 0 days of differentiation, d2 is 
second day of differntiation etc., +VE is RT-PCR for whole 9.5dpc embryo, NT is no template 




Figure 4.3: Tex19.1 protein expression in post-implantation embryos. (A) Anti-Tex19.1 staining (brown precipitate) in 6.5 dpc 
embryos is present in the ectoplacental cone (ec), extraembryonic ectoderm (ex.e), and epiblast (epi). (B) 6.5 dpc IgG control. (C) In 
7.5 dpc embryos Tex19.1 staining is present in extraembryonic tissues but is downregulated in epiblast-derived tissues in the embryo 
with some faint staining present in embryonic mesoderm (mes) and extraembryonic mesoderm (ex.m). (D) 7.5 dpc IgG control.  
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(E) Tex19.1 staining was not detectable in embryonic tissues at 8.5 dpc. Tex19.1 staining was 
not detected in the hindgut endoderm where primordial germ cells are located at this stage. 
Panel shows posterior region of 8.5 dpc embryo. hg, hindgut; al, allantois. (F) At 9.5 dpc Tex19.1 
staining is detected mainly in the placenta (pl). (G) 9.5 dpc IgG control. (H) Higher magnification 
of the placenta at 9.5 dpc, Tex19.1 staining is present in the trophoblast (t) and future 




4.2.4 Analysis of Tex19.1-/- ES cells 
 
In order to analyse if the reduction of Tex19.1-/- pups might be caused by a problem in 
the pluripotent cells, we used embryonic stem cells as a model system. To test if the 
embryonic stem cell lines derived by Ian Adams and Rupert Öllinger expressed 
pluripotency markers western blot analysis was performed on extract from Tex19.1+/+, 
+/- and -/- ES cells. Figure 4.4 shows that Oct4 expression levels appear similar between 
Tex19.1+/+, Tex19.1 +/- and Tex19.1-/- ES cells suggesting that absence of Tex19.1 does 
not affect Oct4 protein levels in ES cells. To test if ES cells have the ability to 
differentiate in the absence of Tex19.1, Tex19.1-/- ES cells were differentiated by 
hanging droplet culture. Figure 4.5 shows that Tex19-/- knockout ES cells down regulate 
pluripotency markers and upregulate markers of the 3 germ layers upon differentiation 
suggesting that Tex19.1 is not required for ES cell differentiation in this assay.  
 
 
Figure 4.4: Oct4 expression in Tex19.1-/- ES cells. For Western blot analysis 20µg of ES cell 
extract was loaded in each lane. Tex19.1 +/+, +/- and -/- ES cells were analysed for Tex19.1 and 







Figure 4.5:  Tex19-/- knockout ES cells can differentiate into the three germ layers in vitro. 
ESCs were differentiated by performing hanging droplet culture in the absence of LIF. Loss of 
pluripotency is indicated by loss of Oct4 and Nanog expression. RT-PCR on testis cDNA was 
performed as a positive control for Tex19.1. Expression of Gata4, Msx3 and Nks2.5 marks 
differentiation into the three germ layers (d0 is 0 days of differentiation, d2 is 2 days of 




Although we could detect no obvious abnormalities in the derivation, maintenance or 
differentiation of Tex19.1-/- ES cells, I investigated whether loss of Tex19.1might cause 
de-repression of retrotransposons in ES cells, as MMERVK10 RNA is upregulated in 
Tex19.1-/- male germ cells. According to the fact that pluripotent cells in the early 
embryo are also a viable target for endogenous retrovirus activity we wanted to know if 
the loss of Tex19.1-/- homozygotes results from an upregulation of retrotransposon in 
those cells. Retrotransposons in mammals are divided into three major classes 
(Maksakova et al., 2006) which are: 
1. Autonomous long interspersed elements (LINEs) 
2. Non-autonomous short interspersed elements (SINEs) and 
3. Endogenous retroviruses (ERVs). 
We tested Tex19.1-/- knockout ES cells by qRT-PCR for upregulation of MMERVK10C, 
a member of each class of retrotransposons and a member of ERV1, ERVK and ERVL 
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families which represent ERV subfamilies. Furthermore we tested the expression of two 
retrotransposons closely related to MMERVK10C. Figure 4.6A shows that 
MMERVK10C RNA expression does not correlate with presence or absence of Tex19.1 
transcript suggesting that MMERVK10C RNA is not mis-expressed in Tex19.1-/- ES 
cells.  Similarly, LINE and SINE retrotransposons show no upregulation in Tex19.1-/-ES 
cells (figure 4.6B). MuLV, IAP and MERVL2a LTR retrotransposons representing the 
ERV1, ERVK and ERVL families of LTR retrotransposons respectively, do not change 
in expression in Tex19.1-/- ES cells either. This appears also to be true for EtnERV2 and 
IAPEY3 elements which are closely related to MMERVK10C (figure 4.6B). In addition, I 
tested a selection of other retrotransposons for expression in Tex19.1-/- ES cells 
compared to controls. Expression of MysERV, ERVB, EtERV and ETnI was not 
increased in Tex19.1-/- ES cells (figure 4.6C). In contrast MusD appeared to be up-
regulated around 7.5-fold in the Tex19.1-/- knockout cell line compared to the wild type 
control. However, analysis of two further control cell lines and two more Tex19.1-/- ES 
cell lines showed that MusD expression was up-regulated by only 1.8-fold in one of the 
Tex19.1-/- lines and even downregulated in the other Tex19.1-/- line by about 10 fold 
compared to controls. Furthermore, in one of the controls, the expression of MusD 
appeared downregulated by about 10 fold. This finding suggests that the variation in 
MusD RNA expression between ES cell lines is not linked to the Tex19.1 mutation and 
possibly results from genetic differences between the cell lines. 
 
A 
  MMERVK10C expression in Tex19.1-/- ES cell lines 
 
B 




 Retrotransposon expression in Tex19.1-/- ES cell lines 
 
D 
       MusD expression in Tex19.1-/- ES cell lines 
 
Figure 4.6: Retrotransposon RNA expression in Tex19.1-/- ES cells. (A-D) Expression levels 
for each gene or repetitive element were normalized to β-actin and expressed relative to one 
wild type control. Each bar represents one biological replicate. Error bars represent standard 
error among three technical replicates.  
 
 
In addition to repression of retrotransposon expression, Tex19.1 has been implicated in 
promoting faithful chromosome segregation in mouse male and female germ cells 
(Öllinger et al., 2008; Chapter 5). Therefore I decided to test if Tex19.1 might play a role 
in preventing aneuploidy in ES cells. ES cell lines, all of which were between passage 
number 10-12, were arrested at pro-metaphase and chromosome spreads prepared for 4 
Tex19.1-/-, 2 Tex19.1+/- and 2 Tex19.1+/+ cell lines. Of each cell line, 25 spreads were 
counted. This revealed high levels of aneuploidy in each of the 4 Tex19.1-/- cell lines 
which were, with a total of 74% percent of spreads being aneuploid, significantly higher 
compared to the 19% of aneuploidy observed in the Tex19.1+/- and Tex19.1+/+ controls 












Figure 4.7: Aneuploidy in Tex19.1-/- ES cell lines. 
(A-C) The majority of cells from 4 different Tex19.1-/- knockout ES cell lines show aneuploidy. (A-
C) shows chromosome metaphase spreads prepared from Tex19.1-/- knockout ES cell lines with 
41 (A), 42 (B) and 44 (C) chromosomes. (D-F) Chromosome metaphase spreads prepared from 
Tex19.1+/- heterozygote and Tex19.1+/+ wild type cell lines are mainly euploid. Scale bars 
represent 5 μm. (G and H) Among 4 different Tex19.1-/- knockout ES cell lines 74% of cells  
show aneuploidy in contrast to 19% of aneuploidy seen in Tex19.1+/- and +/+ control ES cell lines 





In this chapter I set out to gain a better understanding of the role of Tex19.1 during 
embryonic development. Firstly, I collected breeding data from Tex19.1+/- crosses which 
showed a reduction of Tex19.1-/- pups born from the expected ratio which I followed up 
in detail. Next, I analysed the expression pattern of Tex19.1 during early post-
implantation development in order to understand at which stages and cell types mutation 
in Tex19.1 might affect embryonic viability, as Tex19.1 expression patterns had only 
been reported for pre-implantation development and germ cells so far. Since Tex19.1 is 
expressed in pluripotent cells during embryonic development, I tested if Tex19.1-/- ES 
cells could be used as a tool to model Tex19.1 function during embryonic development. I 
finished the chapter by providing evidence that absence of Tex19.1 is associated with 
aneuploidy in ES cells.  
 
4.3.1 Mutation in Tex19.1 compromises embryonic viability 
 
Analysis of 785 pups born from Tex19.1+/- heterozygote crosses on a C57BL/6 
background showed a 33% reduction in the number of Tex19.1-/- mutants (table 4.1). 
This data is similar to the 34% reduction previously reported by our laboratory on a 
mixed genetic background (29/Ola x CD1). In contrast, Yang et al., (2010) reported an 
approximately 50% reduction in the number of Tex19.1-/- homozygotes on a mixed 
genetic background born (C57BL/6 x 129/sv). This discrepancy is likely caused by a 
difference in the experimental set up. The data presented in this thesis suggest that 
Tex19.1-/- animals born from lactating mothers show a stronger reduction of 
homozygotes than pups born as first litters (tables 4.2 and 4.3). It is possible that 
variation in the numbers of pups born as first litters and pups born as litters from 
lactating mothers between the studies accounts for the observed difference. The data 
presented in this thesis shows that the reduction of Tex19.1-/- homozygote increases from 
25% in both sexes among pups born as first litters to 44% in males and 88% in females 
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among pups born from lactating mothers. The fact that lactation is influencing the 
embryonic lethality is further supported by the observation that pups born as subsequent 
litters from females that are not lactating, do not show the increase in lethality of 
Tex19.1-/- homozygotes, but are born with a similar distribution as pups from first litters. 
The reason why embryonic viability is affected in Tex19.1-/- mice and why this effect is 
exacerbated in pups born from lactating mothers, particular females, is not clear. One 
possibility is that Tex19.1 plays a role during embryonic diapause (see chapter 1). In 
order to test if the reduction of Tex19.1-/- homozygotes seen in our experiments is caused 
or exacerbated by blastocysts entering diapause we chemically-induced diapause in 
embryos from Tex19.1+/- matings which, surprisingly, resulted in a 54% reduction of all 
females born  independent of genotype. This suggests that there might be a difference 
between lactation-induced and chemically-induced diapause, as decreased viability of 
lactation-induced diapaused female embryos has not been reported. Furthermore, no 
reduction of Tex19.1+/+ or Tex19.1+/- females was observed in litters that likely had 
undergone lactation-induced diapause (figure 4.3). It is not clear why chemically-
induced diapause would affect viability of female embryos. This observation requires 
further investigation. As mentioned in chapter 1, little is known about genes required by 
the embryo itself to undergo diapause, but for example, gp130-/- embryos are unable to 
resume development after diapause as they are not able to maintain the epiblast during 
developmental arrest (Nichols et al., 2001).  In contrast,  since Tex19.1-/- chemically 
diapaused embryos were born after embryo transfer it appears that Tex19.1 is not 
absolutely required to enter, maintain or exit embryonic diapause. Tex19.1 expression 
may or may not influence viability during embryonic diapause. Further analysis showed 
that a large reduction of Tex19.1-/- homozygote females has occurred by 13.5 dpc in 3 to 
5 days diapaused embryos isolated from lactating mothers (table 4.6). This reduction, of 
63%, is smaller than the reduction observed in table 4.3. This might be caused either by 
the fact that the number of embryos analysed here is too small, which might bias the data 
to some extent, or that the lethality of Tex19.1-/- homozygotes might not occur at one 
certain developmental stage but at several stages depending on how severe the 
individual embryo is affected. Both reasons might also explain the fact that we did not 
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observe a reduction in the number of   Tex19.1-/- homozygous males in this experiment. 
Isolation of lactation-induced diapaused blastocysts showed that reduction of Tex19.1-/- 
embryos does not occur at this stage suggesting that Tex19.1 homozygote embryos die 
around or after implantation. It is currently not clear how loss of Tex19.1 in diapaused 
embryos would cause lethality after implantation, but the here presented data suggests 
that expression of Tex19.1 might be required at a time where a pluripotent stage has to 
be maintained for a prolonged period.  Alternatively, based on the fact that Tex19.1 is 
also expressed in the extraembryonic cell lineages, it is possible that not embryonic 
diapause, but lactation negatively affects embryonic viability of Tex19.1-/- mutants 
(figure 4.3). Survival and growth of the embryo are critically dependent on the 
extraembryonic cell lineages, in particular the placenta (Cross et al., 2003). The placenta 
forms the interface between the maternal and fetal circulation and facilitates nutrient 
uptake, waste elimination, and gas exchange via the mother's blood supply (Watson and 
Cross, 2005). Genes that affect placental development or function cause fetal growth 
restriction or embryonic death between 10.5-12.5dpc, often resulting from an impaired 
nutrient supply (Rashbass et al., 1991; Anson-Cartwright et al., 2000; 
Chawengsaksophak et al., 2004; Lotz et al., 2004). If absence of Tex19.1 should cause 
problems in development or function of the placenta it is possible that this defect affects 
Tex19.1-/-  embryos from lactating mothers more severely due to additional restrains on 
nutrient supply.  However, it is unclear why this would affect Tex19.1-/- females stronger 
than Tex19.1-/- males. Careful analysis of placental gene expression and histology of 
Tex19.1-/- placenta will be required to understand if defects in the extraembryonic cell 








4.3.2 Tex19.1 is expressed in pluripotent cells and 
extraembryonic cell lineages 
 
Figure 4.2 shows that Tex19.1 RNA expression becomes down-regulated upon ES cell 
differentiation which suggests that the reduction of Tex19.1-/- homozygotes could be 
caused by a problem in the pluripotent cells during pre-implantation development, as 
Tex19.1 RNA expression has been reported to be present from the 1 cell through to the 
blastocyst stage in pre-implantation embryos (Kuntz et al., 2008). Figure 4.3 also shows 
that also in the post-implantation embryo, anti-Tex19.1 staining is associated with a 
pluripotent cell state in the embryo proper as Tex19.1 staining is strongly present at 6.5 
dpc in the pluripotent epiblast cells, but is downregulated in epiblast-derived tissues in 
the embryo proper with some faint staining present in embryonic mesoderm and 
extraembryonic mesoderm. From 8.5 dpc onwards, anti-Tex19.1 staining is not 
detectable in the embryonic tissues. The anti-Tex19.1 staining by IHC follows the 
behaviour of Tex19.1 RNA expression presented in a study by Hackett et al., (submitted) 
which shows that Tex19.1 RNA is expressed in the epiblast at 6.5dpc and becomes 
down-regulated during gastrulation. Tex19.1 RNA can only be weakly detected in late 
7.5dpc embryos (Hackett et al., submitted). Interestingly, anti-Tex19.1 staining in the 
post-implantation embryo was not restricted to the embryo proper as staining was also 
present in the ectoplacental cone and extraembryonic ectoderm. In contrast to the 
embryonic lineages, anti-Tex19.1 staining does not become downregulated in 
extraembryonic tissues at 7.5dpc and can be detected at 9.5dpc in the tissue that will 
give rise to the placenta (figure 4.3). This is in accordance with RT-PCR data that 
identified Tex19.1 RNA expression in the placenta (Kuntz et al., 2008). The expression 
pattern of Tex19.1 seems similar to the expression pattern of the pluripotency markers 
Oct4 and Nanog. However, expression of Oct4 and Nanog is more restricted than 
Tex19.1 as Oct4 and Nanog are exclusively expressed in pluripotent early embryo cells, 
the germ cell lineage and pluripotent stem cells but are not expressed in the 
extraembryonic cell lineages (Schöler et al., 1990; Yeom et al., 1996; Niwa et al., 2000; 
Chambers et al., 2003; Mitsui et al., 2003). It appears that expression of Tex19.1 is 
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associated with a pluripotent or germ cell state in embryonic cell lineages but, based on 
the fact that Tex19.1-/- homozygotes are born, albeit at reduced numbers, it is unlikely 
that Tex19.1 is absolutely required for pluripotency. This is further supported by the fact 
that Tex19.1-/- ES cells can be derived and maintained at Mendelian numbers (see 
chapter 4.1). In order to confirm that Oct4 expression was unaffected in Tex19.1-/- 
mutants I performed western blot analysis. Figure 4.4 shows that Tex19.1+/+, Tex19.1+/-    
and Tex19.1-/- ES cells express similar levels of Oct4 protein suggesting that expression 
of pluripotency markers is not impaired in the absence of Tex19.1. Taken together the 
data presented so far suggest that the reduction in Tex19.1-/- homozygotes is not caused 
by problems in maintaining a pluripotent state during embryonic development but could 
nevertheless be caused by problems in the pluripotent cells of the pre- or post-
implantation embryo or result from defects in the development and/or function of the 
placenta. Influenced by the fact that Tex19.1-/- ES cells were readily available in the lab 
at the beginning of this project I decided to characterize those in more detail with the 
hope that they might provide a valuable tool to study the function of Tex19.1 during 
embryonic development and hence provide a system that could help to understand the 
reduction of homozygote embryos that we see in the Tex19.1 mutants.    
 
4.3.3 Characterization of Tex19.1-/- ES cells 
 
As mentioned above, Tex19.1-/- ES cells appear capable of self-renewal, however, 
embryonic lethality could also be caused by defects in the ability to differentiate. For 
example embryos with mutations in Dido3 show defects in differentiation of epiblast 
cells and ES cells also fail to differentiate (Fütterer et al., 2011). Similarly, Gata4-/- 
mutant ES cells show defects in differentiation upon embryoid body formation and LIF 
withdrawal as shown by continued expression of Oct4 (Soudais et al., 1995; Capo-
Chichi et al., 2005). As can be seen from figure 4.5, Tex19.1-/- ES cells are able to down-
regulate pluripotency markers and upregulate markers of all 3 germ layers upon 
differentiation suggesting that Tex19.1 is not essential for pluripotent cell differentiation. 
This result might have been expected as viable Tex19.1-/- mice suggest that Tex19.1-/- 
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pluripotent cells in the early embryo are able to differentiate. Taken together it appears 
that derivation, maintenance and differentiation of ES cells is not impaired in the 
absence of Tex19.1. As mentioned before, ES cells are also a viable target for 
endogenous retrovirus activity and Tex19.1 has been implicated in retrotransposon 
repression in male germ cells. Figure 4.6A shows that MMERVK10C RNA, which is 
upregulated at the RNA level in male germ cells, is not mis-expressed in Tex19.1-/- ES 
cells. Similarly, the other retrotransposons analysed show no up-regulation in the 
absence of Tex19.1 (figure 4B, C and D). Those data suggest that retrotransposons, at 
least the studied elements, are not up-regulated at the RNA level in Tex19.1-/- ES cells. 
Genome wide profiling of retrotransposon expression in Tex19.1-/- and control ES cells 
would be useful to strengthen this observation. However, as evidence collected during 
this project suggests, inhibition of retrotransposons by Tex19.1 might occur at the 
protein rather than the DNA or RNA level. It is still not clear if Tex19.1 has a functional 
role in ES cells or if embryonic lethality is caused by defects in pluripotent epiblast or 
extraembryonic cells. Furthermore Tex19.1-/- ES cells show high levels of aneuploidy 
which limits the use of transcriptional profiling.   
 
4.3.4 Aneuploidy in Tex19.1-/- ES cell lines 
 
Figure 4.7 shows high rates of aneuploidy in the Tex19.1 mutant ES cell lines compared 
to controls. Previous reports suggest that 77% of ES cell lines derived on feeders are 
initially euploid (Robertson et al., 1983; Robertson and Bradley, 1986). In contrast, data 
presented by Nichols and colleagues showed that 14 out of 15 derived ES cell lines were 
characterized by different extents of chromosomal abnormalities, with only one line 
showing an entirely normal karyotype at 4 or 5 passages when ES cells were derived on 
gelatin (Nichols et al., 1990). If there is actually an advantage for the use of feeders, it is 
unclear. It has been reported that differences in aneuploidy levels of ES cell lines in 
different studies might be caused by particular culture conditions and/or mouse strains 
used to generate the ES cell (Sugawara et al., 2006). In the same study it was shown that 
40% of 88 karyotyped ES cell lines were aneuploid (Sugawara et al., 2006). If those 
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aneuploid lines have been generated from an aneuploid parental clone or were initially 
euploid and accumulated aneuploidy during culture is not clear. However, it has been 
suggested that ES cell lines accumulate chromosomal abnormalities during culture 
(Longo et al., 1997; Rebuzzini et al., 2008). Rebuzzini et al., (2008) demonstrated that 
the frequency of euploid cells within an ES cell population decreases with an increasing 
number of passages. In this study 3 ES cell lines were karyotyped at 2 different passage 
numbers. At early passage numbers 35% of metaphase spreads from ES cell line 1 
(passage 13), 49% from cell line 2 (passage 9), and 37% from cell line 3 (passage 7) 
were found to be aneuploid. These numbers increased to 61%, 68% and 79% at passages 
31, 29 and 22, respectively (Rebuzzini et al., 2008). Those data are in accordance with 
another study which reported that ES cells up to passage 15 show around 40% 
aneuploidy which increases to 70-80% by passage 25 (Longo et al., 1997). Taken 
together those data suggest that on average, 40% of ES cells within a population are 
aneuploidy between passages 7-15. This number seems to be reasonable as another 
resent study observes similar numbers of aneuploidy in wild type ES cell lines (33%) 
although it is not clear at which passage number those cells were analysed (Fütterer et 
al., 2011). All ES cell lines analyzed by karyotyping during the course of this thesis had 
been cultured for 10-12 passages at the time of examination. Figure 4.7 shows that the 
aneuploidy levels in the control cell lines were around 19% which is about half the 
amount of aneuploidy observed by Longo et al., (1997) and Rebuzzini et al., (2008). The 
reason for the difference in aneuploidy levels between the control cell lines and the 
published data is not clear but it is possible that this discrepancy is, as mentioned above, 
generated by a certain culture environment and/or mouse strains used to generate the ES 
cell lines. Occurrence of aneuploidy in Tex19.1-/- ES cell lines is, at 74%, significantly 
higher than in the control cells (χ2-test p < 0.0005). Importantly, all cell lines were 
analysed at similar passage numbers. This suggests that Tex19.1 could be either involved 
in faithful chromosome segregation, or that gain or loss of certain chromosomes might 
compensate for the Tex19.1 mutation, and therefore confers a growth advantage of 
aneuploid over euploid Tex19.1-/- cells which would result in aneuploid cells taking over 
the population. As the data presented here merely represent an endpoint, further work 
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would be required to understand the mechanisms that cause aneuploidy in Tex19.1-/- ES 
cells. It would be useful to establish euploid clones from each cell line and monitor their 
karyotype at several passages in order to confirm the initial result presented in this 
thesis. Ideally, this experiment would be carried out with conditional Tex19.1-/- ES cells 
which would avoid genotypic variation between cell lines as variability might be present 
in cell lines that have been generated from different embryos on a mixed genetic 
background. Furthermore, analysis of chromosomes aligned on the mitotic spindle could 
provide better insights into this phenotype. If an increase of lagging chromosomes could 
be observed in the Tex19.1-/- mutants compared to controls it would provide evidence 
that Tex19.1 might be actively involved in faithful chromosome segregation in ES cells. 
 
4.3.5 A role for Tex19.1 during embryonic development 
 
Results in this chapter have shown that Tex19.1-/- mice are born at a reduced rate from 
the expected Mendelian ratio. I have provided evidence that this reduction is exacerbated 
in embryos born from lactating mothers and that under those circumstances, females are 
stronger affected than males. Furthermore, I have extended our knowledge about the 
expression pattern of Tex19.1 and shown that, in addition to the previously reported 
expression in ES cells and the pre-implantation embryo, Tex19.1 is expressed in the 
pluripotent cells of the early-post implantation embryo as well was in the 
extraembryonic cell lineages. Analysis of Tex19.1-/- and control ES cells failed to 
identify retrotransposon upregulation in ES cells in the absence of Tex19.1, but showed 
that Tex19.1-/- ES cells accumulate aneuploidy. If the aneuploidy is caused by 
chromosome segregation defects in the absence of Tex19.1 in ES cells, and if this could 
provide an explanation for the reduced viability of Tex19.1-/- homozygotes requires 
further investigation. The idea that Tex19.1 might be involved in faithful chromosome 












Chapter 5: Characterisation of the role of 














The main focus of my PhD project was to analyse the function of Tex19.1 in the female 
germline. As mentioned under 4.1, Tex19.1 expression has been identified in migrating 
PGCs from 9.5dpc onwards by qRT-PCR (Hackett et al., under revision). RNA 
expression was also confirmed by qRT-PCR in gonads of both sexes at 10.5dpc and 
13.5dpc or 13.5dpc through to adulthood by Hackett et al., (under revision) and Kuntz et 
al., (2008), respectively. In addition, Kuntz and colleagues demonstrated expression of 
Tex19.1 in male and female gonads by in situ hybridization (ISH) which showed 
expression between 12.5-14.5 dpc in the males and 12.5-14.5 dpc in the females (Kuntz 
et al., 2008). Analysis of female gonads by ISH at 15.5dpc showed no expression of 
Tex19.1, however, this is in contrast with RT-PCR data presented in the same study 
which suggest Tex19.1 RNA expression in female gonads at this stage (Kuntz et al., 
2008). It is not clear which of the data is correct but it seems likely that Tex19.1 RNA is 
expressed at 15.5dpc in the female germline as for the ISH a positive control is lacking, 
and Tex19.1 RNA expression was also observed at 16.5 and 18.5dpc until after birth by 
RT-PCR (Kuntz et al., 2008). The stages at which growing oocytes express Tex19.1 are  
less clear, but previous RT-PCR data and the EST expression profile from the unigene 
database (NCBI) suggest that Tex19.1 is expressed in the adult ovary (Childs, 2006). 
Furthermore, Tex19.1 RNA expression has been reported in GV, MI and MII oocytes by 
microarray and qRT-PCR (Chen at al., 2011). 
 
Previous observations from Rupert Öllinger showed that in contrast to Tex19.1-/- 
knockout males, which are largely infertile, Tex19.1-/- knockout females are fertile on a 
mixed genetic background (129/Ola x CD1) but have ~ 50% reduction in litter size 
compared to Tex19.1+/- females (Öllinger et al., 2008). In this chapter I take those initial 
observations further and confirm fertility defects of Tex19.1-/- females on a C57/BL6 
inbred background. I also investigate if the reduction in litter size observed in Tex19.1-/- 
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females results from perturbations in the progression through meiosis and how this 




5.2.1 Tex19.1-/-  females have reduced fertility 
 
Here, I analyze the functional role(s) of Tex19.1 in female germ cell development. In 
order to test if Tex19.1-/- females show fertility defects on an inbred C57/BL6 
background, seven Tex19.1-/- and seven control females were mated with wild-type 
males. All females used in this study were under 6 months of age. In contrast to  
Tex19.1-/- males, Tex19.1-/- females were fertile and generated healthy offspring (figure 
5.1). However, Tex19.1-deficient females exhibit a strong (~33%) reduction in litter size 
compared to control females (figure 5.1). On average Tex19.1-/- females generated 5.46 ± 
3.95 offspring, compared with 8.18 ± 2.4 offspring for their heterozygote siblings 
(Mann-Whitney U test, p<0.05, n = 25 litters each).  
 
 
Figure 5.1 Average litter size observed in Tex19.1+/- and Tex19.1-/- females when mated 
with wild type males. Analysis of pups born from seven Tex19.1-/- and seven Tex19.1+/- females 
shows a ~ 33% reduction in the numbers of pups from Tex19.1-/-  mothers compared to controls 
(Mann-Whitney U test, p<0.05). A total of 25 litters was analysed for each genotype. Graphs 





5.2.2 Tex19.1-/-  females transmit aneuploidies to their offspring 
 
The reduction in litter size observed in Tex19.1-/- deficient females could be due to 
ovarian failures, resulting in functional oocyte loss. However, a comparison of ovarian 
morphology in Tex19.1-/- deficient and control females indicated that follicular 
development is not affected in the absence of Tex19.1 (figure 5.2).  
 
 
Figure 5.2 Ovary histology of Tex19.1-/- and control females. Haematoxylin and eosin stained 
ovary sections from Tex19.1+/- and Tex19.1-/- females. Primordial follicles and all stages of 
growing follicles are present in Tex19.1-/- ovaries. Scale bars are 100μm 
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This observation is supported by the fact that Tex19.1-/- females ovulate on average 9.5 ± 
1.4 oocytes which is comparable to the 9.3 ± 1 oocytes ovulated by Tex19.1+/- females 
(two-tailed t-test, p>0.5) (figure 5.3). The data presented in figure 5.3 were obtained by 
counting the numbers of zygotes obtained from 10 Tex19.1-/- and 10 Tex19.1+/-  females 
which had been mated with wild type males. Taken together, this suggests that the 
reduction in litter size, observed in Tex19.1-/- females, is likely caused by a reduction in 
oocyte quality rather than oocyte number. 
 
 
Figure 5.3 Average number of ovulated oocytes in Tex19.1-/- and Tex19.1+/- females. 
Analysis of zygotes from 10 Tex19.1-/- and 10 Tex19.1+/- females shows that Tex19.1-/-  females 
ovulate the same number of oocytes as controls (two-tailed t-test, p>0.5). Graphs represent 
mean ± standard error for biological replicates. 
 
Based on the data presented in figure 5.3, the germ cell restricted expression of Tex19.1 
in the adult mouse and the chromosome segregation defect observed in Tex19.1-/- males. 
we hypothesized that the reduction in litter size in Tex19.1-/- females could be due to 
generation of aneuploid oocytes resulting from chromosomal segregation errors. To test 
this we karyotyped one-cell zygotes (0.5dpc) from Tex19.1-/- and Tex19.1+/- females 
which revealed ~ 30% increase in chromosomal aberrations in zygotes derived from 
Tex19.1-/- compared to control females (two-tailed Fisher’s exact-test, p<0.004) (figure 
5.4). Of 56 zygotes obtained from Tex19.1-/- females, 64.5% were found to be euploid, 
21.25% hypoploid and 14.25 % hyperploid. In contrast, out of 58 zygotes derived from 
Tex19.1+/- females 93% were euploid and 7% were hypoploid. The hypoploidy observed 
in oocytes derived from Tex19.1+/- females is likely, at least to some extent, caused by 
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technical difficulties during preparation of the chromosome spreads. Taken together 
those data suggest that the reduction in litter size observed in Tex19.1-/- females is 
caused by transmission of aneuploidy to their offspring rather than a reduction in the 




Distribution of aneuploidy in zygotes derived from  










Figure 5.4 Average karyotype of zygotes from Tex19.1-/- and Tex19.1+/- females. (A) The 
diagrams show distribution of euploid, hyperploid and hypoploid cells derived from Tex19.1-/- and 
Tex19.1+/- females. Analysis of zygotes (0.5dpc) from 11 Tex19.1-/- and 13 Tex19.1+/- females, 
which had been mated to wild type males, identified a ~ 30% increase in the number of 
aneuploid zygotes compared to controls (for statistical analysis numbers of hyperploid and 
hypoploid cells were pooled; two-tailed Fisher’s exact-test, p<0.0004). A total of 58 zygotes from 
13 Tex19.1+/- and 56 zygotes from 11 Tex19.1-/- females were analysed for this experiment. (B) 
Spreads of metaphase chromosomes from 0.5dpc 1-cell embryos obtained from Tex19.1-/- and 
Tex19.1+/- embryos. Both pictures for Tex19.1-/- (41 chromosomes) and Tex19.1+/- zygote (40 
chromosomes) belong to the same embryo. Scale bars are 30μm. 
 
 
As mentioned above, the chromosomal abnormalities observed in one-cell zygotes from 
Tex19.1-deficient oocytes are possibly caused by chromosome segregation defects 
occurring during the progression through meiosis. It has been shown that the severe 
subfertility observed in Tex19.1-/- males is caused by germ cell apoptosis resulting from 
defects in chromosome synapsis during prophase I and defects in establishing or 
maintaining the bivalent at metaphase I (Öllinger et al., 2008). We postulated that 
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aneuploidy in offspring from Tex19.1-/- females might result from similar meiotic 
problems during oogenesis as observed in spermatogenesis in the absence of Tex19.1. 
To test this, I performed chromosome spreads on oocytes isolated from 17.5dpc fetal 
ovary and analysed chromosome synapsis. However, in contrast to Tex19.1-/- 
spermatocytes, Tex19.1-/-deficient oocytes appear to complete chromosome synapsis 
normally (figure 5.5). Of Sycp3/Sycp1 stained spreads, 69% and 72% featured complete 
synapsis at pachytene, 4% and 5% were zygotene, 19% and 16% were diplotene and 2% 
and 3% showed asynapsis at pachytene in 244 Tex19.1-/- and 211 Tex19.1+/- oocytes, 
respectively. In addition to defects in chromosome synapsis during prophase I, Tex19.1-/- 
males show high rates of univalent chromosomes at metaphase I suggesting that 
formation or maintenance of bivalents at metaphase I might be impaired in the male 
germline in the absence of Tex19.1 (Öllinger et al., 2008). In order to test if a similar 
defect might result in the aneuploidy rates observed in embryos obtained from Tex19.1-/- 
females, chromosome spreads of pro-metaphase or metaphase I oocytes were performed. 
Of 59 and 71 pro-metaphase I or metaphase I spreads, 98.3% and 98.6% featured 20 
bivalent chromosomes and 1.7% and 1.4% contained univalent chromosomes in 
Tex19.1-/- and  Tex19.1+/- oocytes, respectively (figure 5.6). The data presented here 
suggest that Tex19.1-/- females complete chromosome synapsis and formation of the 




Figure 5.5: Chromosome synapsis in Tex19.1−/− null oocytes and control oocytes. (A and 
B) Synapsis of homologous chromosomes in meiotic cells; Sycp3 (green) is found on both 
synapsed and unsynapsed chromosomes during early meiotic prophase whereas Sycp1 (red) is 
only detected on synapsed chromosomes. Tex19.1+/- and Tex19.1-/- pachytene cells show 
complete synapsis of all chromosomes. (C and D)  Distribution of meiotic stages in 
Sycp3/Sycp1-stained spreads (χ2-test p > 0.1). A total of 244 chromosome spreads from five 
Tex19.1−/− animals and a total of 211 chromosome spreads from five Tex19.1+/−  animals were 













   Distribution of oocytes with bivalents and univalents  in Tex19.1-/- and  
                                                    control oocytes 
 
Figure 5.6: Meiotic chromosome behavior in metaphase I spreads derived from Tex19.1-/- 
and control oocytes. (A) Bivalent formation of chromosomes in meiotic cells. (B) Distribution of 
spreads with 20 bivalents and spreads containing univalents in 59 Tex19.1+/- oocytes and 71 
Tex19.1-/- oocytes (two-tailed Fisher’s exact-test, p>0.5) 
 
This result is again in contrast with the meiotic defects observed during spermatogenesis 
in the absence of Tex19.1 (Öllinger et al., 2008). However, since Tex19.1-/- females 
transmit aneuploidies to their offspring we postulated that defects in chromosome 
segregation must be evident in metaphase II or anaphase II oocytes. To test this I 
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performed chromosome spreads from Tex19.1-/- and control oocytes. In order to do so, 
females were treated with PMS and HCG to induce superovulation. As mentioned in 
chapter 1, ovulated mammalian oocytes remain in metaphase II until entry of the sperm 
induces resumption of meiosis. Therefore spreads to be examined for chromosome 
behavior during metaphase II were collected and analysed immediately after 
superovulation. The chromosomes were stained with DNA FISH for major satellites, 
very large arrays of tandemly repeating, non-coding DNA which constitute the main 
component of functional centromeres, in order to facilitate the chromosome counts. 
Figure 5.7 shows that aneuploidies increase significantly by ~ 30% in metaphase II 
oocytes from Tex19.1-/- females compared to controls (two-tailed Fisher’s exact-test, 
p<0.004). For each genotype, 48 oocytes were analysed. This suggests that in Tex19.1-/- 
females chromosome mis-segregation occurs during the metaphase I to anaphase I 
transition.  
 
To further strengthen our hypothesis that Tex19.1-/- females transmit aneuploidy to their 
offspring, I analysed chromosome spreads prepared from anaphase II oocytes. 
Activation events, that trigger resumption and completion of meiosis in metaphase II 
arrested oocytes, are induced by repetitive intracellular Ca2+ oscillations caused by 
oocyte fertilization by the sperm. During this project I cultured metaphase II oocytes in 
Ca2+ chelated medium and induced meiotic activation by supplementing the media with 
Sr2+ as described (Kishigami and Wakayama, 2007). Firstly, I established conditions and 
timings that would allow me to analyse oocytes at anaphase II.  Figure 5.8 shows that 
under these conditions (see chapter 2) after 30 minutes 87.5% of oocytes were still found 
to be in metaphase II, after one hour 55% of oocytes were found to be still at metaphase 
II and after two hours of culture 80% of oocytes were found to be in anaphase II. After 4 
hours the majority of oocytes (83%) had progressed beyond meiosis. Accordingly, 
Tex19.1-/- and Tex19.1+/- oocytes were analysed for chromosome behaviour during 
anaphase II after two hours of culture. In accordance with the breeding, zygote and MII 
data, Tex19.1-/- anaphase II oocytes showed ~ 34% increase in the occurrence of 
aneuploidy compared to controls (two-tailed Fisher’s exact-test p<0.005) (figure 5.9). A 
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total of 35 oocytes from Tex19.1-/- and 24 oocytes from Tex19.1+/- females were 
analysed. Taken together analysis of 0.5dpc embryos, metaphase II and anaphase II 
oocytes suggest that around 30% of Tex19.1-/- oocytes are aneuploid. The abnormal 
karyotype seems to arise from a defect in chromosome segregation during the metaphase 
I to anaphase I transition which is then transmitted to subsequent generations resulting in 
embryonic lethality.  
 
Further analysis of the chromosome aberrations found in metaphase II oocytes, anaphase 
II oocytes and zygotes derived from Tex19.1-/- females showed that the observed 
aneuploidies resulted from gain or loss both of even and odd numbers of chromosomes 
(figure 5.10A and B). This suggests that chromosome mis-segregation in the absence of 
Tex19.1 is caused by additional or other defects than those that cause classical non-
disjunction as classical non-disjunction leads to loss/gain of 2, 4, 6 etc chromosomes. In 
contrast premature separation of sister chromatids could lead to loss/gain of 1, 2, 3, 4, 5 




















   Distribution of aneuploidy in Tex19.1-/- and  
   control metaphase II oocytes 
 
Figure 5.7: Meiotic chromosome behavior in metaphase II spreads derived from Tex19.1-/- 
oocytes and control oocytes. (A) Metaphase II chromosomes stained with DAPI for DNA 
(Blue) and DNA FISH for major satellites (green). (B) Distribution of euploid, hyperploid and 
hypoploid oocytes among spreads prepared from 48 Tex19.1+/- oocytes and 48 Tex19.1-/- 
oocytes. Aneuploidy levels in Tex19.1-/- metaphase II oocytes were found to be increased by ~ 
30% compared to controls (for statistical analysis numbers of hyperploid and hypoploid cells 






Figure 5.8: Metaphase II – Anaphase II transition in wild type mouse oocytes can be 
induced in culture. (A) Ten out of 10 oocytes collected and analysed immediately after 
superovulation (0h of culture) were found to be in metaphase II. (B) After 1/2h of culture 7 out of 
8 oocytes were found to be in metaphase II, 1 was found to be in anaphase II. (C) After 1h of 
culture 6 out of 11 oocytes were found to be in anaphase II, 5 out of 11 oocytes had remained in 
metaphase II. (D) After 2h of culture 8 out of 10 oocytes were found in anaphase II, 2 out of 10 
oocytes were found to be in metaphase II. (E) Analysis of oocytes after 4h of culture showed that 
5 out of 6 oocytes were found in a state which we classified as post-anaphase II and 1 out of 6 


















   Distribution of aneuploidy in Tex19.1-/- and  
   control anaphase II oocytes 
 
Figure 5.9: Meiotic chromosome behavior in anaphase II spreads derived from Tex19.1-/- 
oocytes and control oocytes. (A) Anaphase II chromosomes stained with DAPI for DNA (Blue) 
and DNA FISH for major satellites (green). (B) Distribution of euploid, hyperploid and hypoploid 
oocytes among spreads prepared from 24 Tex19.1+/- oocytes and 35 Tex19.1-/- oocytes. 
Aneuploidy levels in Tex19.1-/- anaphase II oocytes were found to be increased by ~ 34% 
compared to controls (for statistical analysis numbers of hyperploid and hypoploid cells were 
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Figure 5.10: Karyotypes and distribution of aneuploidy in Tex19.1-/- and Tex19.1+/- derived  
from metaphase II and anaphase II oocytes and zygotes. (A) Distribution of chromosome 
numbers in metaphase II and anaphase II oocytes and one-cell zygotes. (B) Percentage of 
oocytes and zygotes with hyperploidy and hypoploidy arising from even and odd numbers of 
chromosomes. (A and B) The results from 130 oocytes and zygotes derived from Tex19.1+/- and 
139 derived from Tex19.1-/- females are pooled and summarized in this analysis. (C) Metaphase 
II chromosomes from Tex19.1+/- and Tex19.1-/- oocytes stained with DAPI for DNA (Blue) and 





5.3 Discussion  
 
In this chapter I aimed to gain a better understanding of the role of Tex19.1 during 
female meiosis. I show that in the absence of Tex19.1, females have reduced litter size 
and that this is likely caused by transmission of an abnormal karyotype to the embryo by 
the oocyte. I demonstrate that in Tex19.1-/- oocytes, in contrast to Tex19.1-/- 
spermatocytes, synapsis and formation and/or maintenance of the bivalent of 
homologous chromosomes appears to occur normally but that high levels of aneuploidy 
become evident during the second round of meiosis. Tex19.1 is thus linked to inherited 
aneuploidy in female germ cells and Tex19.1-/- mice could provide a valuable model for 
studying mechanisms that lead to chromosome mis-segregation during oogenesis.  
 
5.3.1 Tex19.1-/- females have reduced fertility 
 
Breeding analysis of Tex19.1+/- and Tex19.1-/- females with wild type males revealed a ~ 
33% reduction in litter size in Tex19.1-/- females compared to controls (figure 5.1). 
Causes for female fertility defects can be various: inappropriate hormone levels or 
responses to hormones, sexually transmitted diseases, being underweight or overweight, 
inability to implant the embryo/s, reduction in oocyte number or oocyte quality can all 
have a negative effect on female fertility, to name just a few (Steinberger et al., 1979; 
Hassold and Hunt, 2001; Filis et al., 2009; Akande et al., 2010; Jagarlamudi et al., 2010; 
Souter et al., 2011). As mentioned before, Tex19.1 expression seems to be restricted to 
the germ cells in the adult mouse and therefore we reasoned that the reduction in litter 
size observed in Tex19.1-/- females might be caused by a reduction in oocyte number or 
oocyte quality. Premature reduction in the number of oocytes affects about 1% of human 
females and is caused by premature ovarian failure (POF), a complex disorder 
characterized by a deficiency of oocytes resulting in diminished fertility and shortened 
reproductive lifespan (Jagarlamudi et al., 2010). As described in chapter 1, defects in 
ovarian differentiation, primordial follicle formation, follicular growth, atresia or 
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alterations in ovulation can result in a shortage of oocytes. Many mutant mouse models, 
with mutations in genes that affect PGC development and germ cell proliferation or 
survival as well as in genes that cause severe defects in meiosis when mutated, exhibit a 
lack of functional oocytes (Luoh et al., 1997; Ruggiu et al., 1997; Di Giacomo et al., 
2005). However, in Tex19.1-/- females the reduction in litter size appears to be caused by 
a reduction in oocyte quality rather than oocyte number as Tex19.1-/- females ovulate the 
same number of oocytes as controls. In addition, analysis of one-cell zygotes from 
Tex19.1-/- and control females revealed a ~ 30% increase in aneuploidy in embryos 
derived from Tex19.1-deficient mothers (figures 5.2 and 5.3). All females used in this 
study were mated between 6 weeks and 6 month of age. Reduction in litter size in 
Tex19.1-/- females was evident from 6 weeks onwards and did not increase in ageing 
females up to 6 month of age.  
 
 
5.3.2 Tex19.1-/- oocytes show chromosomal abnormalities in 
meiosis II 
 
Based on the aneuploidy identified in zygotes derived from Tex19.1-/- females, we 
proposed that the reduction in litter size observed in Tex19.1-/- females is likely caused 
by chromosome segregation defects during meiosis, resulting in aneuploidy and 
therewith leading to embryo death.  As mentioned in the previous sections Tex19.1-/- 
males show defects in homologue chromosome synapsis and formation or maintenance 
of bivalent chromosomes at metaphase I. These defects trigger apoptosis in 
spermatocytes which prevents chromosomal abnormalities being transmitted to 
subsequent generations but also leads to male infertility (Öllinger et al., 2008). In female 
germ cells some mutations in meiotic genes that cause spermatocyte death are tolerated 
resulting in the formation of aneuploid oocytes and reduced fertility due to high rates of 
embryo lethality. For example Sycp3-/- mice, which show defects in synaptonemal 
complex formation, are characterised by male infertility but female subfertility (Yuan et 
al., 2000, Yuan et al., 2002). Subfertility in Sycp3-/- females appears to be caused by 
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transmission of high rates of aneuploidy to their offspring rather than by a reduction of 
oocyte number (Yuan et al., 2002). As described under 1.6.2 an abnormal karyotype 
results in growth and developmental retardation of the affected embryo and often 
lethality during gastrulation (Hernandez and Fisher, 1999; Lightfoot et al., 2005).  
 
In Tex19.1-/- mice not only the fertility phenotype appears to display sexual dimorphism 
but also the meiotic stage at which chromosome mis-segregation seems to occur. In 
contrast to Tex19.1-/- males my data suggest that Tex19.1-/- females complete 
chromosome synapsis normally (figure 5.4) (Öllinger et al., 2008). Similarly, bivalent 
formation appears to be unaffected in Tex19.1-/- females (figure 5.5). However, I was 
able to show that aneuploidy is evident in around 30% of metaphase II Tex19.1-/- oocytes 
(figure 5.6). Chromosome spreads from anaphase II oocytes confirm the increase in 
aneuploidy in Tex19.1-/- females observed at metaphase II and in one-cell zygotes (figure 
5.8). Aneuploidy levels at those three different stages were found independently of each 
other to be increased by around 30% in Tex19.1-/- females compared to controls (figures 
5.2, 5.5 and 5.6). The incidence of aneuploidy in metaphase II oocytes, anaphase II 
oocytes and zygotes from Tex19.1-/- females is consistent with the ~ 30% reduction in 
litter size observed in Tex19.1-/- females. This supports the hypothesis that female 
subfertility in Tex19.1-/- mutants is caused by chromosome mis-segregation during 
meiosis. The fact that chromosomal abnormalities are evident in metaphase II oocytes 
suggests that the aneuploidy has been generated at or between metaphase I and/or 
anaphase I. A good experiment to support the theory that chromosome mis-segregation 
during the first meiotic division causes aneuploidy in Tex19.1-/- females would be real 
time imaging of oocytes injected with mCherry-tagged H2B mRNA to visualise the 
chromosomes. Other studies have successfully used this technique to show lagging 
chromosomes, which are an indication of chromosome segregation defects, in mouse 
oocytes during meiosis (Chiang et al., 2010; Jin et al., 2010; Lister et al., 2010). Bivalent 
formation in Tex19.1-/- oocytes was analysed after 3h of culture following germinal 
vesicle breakdown. It is likely that those chromosomes represent the pro-metaphase I or 
early metaphase I stage as it has been previously reported that in cultured mouse oocytes 
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metaphase I is first appearing after 41/2 h. Anaphase I can be first observed after 9h of 
culture (Donahue, 1968). It would also be interesting to analyse Tex19.1-/- oocytes at the 
late metaphase I stage in order to examine if the aneuploidy observed later in meiosis 
could result from defects in maintaining the bivalent in the absence of Tex19.1. In the 
same context it would be useful to analyse cross-over formation in Tex19.1-/- females by 
staining of pachytene oocytes with Mlh1 antibody, as changes in levels or distribution of 
chiasmata have previously been reported to cause aneuploidy in oocytes (Yuan et al., 
2002; Hodges et al., 2005). However, defects in cross-over formation or maintenance 
would cause classical non-disjunction as described in figure 1.7 resulting in oocytes with 
gain or loss of even numbers of chromosomes. In contrast, analysis of the collected 
metaphase II, anaphase II and zygote data showed that   Tex19.1-/- oocytes are 
characterised by both even and odd hypo- and hyperploidies suggesting that 
chromosome mis-segregation in the absence of Tex19.1 is caused by additional or other 
defects than those that cause classical non-disjunction (figure 5.9). Premature separation 
of sister chromatids could lead to loss/gain of 1, 2, 3, 4, 5 etc chromosomes generating 
oocytes with even and odd aneuploidies making it a candidate for the chromosome 
abnormalities observed in Tex19.1-/- females (figures 1.8 and 5.9).  
 
 
5.3.3 How does Tex19.1 promote faithful chromosome 
segregation in the female germline? 
 
During the course of this thesis I was able to advance our understanding of the Tex19.1-/- 
female fertility phenotype.  I showed that subfertility in Tex19.1-/- females is caused by 
transmission of aneuploidy to their offspring. The mechanism by which Tex19.1 
promotes faithful chromosome segregation will require further investigation. It is 
currently unclear if the meiotic problems observed in Tex19.1-/- females correlate with 
upregulation of MMERVK10C or other retrotransposons. MMERVK10C RNA levels in 
15.5dpc fetal ovary were not found to be up-regulated in Tex19.1-/- mutants by qRT-PCR 
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or in adult ovary by ISH (Judith Reichmann, MRes project, 2008). However, 
MMERVK10C appears to be upregulated specifically at the pachytene stage in Tex19.1-/- 
spermatocytes and accordingly it would be useful to repeat this experiment on 18.5dpc 
fetal ovary as the majority of oocytes should be in pachytene at this stage. If the 
upregulation of retrotransposons in Tex19.1-/- testes occurs at the protein level, as 
speculated in chapter 3, upregulation of MMERVK10C at the RNA level might just be a 
down-stream consequence which might not occur in Tex19.1-/- females. Different 
timings of retrotransposon regulation and/or other male/female germ cell specific 
mechanisms for retrotransposon suppression could result in the sexually dimorphic 
phenotype observed in Tex19.1-/- mutants. Alternatively, MMERVK10C might be a target 
for Tex19.1 in male but not female germ cells. Other targets may or may not be shared 
between the sexes. It requires further investigation if the chromosome abnormalities 
during meiosis II, observed in Tex19.1-/- females, can also be found in the males, as due 
to the earlier meiotic defects present in Tex19.1-/- males most spermatocytes undergo 
apoptosis at the pachytene or metaphase I stage. As mentioned under 1.6.3 the 
characterisation of mouse knockout models has linked mutations in several meiotic 
pathways with chromosome mis-segregation. For example mutations in the 
synaptonemal complex protein Sycp3 or Mlh1, which is required for recombination foci 
to mature into chiasmata, result in defective recombination (Yuan et al., 2002; Kneitz et 
al., 2000). This will cause premature separation of homologous chromosomes by pro-
metaphase I which then randomly segregate resulting in the formation of hypo- and 
hyperploidies with even numbers of chromosomes. However, aneuploid oocytes and 
zygotes from Tex19.1-/- females feature even and odd numbers of chromosomes 
indicating that the chromosome mis-segregation occurring between metaphase I and 
anaphase I in the absence of Tex19.1 is possibly caused, at least in part, by premature 
separation of sister chromatids. As described in chapter 1 connection between sister 
chromatids during mitosis and meiosis is facilitated by cohesin protein complexes 
distributed along the chromosome arms as well as along the centromeres. During mitosis 
most of the cohesin complexes dissociate from the chromosome arms during prophase. 
At the onset of anaphase the remaining Scc1/Rad21 at chromosome arms and 
193
centromeres is cleaved by seperase to allow sister chromatid segregation (Losada et al. 
1998; Waizenegger et al. 2000). In contrast, meiotic chromosomes maintain sister 
chromatid cohesion until the onset of anaphase I, which contributes to the tethering of 
bivalents, in order to facilitate separation of homologue chromosomes (Revenkova et al. 
2001; Eijpe et al. 2003. At the onset of anaphase I, degradation of Rec8, through 
seperase activity, releases cohesin from the chromosome arms (Kudo et al., 2006). 
Centromeric Rec8, protected by Sgol2, remains intact until anaphase II to allow 
attachment and movement of sisters to the same pole during the first meiotic division 
(Kudo et al., 2006). At the onset of anaphase II when sisters need to segregate Rec8 is 
cleaved to allow sister chromatid separation. Sgol2-/- mice are infertile and show a 
premature release of Rec8 cohesin complexes from anaphase I centromeres leading to 
complete loss of centromeric cohesion at this stage. This leads to single chromatids 
which can not be segregated appropriately at anaphase II resulting in the formation of 
aneuploid gametes that give rise to infertility (Lee et al., 2008; Llano et al., 2008). 
Defects in sister chromatid cohesin has also been observed in Rad51c-deficient, Bub1+/- 
and Smc1β-/- females (Kuznetsov et al., 2007; Leland et al., 2009). Kuznetsov and 
colleagues (2007) suggest that the phenotype observed in Rad51c-deficient is caused by 
a possible role of Rad51c in resolving the double Holliday junction (HJ). They propose 
that at anaphase I, when the microtubules have attached to the kinetochores of 
homologous chromosomes to pull them apart, unresolved double HJs may cause 
increased tension at the centromeres resulting in a disruption of sister chromatid cohesin 
(Kuznetsov et al., 2007. Data from XO mice, which show disrupted sister chromatid 
cohesion at the centromeres of the unpaired X chromosome at anaphase I, suggest that 
that the spindle force is indeed sufficient to cause premature sister chromatid separation. 
Consistent with this Rad51c-deficient metaphase II oocytes display also broken 
chromosomes (Kuznetsov et al., 2007). However, broken chromosomes were not 
observed in Tex19.1-/- oocytes suggesting that premature separation of sister chromatids 
might be caused by a premature loss rather than a disruption of sister chromatid cohesin 
by spindle forces. Female mice heterozygous for Bub1, a mitotic checkpoint kinase 
gene, transmit aneuploidy, resulting from premature sister chromatid separation during 
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the first meiotic division, to their offspring (Leland et al., 2009). It has been proposed 
that Bub1 plays a role in protecting centromere cohesion through recruitment of Sgol2 
and other proteins and that this function is impaired in Bub1+/- oocytes (Leland et al., 
2009). Premature sister chromatid separation during the first meiotic division is also 
observed in oocytes from older females deficient for the meiosis specific cohesin protein 
Smc1β (Revenkova et al., 2004). Furthermore, Smc1β-/- mutant oocytes show a 
destabilisation of chiasmata resulting in large proportion of homologous chromosomes 
being present as univalents at metaphase I (Hodges et al., 2005). Tex19.1 might fulfill a 
similar role to Bub1 or Smc1β by either protecting or facilitating the formation of sister 
chromatid cohesin. Loss of sister chromatid cohesin in Tex19.1-/- mutants might explain 
the phenotype described in this chapter, 
 
Cohesin has been recently suggested to link mammalian female ageing and the increased 
occurrence of aneuploidy. The occurrence of chromosomal abnormalities was compared 
between oocytes of 2 and 14 month old mice which showed that cohesion and cohesion 
protector Sgol2 levels decline in aging oocytes (Lister et al., 2010). It was further shown 
that distance between sister chromatid centromeres was increased in aging oocytes 
suggesting an age related loss of centromere cohesion. Those observations correlated 
with chromosome segregation defects at anaphase I and mis-alignment of chromosomes 
at metaphase II (Lister et al., 2010). A study carried out by Chiang et al., (2010) came to 
similar conclusions. They also found that distance between centromeres was increased in 
females older than 16 month of age compared to 6–14 weeks old females correlating 
with decreased levels of Rec8 protein in oocytes derived from older females. This might 
predispose those oocytes to meiotic errors involving the premature separation of 
homologous and sister chromatids (Chiang et al., 2010). Furthermore, Hodges and 
colleagues (2005) proposed that a failure to maintain sister chromatid cohesin distal to 
the site of chiasmata formation might result in premature separation of homologous 
chromosomes. If sister chromatid cohesin indeed degenerates with increasing maternal 
age chromosomes with distal crossover events might be particularly vulnerable to an age 
related weakening of the cohesin mediated connection. Loss of distal cohesin will result 
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in the loss of the distal chiasmata and result in an achiasmate homologous pair that will 
segregate randomly at meiosis I (Jones, 2008). Figure 5.10 shows how weakened 
cohesion between sister chromatids can result in chromosome mis-segregation and 
demonstrates that the type of aneuploidies observed in Tex19.1-/- females would be 
consistent with a defect in sister chromatid cohesion. It would be valuable to perform 
chromosome spreads of late metaphase I Tex19.1-/- and control oocytes and analyse the 
distance between centromeres in order to gain further information whether or not sister 
chromatid cohesion might be affected in the absence of Tex19.1. Simultaneous antibody 
staining for Rec8 and Sgol2 should also shed further light on the matter. Possible 
reasons for sister chromatid cohesion impairment in Tex19.1-/- females and how these 











Figure 5.10: Proposed outcomes of weakened sister chromatid cohesion during meiosis. 
(A–E) Diagrams show proposed outcomes of normal (A) or weakened (B-E) sister chromatid 
cohesion in metaphase I (MI). Red boxes follow the behavior of a sister chromatid (or sister 
kinetochore) pair. The status of cohesion and sister kinetochore orientation on the metaphase I 
spindle determines how chromosomes segregate in anaphase I and subsequently the karyotype 
of the metaphase II oocyte. For prediction (E), sister chromatid separation is shown at 



































The main aim of the research presented in this thesis, was to gain a better understanding 
of the Tex19.1-/- phenotype. Specific aims included examination of the basis of 
retrotransposon upregulation during spermatogenesis, characterisation of the function of 
Tex19.1 during embryonic development, investigation of Tex19.1 function during female 
germline development and consequently, an expansion of our knowledge concerning the 
role of Tex19.1 during the germline cycle.  
 
6.1 Retrotransposon upregulation, Tex19.1 and 
spermatogenesis  
 
It was previously shown that Tex19.1-/- males are subfertile due to defects in 
chromosome segregation during meiosis, and that this phenotype correlates with RNA 
upregulation of the retrotransposon MMERVK10C (Öllinger et al., 2008). The 
phenomenon of retrotransposon mis-expression during meiosis has frequently been 
implicated in aberrant chromosome segregation (Bourc'his and Bestor, 2004; 
Kuramochi-Miyagawa et al., 2004; Carmell et al., 2007). To date however, it is not clear 
if retrotransposon upregulation is the cause or consequence of defects in meiotic 
progression but there is a growing number of mouse mutants which associate the two 
events (discussed in chapter 1). It is possible that retrotransposon upregulation is an 
indirect consequence of chromatin or gene expression changes caused by meiotic 
defects. However, Mei1-/- mice, which are characterised by disruptions in chromosome 
synapsis, show no upregulation of LINE1 or IAP retrotransposon RNA (Libby et al., 
2002; Carmell et al., 2007). This suggests that synapsis defects alone are not sufficient to 
cause mis-expression of retrotransposons. Despite the strong link between 
retrotransposon expression and defects in meiotic progression it is currently not clear 
how retrotransposons may cause problems in meiosis. Several possibilities are discussed 
below. Similar to Dnmt3L-/-, Miwi2-/- and Mili-/- mutant males, which also show 
retrotransposon upregulation, Tex19.1-/- knockout spermatocytes are able to initiate 
meiosis and assemble the axial elements of the synaptonemal complex, however they 
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fail to complete homologous chromosome synapsis, resulting in meiotic germ cell 
apoptosis (Bourc'his and Bestor, 2004; Kuramochi-Miyagawa et al., 2004; Carmell et 
al., 2007; Öllinger et al., 2008). However, retrotransposable element specificity, and the 
timing of retrotransposon mis-expression seems to differ between Tex19.1-/-, males and 
Dnmt3L-/-, Miwi2-/- and Mili-/- males. Firstly, during the course of this project, I was able 
to show that retrotransposon upregulation at the RNA level appears to be specific to the 
MMERVK10C element in Tex19.1-/- testes (figure 3.4). This is based on expression 
analysis using repeat annotation of Illumina Mouse Whole Genome WG-6 Beadchip 
probes (repeat annotation and microarray analysis was performed by Ian Adams), which 
revealed an increase in abundance of MMERVK10C endogenous retrovirus transcripts 
but not other retrotransposons in Tex19.1-/- males. Genome wide expression analysis for 
retrotransposons has not been performed for Dnmt3L-/-, Miwi2-/- and Mili-/- knockout 
males, however, it has been shown that all three mutants upregulate transcripts from the 
IAP endogenous retroviruses and LINE1 elements, whereas MMERVK10C transcript 
levels do not change, at least in Dnmt3L-/- testes (Bourc'his and Bestor, 2004; 
Kuramochi-Miyagawa et al., 2004; Carmell et al., 2007; Öllinger et al., 2008; Michael 
Ling, personal communication). Furthermore, MMERVK10C transcripts are upregulated 
specifically in meiotic spermatocytes in Tex19.1-/- knockout mice but not in mitotic 
spermatogonia (Öllinger et al., 2008). In contrast, IAP and LINE1 levels are upregulated 
in spermatogonia and spermatocytes in neonatal Dnmt3L-/-, Miwi2-/- and Mili-/- testes 
supposedly due to impaired de novo methylation of LINE1 and IAP elements in 
quiescent prospermatogonia (Bourc'his and Bestor, 2004; Kuramochi-Miyagawa et al., 
2004; Carmell et al., 2007).  Taken together, this data and previous analysis of the DNA 
methylation status of MMERVK10C, which did not identify any changes in Tex19.1-/- 
knockout testes, suggest that Tex19.1 is not involved in the Dnmt3L/Mili/Miwi2-
dependent mechanism that methylates and silences retrotransposons in quiescent 
prospermatogonia. In accordance with this, I have shown that MMERVK10C is not mis-
expressed in p53-/-Dnmt1-/- fibroblasts despite being hypomethylated which, together 
with Michael Ling’s analysis of MMERVK10C expression in Dnmt3L-/- testes, implies 
that repression of MMERVK10C transcription in somatic cells and germ cells does not 
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rely as heavily on silencing by DNA methylation as IAP elements, for example (figure 
3.5).  These findings however, contrast with the observed increase of MMERVK10C 
expression in fibroblast cells treated with Aza, which is meant to induce DNA 
demethylation (figure 3.6). However, as described in chapter 3, it is possible that 
treatment with Aza induces further changes, in addition to DNA methylation, such as 
H3K9me2 and possibly other histone marks (Wozniak et al., 2007). MMERVK10C 
silencing in ES cells was previously shown to be dependent on Kap1-mediated 
H3K9me3, and given the fact that elements of the ERVK family are strongly enriched for 
this modification in fibroblasts, it is possible that MMERVK10C is also silenced by 
H3K9me3 in somatic cells (Day et al., 2010). I was unable to confirm this hypothesis as I 
did not identify an upregulation of MMERVK10C in Kap1-/- pMEFs (figure 3.7). 
Analysis of MMERVK10C expression in fibroblasts with mutations in different histone 
methyltransferases would be useful to elucidate if this is indeed, one of the main 
mechanisms facilitating MMEVRK10C silencing. The biochemical function of Tex19.1 
is currently unknown. It appears unlikely that H3K9me3 is globally affected in Tex19.1-/- 
testes as the observed RNA upregulation is largely restricted to MMERVK10C. It also 
seems unlikely that Tex19.1 only mediates H3K9me3 at MMERVK10C loci. However, 
the chromatin state of MMERVK10C might change if the element is actively transcribed 
in the absence of Tex19.1. Changes in the chromatin state of MMERVK10C might result 
in the phenotype observed in   Tex19.1-/- mutants. This is based on several mouse 
mutants which implicate histone modifications, such as H3K9me2 and H3K9me3, in the 
formation of homologous chromosome synapsis (Peters et al., 2001; Tachibana et al., 
2007). For example, mice with mutations in the H3K9me3 methyltransferases, Suv39h1 
and Suv39h2, or the H3K9me2 methyltransferase, G9a, are all characterised by impaired 
homologous chromosome pairing and subsequently synapsis defects (Peters et al., 2001; 
Tachibana et al., 2007). It has been proposed by Takada et al. (2011) that H3K9me2 and 
H3K9me3 facilitate close alignment of centromeric regions of unpaired homologous 
chromosomes which in turn mediates progression of their pairing during early meiotic 
prophase. However, retrotransposon expression in these mutants has not been analysed 
and it would be very informative to perform qPCR for MMERVK10C and IAP 
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expression, both ERVK elements, in order to see if either element might be upregulated 
and a possible mediator or contributor to the observed phenotype. This is based on 
speculations by Öllinger et al. (2010) which propose that an altered chromatin state of 
retrotransposon elements might allow their participation in the homology search. 
Homology drives chromosome pairing and therefore participation of retrotransposons in 
the homology search, which are abundant and distributed throughout the genome, might 
mediate illegitimate recombination between non-homologous sequences (Öllinger et al., 
2010; Romanish et al., 2010). It is possible that loss of transcriptional repression of 
MMERVK10C in Tex19.1-/- males results in a change of the chromatin environment of 
those elements with the consequence of illegitimate recombination between non-
homologous sequences. One caveat with hypothesis is that early recombination foci are 
not depleted of retrotransposon sequences as one might expect if this theory should be 
true. As a matter of fact it has been reported that elements belonging to the MaLR 
retrotransposon superfamily are enriched at human and mouse recombination hot spots 
(Smagulova et al., 2011). Furthermore, in order to strengthen this hypothesis it would be 
important to determine if MMERVK10C transcription is indeed affected in Tex19.1-/- 
testes. Culture of Tex19.1-/- and control testes in presence of actinomycin D, an inhibitor 
of transcription, and subsequent qPCR analysis should give insights whether the increase 
of MMERVK10C transcript in Tex19.1-/- males is caused by an increase in transcription 
or RNA stability. However, upregulation of retrotransposon RNA might not only result 
from a defect in transcriptional inhibition but any stage of the retrotransposon life cycle. 
Inhibition lost at the DNA, RNA or protein level might all lead to increased 
retrotransposition events which in turn will result in the transcription of more elements 
and hence elevated RNA levels.  
 
During the course of this thesis I also investigated if Tex19.1 might act as a translational 
regulator of retrotransposons as increased stability of the MMERVK10C RNA by being 
more efficiently translated could explain the RNA upregulation observed in Tex19.1-/- 
testes. In accordance with this theory I was able to identify an upregulation of LINE1 
ORF1p in Tex19.1-/- testes compared to controls but I was not able to observe a shift in 
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LINE1 or MMERVK10C RNA into the more translated part of a sucrose gradient (figures 
3.8, 3.9 and 3.15). One of the shortcomings of the analysis presented here is that 
MMERVK10C protein expression could not be examined as functional antibodies are 
lacking. Sucrose gradient data and a poly A capture assay suggested that Tex19.1 is not 
associated with polysomes and does not bind to polyadenylated RNAs (figures 3.12 and 
3.14). Furthermore, transfection of ES cells with reporter plasmids suggested that LINE1 
is not a target for translational inhibition by Tex19.1. Taken together those data, also 
when largely correlative, suggest that Tex19.1 is not a translational repressor of 
MMERVK10C or LINE1 retrotransposons. Instead, it appears that Tex19.1 might repress 
retrotransposons at the level of protein stability. This hypothesis is based on the fact that 
Tex19.1 forms a stable complex with Ubr2 (figure 3.16) (Yang et al., 2010). In respect 
to the phenotypes of Tex19.1-/- mutant mice described in this thesis and by Öllinger et al. 
(2008) the interaction between Tex19.1 and Ubr2 was of great interest. The to date 
reported physiological functions of the N-end rule pathway (see also 3.1) are manifold 
and include the elimination of mis-folded proteins, signaling by transmembrane 
receptors, regulation of fat metabolism, function during apoptosis, chromosome 
segregation as well as bacterial and viral infections (Varshavsky, 2011). Tex19.1 and 
Ubr2 might target retrotransposons for degradation as it has been previously reported 
that the integrase protein of the human deficiency virus (HIV) represents an N-end rule 
substrate (Varshavsky, 2011). Other viral proteins, including retrotransposon proteins, 
might also be targets for N-end rule mediated proteolysis. Furthermore I have been able 
to show that Tex19.1 stimulates N-end rule mediated protein turnover when transfected 
into HeLa cells (figure 3.17).  In order to directly test if LINE ORF1p stability is 
increased in the absence of Tex19.1, testes culture of Tex19.1-/- and control tissue in 
presence cycloheximide, an inhibitor of translation, and subsequent western blot analysis 
for LINE1 ORF1p might reveal if LINE1 ORF1p levels are elevated in the absence of 
Tex19.1 due to increased translation or indeed increased protein stability. Different 
mechanisms of retrotransposon suppression in male and female germ and ES cells might 
underlie the variation in the phenotypes between the sexes and cell types. MMERVK10C 
and other retrotransposons might be targets for N-recognins in male but not female germ 
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cells or alternatively other mechanisms might silence MMERVK10C in oocytes and 
therefore loss of N-end rule mediated repression would not result in a phenotype in the 
female germline. However, these are merely speculations and further work will be 
required to establish if these assumptions are true.  
 
In conclusion the data I presented here suggest that Tex19.1 silences retrotransposons at 
the protein rather than the DNA or RNA level. I propose a hypothesis in which Tex19.1 
mediates, together with Ubr2, the turnover of retroviral proteins. If this inhibition is lost 
increased retrotransposition and a subsequent increase in the numbers of transcribed 
elements might explain the increase in MMERVK10C abundance in Tex19.1-/- testes. 
Alternatively increased stability of retroviral proteins might result in an increase of 
retroviral particle formation which might in turn lead to increased stability of retroviral 
RNAs. The difference between the LINE1 and MMERVK10C data, which is RNA 
upregulation of MMERVK10C but not LINE1 RNA in Tex19.1-/- testes, might arise from 
the fact that other mechanisms might inhibit later stages of the LINE1 but not 
MMERVK10C life cycle. It is currently not clear how many, if any, further 
retrotransposons are targets for Tex19.1 or in which way MMERVK10C or LINE1 are 
special so that they provide substrates for Tex19.1 but not for example IAP or IAPE. 
Increased retrotransposition or an increase in viral protein expression might both be able 
to cause defects in meiotic progression. Increased retrotransposition causes increased 
DNA damage. It has been shown very elegantly that Mael-/- mutants, which upregulate 
IAP and LINE retrotransposons and exhibit defects in chromosome synapsis, show 
extensive retrotransposition induced DNA damage, in absence of meiotic Spo11-
dependent DSB by crossing Spo11-/- mutants with Mael-/- mice (Soper et al., 2008). 
DNA damage caused by retrotransposition events could interfere with normal meiotic 
recombination by attracting recombination proteins possibly resulting in attenuated 
levels of recombination proteins on Spo11-dependent DNA double strands breaks. 
Similarly, cytotoxicity of individual retrotransposon-encoded proteins may contribute to 
germ cell apoptosis in mouse mutants that correlate mis-expression of retrotransposons 
with defects in meiotic progression (Öllinger et al., 2010). However, it can not be 
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excluded that the relationship between upregulation of retrotransposons and aberrant 
progression through meiosis is indirect and an independent consequence of chromatin or 
gene expression changes. A retrotransposon knock-in model would provide a valuable 
tool to dissect the cause, consequence or indirect association between meiotic defects 
and retrotransposon mis-expression. In order to address this we aimed to generate a 
mouse model conditionally expressing IAP RNA.  We chose IAP over other 
retrotransposons as it has been better characterized and more reagents are available to 
study this element compared to other retrotransposons in the mouse genome. I generated 
an IAP expressing construct in a pROSA targeting vector. Transient transfection into ES 
cells showed that the construct is functional. Unfortunately, we have been unsuccessful 
to generate correctly targeted ES cell clones so far. However, a mouse model with 
ectopic retrotransposon expression will provide an important tool in order to understand 
the relationship between retrotransposon upregulation and chromosome segregation and 
therefore this project should be further pursued.  
 
6.2 Aneuploidy in Tex19.1-/- ES cells and decreased viability of 
Tex19.1-/- embryos 
 
6.2.1 Aneuploidy in Tex19.1-/- ES cells 
 
In addition to its previous attributed role in promoting genetic and chromosomal stability 
during spermatogenesis I provide preliminary evidence that Tex19.1 might also be 
required to facilitate faithful chromosome segregation in pluripotent cells (figure 4.7). 
Interestingly the interaction partner of Tex19.1, Ubr2 has previously been implicated in 
faithful chromosome segregation during mitosis. Although the underlying mechanisms 
remain unclear, it has been shown that Ubr2-/- fibroblasts display genome instability 
caused by spontaneous gaps or breaks in metaphase chromosomes as well as an increase 
of chromosome mis-segregation at anaphase (Ouyang et al., 2006). The factors that 
might be involved in mediating the role of Ubr2 in promoting genetic and chromosomal 
stability include C-terminal fragments of the Scc1p/Rad21 cohesin subunit (Varshavsky, 
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2011). In eukaryotes C-terminal fragments of the Scc1p/Rad21 cohesin subunit are 
produced by separase through cleavage of Scc1p/Rad21 at the metaphase to anaphase 
transition to allow sister chromatid separation (figure 6.1) (Uhlmann et al., 1999; 
Uhlmann et al., 2000; Rao et al., 2001). Scc1p/Rad21 C-terminal fragments are normally 
short lived (t1/2<2 min) due to degradation by ubiquitin/proteasome dependent N-end 
rule pathway (Rao et al., 2001). In ubr1Δ S. cerevisiae cells, which lack the N-end rule 
pathway as ubr1, a homologue of Ubr1 and Ubr2,  represents the sole N-recognin in 
yeast, the Scc1p fragment appears to be metabolically stabilized resulting in increased 
aneuploidy and cell lethality (Rao et al., 2001). Similarly, overexpression of Scc1p 
fragments with mutations in the destabilizing residue, which generates a long-lived 
derivative of the Scc1p fragment, causes increased frequency of chromosome loss and 
compromised cell viability (Rao et al., 2001). Those data suggest that removal of this 
cohesin fragment is critical to ensure high fidelity of chromosome cohesion and 
segregation. It has been postulated that rapid degradation of the cleaved cohesin protein 
ensures that only uncleaved Scc1p/Rad21 proteins are incorporated into reconstituting 
cohesin complexes (Rao et al., 2001; Varshavsky, 2011). It is plausible to speculate that 
at least part of the Tex19.1-/- phenotypes might be mediated by defects in the N-end rule 
pathway and future work should explore this possibility. This is based on the observed 
interaction between Ubr2 and Tex19.1 and the similarities in the phenotypes of mutants 
of either gene which suggest that Tex19.1 might mediate Ubr2 dependent N-end rule 
photolytic degradation of target proteins (figure 3.17) (Yang et al., 2010). This is 
supported by the fact that Tex19.1 appears to promote N-end rule dependent protein 
degradation in HeLa cells (figure 3.18). Accordingly defects in mitotic chromosome 
segregation in Tex19.1-/- pluripotent cells might be mediated by defects in N-end rule 
protein degradation in the absence of Tex19.1. In order to show that this mechanism is 
responsible for the aneuploidy in Tex19.1-/- ES cells, Tex19.1-/- and control ES cells 
should be analysed and compared for protein levels of the Rad21 C-terminal fragment. 
Overexpression of a long-lived Rad21 C-terminal fragment in ES cells followed by 
karyotyping should reveal if rapid turnover of cleaved cohesin is required for fidelity of 
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chromosome segregation in pluripotent cells. The above described data obtained from S. 
cerevisiae suggest that this might be the case. 
 
 
Figure 6.1: Alignment of separase target sites and by cleavage generated N-end rule 
degradation signals for Scc1. Amino acid residues shown in black as single-letter 
abbreviations. Arrowhead and red d residues indicate the cleavage sites and N-terminal 
residues of the corresponding C-terminal fragments. Sc, Mm and Hs refer to S. cerevisiae, M. 
musculus and H. sapiens, respectively.  R is a primary de-stabilising residue, E a secondary de-
stabilising residue. Figure was taken and modified from Varshavsky (2011).  
 
 
6.2.2 Decreased viability of Tex19.1-/- embryos 
 
The data I present in chapter 4 also demonstrate that absence of Tex19.1 compromises 
viability of embryos of both sexes (table 4.1). I show that lethality of Tex19.1-/- males 
and females is exacerbated in pups born from lactating mothers but with females being 
considerably stronger affected than males (table 4.3). It is currently not clear which 
mechanisms cause the here observed problems. One of the weaknesses of this study is 
that I am not able to distinguish if embryonic lethality is increased in response to 
embryonic diapause or in response to lactation, as the analysis of chemically induced 
diapaused embryos was inconclusive. Furthermore, chemically induced diapause might 
differ from lactation induced diapause as I observed a strong reduction of all females 
irrespective of genotype in chemically diapaused embryos which is not observed in 
naturally diapaused embryos. However, no comparable studies about this matter exist to 
date. Similarly to Tex19.1-/- mice, Ubr2-/- mice exhibit male infertility, female subfertility 
and embryonic lethality of mutant females (Kwon et al., 2003; Öllinger et al., 2008; An 
et al., 2009; Yang et al., 2010; chapters 4 and 5 of this thesis). In order to test if 
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aneuploidy is increased in Tex19.1-/- embryos, as observed in Tex19.1-/- ES cells, 
karyotyping of Tex19.1-/- and control diapaused blastocysts needs to be performed. 
Karyotyping of blastocysts will be technically challenging due to such a small tissue 
source. However, karyotyping of blastocyst cells has been previously reported 
(Lightfoot et al., 2005). DNA FISH analysis using a Neo probe in order to help to 
distinguish between Tex19.1+/+, Tex19.1+/- and Tex19.1-/- embryos, as demonstrated by 
Spencer and colleagues (2011), could be used for blastocyst genotyping. DNA FISH for 
major satellites could be applied at the same time in order to facilitate chromosome 
counts (see chapter 5). Sectioning of early post-implantation embryos and terminal 
deoxynucleotidyl transferase end labelling (TUNEL) in order to detect DNA 
fragmentation, a well known biomarker for apoptosis in tissue, should be performed for 
Tex19.1-/- and control embryos in order to analyse if there is indeed an increase in 
apoptosis in Tex19.1-/- mutants post-implantation as would be expected for aneuploid 
embryos (Gavrieli et al., 1992; Lightfoot et al., 2006). However, it is not clear if the 
aneuploidy observed in Tex19.1-/- ES cells is representative for the role of Tex19.1 
during embryonic development. Based on the observation that arrested blastocysts 
contain fewer cycling cells compared to nondelayed embryos it appears unlikely that 
Tex19.1-/- embryos accumulate high rates of aneuploidy during diapause (Given, 1988; 
Given and Weitlauf, 1981; Battle-Morera et al., 2008). Furthermore, it is unclear how a 
chromosome segregation defect would affect female embryos stronger during diapause 
than male embryos as observed for Tex19.1-/- embryos.  
 
Alternatively, based on observations from the male germline, Tex19.1 might function in 
suppression of retrotransposons in pluripotent cells during embryonic development. The 
male-female sex bias might be caused by arrested female Tex19.1-/- embryos being more 
vulnerable to loss of post-transcriptional inhibition of retrotransposons by absence of 
Tex19.1 than Tex19.1-/- males. This could result from a potent retrotransposon on the X 
chromosome or increased retrotransposon expression in XX pluripotent cells as XX ES 
cells have been shown to be hypomethylated compared to XY ES cells (Zvetkova et al., 
2005). However, there is no evidence for this hypothesis at the moment.  
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Causes known to affect the viability of female embryos involve defects in X-
chromosome inactivation. X-chromosome inactivation (XCI) achieves balance of the X-
chromosome dosage between XX and XY individuals during embryogenesis (Augui et 
al., 2011). In mice an imprinted process is initiated during the early cleavage stages 
which results in the inactivation of the paternal X-chromosome (Xp). Xp silencing is 
maintained in extraembryonic tissues but reversed in the inner cells mass where a 
subsequent wave of a random form of XCI occurs which silences either the Xp or the 
maternal X-chromosome (Xm) (Okamoto and Heard, 2006). Mutations that affect 
dosage compensation result in female lethality during early post-implantation 
development or before 13.5dpc depending on the defect (Okamoto and Heard, 2006; 
Augui et al., 2011). In addition to the N-end rule pathway Ubr2 is also involved in 
monoubiquitination of histone 2A (H2A) (An et al., 2010). H2A monoubiquitination 
mediated by Ring1B is known to be required for XCI (de Napoles et al., 2004). It is 
possible that Tex19.1 and Ubr2 also play a role in XCI. However, it is not clear why 
defects in dosage compensation should be exacerbated during embryonic diapause. 
Furthermore, increased lethality of Tex19.1-/- males during diapause suggests that 
mechanisms other than XCI at least contribute to the phenotype described in chapter 4 
(table 4.3).  
 
6.3 Increased levels of aneuploidy in the germline of Tex19.1-/- 
females 
 
During the course of this project I was able to demonstrate that Tex19.1 not only 
promotes genetic and chromosomal stability during spermatogenesis, as previously 
reported, and possibly early embryonic development, but also during female meiosis. 
The data presented here suggest that in absence of Tex19.1 sister chromatid cohesion in 
mouse oocytes might be prematurely lost resulting in chromosome mis-segregation and 
aneuploid offspring. As described under 1.6, premature sister chromatid separation as 
well as non-disjunction of whole bivalents at meiosis I have been postulated to 
209
contribute to the generation of human aneuploidy. Which of the two is the more 
prevalent mechanism is still subject to debate (see 1.6). Analysis and karyotyping of 
meiosis I human oocytes has been extremely limited due to the fact that meiosis I 
oocytes are difficult to obtain and most human oocytes are collected at the metaphase II 
stage after super ovulation.  Studies of human trisomies have provided valuable insights 
regarding the mechanisms that result in human aneuploidy. However, analysis of 
trisomies is not able to distinguish if the abnormal karyotype has been generated through 
a non-disjunction event or premature sister chromatid separation (figures 1.14 and 1.15). 
Premature sister chromatid separation observed in human metaphase II oocytes might be 
caused by a loss of sister chromatid cohesin or be the result of univalents achieving bi-
orientation while aligning to the metaphase plate, which could lead to the equational 
segregation of sister chromatids to opposite poles (Kouznetsova et al., 2007). This 
demonstrates that the relationship between non-disjunction, premature sister chromatid 
separation and the occurrence of aneuploidy might be difficult to dissect. The data 
presented in this thesis suggest that Tex19.1-/- females are aneuploid due to premature 
separation of sister chromatids (figure 5.9). If this hypothesis can be confirmed,  
Tex19.1-/- oocytes would provide a valuable tool to dissect the cause and consequences 
of premature sister chromatid separation during meiosis. Several mouse mutants for 
SAC genes and nondisjunction have been described previously (Edelmann et al., 1996; 
Yuan et al., 2002; Revenkova et al., 2004; Hodges et al., 2005; Homer et al., 2005). A 
few mouse mutants attribute aneuploidy to premature sister chromatid separation 
(Revenkova et al., 2004; Leland et al., 2009). The Tex19.1-/- females might provide a 
valuable model for the study of the mechanisms that lead to premature sister chromatid 
separation and therewith advance our understanding of the causes of human aneuploidy.  
The biggest limitation of the study presented here is that the aneuploidy data solely rely 
on chromosome counts from fixed oocytes. I found that artificial chromosome loss, 
chromosome superposition and poor morphology were common issues with this method. 
The high rates of hypoploidy observed in both Tex19.1+/- and Tex19.1-/- oocytes are 
probably attributable to an artificial loss of chromosomes during the fixation procedure. 
However, in order to strengthen the observations made in chapter 5 several chromosome 
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spreads were counted independently, without knowledge of the corresponding genotype, 
by myself and Ian Adams. Furthermore, consistent aneuploidy levels around 30%, which 
are sufficient to explain the reduction in litter size observed, in 3 different stages of 
oocyte development suggest that Tex19.1-/- oocytes indeed exhibit defects in meiotic 
chromosome segregation. Further work should concentrate on elucidating the molecular 
mechanisms that underlie the chromosome segregation defects observed in Tex19.1-/- 
female germ cells. As described under 1.4 correct meiotic chromosome behavior 
requires the replacement of mitotic cohesin proteins by meiotic cohesins. For example 
Rad21 is largely replaced by Rec8. However, IF studies of meiotic male germ cells have 
shown that the mitotic cohesin proteins Stag2 and Rad21 are localised to meiotic 
chromosomes during the early stages of prophase I and are still present at the dipolotene 
stage (Prieto et al., 2002). It is possible that delayed turnover of Rad21 C-terminal 
fragments leads to incorporation of this unfunctional protein fragment into the meiotic 
cohesin complexes resulting in defects in sister chromatid cohesin as observed in the 
Tex19.1-/- female germline. Alternatively Rad21 C-terminal fragments might interfere 
with cohesin loading onto the chromosomes.  Another possibility is that Rec8 C-terminal 
fragments are targets for Tex19.1 and Ubr2. Rec8 C-terminal fragments produced by 
seperase cleavage during the metaphase I to anaphase I transition might associate with 
the remaining cohesin complexes that facilitate centromeric cohesion. This might 
replace some of the bound cohesin proteins and weaken sister chromatid cohesin at the 
centromeres which might result in premature sister chromatid separation. Another 
possibility is that Rec8 fragments after seperase cleavage associate with Sgol2 which 
might interfere with the protection of centromeric cohesin from cleavage. One of the 
caveats with this theory is that the Rec8 C-terminal fragments do not contain an N-
degron but, according to the N-end rule, stabilising residues (Kudo et al., 2009). The 
cleavage sites for Rec8 have been determined by in vitro analysis. Two of the C-terminal 
fragments produced by separase cleavage of Rec8 have alanine as their N-terminal 
residue which is a stabilising amino acid. Only the smallest one has glutamic acid as N-
terminal fragment which is a secondary de-stabilising residue. It is possible that Tex19.1 
might be involved in targeting Ubr2 to proteins that do not contain N-terminal residues, 
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such as mouse or human Rec8, during meiosis. If Rec8 should indeed represent a target 
for Tex19.1 and Ubr2, this could also explain why S. cerevisiae can cope without 
Tex19.1.This is based on the fact that the two cleavage products of Rec8 after seperase 
cleavage in yeast have lysine as N-terminal residue which is a primary de-stabilising 
amino acid. It would be interesting to examine the N-terminal residues of cohesin 
fragments of further non-mammalian species, which do not posses Tex19.1, to see 
whether or not those fragments have N-degrons. To test if N-end rule mediated protein 
degradation is affected in Tex19.1-/- oocytes, mRNA produced from the GFP-reporters 
described in chapter 1 should be injected into Tex19.1-/- and control oocytes. In addition 
injection of mRNA expressing Rad21 or Rec8 long-lived C-terminal fragments into wild 
type oocytes would help to elucidate if stability of the mitotic or meiotic cohesin 
fragments can cause defects in chromosome segregation during meiosis. 
 
The main aim of my PhD project was the phenotypic characterization of Tex19.1-/- 
females. I have been able to show that Tex19.1-/- females are subfertile and transmit high 
rates of aneuploidy to their offspring. This increase in aneuploidy in Tex19.1-/- oocytes 
presumably results from a defect during the first meiotic division and might be caused 
by premature separation of sister chromatids. I propose a hypothesis which suggests that 
this might be caused by insufficient turnover of non-functional cohesin protein 
fragments which are incorporated into the meiotic cohesin complex. This model is 
summarized in figure 6.2. Weakened sister chromatid cohesin could then cause 
premature separation during the first meiotic division resulting in the formation of 









Figure 6.2 Proposed model for the role of Tex19.1 during female meiosis (adapted from 








6.4 Conclusion  
 
In conclusion, the data presented in this thesis suggest that Tex19.1 promotes, in addition 
to its previous attributed role during spermatogenesis, genetic and chromosomal stability 
during female germline development, and possibly during early embryonic development.  
The next step will be to elucidate the molecular/biochemical function of Tex19.1 in 
order to fully appreciate the Tex19.1-/- phenotypes characterised during this project. A 
role for Tex19.1 in the N-end rule pathway would suggest that certain proteins might be 
stabilised in the absence of Tex19.1. Increased stability of some of these proteins, such 
as cohesin and/or retrotransposon protein fragments, could potentially mediate, or 
modulate, the observed Tex19.1-/- phenotypes. It is possible that the embryonic lethality 
as well as the male and female fertility phenotypes are caused by defects in N-end rule 
mediated protein turn over. Given the high rate of aneuploidy observed among early 
pregnancies in humans understanding of the mechanisms that influence chromosome 
segregation during gametogensis and early embryonic development is of critical 
importance to provide information regarding the occurrence of aneuploidy and the 
resulting reproductive diseases in our species. The Tex19.1-/- mice might provide a 
valuable model system to advance our understanding of chromosome mis-segregation 
during mitosis and meiosis and possibly mechanisms that underlie the high incidence of 
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Abstract 
Retrotransposons are highly prevalent in mammalian genomes due to their ability to amplify in 
pluripotent cells or developing germ cells. Host mechanisms that silence retrotransposons in germ 
cells and pluripotent cells are important for limiting the accumulation of the repetitive elements in 
the genome during evolution. However, although silencing of selected individual retrotransposons 
can be relatively well-studied, many mammalian retrotransposons are seldom analysed and their 
silencing in germ cells, pluripotent cells or somatic cells remains poorly understood. Here we show, 
and experimentally verify, that cryptic repetitive element probes present in Illumina and Affymetrix 
gene expression microarray  platforms  can accurately  and sensitively  monitor  repetitive  element 
expression  data.  This  computational  approach  to  genome-wide  retrotransposon  expression  has 
allowed  us  to  identify  the  histone  deacetylase  Hdac1  as  a  component  of  the  retrotransposon 
silencing machinery in mouse embryonic stem cells, and to determine the retrotransposon targets of 
Hdac1 in these cells.  We also identify retrotransposons that are targets of other retrotransposon 
silencing  mechanisms  such  as  DNA  methylation, Eset-mediated  histone  modification,  and 
Ring1B/Eed-containing  polycomb  repressive  complexes  in  mouse  embryonic  stem  cells. 
Furthermore,  our  computational  analysis  of  retrotransposon  silencing  suggests  that  multiple 
silencing mechanisms are independently targeted to retrotransposons in embryonic stem cells, that 
different  genomic  copies  of  the  same  retrotransposon  can  be  differentially  sensitive  to  these 
silencing mechanisms,  and helps  define retrotransposon sequence elements  that  are  targeted  by 
silencing machineries. Thus repeat annotation of gene expression microarray data suggests that a 




Repetitive DNA sequences make up almost half the mammalian genome. A large proportion of 
mammalian repetitive DNA sequences use RNA intermediates to amplify and insert themselves into 
new locations in the genome. Mammalian genomes contain hundreds of different types of these 
mutagenic  retrotransposons,  but  the  mechanisms  that  host  cells  use  to  silence  most  of  these 
elements are poorly understood. Here we describe a computational approach to monitor expression 
of hundreds of different retrotransposons in gene expression microarray datasets.  This approach 
reveals new retrotransposon targets for silencing mechanisms such as DNA methylation, histone 
modification and polycomb repression in mouse embryonic stem cells, and identifies the histone 
deacetylase  Hdac1  as  a  regulator  of  retrotransposons  in  this  cell  type.  These  computational 
predictions  are  verified  experimentally  by qRT-PCR in  Dnmt1-/- Dnmt3a-/- Dnmt3b-/- embryonic 
stem  cells,  Ring1B-/- embryonic  stem  cells  and  Hdac1-/- embryonic  stem  cells.  We  also  use 
microarray analysis of retrotransposon expression to show that the pluripotency-associated Tex19.1 
gene  has  exquisite  specificity  for  MMERVK10C elements  in  developing  male  germ  cells. 
Importantly, our computational analysis also suggests that different genomic copies of individual 
retrotransposons  can  be  differentially  regulated,  and  helps  identify  the  sequences  in  these 
retrotransposons that are being targeted by the host cell's silencing mechanisms. 
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Introduction
Repetitive DNA sequences account for around forty per cent of sequenced mammalian genomes 
[1,2]. The most basic repetitive elements in mammalian genomes are tandem arrays of repeated 
monomeric DNA sequences. These simple repeats and satellite sequences have repeating units of 
around 1-5 bp and 100-500 bp respectively [3]. More complex classes of repetitive element include 
DNA transposons and retrotransposons, mobile genetic elements that are able to integrate into new 
sites in the genome. DNA transposons typically encode a transposase enzyme that catalyses the 
non-replicative mobilization of the DNA transposon through a cut and paste mechanism [4]. In 
contrast, retrotransposons mobilize using a replicative copy and paste mechanism that involves an 
RNA  intermediate.  However  this  retrotransposition  can  occur  by  fundamentally  different 
mechanisms  depending  on  the  structure  of  the  retrotransposon  [5,6].  DNA  transposons  and 
retrotransposons account for ~0.9% and ~37% of the mouse genome respectively [2]. However, 
while DNA transposon activity appears to be extinct in the mouse genome, retrotransposons remain 
active [2]. Mouse retrotransposons include long interspersed elements (LINEs), short interspersed 
elements (SINEs), and long terminal repeat (LTR) retrotransposons [3]. Full-length class I  LINEs 
are ~7 kb long and encode two proteins that are required for the reverse-transcription of  LINE-1 
RNA and its  subsequent  integration  into new sites  in the genome [7].  SINEs are  derived from 
reverse-transcription  of  small  cellular  RNAs  and  utilise  LINE-1 proteins  in  trans to  mediate 
retrotransposition [8]. LTR retrotransposons, also known as endogenous retroviruses (ERVs), either 
encode gag,  pol, pro and sometimes also env genes, or use the retroviral genes encoded by other 
ERVs, to drive a retroviral life-cycle [2,3,9]. 
Retrotransposons have the potential  to alter  the genomic landscape and change gene expression 
when they amplify or integrate into new sites in the host genome, providing an important driving 
force for evolutionary change [10]. Although retrotransposition can occur in somatic cells [11,12], 
repetitive  elements  need  to  amplify  in  germ cells,  or  their  pluripotent  precursors,  in  order  to 
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successfully propagate. The Repeatmasker database of repetitive elements [13] currently contains 
consensus sequences for 1221 different types of repetitive element,  each of which is present in 
multiple  copies  in  the  mouse  genome.  These  1221  repetitive  elements  are  organized  into  16 
different  classes  comprising  a  total  of  45  families  (see  Supporting  Figure  S1  for  a  schematic 
overview of this organization). The repetitive element classes that contain the greatest number of 
different  repetitive  elements  are  LTR  retrotransposons  (471  elements),  simple  repeats  (315 
elements), DNA transposons (156 elements) and  LINE retrotransposons (122 elements). Many of 
the repetitive elements that are present in the mammalian genome are poorly characterized, and it is 
often not clear whether different elements within each class or family are active at similar stages of 
germ  cell  or  pluripotent  cell  development,  or  whether  different  elements  are  recognized  and 
regulated by the same host defence mechanisms. Indeed the rich diversity of successful repetitive 
elements in the mammalian genome may indicate that different elements have evolved different 
strategies to evade recognition or suppression by host defence mechanisms.
The high  mutational  load  associated  with  excessive  amplification  of  repetitive  elements  in  the 
developing germline is likely to be detrimental to the evolutionary success of the host organism. 
Much progress has been made in identifying and understanding the mechanisms that suppress the 
activity  of  repetitive  elements  in  germ  cells  and  pluripotent  cells,  particularly  transcriptional 
repression of retrotransposon activity in mice [reviewed in 14–17]. Epigenetic modifications such 
as  DNA  methylation,  histone  methylation  and  histone  deacetylation  are  all  implicated  in 
transcriptional  silencing  of  retrotransposons.  DNA  methylation  is  required  for  transcriptional 
repression of  intracisternal  A particle  (IAP)  elements,  a  member  of  the  ERVK family  of  LTR 
retrotransposons,  in  somatic  cells  and  germ cells  [18,19].  Targeting  DNA  methylation  to  IAP 
elements during male fetal germ cell development requires the interaction between the piwi-piRNA 
pathway and DNA methyltransferase enzymes [reviewed in 15–17]. In pluripotent cells such as 
embryonic  stem (ES)  cells,  mutations  in  all  three  catalytically  active  DNA  methyltransferases 
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greatly reduce the levels of DNA methylation in the genome [20], and these  Dnmt1-/- Dnmt3a-/- 
Dnmt3b-/- triple knock out (Dnmt TKO) ES cells have increased expression of IAP retrotransposons 
[21,22].  However, the  increase  in  IAP expression  in  Dnmt  TKO ES cells  is  relatively  modest 
compared to somatic cells, and ES cells appear to rely more on the transcriptional co-repressor 
Kap1 to repress  IAP elements [21–23]. Kap1 probably acts through recruitment of histone H3K9 
methyltransferases, primarily Eset (also known as Setdb1 or Kmt1e), to deposit repressive histone 
modifications on IAP chromatin [22,23]. Together Kap1 and Eset have been shown to target various 
ERV1, ERVK and ERVL LTR retrotransposons [22–24]. However, different silencing mechanisms 
are likely to be operating on retrotransposons that are not enriched for H3K9 methylation in mouse 
ES cells [16,25]. Polycomb repressive complex (PRC)-mediated H3K27 trimethylation and Lsd1-
dependent  H3K4  demethylation  are  also  implicated  in  transcriptional  repression  of  LTR 
retrotransposons  in  mouse  ES  cells  [26,27],  and  histone  deacetylation has  been  implicated  in 
transcriptional silencing of newly-integrated LINE-1 elements in undifferentiated human embryonal 
carcinoma  (EC)  cells  [28].  Histone  deacetylases,  DNA  methyltransferases,  histone  lysine 
methyltransferases and PRC proteins are all also implicated in transcriptional silencing of retroviral 
LTRs  in  human  somatic  cells  [e.g.  29,30],  and  some  of  the  mechanisms  operating  to  repress 
retrotransposon transcription in somatic cells may operate in pluripotent cells too. In addition to 
transcriptional silencing, retrotransposon activity is also regulated at post-transcriptional levels in 
germ cells and pluripotent cells through the activity of miRNAs and endogenous small interfering 
RNAs (endo-siRNAs) [31–33]. Other host factors, such as Apobec proteins [34] and the Trex1 
endonuclease [35], have been shown to suppress retrotransposon activity post-transcriptionally in 
somatic cell types, and similar factors presumably also operate in pluripotent cells [36] and germ 
cells. Thus, multiple mechanisms probably combine to bring about effective silencing of different 
classes of retrotransposon in different cell types.
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Although silencing of repetitive elements has been studied by qRT-PCR and Northern blotting of 
representative candidate elements in ES cells and in other cell types, few genome-wide studies of 
the repetitive element expression have been performed to date [22,23,37]. Therefore it is often not 
clear how many different repetitive elements are being targeted by a specific silencing mechanism 
in any particular cell type. Given the antagonistic evolutionary relationship between retrotransposon 
expression  and  host  silencing  mechanisms,  identifying  repetitive  elements  that  have  escaped 
specific host silencing mechanisms may generate some insight into how these mechanisms are able 
to determine which regions of the genome or transcriptome to target. Microarrays are widely used 
for gene expression profiling,  and a large volume of microarray  gene expression data  obtained 
under various experimental conditions has been deposited in freely-accessible repositories such as 
NCBI GEO [38]. Microarray analysis of gene expression has been able to identify some changes in 
repetitive  element  gene  expression  [e.g.  26,39],  but  although  a  number  of  probes  present  on 
commercially available microarrays are identical to repetitive element sequences, few probes on 
these arrays are explicitly annotated as recognising repetitive elements.
The purpose of this study is to computationally extract information about genome-wide silencing of 
repetitive elements in germ cells and stem cells from microarray gene expression data. Using this 
approach we identify retrotransposons that are silenced by DNA methylation and various histone 
modifications in mouse embryonic stem cells. We also identify the histone deacetylase Hdac1 as a 
regulator of retrotransposons in mouse ES cells. Our results demonstrate that different silencing 
mechanisms can  be  independently  recruited  to  retrotransposons  in  a  modular  manner,  and that 
different genomic copies of individual retrotransposons can be differentially  sensitive to loss of 
these  silencing  mechanisms.  Lastly  we  show  that  analysing  the  sequence  variation  between 




Identification of Repetitive Element Probes in the Illumina and Affymetrix Gene Expression 
Microarray Platforms
Previously, in a study designed to refine and improve the detection of gene expression changes in 
Illumina Mouse WG-6 Beadchip microarrays data, more than 4,000 probes in the Illumina Mouse 
WG-6 Beadchips were identified that map to regions of the mouse genome that are at least partially 
masked by Repeatmasker [40]. Although information from these probes was discarded from gene 
expression microarray data in that study in order to improve the analysis of the remaining single-
copy probes [40], these repeat probes could potentially  contain information about genome-wide 
repetitive element expression in microarray datasets. We therefore investigated how well different 
classes of repetitive element are represented in Illumina Beadarrays, and whether these probes could 
monitor repetitive element expression on a genome-wide level. 
The Illumina Mouse WG-6 Beadchips each contain ~46,000 probes. We identified ~2,300 repetitive 
element probes in version 1.0, version 1.1 and version 2.0 of these arrays (Table 1) by comparing 
the genomic locations of the probes with the Repeatmasked regions of the mouse genome (see 
Materials  and Methods).  The proportion of repetitive element  probes identified  on the Illumina 
Beadchips  in  this  analysis  (~5%) is  around half  that  reported  previously  [40]. This  difference 
appears to be a consequence of using stricter criteria to identify repetitive element probes in the 
current study. In each version of the Illumina Mouse WG-6 Beadchip analyzed, ~1400 probes were 
in the correct orientation to detect sense repetitive element transcripts. Text files containing the 
repetitive element probe names and sequences identified in the Illumina Mouse WG-6 Beadchip are 
included online (Supporting Datasets S2-S4). Of the 1221 different repetitive elements in the mouse 
genome annotated in the Repeatmasker database, ~320 are represented by probes in the different 
versions of the Illumina Mouse WG-6 Beadchips (Table 2). Repetitive elements belonging to the 
LINE and SINE classes are well represented on these arrays, and repetitive elements belonging to 
the LTR retrotransposon and DNA transposon classes are reasonably represented (Table 2). Simple 
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repeats and satellite repeats are also present but less well represented on the Illumina Mouse WG-6 
Beadchips (Table 2). Thus Illumina Mouse WG-6 Beadchips have a good coverage of probes for 
monitoring  transposon  and  retrotransposon  expression  during  genome-wide  transcriptional 
profiling.
We applied  the  same rationale  to  identify  repetitive  element  probes  present  in  the  Affymetrix 
Murine  Genome  U74Av2  and  Mouse  Expression  430  2.0  GeneChips  (Table  1).  The  Murine 
Genome U74Av2 and Mouse Expression 430 2.0 GeneChips contain ~4,200 and ~26,000 probes 
respectively that are in the correct orientation to detect sense transcripts from repetitive elements. 
Text files containing the repetitive element probe names and sequences identified in the Affymetrix 
Gene Expression GeneChips are included online (Supporting Dataset S5, S6). Like the Illumina 
Mouse WG-6 Beadchip arrays, the Affymetrix arrays also have good representation of repetitive 
elements  belonging  to  LINE and  SINE classes,  and the  Affymetrix  Mouse  Expression  430 2.0 
GeneChip also has good coverage of LTR retrotransposons and DNA transposons (Table 2). The 
Affymetrix  Murine Genome U74Av2 GeneChip has  reasonable  coverage  of  repetitive  elements 
within  the  LTR  retrotransposon  and  DNA  transposon  class  (Table  2).  Thus  Affymetrix  Gene 
Expression GeneChips also contain a wide range probes that can be used to monitor transposon and 
retrotransposon expression.
Computational  Analysis  of  Repetitive  Element  Expression  in  Tex19.1-/- Testes  From 
Microarray Gene Expression Profiles
We  had  previously  identified  upregulation  of  the  MMERVK10C (ERVK  family)  LTR 
retrotransposon  in  mouse  germ  cells  lacking  the  pluripotency-associated  Tex19.1-/- gene  by 
analysing individual probe sequences upregulated in Illumina Beadchip microarray data [39]. In 
order to test whether any additional retrotransposons might be targets for  Tex19.1 in developing 
male germ cells we used the repeat probes in the Illumina Mouse WG-6 v2.0 Beadchip to assess 
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genome-wide repetitive element expression in  Tex19.1-/- testis microarray data. As Tex19.1-/- male 
mice have defects in progression through meiosis that perturb the normal cellular composition of 
the testis, gene expression profiling was performed on 16 dpp prepubertal testes undergoing the first 
wave of spermatogenesis where defects in meiosis are first becoming apparent [39]. In addition, the 
Tex19.1 mutation  was  backcrossed  onto  an  inbred  C57BL/6  genetic  background  in  order  to 
minimize genetic variation between the animals used for this microarray analysis. 19,089 probes on 
the Illumina Beadarray were expressed in 16 dpp testes in this experiment (Figure 1A), with most  
showing no significant change in expression in Tex19.1-/- testes. The expression level of 158 probes 
(0.8%) are  downregulated  at  least  2  fold  in  Tex19.1-/- testes  at  a  significance  level  of  p<0.01. 
However, the apparent downregulation of many of these probes may be a consequence of the delay 
in meiotic progression that is becoming evident in  Tex19.1-/- testes at 16 dpp [39]. On the other 
hand, 10 probes (0.05%) are upregulated at least 2 fold in Tex19.1-/- testes at p<0.01. 
In general the repetitive element probes behaved similarly to other probes on the array (Figure 1A). 
512 (2.7%) of the 19,089 probes expressed in 16 dpp testes are repeat probes. These 512 repeat 
probes  represent  173  different  repetitive  elements.  LTR  retrotransposon,  LINE,  SINE,  DNA 
transposon,  and satellite  transcripts  were all  expressed similarly  in  Tex19.1-/- and  control  testes 
(Figure 1A). However, 6 repeat probes belonging to the LTR retrotransposon class appear to be 
behaving  as  outliers  from  the  total  probe  population  (Figure  1A).  These  outlying  probes  are 
upregulated  2-4  fold  in  Tex19.1-/- testes,  and  all  belong  to  the  ERVK  family  of  LTR 
retrotransposons  (Figure  1B).  All  of  these  6  probes  are  complementary  to  the  MMERVK10C 
repetitive  element  (Figure  1C).  Indeed,  although  the  124  LTR retrotransposon  probes  that  are 
expressed in this dataset do not behave differently from the 18,577 non-repeat probes (Figure 1D, 
Wilcoxon rank sum test p=0.5), the 9  MMERVK10C probes expressed in this dataset represent a 
distinct population from the non-repeat probes (Figure 1D, Wilcoxon rank sum test, p<0.0001). The 
MMERVK10C probes also appear to be behaving differently from other LTR retrotransposon and 
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ERVK retrotransposon probes in this dataset (Wilcoxon rank sum tests, p<0.0001). Only four non-
repeat  probes  are  upregulated  in  Tex19.1-/- testes,  and  none  of  these  probes  map  close  to 
MMERVK10C loci  in  the  reference  genome,  suggesting  that  the upregulation  of  MMERVK10C 
elements in Tex19.1-/- testes is likely to be caused by loss of a trans-acting retrotransposon silencing 
mechanism rather  than  changes  in  non-repetitive  gene  expression  affecting  the  local  chromatin 
structure and influencing expression of nearby retrotransposon sequences. 
The unique behaviour of  MMERVK10C repeat probes in the microarray data was confirmed by 
identifying probes whose expression changed at least 2 fold (p<0.01) in Tex19.1-/- testes relative to 
control testes.  6 (1.2%) of the 512 repeat  probes change expression at  least  2 fold (p<0.01) in 
Tex19.1-/- testes,  and  all  6  of  these  repeat  probes  are  derived  from  MMERVK10C-int LTR 
retrotransposon  sequences.  We  confirmed  that  each  of  these  MMERVK10C probe  sequences 
matches multiple genomic loci (≥48/50 nt identity) by BLAT suggesting that each probe is able to 
detect expression from multiple genomic copies of the  MMERVK10C LTR retrotransposon (data 
not shown). Furthermore, we also confirmed that the non-complementary repeat probes recognizing 
antisense  repetitive  element  transcripts  did  not  show  any  significant  change  in  expression  in 
Tex19.1-/- testes (data not shown). Thus repeat-annotation of the Tex19.1-/- Illumina Beadchip data 
suggests  that  expression  of  MMERVK10C retrotransposons  is  significantly  and  specifically 
upregulated in  Tex19.1-/- testes. The systematic annotation and analysis of the C57BL/6 Tex19.1-/- 
testis microarray data presented here is consistent with our previous findings that  MMERVK10C 
elements are upregulated in  Tex19.1-/- testes from a mixed (129/Ola x CD1) genetic background 
[39], but importantly also extends the range and variety of repetitive elements analysed in these 
animals. Intriguingly,  MMERVK10C remains the only repetitive element among the 173 elements 
represented in this dataset whose expression changes by more than 2 fold in the absence of Tex19.1. 
Retrotransposon Derepression in Tex19.1-/- Testes is Restricted to MMERVK10C Elements
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Our computational  analysis  of  Tex19.1-/- testis  microarray  data  suggests  that  repetitive  element 
misexpression in  Tex19.1-/- testes is largely restricted to upregulation of  MMERVK10C elements 
(Figure 1A-D). We verified the upregulation of MMERVK10C elements in an independent group of 
C57BL/6  Tex19.1-/- testes  by  qRT-PCR  (Figure  1E).  The  ~2  fold  qRT-PCR  upregulation  of 
MMERVK10C elements  in  C57BL/6  Tex19.1-/- testes  is  similar  to  the  ~4  fold  qRT-PCR 
upregulation of this element reported previously using animals on a mixed genetic background [39]. 
The slightly lower level of upregulation of MMERVK10C seen in C57BL/6 animals may be caused 
by differences in the rate of testis development between these genetic backgrounds. In order to 
investigate  the apparent  specificity  of the  MMERVK10C upregulation evident in the microarray 
analysis we tested expression of  LINE-1 and some representative ERV1, ERVK and ERVL LTR 
retrotransposon sequences in Tex19.1-/- testes by qRT-PCR. qRT-PCR for LINE-1 retrotransposons 
(Figure 1E) confirmed the repeat-annotation analysis suggesting that these elements do not change 
expression in Tex19.1-/- testes (Figure 1A-D). Furthermore, RLTR4, ETnERV2 and MERVL2a LTR 
retrotransposons representing the ERV1, ERVK and ERVL families of LTR retrotransposons also 
do not change expression in Tex19.1-/- testes in either the Illumina Beadarray data (Figure 1A-D) or 
by qRT-PCR (Figure 1E). Thus  MMERVK10C elements appear to be behaving differently from 
other LTR retrotransposons in Tex19.1-/- testes.
The Illumina Beadarrays  used to profile  gene expression in  the  Tex19.1-/- testes contain probes 
representing around a third of the LTR retrotransposons present in the mouse genome. Therefore 
although  the  computational  and  experimental  data  both  suggest  that  MMERVK10C elements 
respond  differently  from  other  retrotransposons  in  the  genome  to  the  loss  of  Tex19.1,  we 
investigated whether LTR retrotransposons that were closely related to MMERVK10C might also be 
upregulated in  Tex19.1-/- testes.  We used MMERVK10C pol  and pro protein sequences to identify 
repetitive elements closely related to MMERVK10C (Figure 2A). MMERVK10C appears to be most 
closely  related  to  IAP elements,  with  the pol  protein  sequences  of  MMERVK10C,  IAPEz and 
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IAPEY3 all having around 75% similarity to each other. Although there are numerous IAP probes in 
the Illumina Beadarrays, these probes do not appear to be changing in Tex19.1-/- testes (Figure 2B). 
Furthermore we tested expression of IAPEz and IAPEY3 elements in Tex19.1-/- testes by qRT-PCR 
(Figure  2C)  and  found  that,  as  suggested  by  computational  analysis  of  the  microarray  data, 
expression of these elements is not changing in Tex19.1-/- testes. We also tested expression of the 
MMERVK9E retrotransposon that is related to  MMERVK10C but not represented on the Illumina 
Beadarrays.  MMERVK9E has  around  65%  similarity  to  MMERVK10C across  the pol  protein 
sequence, but is not part of the cluster of  IAP elements evident in the  MMERVK10C phylogeny 
(Figure 2A). However, qRT-PCR data shows that MMERVK9E elements do not change expression 
in Tex19.1-/- testes either (Figure 2C). Thus retrotransposon derepression in Tex19.1-/- testes appears 
to be intriguingly restricted to MMERVK10C elements. 
Different  Transcriptional  Silencing  Mechanisms  Have  Distinct  Effects  on  Genome-Wide 
Repression of Repetitive Elements
Our  data  on  Tex19.1-/- testes  suggests  that  only  a  small  number  of  retrotransposon  RNAs  are 
sensitive  to loss of  Tex19.1 in  germ cells.  We therefore next investigated  whether loss of well 
established  retrotransposon  silencing  mechanisms  had  more  extensive  effects  on  genome-wide 
repression of retrotransposons using ES cells as a model. We computationally analysed repetitive 
element expression in previously published gene expression microarray datasets from Dnmt TKO 
ES cells carrying mutations in all three catalytically active DNA methyltransferases [41], and from 
ES cells transiently transfected with shRNAs to knock-down the histone H3K9 methyltransferase 
Eset [42]. Although the Dnmt TKO and EsetshRNA ES cell gene expression profiles were performed 
on Affymetrix and Illumina platforms respectively,  and may therefore have some differences in 
coverage  of  individual  retrotransposons  or  sensitivity  of  detection  limits,  different  classes  of 
repetitive elements are similarly represented on these platforms (Table 2) and some genome-wide 
comparisons  will  still  be  informative.  We also included data  from Affymetrix  gene expression 
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profiling  of  ES cells  carrying  mutations  in  the  Hdac1 histone  deacetylase  enzyme [43]  in  this 
analysis.  Although the  HDAC family  of  histone  deacetylases  are  implicated  in  retrotransposon 
silencing by virtue of being targets of trichostatin A [28,44,45], the role and retrotransposon targets 
of the different HDAC histone deacetylases has not yet been defined. Genome-wide analysis of 
retrotransposon silencing in Dnmt TKO, EsetshRNA and Hdac1-/- ES cells could therefore uncover new 
or additional retrotransposon targets for these mechanisms in ES cells. 
Repeat-annotation of  Dnmt TKO,  EsetshRNA and  Hdac1-/- ES cells (Figure 3) confirmed that LTR 
retrotransposons are upregulated in all of these mutant ES cells. Interestingly, although individual 
retrotransposon sequences could be selected that show upregulation in each of these mutant ES cell 
lines,  the  genome-wide  overview  of  retrotransposon  behaviour  shows  striking  differences  in 
retrotransposon behaviour  between mutant  ES lines  (Figure 3A,  3C,  3E).  Dnmt TKO ES cells 
appear to modestly upregulate a number of LTR retrotransposon probes around 2-8 fold, which 
behave similarly to the upregulated non-repeat probes in the array, but other classes of repeat probe 
do not appear to change (Figure 3A). The upregulated group of LTR retrotransposon probes in 
Dnmt TKO ES cells is primarily composed of ERV1 and ERVK classes of LTR retrotransposon 
(Figure 3B). In contrast EsetshRNA ES cells appear to strongly upregulate most LTR retrotransposon 
probes in the array, and these upregulated LTR retrotransposon probes appear to be responding 
more strongly to loss of Eset than the upregulated non-repeat probes in the dataset (Figure 3C). The 
range of LTR retrotransposon probes upregulated in  EsetshRNA ES cells is more expansive than in 
Dnmt  TKO  ES  cells  with  probes  belonging  to  ERV1,  ERVK  and  ERVL  classes  all  being 
upregulated (Figure 3D).  Furthermore,  EsetshRNA ES cells  appear  to modestly  upregulate  LINE-1 
probes (Figure 3C), a group of retrotransposons that does not strongly change expression in Dnmt 
TKO ES cells  (Figure 3A).  Thus  Eset appears to have a stronger and more widespread role in 
repressing retrotransposons in ES cells than DNA methylation. Interestingly, Hdac1 also has a role 
in repressing retrotransposons in ES cells (Figure 3E). However the role of  Hdac1 appears to be 
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distinct from the roles of DNA methylation and Eset histone methyltransferase.  Hdac1-/- ES cells 
upregulate  one group of  LTR retrotransposon probes  4-8  fold,  a  relatively  strong upregulation 
compared to  non-repeat  probes  in  the dataset,  and downregulate  a  second large  group of  LTR 
retrotransposon probes around 2-4 fold (Figure 3E). The upregulated and downregulated groups of 
LTR retrotransposon probes are both primarily composed of ERVK class LTR retrotransposons 
(Figure 3F, pink dots), and these changes in ERVK probe expression are comparable in magnitude 
to the changes in non-repetitive gene expression that occur in  Hdac1-/- ES cells (Figure 3F, grey 
dots, [43]). The observation that LTR retrotransposon expression is altered in  Hdac1-/- ES cells is 
consistent with data showing that human HDAC1 can silence avian retroviral LTR reporter genes in 
somatic HeLa cells.[29,30], and identifies Hdac1 as a novel regulator of retrotransposon expression 
in mouse ES cells. Hdac1-/- ES cells do not appear to change expression of other classes of repeat 
probe (Figure 3E), and therefore Hdac1 appears to be more restricted than either DNA methylation 
or  Eset  in  the  range  of  retrotransposon sequence  classes  that  it  affects.  However  unlike  DNA 
methylation  or  Eset,  Hdac  can  have  both  positive  and  negative  effects  on  expression  of 
retrotransposons. Thus although the Dnmt TKO, EsetshRNA, and Hdac1-/- ES cell lines all upregulate 
individual retrotransposons, these mechanisms appear to have different effects on retrotransposon 
expression at a genome-wide level.
Interactions Between Retrotransposon Silencing Mechanisms in ES Cells
We next investigated how the Dnmt, Eset and Hdac1 transcriptional repression mechanisms interact 
in ES cells by identifying distinct and overlapping retrotransposon targets for these mechanisms. 
We identified repeat probes in each of the Dnmt TKO, EsetshRNA, and Hdac1-/- ES cell datasets that 
changed expression at least 2 fold (p<0.01) relative to the appropriate wild-type control datasets. 84 
(0.8%) of the 10,316 expressed repeat probes changed expression at least 2 fold (p<0.01) in the 
Dnmt TKO ES cells, with multiple probes for MMERGLN and RLTR1B (ERV1 family), and IAP 
and RLTR45 (ERVK family) retrotransposons all showing upregulation in these cells (Figure 4A, 
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4B).  These  findings  correlate  well  with  recent  RNA-seq  data  from  Dnmt  TKO  ES  cells: 
MMERGLN,  RLTR1B,  IAP and  RLTR45 are all upregulated ~2.5-13 fold in Dnmt TKO ES cell 
RNA-seq data [22]. However the two other elements (MMERVK10C and  RMER16) reported as 
upregulated >2 fold in Dnmt TKO ES cells by RNA-seq (~2.3 fold upregulation for each [22]) have 
no detectable change in expression in the microarray data suggesting that microarray analysis is less 
sensitive than RNA-seq for detecting some changes in LTR retrotransposon expression. In EsetshRNA 
ES cells, 125 (45%) of the 277 expressed repeat probes changed expression at least 2 fold (p<0.01), 
with multiple  probes for  MMERGLN (ERV1 family),  MMERVK10C, IAP and  RLTR45 (ERVK 
family),  MERVL (ERVL  family)  and  LINE-1 repetitive  elements  all  showing  upregulation  in 
EsetshRNA ES  cells  (Figure  4C,  4D).  These  elements  represent  a  small  subset  of  those  reported 
previously as being uregulated in  Eset-/- ES cells [22,24], which may reflect greater loss of  Eset 
function in Eset-/- conditional knockout ES cells than in ES cells transiently transfected with knock-
down shRNAs. Interestingly, although comparison of the Dnmt TKO and EsetshRNA ES cell datasets 
suggest that some retrotransposon sequences (MMERGLN, IAP, RLTR45) are co-repressed by both 
DNA methyltransferases and Eset histone methyltransferase, analysis of the  Hdac1-/- ES cell data 
shows striking divergences in the behaviour of these elements (Figure 4E, 4F). 74 (3.7%) of the 
1971 expressed repeat probes changed expression at least 2 fold (p<0.01) in Hdac1-/- ES cells, with 
multiple  probes  for  the  ETnERV3 and  RLTR45 (ERVK  family)  retrotransposons  showing 
upregulation  in  Hdac1-/- ES cells  (Figure  4E,  4F).  These elements  share  considerable  sequence 
similarity at the nucleotide level (84% identity over 4.2 kb of sequence). Interestingly, although 
RLTR45 and  IAP elements both appear to be co-repressed by DNA methyltransferases and Eset 
histone methyltransferase (Figure 4A-D), multiple probes for IAP (ERVK family) retrotransposons 
behaved quite differently from the  RLTR45 probes and were downregulated in  Hdac1-/- ES cells 
(Figure  4E,  4F).  Although  Hdac1  typically  acts  as  a  transcriptional  repressor,  the  apparent 
downregulation of IAP elements in Hdac1-/- ES cells would parallel the behaviour of some single-
copy gene  targets  of  Hdac1 [43]. We verified  the  microarray  analysis  of  LTR retrotransposon 
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expression  by  performing  qRT-PCR on  Hdac1-/- ES  cells:  significant  upregulation  of  RLTR45 
elements (11 fold, p<0.05) and downregulation of IAP elements (2.5 fold, p<0.05) was confirmed 
using this methodology (Figure 5A). Thus expression of some LTR retrotransposons is perturbed in 
the absence of  Hdac1 in mouse ES cells. Furthermore, the differences between  RLTR45 and  IAP 
expression  in  Hdac1-/- ES  cells  suggests  that  an  Hdac1-dependent  transcriptional  silencing 
mechanism is being recruited to retrotransposons independently of DNA methyltransferase or Eset 
histone methyltransferase activity.
The changes  in  IAP and  RLTR45 element  expression in  Hdac1-/- ES cells  could be an indirect 
consequence of other gene expression changes that occur in Hdac1-/- ES cells [43], or may reflect a 
more direct role for Hdac1 in transcriptional regulation of these elements. To investigate whether 
RLTR45 and IAP are direct targets of Hdac1 in ES cells, we analysed high throughput sequencing 
data from ES cell chromatin Hdac1 immunoprecipitation (Hdac1 ChIP-seq from mouse ES cells 
[38]) for enrichment of repetitive element sequences [25]. Interestingly,  RLTR45 LTR sequences 
are enriched in Hdac1 ChIP-seq relative to whole cell extract controls (Figure 5B), suggesting that  
Hdac1 is negatively regulating RLTR45 expression in ES cells through physically associating with 
RLTR45 LTRs.  In  contrast  IAP LTR sequences  are  depleted  in  Hdac1  ChIP-seq  (Figure  5B), 
consistent  with  the  downregulation  of  IAP expression  in  Hdac1-/- ES  cells  being  an  indirect 
consequence of other changes in gene expression in these cells. Taken together, these data suggest 
that Hdac1 is directly recruited to RLTR45 retrotransposons to silence their expression in ES cells. 
Identifying LTR Retrotransposon Targets of Polycomb Repressive Complexes in ES Cells
Our genome-wide analysis of retrotransposon silencing in Dnmt TKO,  EsetshRNA, and  Hdac1-/- ES 
cells  suggests  that  multiple  mechanisms  contribute  to  silencing  individual  retrotransposon 
sequences in ES cells. These silencing mechanisms may be recruited sequentially or independently 
to  target  sequences.  To  investigate  the  interaction  between  different  transcriptional  repression 
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complexes at retrotransposon sequences in more detail, we examined retrotransposon silencing in 
ES cells carrying mutations in components of the polycomb repressive complexes PRC1 and PRC2.
Conventional  repression  of  gene  expression  by the  polycomb  repressive  complexes  PRC1 and 
PRC2 is thought to involve PRC2 methylating histone H3K27 and sequentially recruiting PRC1 to 
target loci [reviewed in 46]. However, a recent study on ES cells carrying mutations in the PRC1 
component  Ring1B, or mutations in the PRC2 component  Eed, or mutations in both  Ring1B and 
Eed has suggested that PRC1 and PRC2 are recruited independently and act redundantly to repress 
MuLV and  IAP repetitive elements in this cell type [26]. We therefore computationally analysed 
genome-wide retrotransposon silencing in Ring1B-/-, Eed-/-, and Ring1B-/- Eed-/- ES cells to determine 
whether any additional LTR retrotransposons are redundantly regulated by polycomb repressive 
complexes,  and  also  to  test  whether  any  LTR  retrotransposons  are  regulated  by  conventional 
sequential  targeting of polycomb repressive complexes.  Ring1B-/- Eed-/- ES cells  have numerous 
differences  in  gene  expression  compared  to  wild-type  ES  cells  [26],  and  although  LTR 
retrotransposon probes do not appear to be preferentially affected by loss of both PRC1 and PRC2 
relative to other probes in the dataset, a number of ERV1 and ERVK probes are upregulated in 
Ring1B-/- Eed-/- ES cells (Figure 6A). A smaller subset of LTR retrotransposon probes is upregulated 
in  Ring1B-/- (Figure  6C)  and  Eed-/- (Figure  6E)  single  knockout  ES  cells.  We  identified  LTR 
retrotransposon probes that were strongly upregulated at least 4 fold (p<0.01) in Ring1B-/- Eed-/- ES 
cells (Figure 6B) and monitored how these LTR retrotransposons behaved in Ring1B-/- (Figure 6D) 
and Eed-/- (Figure 6F) single knockout ES cells. MMVL30 (ERV1 family) probes were upregulated 
in  Ring1B-/- Eed-/- double knockout ES cells, but did not change greatly in either in  Ring1B-/- or 
Eed-/- single knockout ES cells, consistent with these elements being redundantly and independently 
regulated  by PRC1 and PRC2 [26]. A small  number of  IAP probes  also appeared  to  be  more 
strongly upregulated in Ring1B-/- Eed-/- double knockout ES cells than in either single knockout cell 
line:  4 of the 112  IAP probes that  are  expressed in this  dataset  are  upregulated at  least  4 fold 
(p<0.01) in Ring1B-/- Eed-/- double knockout ES cells, but no IAP probes are upregulated by these 
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criteria in either single knockout cell line (Figure 6B, 6D, 6F). This is consistent with previous 
observations that  IAP elements are redundantly and independently regulated by PRC1 and PRC2 
[26]. RLTR45 (ERVK family) probes are also more strongly upregulated in Ring1B-/- Eed-/- double 
knockout ES cells than in either single knockout cell line suggesting that this element is a novel 
retrotransposon target for redundant silencing by polycomb repressive complexes (Figure 6B, 6D, 
6F). 
Interestingly,  genome-wide analysis  of retrotransposon expression also suggests that  some LTR 
retrotransposon probes are being repressed by conventional sequential  recruitment of PRC2 and 
PRC1. RLTR44 (ERVK family) probes appear to be similarly upregulated in Ring1B-/- Eed-/- double 
knockout and single knockout ES cells (Figure 6B, 6D, 6F). The slightly lower upregulation of 
RLTR44 probes in Ring1B-/- ES cells compared to Eed-/- ES cells may represent Ring1A-containing 
PRC1  complexes  contributing  to  polycomb-mediated  repression  in  ES  cells  [47].  RLTR44 
retrotransposons do however appear to be a novel retrotransposon target for conventional sequential 
silencing by polycomb repressive complexes. Thus computational analysis of gene expression in 
polycomb mutant cell lines suggests that PRC1 and PRC2 interact in different ways on different 
retrotransposon targets to bring about silencing of these repetitive elements in ES cells. 
Differential Regulation of Retrotransposon Genomic Loci
During analysis of the  Ring1B-/- Eed-/- double knockout and single knockout ES cells, we noticed 
that probes for RLTR4 retrotransposons were strongly upregulated in all three cell lines (Figure 6B, 
6D, 6F). However the  RLTR4 probes that are upregulated correspond mainly to the LTR region 
(RLTR4_Mm) but usually not the internal region (RLTR4-int) of this element  (Figure 7A). This 
suggests that the upregulation of these probes may represent expression from a subset of  RLTR4 
loci, possibly corresponding to truncated or chimaeric elements. We therefore mapped the genomic 
location of the  RLTR4 LTR and internal probes that were upregulated in  Ring1B-/- ES cells back 
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onto  the  genome  using  BLAT.  In  contrast  to  the  retrotransposon  probes  upregulated  in  other 
datasets analysed in this study, the RLTR4 probes upregulated in Ring1B-/- ES cells did not map to 
multiple genomic loci. Rather all of the upregulated RLTR4 probes mapped only to a single RLTR4-
containing genomic locus on chromosome 8 (chr8:125949704-125958431). The RLTR4 probes that 
did not change expression in  Ring1B-/- ES cells mapped to multiple loci in the genome. Thus the 
upregulation of a subset of  RLTR4 probes in  Ring1B-/- ES cells may represent upregulation of a 
single  genomic  copy  of  this  element.  This  locus  appears  to  contain  RLTR4-int and  MuLV-int 
sequences flanked by RLTR4_Mm sequences that each contains an inversion and a ~200 bp deletion 
relative to the 742 bp consensus sequence. qRT-PCR using primers designed to specifically detect 
the  RLTR4-int sequence  at  this  locus  confirmed  that  expression  of  this  region  is  strongly 
upregulated in Ring1B-/- ES cells (Figure 7B), whereas qRT-PCR using primer sets that recognize 
multiple  copies  of  RLTR4-int suggest  that  these  elements  are,  in  general,  not  upregulated  in 
Ring1B-/- ES cells  (Figure 7B). qRT-PCR also confirmed that representative ERV1, ERVK and 
ERVL LTR retrotransposons  were  not  changing  expression  in  Ring1B-/- ES  cells  (Figure  7B), 
consistent with the computational analysis. The divergent copy of RLTR4 on chromosome 8 appears 
to be silenced by conventional polycomb repression as it is de-repressed in both Ring1B-/- and Eed-/- 
single  knockout  ES  cells  (Figure  6).  This  copy  of  RLTR4 could  have  acquired  Ring1B target 
sequences through mutations and re-arrangement to make it a target for conventional polycomb 
silencing. However as RLTR4 is derived from MuLV [48], a target of redundant silencing by PRC1 
and PRC2 [26], it  is  perhaps  more  likely  that  changes  in  this  divergent  copy of  RLTR4 have 
removed sequences that allow PRC2-independent silencing of this locus by PRC1, making it behave 
as a conventional target for polycomb repression. 
Many of the changes in retrotransposon expression that we have characterized in ES cells and germ 
cells involve subsets of probes for particular retrotransposons changing expression (Figure 1, 4, 5) 
suggesting that different genomic copies of these retrotransposons may be differentially regulated in 
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these cell types. In Tex19.1-/- testes, six of the nine expressed MMERVK10C probes in the dataset 
are upegulated at least 2 fold (Figure 1). All six of the upregulated MMERVK10C probes are located 
in the MMERVK10C env open reading frame. Two of the remaining three MMERVK10C probes are 
also located in the env gene and are upregulated in  Tex19.1-/- testes, but are just below the 2 fold 
change  threshold.  The  single  MMERVK10C probe  that  is  located  in  the  gag region  does  not 
significantly change expression in the Tex19.1-/- testis dataset. We validated the computational data 
by qRT-PCR and confirmed that the gag and env regions of MMERVK10C are indeed differentially 
sensitive to loss of  Tex19.1 in mouse testes (Figure 7C). Interestingly, we noted that primer sets 
designed to different parts of MMERVK10C env (env.a – env.d) were also differentially sensitive to 
loss  of  Tex19.1 (Figure  7C).  These  data  suggest  that  a  subset  of  MMERVK10C loci  may  be 
upregulated in  Tex19.1-/- testes. Cloning and sequencing multiple independent clones of the env.c 
PCR product confirmed that multiple  MMERVK10C loci were expressed in  Tex19.1-/- and control 
testes (data not shown). The pol sequence is not covered by probes on the array but this region of 
MMERVK10C is also significantly upregulated in Tex19.1-/- testes (Figure 7C). Although in silico  
PCR  suggests  that  the  different  MMERVK10C primer  sets  detect  different  numbers  of 
MMERVK10C loci (gag primers detect 95 loci,  pol primers detect 164 loci,  env.a – env.d primers 
detect  78,70,179 and 40 loci  respectively),  the  qRT-PCR data  suggest  that  expression  of  these 
amplicons is differentially affected by loss of Tex19.1. We investigated the differential regulation of 
MMERVK10C gag and  env regions by mapping the six strongly upregulated  env probes and the 
single  unaffected  gag probe  to  individual  MMERVK10C genomic  loci,  and  assembled  the 
MMERVK10C genomic loci into contigs. As MMERVK10C sequences that have retained flanking 
RLTR10 LTRs  are  more  likely  to  be  transcriptionally  active  we  selected  RLTR10-flanked 
MMERVK10C contigs  for  further  analysis  (Figure  7D).  Only  18  of  the  250  RLTR10-flanked 
MMERVK10C contigs (7%) that we identified in the mouse genome are approximately full-length 
(contain >95% of  MMERVK10C reference sequence). Interestingly, many of the  RLTR10-flanked 
MMERVK10C contigs  contain  recurrent  deletions:  one  recurrent  deletion  in  the  upregulated 
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MMERVK10C contigs  removes  the  start  of  the  gag open  reading  frame  (nucleotides  399-870 
deleted  in  33% of  these  contigs)  and appears  to  be  associated  with  recurrent  deletions  in  env 
(nucleotides 5810-6646 deleted in 33% of all contigs, 5810-6651 deleted in 20% of contigs). The 
presence of recurrent deletions in the MMERVK10C open reading frames at distinct genomic loci 
suggests that transcripts carrying these deletions may be actively retrotransposing, presumably in a 
non-autonomous manner through the activity of endogenous retroviral proteins provided in trans. 
The upregulated probes appeared to be highly representative of the RLTR10-flanked MMERVK10C 
loci, with 197 of the 250  RLTR10-flanked  MMERVK10C contigs matching only the upregulated 
probes (Figure 7D). No RLTR10-flanked MMERVK10C contig matched all upregulated probes, or 
all  the  upregulated  qRT-PCR  primer  sets,  suggesting  that  multiple  genomic  copies  of 
MMERVK10C are  upregulated  in  Tex19.1-/- testes.  In  contrast,  only  two  RLTR10-flanked 
MMERVK10C contigs matched only the unaffected probe (Figure 7D). Interestingly, 12 of the 15 
RLTR10-flanked MMERVK10C contigs that matched both sets of probes were approximately full-
length sequences, whereas the contigs that matched only the upregulated probes usually contained 
deletions  with  recurrent  breakpoints.  (Figure  7D).  Furthermore,  qRTPCR  primers  designed  to 
amplify sequences within the 5810-6646 deletion (env.a) do not change expression in  Tex19.1-/- 
testes,  but  those  amplifying  env sequences  outside  this  deletion  (env.b,  env.c,  and  env.d)  are 
upregulated (Figure 7C, 7D). Thus de-repression of specific subsets of MMERVK10C loci could be 
contributing  to  the  differential  regulation  of  different  regions  of  MMERVK10C gag and  env 
amplicons in  Tex19.1-/- testes (Figure 7C). The upregulated pol and env.b/env.c primer sets can 
detect expression from RLTR10-flanked MMERVK10C contigs encoding intact pol and env proteins 
respectively (>90% of open reading frame intact relative to MMERVK10C reference sequence), but 
not contigs where the gag, pol, pro and env proteins are all intact. This suggests that the upregulated 
MMERVK10C transcripts may have some protein coding potential, but may need to rely on proteins 
provided  in trans  for retrotransposition.  Some of the deletions in the upregulated  MMERVK10C 
contigs, particularly the consistent disruption to parts of the gag region, may be removing sequences 
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used  to  recruit  Tex19.1-independent  retrotransposon  silencing  mechanisms.  These  loci  would 
therefore be more reliant on the  Tex19.1-dependent pathway for repression in germ cells, and be 
specifically  de-repressed  in  Tex19.1-/- testes.  Thus  the  differential  regulation  of  MMERVK10C 
probes  in  Tex19.1-/- testes  may  be  caused  by  the  emergence  of  variant  non-autonomous 
MMERVK10C elements that have deleted the sequences used to target silencing mechanisms to 
MMERVK10C.
We  noted  that  IAP retrotransposon  probes  in  Dnmt  TKO  ES  cells  lines  were  also  exhibiting 
bimodal behaviour (Figure 4B). To investigate whether this represents differential regulation of IAP 
loci we designed qRT-PCR primers to IAP loci matching either upregulated or unaffected IAP-int 
probes (Figure 7E). qRT-PCR confirmed that some IAP loci are upregulated in Dnmt TKO ES cells, 
whereas others do not change expression (Figure 7F). As expected from the computational analysis 
of retrotransposon expression in Dnmt TKO ES cells, expression of LINE-1 elements do not change 
in Dnmt TKO ES cells, and MMERGLN elements are upregulated, when assessed experimentally 
by qRT-PCR (Figure 7F). Our finding that different genomic copies of  IAP may be differentially 
sensitive to loss of DNA methyltransferases is consistent with recent findings from RNA-seq of 
Dnmt TKO ES cells [22]. A simple interpretation of this phenomenon would be that the IAP loci 
that are not changing expression in Dnmt TKO ES cells are divergent defective copies of the IAP 
element. However, the unaffected  IAP-int probes are detecting some  IAP expression in ES cells, 
albeit at a lower level than the upregulated probes, suggesting that the IAP loci that are detected by 
the unaffected IAP-int probes are not all transcriptionally inert. To investigate why some IAP loci 
are insensitive to DNA methylation we identified the genomic IAPEz-int contigs that matched either 
the upregulated or the unaffected IAP-int probes. Although many of the contigs that only matched 
the  unaffected  IAP-int probes  carried  large  deletions,  one  locus  (chr10:22250294-22243066) 
contained a relatively intact IAPEz-int region flanked by IAP LTRs. Interestingly both of the LTRs 
at  this  locus  contain  a  small  10  bp  deletion  (Figure  7G)  that  removes  the  conserved  AP-1 
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transcription factor binding site [49]. Only 5 of the 16141 IAP LTRs in the mouse genome carry 
this, or a similar, deletion of the AP-1 binding site, and none of the  IAP contigs that only match 
upregulated IAP-int probes contain this deletion in their LTRs. We confirmed that this copy of IAP 
(IAP_chr10)  was not  upregulated  in  Dnmt TKO ES cells  by qRT-PCR (Figure  7F).  However, 
mRNA from this locus was readily detected in wild-type and Dnmt TKO ES cells, suggesting that 
this copy of IAP is constitutively expressed. Loss of the AP-1 binding site in the IAP LTRs at this 
locus therefore does not appear to silence expression of this element,  but may render this locus 
insensitive to regulation by DNA methylation. Interestingly, DNA methylation has been shown to 
inhibit  binding of AP-1 to  gene promoters  [50].  Inhibition of AP-1 binding to  IAP LTRs may 
therefore be contributing to DNA methylation-mediated repression of  IAP elements in mouse ES 
cells.
Taken  together,  computational  analysis  of  genome-wide  retrotransposon silencing  suggests  that 
individual loci for a particular retrotransposon can have different sensitivities to retrotransposon 
suppression mechanisms. Mapping the changes that are present in differentially regulated loci may 




Evaluation of the Microarray Repeat-Annotation Approach
In this  manuscript  we describe  a  simple  computational  approach to  monitor  repetitive  element 
expression in  microarray  gene expression data.  We have used repeat-annotation  of pre-existing 
datasets  to  identify  retrotransposons  regulated  by  DNA  methylation  and  different  histone 
modifications in mouse ES cells (Table 3). We have verified that repeat probes present in gene 
expression microarrays are accurately reporting repetitive element expression by confirming our 
findings from Tex19.1, Ring1B and Dnmt TKO microarray analyses by qRT-PCR. In general there 
appears to be good qualitative correlation between repeats that we identified as changing expression 
in microarray datasets, and our qRT-PCR verification. Importantly there is also good correlation 
between repeat probes that are not changing expression in the microarray datasets and our qRT-
PCR verification of these repetitive elements. Furthermore, we have used this approach to identify 
Hdac1 as a component of the retrotransposon silencing machinery in mouse ES cells (Figure 3, 
Figure 4). Application of this methodology to gene expression microarray data is likely to generate 
new insights into retrotransposon regulation in mammals, and help to identify further components 
of the defence mechanisms that protect the mammalian genome from retrotransposition. Consistent 
with previous re-annotation workflows designed to remove non-informative probes from microarray 
analyses [40], we found that commercially available mouse gene expression microarray platforms 
contain a number of probes that map to repetitive regions of the genome.  Although expression 
information  from these probes can be discarded to  improve analysis  of  gene expression in the 
remaining dataset [40], we show here that the information from these probes can be extracted to 
accurately monitor repetitive element expression.
Repeat-annotation of microarray data can significantly expand the repertoire of repetitive elements 
studied in an experiment compared to testing selected representative candidates. Indeed this study 
has identified new target retrotransposons for polycomb repressive complexes and Hdac1 histone 
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deacetylase in mouse ES cells. Although the range of repetitive elements analysed by microarray 
repeat-annotation will not be as wide as that analysed by RNA-seq [22,23], between one and two 
thirds of all retrotransposons in the mouse genome are represented by probes on the microarray 
platforms that we have analysed here. A direct comparison between microarray repeat annotation 
(this study) and RNA-seq [22] for detecting changes in retrotransposon expression in Dnmt TKO 
ES cells  shows good correlation  between these  methods  (the  four  retrotransposons  detected  as 
upregulated by microarray analysis are the four most strongly upregulated retrotransposons detected 
by RNA-seq). However, two additional LTR retrotransposons were detected as upregulated in Dnmt 
TKO ES cells only by RNA-seq, despite representation of these elements on the microarray. Thus 
microarray  analysis  may  be  less  sensitive  than  RNAseq  for  detecting  some  changes  in  LTR 
retrotransposon expression, particularly when only a small number of genomic copies are changing 
expression [22]. In addition, although we have focused on retrotransposon silencing in mouse germ 
cells and pluripotent cells, the computational approach that we describe here can be readily applied 
to microarray data from human cells and tissues to inform on retrotransposon expression in relation 
to  retrotransposition  in  somatic  mosaicism  [12,37],  epigenetic  changes  in  cancer  [51,52], 
reprogramming somatic cells into iPS cells [53], and toxicological insults [54]. As repeat-annotation 
can be applied to pre-existing microarray data as well as new datasets, this methodology can be 
used to extract information from many of the ~18,000 microarray gene expression data series that 
have  been  generated  and  deposited  in  publicly  available  databases  [38].  This  makes  repeat-
annotation of microarray data an attractive approach to test hypotheses and generate initial findings 
upon which more detailed research can be built.  Thus microarray repeat-annotation represents a 
simple and cost-effective addition to the methods available to study repetitive element silencing at a 
genome-wide level.
Differential Regulation of Specific Genomic Copies of a Retrotransposon
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One of the features of the computational approach that we have outlined here is that our analysis is 
based  on  aligning  probe  sequences  to  Repeatmasked  regions  of  the  genome,  rather  than  to 
Repeatmasker  consensus  sequences.  If  different  genomic  copies  of  a  repetitive  element  are 
behaving  in  different  ways  in  an  experiment  then  repeat-annotation  of  microarray  data  can 
potentially monitor expression from divergent genomic copies of a repetitive element. Clearly the 
extent to which multiple genomic copies of a particular element can be monitored will depend on 
the coverage of probes for that element. In the Affymetrix Mouse Expression 430 2.0 GeneChip 
platform that contains ~26,000 repeat probes we have been able to detect differential regulation of 
different  genomic  copies  of  RLTR4 elements  in  Ring1B-/- ES cells,  IAP,  RLTR45  and RLTR1B 
elements in Dnmt TKO ES cells and ETnERV3 and RLTR45 in Hdac1-/- ES cells. Remarkably, for 
Ring1B-/- ES cells we were able to detect expression changes that are possibly arising from only a 
single divergent copy of  RLTR4. Thus repeat-annotation of microarray data appears to be able to 
monitor expression from divergent genomic copies of a repetitive element.
For MMERVK10C elements, analysis of the genomic loci matching retrotransposon probes was able 
to generate some insight into why some genomic copies of these elements are more sensitive to loss 
of suppression mechanisms than others. Loss of parts of the gag or env regions of  MMERVK10C 
may be associated with genomic copies becoming more sensitive to Tex19.1-dependent suppression 
in male germ cells (Figure 7D). Interestingly, non-autonomous variants of IAP (IAP1) that carry 
deletions in the gag region retrotranspose more frequently than their full-length counterparts [55]. 
Thus sequences in the gag region of both IAP and MMERVK10 may be being used by host defence 
mechanisms to target these elements for silencing. In addition, analysis of differentially regulated 
IAP loci allowed us to identify a region in the  IAP LTR that may be targeted by host silencing 
mechanisms (Figure 7G). DNA methylation at this conserved AP-1 transcription factor binding site 
may contribute  to  Dnmt-dependent  repression  of  IAP elements  in  ES cells  by inhibiting  AP-1 
binding. However,  further  experimental  work  is  needed  to  functionally  characterize  the 
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consequences of these deletions for  MMERVK10C and  IAP silencing in germ cells and ES cells. 
Our analysis of MMERVK10C and IAP elements suggests that the behaviour of sequence variants in 
a retrotransposon's population can potentially be used to identify cis-acting sequences involved in 
retrotransposon suppression. In this respect, although repeat-annotation of microarray data may give 
some  indication  of  differential  regulation  of  repeat  loci,  RNA-seq  may  potentially  be  a  more 
powerful approach to identify which genomic copies of an element are responsible for changes in 
expression.
As with all studies reporting changes in retrotransposon expression, determining whether changes in 
RNA or protein levels are caused by misregulation of one copy or many copies of a retrotransposon 
can be difficult. However, determining the sequence of the retrotransposon loci or transcripts that 
change expression in microarray datasets is an important prerequisite for assessing the functional 
potential  of  the  mis-expressed  retrotransposons.  Finer  sub-classification  of  repeat  probes  to 
distinguish between expression of functional and non-functional copies of a retrotransposon, for 
example  active  and inactive  LINE-1 elements,  may not  be accurate  due  to  the  short  length  of 
microarray probes: longer sequences are usually required to unambiguously identify a particular 
retrotransposon subfamily.  Furthermore,  none of the  LINE-1 probes present in the Illumina and 
Affymetrix arrays analysed here match the consensus monomer sequences  that distinguish active 
Tf,  Gf  and  A-type  LINE-1 elements.  Thus  microarray  repeat-annotation  may  not  be  able  to 
distinguish whether functional or non-functional genomic copies of a particular retrotransposon are 
deregulated,  but may be useful in identifying subpopulations  of genomic copies that include or 
exclude the misregulated retrotransposon sequence.
Regulation of Retrotransposon Expression in Mouse ES Cells and Germ Cells
We have used repeat-annotation of microarray data to investigate whether some of the established 
mechanisms for retrotransposon silencing have additional retrotransposon targets in mouse ES cells. 
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This analysis has demonstrated that there is a complex interplay between DNA methylation and 
histone modifications regulating the expression of the spectrum of repetitive elements in the mouse 
genome (Table 3). The LTR retrotransposons that we identified as being upregulated in Dnmt TKO 
ES cells  overlap well  with those identified  recently by RNA-seq of  Dnmt TKO ES cells  [22]. 
Interestingly, many repetitive elements that belong to the same ERVK LTR retrotransposon family 
as  IAP elements  were  not  upregulated  in  Dnmt  TKO  ES  cells  suggesting  that  related 
retrotransposons can  differ  in  their  sensitivity  to  DNA methylation.  Similarly,  our  finding that 
MMERVK10C, but not closely related  retrotransposons such as  IAP, are upregulated in  Tex19.1-/- 
testes suggests that closely related retrotransposons differ in sensitivity to regulatory mechanisms in 
developing germ cells as well as ES cells. The differential behaviour of  IAP and  MMERVK10C 
elements in  Tex19.1-/- testes could be caused by differences in the availability of transcriptional 
factors or by differences in silencing mechanisms associated with these elements. However as IAP 
LTRs  are  able  to  drive  expression  in  spermatogonia  [8,19],  which  are  present  in  the  16  dpp 
Tex19.1-/- testes analysed here, the differential  behaviour of  IAP and  MMERVK10C in  Tex19.1-/- 
testes may reflect differences in silencing mechanisms acting on these elements. DNA methylation 
plays an important role in silencing IAP elements in spermatogonia [19], and redundancy between 
silencing mechanisms may well be contributing to the differential behaviour of MMERVK10C and 
IAP elements  in  Tex19.1-/- testes.  Some  of  the  retrotransposon  targets  for  DNA  methylation, 
Tex19.1, and the other silencing mechanisms that we have studied, may be obscured by redundancy 
between silencing mechanisms, and each of the mechanisms that we have studied here may have a 
broader range of targets than we have been able to identify. 
Like  IAP elements,  the  RLTR45  ERVK LTR retrotransposon and the  MMERGLN and  RLTR1B 
ERV1 LTR retrotransposons are all upregulated in Dnmt TKO ES cells. The level of upregulation 
of IAP, MMERGLN, RLTR45 and RLTR1B retrotransposons in Dnmt TKO ES cells was relatively 
low, consistent with previous observations for IAP elements [21]. Additional mechanisms are likely 
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to play a role  in transcriptionally  repressing these retrotransposons in ES cells,  and Kap1/Eset-
mediated repression appears to be one of the silencing pathways that plays a prominent role in 
repression of these elements [this study,22,23]. At least for IAP elements, differentiated cells may 
rely more heavily on DNA methylation than Kap1/Eset for repression [21,23]. It will be interesting 
to test whether transcription of  MMERGLN,  RLTR1B and  RLTR45 repetitive elements is directly 
regulated by DNA methylation, and whether DNA methylation plays a dominant role in repressing 
these repetitive elements in differentiated cells.
MMERGLN and  RLTR45 elements behaved similarly to  IAP elements in  EsetshRNA ES cells.  Our 
finding that  MMERGLN,  RLTR45 and  MMERVK10C are all upregulated in  EsetshRNA ES cells  is 
consistent with these elements being enriched for H3K9Me3 in ES cells [22,25], and with recent 
RNA-seq and ChIP-seq data from  Eset-/- ES cells [22]. We also found that  MERVL-int elements 
were upregulated in EsetshRNA ES cells. These elements have also been reported to be upregulated in 
Kap1-/- ES cells [23]. ERVL retrotransposons are enriched for H3K27Me3 but not H3K9Me3 in ES 
cells [25], and the upregulation of MERVL-int (this study) and MTA [24] ERVL retrotransposons in 
EsetshRNA and Eset-/- ES cells may be an indirect effect of loss of Eset function. As ES cells lacking 
Eset differentiate towards the trophectoderm lineage [42], some of the changes in gene expression 
in EsetshRNA and Eset-/- ES cells may be an indirect consequence of this change in cell fate, or indeed 
any other change in gene expression. Indeed all of the microarray analyses of gene expression in ES 
cells that we have repeat-annotated are subject to the caveat that some changes in gene expression 
in these datasets may be consequences of differences in the proportion or type of differentiated cells 
present in the ES cell cultures. Further experiments will be required to determine why some ERVL 
retrotransposons are modestly upregulated in EsetshRNA and Eset-/- ES cells. 
Importantly  this  study  also  identifies  the  histone  deacetylase  Hdac1  as  a  regulator  of 
retrotransposon expression in mouse ES cells. The HDAC family of histone deacetylases has been 
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implicated  in  retrotransposon suppression in some cell  types  [28,44,45], and HDAC1 has  been 
shown to  suppress  expression  from avian  retroviral  LTRs  in  somatic  HeLa  cells  [29,30]. The 
microarray analysis that we present here extends these findings by identifying the retrotransposon 
elements that are regulated by Hdac1 in mouse ES cells. Interestingly, although RLTR45 and IAP 
elements behaved similarly in Dnmt TKO and EsetshRNA ES cells, these elements were misregulated 
in opposite directions in Hdac1-/- ES cells. Thus the silencing mechanisms operating on repetitive 
elements  appear  to  be modular,  with different  combinations  of  mechanisms acting on different 
elements (Table 3). Furthermore, these data suggest that the  Hdac1-mediated and Dnmt-mediated 
silencing mechanisms operating on these elements are being targeted independently to RLTR45 and 
IAP retrotransposons. The upregulation of RLTR45 elements in Hdac1-/- ES cells, together with the 
enrichment of RLTR45 sequences in Hdac1 ChIP-seq data from ES cells, suggests that an Hdac1-
containing repressor complex may be recruited to  RLTR45 loci and silence this element. Further 
analysis of Hdac1-binding and histone modification at RLTR45 elements is likely to generate more 
mechanistic insight into this silencing event. The downregulation of  IAP elements in  Hdac1-/- ES 
cells parallels the behaviour of some endogenous genes in these ES cells [43]. It will be informative 
to determine whether Hdac1 is acting directly  on  IAP elements  to promote their  transcriptional 
activation, or the increased activity of Hdac2 in Hdac1-/- ES cells is responsible for downregulation 
of IAP elements [43].  Interestingly,  LINE-1 elements did not appear to be upregulated in Hdac1-/- 
ES cells (Figure 5A), which contrasts with Hdac1's role in repressing  LINE-1 elements in neural 
stem cells [56]. Again, further experiments will be required to distinguish whether this difference 
reflects  different chromatin environments between pluripotent ES cells  and somatic neural stem 
cells, an effect of different Sox2-interacting partners in these cell types, or redundancy between 
multiple pathways operating to suppress LINE-1 activity in ES cells.
In summary we have shown that genome-wide silencing of repetitive elements can be monitored by 
extracting this information from microarray gene expression data, revealing a complex interplay 
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between mechanisms that act to control retrotransposon expression in mouse ES cells and germ 
cells,  and  important  differences  in  the  behaviour  of  different  genomic  copies  of  individual 
retrotransposons.  This  computational  approach has  expanded  our  knowledge  of  retrotransposon 
targets  for  known  silencing  mechanisms,  identified  Hdac1  as  a  regulator  of  retrotransposon 
expression in ES cells, and demonstrated that epigenetic silencing mechanisms are independently 




Animal work was conducted according to UK Home Office regulations and local guidelines for 
animal welfare. 
Animals
Mice were housed and bred according to UK Home Office regulations  and local guidelines for 
animal  welfare.  Tex19.1-/- mice  [39]  were  backcrossed  three  times  to  inbred  C57BL/6 mice  to 
reduce genetic variation prior to microarray analysis. Animals were culled at 16 days post partum 
(dpp)  by  cervical  dislocation  and  testes  from  Tex19.1-/- experimental  mice  and  Tex19.1+/+ and 
Tex19.1+/- control littermates and frozen on liquid nitrogen prior to RNA isolation.
ES cell culture
Ring1B-/- feeder-dependent ES cells [57] were cultured at 37°C, 5% CO2 on a mitomycin C-treated 
mouse embryonic  fibroblast  feeder  layer,  feeder-independent  Dnmt TKO and  Hdac1-/- ES cells 
[20,43]were cultured at 37°C, 5% CO2 on gelatinized tissue-culture flasks.  Ring1B-/- and  Hdac1-/- 
ES cells were cultured using DMEM (Invitrogen) supplemented with 15% fetal calf serum, 1 x non-
essential amino acids, 1 mM sodium pyruvate, 100 units/mL penicillin, 0.1 mg/mL streptomycin, 
50 μM β-mercaptethanol and leukemia inhibitory factor. Dnmt TKO ES cells were cultured using 
GMEM (Invitrogen) with 10% fetal calf serum rather than DMEM with 15% fetal calf serum. ES 
cells were harvested using trypsin-EDTA, then pelleted for RNA isolation.
RNA isolation and Illumina Beadarray Gene Expression Profiling
RNA was isolated from 16 dpp testis or ES cell pellets using TRIzol (Invitrogen) according to the 
manufacturer’s  instructions.  RNA was treated  with DNAseI (Roche)  for  2h at  37°C to remove 
genomic  DNA contamination.  For  Illumina  Beadarrays  of  16  dpp  testes,  cRNA samples  were 
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prepared using Illumina TotalPrep RNA Amplification Kit (Ambion) and hybridized to Illumina 
Mouse  WG-6 v2.0 Beadarrays according to the manufacturers’ protocols. The raw and processed 
Tex19.1  microarray  data  have  been  deposited  in  the  publicly  accessible  GEO  database  [38], 
accesssion number GSE30461.
qRT-PCR
cDNA synthesis was performed on DNaseI-treated RNA using random primers and Superscript III 
reverse  transcriptase  (Invitrogen)  according  to  the  manufacturer’s  instructions.  qRT-PCR  was 
performed  using  Brilliant  II/III  SYBR  Green  QPCR  Master  Mix  (Agilent  Technologies)  or 
Quantitect  SYBR Green detection kit (Qiagen) and a CFX96 Real-Time PCR Detection System 
(Bio-Rad). Relative changes in gene expression were calculated by  normalising gene expression 
levels from different samples to β-Actin or  Gapdh as indicated. Expression levels in experimental 
samples are expressed relative to wild type ES cells or littermate controls. Three technical replicates 
were performed for each biological sample, and cDNA prepared from each RNA sample in the 
absence of reverse transcriptase showed no significant qRT-PCR signals. For qRT-PCR of 16 dpp 
testes,  the  Sertoli  cell-expressed  Sdmg1 gene  [58] was used  to  verify  normalization  between 
animals.  A  two-tailed  t-test  was  used  to  determine  statistical  significance  of  qRT-PCR  gene 
expression changes. The sequences of the primers used for qRT-PCR are available with the online 
version of this paper (Supporting Figure S7).
Repeat Annotation of Illumina Probes
The  DNA  sequence  of  the  50-mer  probes  used  in  Illumina  Mouse  WG-6  Beadchips  were 
downloaded from the manufacturers website [59]. For each Beadchip version the probe sequences 
were used to search the mm9 release of the mouse genome by individual chromosome using BLAT 
[60]. The BLAT parameters used were -minIdentity=95 -stepSize=5 -repMatch=2253. Experimental 
data  suggests  that  the  50  nt  Illumina  Beadchip  probes  will  hybridize  to  mRNAs containing  2 
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mismatches in the probe sequence with an efficiency of greater than 90% [61]. A Perl script was 
used to compare the genome co-ordinates of the top hit (with a 48/50 nt identity minimum cut-off)  
for each probe sequence with the co-ordinates of the Repeatmasked regions of the mm9 release of 
the mouse genome downloaded from the UCSC genome browser [62]. Probes that overlapped a 
Repeatmasked region by at least 48 nt, and were in the appropriate orientation to recognize sense 
transcripts  were  selected  and  annotated  with  the  Repeatmasker  class,  family  and  element 
corresponding to  that  genomic region. Tables  containing  the repetitive element  probes for each 
Illumina  Beadchip  were  imported  into  R  [63] and  used  to  annotate  Illumina  Beadchip  gene 
expression  data.  These  annotation  tables  are  available  with  the  online  version  of  this  paper 
(Supporting Dataset S2-S4). 
Pre-processing of Illumina Beadchip Gene Expression Data
Illumina Beadchip gene expression data for  Eset shRNA knock-down ES cells were downloaded 
from the NCBI GEO repository [38], accession number GSE17439 [42]. All analysis of Illumina 
Mouse Whole Genome WG-6 Beadchip microarrays was performed on probe-level data. Probe-
level expression data were background-subtracted in Illumina Beadstudio, then imported into the 
lumi Bioconductor package [64] in R. The data were then log-transformed, and quantile-normalized 
in lumi. The expression data and present/absent calls were exported from lumi and any probes that 
were called as absent in all samples in the experiment were removed from the dataset. 
Repeat Annotation of Affymetrix Probes
These Affymetrix Murine Genome U74Av2 and Mouse Expression 430 2.0 GeneChips contain 
~12,000 and ~45,000 probesets  respectively,  with each probeset  containing  ~11 different  25 nt 
probes targeting a specific transcript. The DNA sequence of the 25-mer probes used in Affymetrix 
Mouse Gene Expresson Arrays were downloaded from the manufacturer's website [65]. For each 
version of these arrays the probe sequences were used to BLAT search  the mm9 release of the 
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mouse genome by individual  chromosome.  The BLAT search parameters were -minIdentity=95 
-tileSize=11 -stepSize=5 -repMatch=110. The genome co-ordinates of the top hit (with a 24/25 nt 
identity  minimum  cut-off)  for  each  probe  sequence  were  compared  to  the  co-ordinates  of  the 
Repeatmasked  regions  of  the  mm9 release  of  mouse  genome  using  a  Perl script.  Probes  that 
overlapped a Repeatmasked region by at  least  24 nt, and were in the appropriate  orientation to 
recognize sense transcripts, were selected and annotated with the Repeatmasker class, family, and 
element corresponding to that genomic region. Tables containing the repetitive element probes for 
each Affymetrix array platform were imported into R. These annotation tables are available with the 
online version of this paper (Supporting Dataset S5, S6).
Pre-processing of Affymetrix Microarray Gene Expression Data
Affymetrix Mouse Gene Expression data for  Ring1B-/-,  Eed-/-,  Ring1B-/- Eed-/-,  Hdac1-/- and Dnmt 
TKO  ES  cells  were  downloaded  from  the  NCBI  GEO  repository  [38], accession  numbers 
GSE19076 [26], GSE20177 [41] and GSE5583 [43]. Raw Affymetrix data were imported into the 
affy Bioconductor package [66] in R. Probe expression values were background-corrected using the 
robust multi-array average algorithm [67] in  affy. Expression values for the perfect match probes 
were extracted from affy, log-transformed, then quantile-normalized. Summation across probesets 
was not performed so that the Affymetrix data could be analysed at the probe level. Probes that 
were expressed at more than the sample median level in at least half the arrays for one experimental  
condition in a dataset were considered to be present [68]. Absent probes were removed from the 
dataset to simplify the analysis. Some probe sequences in the Affymetrix Gene Expression platform 
are present in more than one probeset, and these redundant probes are present at multiple locations 
in the array. Therefore some 25-mer DNA sequences are represented by more than one probe in the 
Affymetrix datasets. 
Identification of Differentially Expressed Probes in Illumina and Affymetrix Microarray Data
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For  both  Illumina  and  Affymetrix  data,  the  R  Bioconductor  package  limma [69]  was used  to 
identify probes that were expressed at different levels in experimental and control conditions by 
linear  modeling.  The  Benjamini-Hochberg  method  was  used  to  correct  for  multiple  testing  in 
limma,  and  adjusted  p-values  of  ≤0.01  were  considered  to  be  statistically  significant.  Tables 
corresponding  to  all  expressed  probes  in  the  experiment,  and  probes  that  statistically  changed 
during the experiment, were repeat-annotated in R using the tables generated in sections 2.5 and 
2.7. The resulting data were graphed using R. MA-plots show the log fold change in expression of 
each probe, plotted against the average expression of that probe in the dataset. Probability density 
functions for the microarray data were generated by kernel density estimation in R.
Phylogenetic Analysis 
Close relatives of  MMERVK10C were found by using  MMERVK10C as a template for Genewise 
[70] to predict  pol and  pro sequences in the Repbase database of repetitive DNA sequences [3]. 
Multiple  protein  alignment  was  performed  using  ClustalW  [71],  and phylogenetic  trees  were 
constructed  using MEGA4 [72]  to  apply  the  neighbour-joining  method  [73]. Phylogenies  were 
based on the proportion of amino acid sites at which sequences are different, with pairwise deletion 
to remove gaps in alignments as the need arises. The reliability of each interior branch of a given 
topology was assessed using the bootstrap interior branch test with 1000 bootstraps. 
Assembly of Repeatmasker Genomic Hits into Contigs 
The co-ordinates  of the Repeatmasked regions of the mm9 release of the mouse genome were 
downloaded from the UCSC genome browser [62], and regions Repeatmasked for MMERVK10C-
int or IAP-int were extracted. The hits were ordered by their co-ordinates and adjacent hits that were 
in the same orientation on the same chromosome, were collinear on the consensus sequence, and 
were separated by less than the length of the consensus sequence were assembled into the same 
contig.  IAP-int contigs that had  IAP LTRs located within 50 bp of both ends of the contig were 
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identified  for  further  analysis.  A  similar  approach  was  used  to  identify  RLTR10-flanked 
MMERVK10C contigs, with RLTR10 genomic loci greater than 250 bp included in the assembly.
LTR Retrotransposon Enrichment in ChIP-seq Data
Hdac1 ES cell ChIP-seq and control ES cell whole cell extract datasets were downloaded from the 
GEO repository (accession number GSE27844). LTR retrotransposon enrichment was calculated 
using  the  Repeat  Enrichment  Estimator  web application  [25],  and data  for  either  all  IAP LTR 
sequences, or all RLTR45 LTR sequences, were combined.
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Figure Legends
Figure 1. Genome-Wide Repetitive Element Expression in Tex19.1-/- Testes
(A-C) MA-plots showing the mean expression level for each expressed probe in the Tex19.1 testis 
Illumina  Beadarray  data  plotted  against  the fold upregulation  of  that  probe in  Tex19.1-/- testes. 
Probes for repeat families (A), classes of LTR retrotransposons (B), and the MMERVK10C element 
(C) are colour-coded in each plot according to the legend. Note the group of six  MMERVK10C 
ERVK LTR retrotransposon probes upregulated in Tex19.1-/- testes. (D) Plot showing the behaviour 
of the entire  MMERVK10C probe population in  Tex19.1-/- testes. Vertical  lines indicate a 2 fold 
change.  (E)  qRT-PCR verification  of  MMERVK10C upregulation  in  C57BL/6  Tex19.1-/- testes. 
Expression  levels  for  each  repetitive  element  (mean  ±  standard  error  for  three  animals)  were 
normalized  to  β-Actin and  expressed  relative  to  littermate  controls.  Representative  LTR 
retrotransposons  belonging  to  ERV1,  ERVK  and  ERVL  classes  do  not  change  expression  in 
Tex19.1-/- testes.  Sdmg1 is  a  single-copy  control  gene  for  Sertoli  cell  expression  to  verify 
normalization between animals.  MMERVK10C env.c and LINE1 ORF2 primer sets (Supporting 
Figure  S7)  were  used  to  assess  MMERVK10C and  LINE-1 expression.  Asterisk  indicates  a 
statistically significant difference (p<0.05).
Figure 2. Closely Related Retrotransposons are Differentially Sensitive to Loss of Tex19.1
(A)  Phylogeny  of  mouse  retrotransposon pol and pro proteins.  MMERVK10C sequences  are 
highlighted  in  red.  The  MMERVK10C sequences  lie within  a  cluster  of  IAP-type  sequences 
(yellow).  (B)  Plot  showing  the  likelihood  of  IAP probes  changing  expression  in  the  Tex19.1-/- 
microarray dataset. (C) qRT-PCR for retrotransposons closely related to MMERVK10C in Tex19.1-/- 
knockout and littermate  control  testes  at  16 dpp.  Expression  levels  for  each  repetitive  element 
(mean ± standard error for three animals) were normalized to  β-Actin and expressed relative to 
littermate controls. MMERVK10C env.c and IAP primer sets (Supporting Figure S7) were used to 
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assess MMERVK10C and IAPEz expression. Asterisk indicates a statistically significant difference 
(p<0.05).
Figure 3. Different Transcriptional Silencing Mechanisms Have Distinct Effects on Genome-
Wide Repression of Repetitive Elements
(A, B) MA-plots for Dnmt1-/- Dnmt3A-/- Dnmt3B-/- triple knockout (Dnmt TKO) ES cell Affymetrix 
Gene Expression data. The mean expression level for each expressed probe is plotted against the 
fold upregulation of that probe in Dnmt TKO ES cells. Probes for repeat families (A), and classes of 
LTR retrotransposons (B) are colour-coded in each plot according to the legend. A group of ERV1 
and  ERVK  LTR  retrotransposons  can  be  seen  to  be  upregulated  relative  to  the  total  probe 
population in the Dnmt TKO ES cells. (C, D) MA-plots for EsetshRNA ES cell Illumina Beadchip data 
with  probes  for  repeat  families  (C),  and  classes  of  LTR  retrotransposons  (D)  colour-coded 
according  to  the  legend.  Probes  for  different  ERV1,  ERVK  and  ERVL  LTR  retrotransposon 
families  are  strongly  upregulated,  and  multiple  LINE-1 probes  are  modestly  upregulated,  in 
EsetshRNA ES cells.  (E,  F) MA-plots for  Hdac1-/- ES cell  Affymetrix Gene Expression data  with 
probes for repeat families (E), and classes of LTR retrotransposons (F) colour-coded according to 
the legend. One group of ERVK LTR retrotransposon probes is upregulated in  Hdac1-/- ES cells, 
another group is downregulated.
Figure 4. Genome-Wide Retrotransposon Targets of Transcriptional Repression Mechanisms 
in Mouse ES Cells
(A, C, E) Histograms showing repeat probes that change expression at least 2 fold (p<0.01) in Dnmt 
TKO,  EsetshRNA, and  Hdac1-/- ES cells respectively. (B, D, F) Plots showing the behaviour of the 
selected  retrotransposon  probe  populations  in  Dnmt  TKO,  EsetshRNA,  and  Hdac1-/- ES  cells 
respectively. Retrotransposons are colour-coded according to the legend. Vertical lines indicate the 
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2 fold change cut-off used in panels A, C and E. Note the divergent behaviour of IAP and RLTR45 
retrotransposons in Hdac1-/- ES cells in contrast to Dnmt TKO and EsetshRNA ES cells.
Figure 5. Hdac1 Regulates Expression of LTR Retrotransposons in Mouse ES Cells
(A) qRT-PCR verification of LINE-1, RLTR45 and IAP expression in Hdac1-/- ES cells. Expression 
levels  (mean  ±  standard  error  for  three  biological  replicates)  were  normalized  to  β-Actin and 
expressed relative to control ES cells.  IAP and LINE1 5'UTR primer sets (Supplementary Figure 
S7) were used to assess  IAP and  LINE-1 expression. Asterisks indicate a statistically significant 
difference (p<0.05) for  RLTR45 and  IAP elements.  RLTR45 expression is upregulated in  Hdac1-/- 
ES cells, but IAP expression is downregulated. (B) Enrichment of LTR retrotransposon sequences 
in Hdac1 ChIP-seq data  from mouse ES cells.  The maximum likelihood of enrichment  (± 95% 
confidence intervals) for RLTR45 LTR and IAP LTR sequences Hdac1 ChIP-seq relative to whole 
cell extract is shown.  RLTR45 LTR sequences are enriched in the Hdac1 ChIP-seq indicating a 
physical association between Hdac1 and RLTR45 retrotransposon chromatin, in contrast  IAP LTR 
sequences are depleted.
Figure 6. LTR Retrotransposon Targets of Polycomb Repressive Complexes in ES Cells
(A, C, E) MA-plots for Ring1B-/- Eed-/- double knockout, Ring1B-/- single knockout and Eed-/- single 
knockout ES cells showing how different classes of LTR retrotransposons change expression in 
these cell lines. (B, D, F) Plots showing the behaviour of selected retrotransposon probe populations 
in Ring1B-/- Eed-/- double knockout,  Ring1B-/- single knockout and Eed-/- single knockout ES cells. 
The  selected  retrotransposons  are  all  represented  by  multiple  upregulated  probes  (≥4  fold 
upregulation, p<0.01) in Ring1B-/- Eed-/- ES cells. Vertical lines indicate a 4 fold change. Note that 
some retrotransposons (e.g. MMVL30, RLTR45) are upregulated in double knockout but not single 
knockout ES cells, other retrotransposons (e.g. RLTR44) are upregulated in all three ES cell lines. 
Retrotransposon probes are colour-coded as shown in the plot legends.
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Figure 7. Differential Regulation of Retrotransposon Genomic Loci
(A) Plot showing the differential behaviour of different RLTR4 retrotransposon probe populations in 
Ring1B-/- single knockout ES cells. Different RLTR4 probe populations are colour-coded as shown 
in the legend, and vertical lines indicate a 4 fold change. (B)  qRT-PCR verification of repetitive 
element  expression  in  Ring1B-/- ES  cells.  Expression  levels  (mean  ±  standard  error)  were 
normalized to  β-Actin and expressed relative to wild-type control ES cells. MMERVK10C env.c 
and LINE1 5'UTR primer sets (Supplementary Figure S7) were used to assess MMERVK10C and 
LINE-1 expression.The asterisk indicates a statistically significant difference (p<0.05). Note that 
different primers for RLTR4 elements behave differently in the qRT-PCR assay. (C) qRT-PCR for 
different  MMERVK10C primer sets in  Tex19.1-/- knockout and littermate control testes at 16 dpp. 
Expression  levels  (mean  ±  standard  error  for  three  animals)  were  normalized  to  β-Actin and 
expressed  relative  to  littermate  controls.  Asterisks  indicate  statistically  significant  differences 
(p<0.05) (D) Plot showing the  MMERVK10C genomic contigs flanked by  RLTR10C LTRs that 
match  only  upregulated  probes  (blue),  only  unaffected  probes  (brown),  neither  class  of  probes 
(grey),  or  both  classes  of  probe  (green)  in  Tex19.1-/- testes.  Each  contig  is  represented  by  a 
horizontal line that indicates the regions of the MMERVK10C sequence within it. The upregulated 
MMERVK10C contigs  appear  to  contain  recurrent  deletions  and  may  be  non-autonomous.  The 
positions of the qRT-PCR primers used in (C) are shaded orange. (E) Plot showing the bimodal 
behaviour  of  IAP-int retrotransposon  probe  populations  in  Dnmt  TKO ES cells.  Vertical  lines 
indicate a 4 fold change. (F) qRT-PCR for of repetitive elements in Dnmt TKO ES cells. Expression 
levels  (mean  ±  standard  error)  were  normalized  to  Gapdh and  expressed  relative  to  wild-type 
control ES cells. The asterisk indicates a statistically significant difference (p<0.05). The  LINE1 
5'UTR.b primer set (Supplementary Figure S7) was used to assess  LINE-1 expression. Note the 
difference in behaviour between the two IAP-int primer sets. The IAP contig carrying deletions in 
the AP-1 binding site shown in panel G (IAP_chr10 primers) is expressed but not upregulated in 
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Dnmt TKO ES cells. (G) Sequence alignment between an LTR of a full-length  IAP element that 
does not change expression in Dnmt TKO ES cells (IAP_chr10), and the consensus sequence for the 




Supporting Figure S1 – repeat_organization.pdf
pdf showing a schematic diagram of Repeatmasker organization of murine repetitive elements into 
classes and families
Supporting Dataset S2– Ms6V1_repprobes.txt
Tab-delimited text file containing complementary repeat probes in Illumina Mouse 6V1 Beadchips
Supporting Dataset S3 - Ms6V1_1_repprobes.txt
Tab-delimited  text  file  containing  complementary  repeat  probes  in  Illumina  Mouse  6V1.1 
Beadchips
Supporting Dataset S4 - Ms6V2_repprobes.txt
Tab-delimited text file containing complementary repeat probes in Illumina Mouse 6V2 Beadchips
Supporting Dataset S5 - MG_U74Av2_repprobes.txt
Tab-delimited  text  file  containing  complementary  repeat  probes  in  Affymetrix  Murine  Genome 
U74Av2 GeneChips
Supporting Dataset S6 - Mouse430_2_repprobes.txt
Tab-delimited  text  file  containing  complementary  repeat  probes  in  Affymetrix  Mouse430  2.0 
GeneChips
Supporting Figure S7- primer_sequences.pdf




WG6 v1.0 WG6 v1.1 WG6 v2.0 U74Av2 430 2.0
All probes 46,005 46,632 45,281 197,993 496,468
Probes matching repetitive elements 
(non-complementary)
899 912 867 2,636 19,870
Probes  matching  repetitive  elements 
(complementary)
1,397 1,425 1,438 4,239 26,124
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Table 2. Number of Different Repetitive Elements Represented by Complementary Probes in 
Mouse  Gene  Expression  Microarray  Platforms.  Mouse  genome  data  is  derived  from 
Repeatmasker annotation of the mm9 assembly of the sequenced genome downloaded from the 
UCSC genome browser [62]. 
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ES cells Testes








MMERGLN   - - - -
RLTR1B  - - - - -
RLTR4 - - - ( ) ( ) -





IAP    - ( ) -
RLTR44 - - -   -
RLTR45    -  -
MMERVK10C -*  - - - 









LINE-1 -  - - - -
Table 3.  Summary of  Changes in  Repetitive  Element  Expression Detected by Microarray 
Repeat-Annotation in  this  Study. Statistically  significant  upregulation  and  downregulation  of 
repetitive element expression in mutant ES cell lines or testes is indicated by up and down arrows 
respectively. Changes that only appear to affect a small number of probes for a repetitive element 
are indicated in brackets. The degree of change in gene expression detected for these elements is 
detailed  in the main  text.  *Although changes  in  MMERVK10C expression were not detected  in 
Dnmt TKO ES cell microrray data in this study, RNA-seq analysis suggests that some genomic 
copies of MMERVK10C are upregulated in Dnmt TKO ES cells [22].
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